	NGenes	Direction	PValue	FDR
NIKOLSKY_BREAST_CANCER_20Q11_AMPLICON	41	Down	7.34581010579188e-10	3.47016069397608e-06
AIGNER_ZEB1_TARGETS	34	Up	3.58985624151337e-07	0.000585431358546626
CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_CDC25_UP	71	Down	3.71781133708695e-07	0.000585431358546626
CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_UP	167	Down	7.26257296679915e-07	0.000857709867378979
WHITFIELD_CELL_CYCLE_LITERATURE	50	Down	3.12541229262727e-06	0.00295288953407424
NIKOLSKY_BREAST_CANCER_1Q21_AMPLICON	38	Down	6.93942193489398e-06	0.00546363820340653
CROONQUIST_NRAS_SIGNALING_DN	89	Down	1.41088794840754e-05	0.00854773399458205
TANG_SENESCENCE_TP53_TARGETS_DN	62	Down	1.44754174336699e-05	0.00854773399458205
LY_AGING_MIDDLE_DN	24	Down	1.88217858871826e-05	0.00965751362624481
ISHIDA_E2F_TARGETS	61	Down	2.04764812120099e-05	0.00965751362624481
SA_TRKA_RECEPTOR	24	Down	2.24878598409596e-05	0.00965751362624481
REACTOME_CHOLESTEROL_BIOSYNTHESIS	24	Down	2.91586919008794e-05	0.0114788050449795
SCHMIDT_POR_TARGETS_IN_LIMB_BUD_UP	30	Down	3.21004155800242e-05	0.0116647971692334
BIOCARTA_TRKA_PATHWAY	20	Down	3.73439453326112e-05	0.0126009141250897
MORI_LARGE_PRE_BII_LYMPHOCYTE_UP	123	Down	4.68569988943052e-05	0.0147568308517799
CROONQUIST_IL6_DEPRIVATION_DN	124	Down	7.01812376472098e-05	0.01989835053153
KAMMINGA_EZH2_TARGETS	52	Down	7.85655664245681e-05	0.01989835053153
ROLEF_GLIS3_TARGETS	21	Up	7.87764390080607e-05	0.01989835053153
WENG_POR_TARGETS_GLOBAL_UP	20	Down	8.00314691149598e-05	0.01989835053153
NIKOLSKY_BREAST_CANCER_19P13_AMPLICON	7	Down	9.84092622758769e-05	0.0232442677495621
BIOCARTA_VIP_PATHWAY	33	Down	0.000142973158912098	0.0315909170675916
CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_UP	178	Down	0.000147121120975236	0.0315909170675916
BIOCARTA_NOS1_PATHWAY	22	Down	0.000170058916911844	0.0349286227605022
AMUNDSON_GAMMA_RADIATION_RESPONSE	52	Down	0.000192038334727092	0.0372901774671768
PLASARI_TGFB1_SIGNALING_VIA_NFIC_10HR_UP	92	Up	0.000197344292269141	0.0372901774671768
BIOCARTA_GPCR_PATHWAY	52	Down	0.000221573564311624	0.0397517769009021
ZHAN_MULTIPLE_MYELOMA_PR_UP	48	Down	0.000227201095750287	0.0397517769009021
MARKEY_RB1_ACUTE_LOF_DN	281	Down	0.00025105460488758	0.0411886141355368
BURTON_ADIPOGENESIS_PEAK_AT_24HR	47	Down	0.000261181270017591	0.0411886141355368
KOBAYASHI_EGFR_SIGNALING_24HR_DN	329	Down	0.000261570369192655	0.0411886141355368
KIM_BIPOLAR_DISORDER_OLIGODENDROCYTE_DENSITY_CORR_DN	75	Up	0.000289701020331716	0.0441466974208718
KUMAMOTO_RESPONSE_TO_NUTLIN_3A_DN	15	Down	0.000309518283549342	0.0446724664343081
TAKAYAMA_BOUND_BY_AR	17	Up	0.000314029589531582	0.0446724664343081
VIETOR_IFRD1_TARGETS	27	Down	0.000324266274728244	0.0446724664343081
BIOCARTA_SRCRPTP_PATHWAY	17	Down	0.00033097720685876	0.0446724664343081
WIEMANN_TELOMERE_SHORTENING_AND_CHRONIC_LIVER_DAMAGE_DN	6	Down	0.000355486886014668	0.0466477791537025
HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_UP	225	Down	0.000391273049731851	0.0499560509981963
XU_RESPONSE_TO_TRETINOIN_DN	21	Down	0.000416826106979652	0.0518180665624178
KORKOLA_YOLK_SAC_TUMOR	83	Up	0.000432051744519912	0.0521343006390856
REACTOME_COPI_MEDIATED_TRANSPORT	14	Up	0.000441442003717914	0.0521343006390856
BIOCARTA_MEF2D_PATHWAY	21	Down	0.000473930795217123	0.0543408431485959
YU_MYC_TARGETS_UP	50	Down	0.00048313196702816	0.0543408431485959
EGUCHI_CELL_CYCLE_RB1_TARGETS	24	Down	0.00052872879906773	0.0580863917859525
BIOCARTA_ACH_PATHWAY	16	Down	0.000615406803634813	0.0660723122811558
WEST_ADRENOCORTICAL_CARCINOMA_VS_ADENOMA_DN	18	Down	0.000678528382772852	0.0704224687677241
MONTERO_THYROID_CANCER_POOR_SURVIVAL_UP	14	Down	0.000706473737650824	0.0704224687677241
REACTOME_IRON_UPTAKE_AND_TRANSPORT	35	Up	0.000706947360392059	0.0704224687677241
BIOCARTA_FMLP_PATHWAY	46	Down	0.000715554297385851	0.0704224687677241
BIOCARTA_TCR_PATHWAY	59	Down	0.000734597021842323	0.0708211496159823
ONDER_CDH1_SIGNALING_VIA_CTNNB1	145	Up	0.000768676801460818	0.0720705382986912
ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER	169	Down	0.000781221723960374	0.0720705382986912
SCIAN_CELL_CYCLE_TARGETS_OF_TP53_AND_TP73_DN	28	Down	0.0008072392178631	0.0720705382986912
CHANG_CYCLING_GENES	201	Down	0.000808581399202081	0.0720705382986912
LIU_CDX2_TARGETS_DN	7	Up	0.000852504109868186	0.0733548835397188
MORI_PRE_BI_LYMPHOCYTE_UP	112	Down	0.000856855692831063	0.0733548835397188
ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_24HR	158	Down	0.000872140577121835	0.0733548835397188
SANCHEZ_MDM2_TARGETS	22	Down	0.00088510337886621	0.0733548835397188
MORI_IMMATURE_B_LYMPHOCYTE_DN	134	Down	0.000936320123922639	0.0754809774435744
VERRECCHIA_RESPONSE_TO_TGFB1_C6	15	Up	0.000945092932017947	0.0754809774435744
MORI_PLASMA_CELL_UP	55	Up	0.000958691500130073	0.0754809774435744
FERRARI_RESPONSE_TO_FENRETINIDE_UP	33	Up	0.00102309437538023	0.0792311119556758
GAUSSMANN_MLL_AF4_FUSION_TARGETS_A_DN	150	Up	0.00106421339756985	0.0798040718867702
ODONNELL_TARGETS_OF_MYC_AND_TFRC_DN	54	Down	0.0011082496118894	0.0798040718867702
BIOCARTA_STATHMIN_PATHWAY	19	Down	0.00111029834144931	0.0798040718867702
PID_PI3K_PLC_TRK_PATHWAY	52	Down	0.00111295676235402	0.0798040718867702
BURTON_ADIPOGENESIS_3	135	Down	0.00112091600601111	0.0798040718867702
WHITEFORD_PEDIATRIC_CANCER_MARKERS	172	Down	0.00113185284005368	0.0798040718867702
KEGG_APOPTOSIS	82	Down	0.00118819497674169	0.0825446039724667
BIOCARTA_AGPCR_PATHWAY	20	Down	0.00125357801796687	0.082988699666606
REICHERT_MITOSIS_LIN9_TARGETS	34	Down	0.00125647024614968	0.082988699666606
SHEPARD_BMYB_TARGETS	85	Down	0.00126724293042047	0.082988699666606
BIOCARTA_BAD_PATHWAY	35	Down	0.00126752988196864	0.082988699666606
BIOCARTA_CREB_PATHWAY	44	Down	0.00128242486783705	0.082988699666606
MARKEY_RB1_CHRONIC_LOF_UP	156	Down	0.00139072563658595	0.088780917665298
MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_DN	33	Up	0.00143207977906209	0.0902019316838577
BIOCARTA_RACCYCD_PATHWAY	44	Down	0.00147771513438004	0.0918516617738328
MIKKELSEN_NPC_HCP_WITH_H3K27ME3	251	Up	0.00164327584773382	0.100816040320709
BIOCARTA_GCR_PATHWAY	28	Down	0.00166664157105943	0.10093865104724
ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_6HR	107	Down	0.00172367201637593	0.103071222852657
BIOCARTA_CALCINEURIN_PATHWAY	20	Down	0.0017577868392442	0.10379731285737
HAN_JNK_SINGALING_DN	53	Up	0.00185525139863825	0.108200093915643
MAINA_HYPOXIA_VHL_TARGETS_UP	5	Up	0.0019566466684726	0.112721937339812
PID_RAS_PATHWAY	33	Down	0.00204269042247848	0.116261078985401
CUI_TCF21_TARGETS_UP	60	Up	0.00209969325675294	0.118082749344058
FERRANDO_HOX11_NEIGHBORS	26	Down	0.00213102762255625	0.118434993987714
MALIK_REPRESSED_BY_ESTROGEN	10	Up	0.0022962519867495	0.124963359010118
BURTON_ADIPOGENESIS_7	73	Down	0.00230139971081292	0.124963359010118
ASTON_MAJOR_DEPRESSIVE_DISORDER_UP	59	Down	0.00237198655344402	0.126494779146053
KEGG_VIBRIO_CHOLERAE_INFECTION	59	Up	0.00238315735478382	0.126494779146053
ALONSO_METASTASIS_EMT_DN	11	Up	0.0024590750859971	0.129074118958337
ST_DIFFERENTIATION_PATHWAY_IN_PC12_CELLS	58	Down	0.00251132168884816	0.130367952287019
BIOCARTA_SPPA_PATHWAY	33	Down	0.00257187073857519	0.131305071559256
KEGG_TERPENOID_BACKBONE_BIOSYNTHESIS	14	Down	0.00260034584559872	0.131305071559256
GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP	707	Down	0.00261275967962957	0.131305071559256
LE_NEURONAL_DIFFERENTIATION_DN	23	Down	0.00272910566400883	0.134467815012638
KEGG_PHENYLALANINE_METABOLISM	18	Up	0.00273521199569585	0.134467815012638
HALMOS_CEBPA_TARGETS_UP	72	Up	0.00276108764949744	0.134467815012638
BIOCARTA_CACAM_PATHWAY	14	Down	0.00284475187105642	0.137128651417046
BIOCARTA_CARM1_PATHWAY	17	Down	0.00298518683922579	0.142066962503818
MISSIAGLIA_REGULATED_BY_METHYLATION_DN	153	Down	0.00300734467620274	0.142066962503818
REN_BOUND_BY_E2F	74	Down	0.00307120538190519	0.143647269545744
NIELSEN_GIST_AND_SYNOVIAL_SARCOMA_UP	36	Up	0.0031709215804058	0.146429749313907
KOINUMA_COLON_CANCER_MSI_UP	17	Down	0.0032657191729744	0.146429749313907
MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_3	5	Down	0.00327018207011917	0.146429749313907
ODONNELL_TFRC_TARGETS_DN	146	Down	0.00328292695026235	0.146429749313907
BIOCARTA_HCMV_PATHWAY	25	Down	0.00330625812947408	0.146429749313907
PUJANA_BREAST_CANCER_WITH_BRCA1_MUTATED_UP	70	Down	0.00331667721773667	0.146429749313907
FARMER_BREAST_CANCER_CLUSTER_2	36	Down	0.00342839712085098	0.146982756778187
MILICIC_FAMILIAL_ADENOMATOUS_POLYPOSIS_UP	7	Up	0.0034514284475245	0.146982756778187
MARKEY_RB1_CHRONIC_LOF_DN	130	Up	0.00345432376661889	0.146982756778187
REACTOME_TRANSFERRIN_ENDOCYTOSIS_AND_RECYCLING	23	Up	0.00349092692248002	0.146982756778187
LEE_EARLY_T_LYMPHOCYTE_UP	134	Down	0.00351405372184947	0.146982756778187
BIOCARTA_IGF1R_PATHWAY	41	Down	0.00351588728110397	0.146982756778187
KONG_E2F3_TARGETS	113	Down	0.00360290655861285	0.149299391077957
REACTOME_G0_AND_EARLY_G1	28	Down	0.00373171127621982	0.153292209294456
KEGG_NATURAL_KILLER_CELL_MEDIATED_CYTOTOXICITY	96	Down	0.00380034303313863	0.154765693866783
REACTOME_TRANSPORT_OF_GLUCOSE_AND_OTHER_SUGARS_BILE_SALTS_AND_ORGANIC_ACIDS_METAL_IONS_AND_AMINE_COMPOUNDS	45	Up	0.00387363283306443	0.156402064131593
PID_VEGFR1_PATHWAY	40	Down	0.00397800305849284	0.159254969901018
BIOCARTA_HDAC_PATHWAY	34	Down	0.00406496433102216	0.159257491260455
GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_DN	99	Down	0.00407813506928551	0.159257491260455
KEGG_VEGF_SIGNALING_PATHWAY	67	Down	0.00407920331128599	0.159257491260455
GREENBAUM_E2A_TARGETS_UP	54	Down	0.00415537818772645	0.160471725122352
PID_PRL_SIGNALING_EVENTS_PATHWAY	33	Down	0.00425943569265432	0.160471725122352
PEART_HDAC_PROLIFERATION_CLUSTER_DN	105	Down	0.00427989539148906	0.160471725122352
DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP	392	Down	0.00429683091110679	0.160471725122352
KENNY_CTNNB1_TARGETS_UP	62	Down	0.00430985427905956	0.160471725122352
DELACROIX_RAR_TARGETS_DN	33	Down	0.00433801769042844	0.160471725122352
SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX4_UP	14	Down	0.00434809077384865	0.160471725122352
HORIUCHI_WTAP_TARGETS_DN	449	Down	0.00449142200855514	0.16336831557259
REACTOME_MITOTIC_G2_G2_M_PHASES	115	Down	0.00453156521657639	0.16336831557259
BIOCARTA_ETS_PATHWAY	28	Down	0.00454610264591973	0.16336831557259
BIOCARTA_FCER1_PATHWAY	50	Down	0.00459608056670746	0.16336831557259
BIOCARTA_NGF_PATHWAY	30	Down	0.00459948898627318	0.16336831557259
KEGG_CHRONIC_MYELOID_LEUKEMIA	82	Down	0.00466869004091542	0.164588744427496
XU_HGF_SIGNALING_NOT_VIA_AKT1_6HR	44	Down	0.00477076085003774	0.166941290782061
BIOCARTA_ERK5_PATHWAY	27	Down	0.00481846063623811	0.167319892681497
PAL_PRMT5_TARGETS_UP	312	Down	0.00485241856421785	0.167319892681497
SA_REG_CASCADE_OF_CYCLIN_EXPR	14	Down	0.00490821293397283	0.168017376087592
SONG_TARGETS_OF_IE86_CMV_PROTEIN	71	Down	0.00501539762139567	0.1704513551329
MIKKELSEN_PARTIALLY_REPROGRAMMED_TO_PLURIPOTENCY	10	Down	0.00526734095728387	0.17773513344435
SIG_BCR_SIGNALING_PATHWAY	51	Down	0.0053468571930031	0.179138676452104
REACTOME_RECYCLING_OF_BILE_ACIDS_AND_SALTS	10	Up	0.00542999139457167	0.180642812309553
GAUSSMANN_MLL_AF4_FUSION_TARGETS_C_DN	24	Up	0.0054727226742979	0.180791202191492
REACTOME_MITOTIC_PROMETAPHASE	98	Down	0.00552499159738617	0.18125041879203
PHONG_TNF_TARGETS_DN	8	Up	0.00564870209850912	0.183092816967692
ZIRN_TRETINOIN_RESPONSE_UP	23	Up	0.00565866877165179	0.183092816967692
NIKOLSKY_BREAST_CANCER_17Q11_Q21_AMPLICON	138	Up	0.00576914058134901	0.185397415689066
OSADA_ASCL1_TARGETS_UP	47	Up	0.00588610485688926	0.187878103675303
REACTOME_LATENT_INFECTION_OF_HOMO_SAPIENS_WITH_MYCOBACTERIUM_TUBERCULOSIS	24	Up	0.00617302049081886	0.194882414056551
VANDESLUIS_COMMD1_TARGETS_GROUP_4_UP	15	Up	0.00620001047873632	0.194882414056551
MEISSNER_BRAIN_HCP_WITH_H3K27ME3	162	Up	0.00626730403369536	0.194882414056551
PYEON_HPV_POSITIVE_TUMORS_UP	120	Down	0.00627056031680689	0.194882414056551
BYSTRYKH_HEMATOPOIESIS_STEM_CELL_RUNX1	13	Up	0.00631779642822454	0.195067126319822
PIEPOLI_LGI1_TARGETS_UP	22	Up	0.00645176030627412	0.197909842122331
KEGG_B_CELL_RECEPTOR_SIGNALING_PATHWAY	74	Down	0.00652829755565651	0.198043220793491
GOLDRATH_ANTIGEN_RESPONSE	447	Down	0.00653995394660979	0.198043220793491
GROSS_HYPOXIA_VIA_ELK3_ONLY_UP	49	Up	0.00666281086392493	0.198935378918471
KEGG_GLIOMA	62	Down	0.00668207416819877	0.198935378918471
FRASOR_RESPONSE_TO_SERM_OR_FULVESTRANT_DN	59	Down	0.00669575047587571	0.198935378918471
REACTOME_DARPP_32_EVENTS	30	Down	0.00682414480083797	0.200367985411243
RAY_ALZHEIMERS_DISEASE	12	Down	0.00686714424295015	0.200367985411243
SCHRAETS_MLL_TARGETS_UP	65	Up	0.00687121372494102	0.200367985411243
NABA_ECM_GLYCOPROTEINS	135	Up	0.00701412416594496	0.202430815072208
LI_CISPLATIN_RESISTANCE_UP	53	Up	0.00706630827042145	0.202430815072208
HEIDENBLAD_AMPLICON_8Q24_UP	52	Down	0.00708102311258535	0.202430815072208
CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP	233	Down	0.00711336056350266	0.202430815072208
GAVIN_FOXP3_TARGETS_CLUSTER_P6	99	Down	0.00718435169577313	0.203226810843307
MCGARVEY_SILENCED_BY_METHYLATION_IN_COLON_CANCER	54	Up	0.00735136195546571	0.206612015940444
SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_UP	185	Down	0.00739149675993543	0.206612015940444
REACTOME_AMINO_ACID_TRANSPORT_ACROSS_THE_PLASMA_MEMBRANE	23	Up	0.00758965572119821	0.210903138982002
TESAR_ALK_AND_JAK_TARGETS_MOUSE_ES_D4_UP	3	Up	0.00774122977145234	0.212334113327449
SHI_SPARC_TARGETS_UP	28	Up	0.00774803747012018	0.212334113327449
CALVET_IRINOTECAN_SENSITIVE_VS_RESISTANT_DN	6	Up	0.00781580013205783	0.212334113327449
BIOCARTA_ECM_PATHWAY	42	Down	0.00782094320892805	0.212334113327449
REACTOME_INSULIN_RECEPTOR_RECYCLING	20	Up	0.00798804835520045	0.214784382530704
WEINMANN_ADAPTATION_TO_HYPOXIA_DN	59	Up	0.00801941747550538	0.214784382530704
BENPORATH_PROLIFERATION	183	Down	0.0080475943496898	0.214784382530704
BIOCARTA_EDG1_PATHWAY	41	Down	0.00819759351801863	0.217558605500674
REACTOME_PASSIVE_TRANSPORT_BY_AQUAPORINS	4	Down	0.00831739553832557	0.219504896776816
REACTOME_CYCLIN_A_B1_ASSOCIATED_EVENTS_DURING_G2_M_TRANSITION	16	Down	0.00836651306239305	0.219574487259693
BIOCARTA_LONGEVITY_PATHWAY	21	Down	0.00855352381780143	0.223242245940851
ONDER_CDH1_TARGETS_2_DN	539	Up	0.00862305494231602	0.223820393118137
MASRI_RESISTANCE_TO_TAMOXIFEN_AND_AROMATASE_INHIBITORS_DN	24	Up	0.0087173372346297	0.224232363312687
FINETTI_BREAST_CANCER_KINOME_RED	19	Down	0.00873386004435529	0.224232363312687
LUCAS_HNF4A_TARGETS_DN	11	Up	0.00886078000709718	0.224624158255628
HUANG_FOXA2_TARGETS_UP	66	Up	0.00887749048643929	0.224624158255628
SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE	120	Down	0.00896010517547535	0.224624158255628
REACTOME_DESTABILIZATION_OF_MRNA_BY_BRF1	20	Down	0.00896535315941101	0.224624158255628
VERNELL_RETINOBLASTOMA_PATHWAY_UP	81	Down	0.00902178349142633	0.224624158255628
BIOCARTA_CELLCYCLE_PATHWAY	27	Down	0.00907630391669943	0.224624158255628
REACTOME_ROLE_OF_DCC_IN_REGULATING_APOPTOSIS	13	Up	0.00912827725913425	0.224624158255628
SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_2	43	Up	0.00912951701631682	0.224624158255628
AFFAR_YY1_TARGETS_DN	286	Down	0.00918122789252396	0.224726013286441
ACEVEDO_FGFR1_TARGETS_IN_PROSTATE_CANCER_MODEL_DN	351	Up	0.00929583003064916	0.22569441128036
PID_IL2_STAT5_PATHWAY	34	Down	0.00931634424209785	0.22569441128036
BIOCARTA_PTEN_PATHWAY	23	Down	0.00943140835399073	0.227316189103328
ELVIDGE_HIF1A_TARGETS_UP	93	Up	0.00966021640529333	0.230541737934889
REACTOME_CELL_CYCLE_MITOTIC	373	Down	0.00969070593218108	0.230541737934889
SA_PTEN_PATHWAY	20	Down	0.00971164391385327	0.230541737934889
KANG_DOXORUBICIN_RESISTANCE_UP	67	Down	0.00985714931479191	0.231706756571485
BORCZUK_MALIGNANT_MESOTHELIOMA_DN	123	Up	0.00985881838926089	0.231706756571485
REACTOME_SIGNALLING_TO_RAS	33	Down	0.0100801329976483	0.235566514143896
MCMURRAY_TP53_HRAS_COOPERATION_RESPONSE_UP	28	Down	0.0101227778093165	0.235566514143896
PID_PLK1_PATHWAY	61	Down	0.0103762235949805	0.237479029177052
COLIN_PILOCYTIC_ASTROCYTOMA_VS_GLIOBLASTOMA_UP	51	Down	0.0103806645705818	0.237479029177052
REACTOME_RECRUITMENT_OF_MITOTIC_CENTROSOME_PROTEINS_AND_COMPLEXES	103	Down	0.0103908257190329	0.237479029177052
PID_PDGFRA_PATHWAY	30	Down	0.010406045520671	0.237479029177052
DACOSTA_ERCC3_ALLELE_XPCS_VS_TTD_UP	30	Up	0.0105328051589132	0.239216209474547
KEGG_ASCORBATE_AND_ALDARATE_METABOLISM	11	Up	0.0106130271522279	0.239566300941697
REACTOME_TETRAHYDROBIOPTERIN_BH4_SYNTHESIS_RECYCLING_SALVAGE_AND_REGULATION	22	Down	0.0106496450460958	0.239566300941697
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_3	21	Up	0.0109377770625652	0.2448817954671
KANG_FLUOROURACIL_RESISTANCE_DN	21	Up	0.0110091282829212	0.245316613247734
SUMI_HNF4A_TARGETS	29	Up	0.0112131662251166	0.248690127922304
GAUSSMANN_MLL_AF4_FUSION_TARGETS_E_DN	30	Up	0.0113107035926004	0.24890986948685
GENTLES_LEUKEMIC_STEM_CELL_UP	31	Up	0.0114523197859678	0.24890986948685
KEGG_NON_SMALL_CELL_LUNG_CANCER	55	Down	0.0114813127496949	0.24890986948685
BILANGES_SERUM_AND_RAPAMYCIN_SENSITIVE_GENES	86	Down	0.0114985489510853	0.24890986948685
REACTOME_REGULATION_OF_COMPLEMENT_CASCADE	9	Up	0.0115171063171094	0.24890986948685
OZEN_MIR125B1_TARGETS	42	Up	0.0115616426878048	0.24890986948685
PID_INSULIN_GLUCOSE_PATHWAY	34	Down	0.0115919075544257	0.24890986948685
WU_APOPTOSIS_BY_CDKN1A_VIA_TP53	94	Down	0.011645827330731	0.248936146200783
FEVR_CTNNB1_TARGETS_DN	783	Down	0.011808743016215	0.250943207094021
PETRETTO_LEFT_VENTRICLE_MASS_QTL_CIS_DN	11	Down	0.0118459642637525	0.250943207094021
PID_TXA2PATHWAY	70	Down	0.0120241646647712	0.25283807485805
KEGG_GLYCOSPHINGOLIPID_BIOSYNTHESIS_GANGLIO_SERIES	14	Down	0.0120424569947208	0.25283807485805
WOTTON_RUNX_TARGETS_DN	42	Down	0.0122481750354975	0.254634047104847
REACTOME_G_BETA_GAMMA_SIGNALLING_THROUGH_PI3KGAMMA	20	Down	0.0122604931600027	0.254634047104847
REACTOME_POST_NMDA_RECEPTOR_ACTIVATION_EVENTS	38	Down	0.0123034538776803	0.254634047104847
PARK_HSC_VS_MULTIPOTENT_PROGENITORS_UP	28	Down	0.0123436064324746	0.254634047104847
HORTON_SREBF_TARGETS	38	Down	0.0125120754181405	0.256565968307999
REACTOME_AMINE_LIGAND_BINDING_RECEPTORS	13	Up	0.0125458803300482	0.256565968307999
BIOCARTA_RAS_PATHWAY	41	Down	0.0127084964499431	0.258771281161772
KEGG_PORPHYRIN_AND_CHLOROPHYLL_METABOLISM	25	Up	0.0128484607979618	0.259039344954253
BIOCARTA_TFF_PATHWAY	33	Down	0.0129228314094366	0.259039344954253
NIKOLSKY_BREAST_CANCER_7Q21_Q22_AMPLICON	102	Up	0.0129646719383287	0.259039344954253
GALLUZZI_PREVENT_MITOCHONDIAL_PERMEABILIZATION	33	Down	0.0129670804023914	0.259039344954253
KEGG_DNA_REPLICATION	38	Down	0.012995835045334	0.259039344954253
MOHANKUMAR_TLX1_TARGETS_DN	233	Up	0.0133544604493162	0.264758931846022
MORI_EMU_MYC_LYMPHOMA_BY_ONSET_TIME_UP	138	Down	0.0133948739862826	0.264758931846022
VALK_AML_WITH_FLT3_ITD	63	Up	0.0134781824936049	0.265295558749124
TSUTSUMI_FBXW8_TARGETS	10	Up	0.0136491702815506	0.267171346127114
ONDER_CDH1_TARGETS_3_UP	23	Up	0.0136865930911858	0.267171346127114
NABA_CORE_MATRISOME	186	Up	0.0138113372823447	0.267270620297111
OXFORD_RALA_AND_RALB_TARGETS_UP	10	Down	0.0138406731654874	0.267270620297111
ZHAN_EARLY_DIFFERENTIATION_GENES_DN	59	Down	0.0138614102397951	0.267270620297111
BOSCO_EPITHELIAL_DIFFERENTIATION_MODULE	45	Up	0.0141875620438948	0.272447329655931
MEISSNER_NPC_HCP_WITH_H3K27ME3	52	Up	0.0142579858936187	0.272691195795363
DIERICK_SEROTONIN_FUNCTION_GENES	4	Up	0.01441961511984	0.273914251052606
SIMBULAN_PARP1_TARGETS_DN	21	Down	0.0144379018865578	0.273914251052606
WENG_POR_TARGETS_LIVER_UP	42	Down	0.0145085510812324	0.274153581230967
MIKKELSEN_MEF_ICP_WITH_H3K27ME3	157	Up	0.0146094626084005	0.274960563195553
PASTURAL_RIZ1_TARGETS_DN	3	Up	0.0148886575196505	0.275879781370226
REACTOME_ACYL_CHAIN_REMODELLING_OF_PI	5	Down	0.015019355736192	0.275879781370226
REACTOME_DAG_AND_IP3_SIGNALING	32	Down	0.0151546956440251	0.275879781370226
REACTOME_CREB_PHOSPHORYLATION_THROUGH_THE_ACTIVATION_OF_CAMKII	14	Down	0.0152929492306082	0.275879781370226
BOYLAN_MULTIPLE_MYELOMA_C_CLUSTER_UP	44	Down	0.0153101882130619	0.275879781370226
ZEMBUTSU_SENSITIVITY_TO_FLUOROURACIL	28	Down	0.015319008818113	0.275879781370226
BIOCARTA_SHH_PATHWAY	19	Down	0.015355809999111	0.275879781370226
PID_FOXM1_PATHWAY	46	Down	0.0153990006209476	0.275879781370226
HE_PTEN_TARGETS_UP	21	Down	0.0154335189525125	0.275879781370226
SESTO_RESPONSE_TO_UV_C7	87	Down	0.0154827957321678	0.275879781370226
SCHAEFFER_PROSTATE_DEVELOPMENT_12HR_UP	165	Up	0.0154851526349123	0.275879781370226
MATTIOLI_MGUS_VS_PCL	145	Down	0.0155422586685558	0.275879781370226
REACTOME_REGULATION_OF_KIT_SIGNALING	21	Down	0.0155425609683516	0.275879781370226
BIOCARTA_CSK_PATHWAY	23	Down	0.0155519192670559	0.275879781370226
PID_NFKAPPAB_ATYPICAL_PATHWAY	27	Down	0.015653075325976	0.275879781370226
ZHU_CMV_8_HR_UP	71	Down	0.0157425135456625	0.275879781370226
GAVIN_IL2_RESPONSIVE_FOXP3_TARGETS_UP	29	Down	0.0157695920527137	0.275879781370226
XU_HGF_SIGNALING_NOT_VIA_AKT1_48HR_UP	49	Down	0.0157868312391109	0.275879781370226
PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_UP	81	Up	0.0159280833640482	0.275879781370226
ZHANG_TLX_TARGETS_60HR_DN	332	Down	0.015985667226946	0.275879781370226
BOYAULT_LIVER_CANCER_SUBCLASS_G56_UP	15	Down	0.0160326314770719	0.275879781370226
OHM_EMBRYONIC_CARCINOMA_UP	9	Up	0.0160866161046778	0.275879781370226
ZHENG_RESPONSE_TO_ARSENITE_DN	26	Up	0.0161801625584081	0.275879781370226
OKAMOTO_LIVER_CANCER_MULTICENTRIC_OCCURRENCE_UP	40	Down	0.0162021185440639	0.275879781370226
KAUFFMANN_MELANOMA_RELAPSE_DN	9	Up	0.0162890431456726	0.275879781370226
PID_IL2_PI3K_PATHWAY	51	Down	0.0163899435689994	0.275879781370226
PETROVA_PROX1_TARGETS_UP	35	Down	0.0164061175079962	0.275879781370226
REACTOME_AQUAPORIN_MEDIATED_TRANSPORT	38	Down	0.0164222461705472	0.275879781370226
RICKMAN_HEAD_AND_NECK_CANCER_A	99	Up	0.0164875371303609	0.275879781370226
ZHAN_V2_LATE_DIFFERENTIATION_GENES	65	Down	0.0165255752011833	0.275879781370226
KUROKAWA_LIVER_CANCER_EARLY_RECURRENCE_DN	19	Down	0.0165421673566058	0.275879781370226
HEIDENBLAD_AMPLIFIED_IN_PANCREATIC_CANCER	51	Down	0.0166043923596108	0.275879781370226
CHOI_ATL_ACUTE_STAGE	4	Up	0.0166088783623696	0.275879781370226
JAEGER_METASTASIS_DN	294	Up	0.01664389028165	0.275879781370226
THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP	87	Down	0.0169419160181518	0.279837801642479
FURUKAWA_DUSP6_TARGETS_PCI35_DN	101	Down	0.0171928020252529	0.282992323230993
MEISSNER_NPC_HCP_WITH_H3K4ME2_AND_H3K27ME3	249	Up	0.0173087312337096	0.283911272041819
REACTOME_TELOMERE_MAINTENANCE	53	Down	0.0174536013007958	0.284955391699356
PID_BCR_5PATHWAY	83	Down	0.0174935700484463	0.284955391699356
REACTOME_CELL_CYCLE	443	Down	0.0175814694512571	0.284955391699356
ABE_VEGFA_TARGETS_30MIN	47	Down	0.0176136694276486	0.284955391699356
BIOCARTA_PTC1_PATHWAY	14	Down	0.0178165177217108	0.286496374096272
PID_CXCR3_PATHWAY	50	Down	0.0178302146452802	0.286496374096272
LEE_LIVER_CANCER_SURVIVAL_DN	282	Down	0.0180650819255508	0.28928626107221
VALK_AML_CLUSTER_13	38	Up	0.0182452562112251	0.291184426830497
REACTOME_IL_RECEPTOR_SHC_SIGNALING	27	Down	0.0183773433656003	0.291369279723328
ZERBINI_RESPONSE_TO_SULINDAC_DN	7	Down	0.0183801958843251	0.291369279723328
NIKOLSKY_BREAST_CANCER_17Q21_Q25_AMPLICON	393	Up	0.0186664299745843	0.294287622869285
TING_SILENCED_BY_DICER	44	Up	0.0186888837554584	0.294287622869285
REACTOME_ASPARAGINE_N_LINKED_GLYCOSYLATION	88	Up	0.0188379626055712	0.294945558575374
ZHANG_TLX_TARGETS_DN	110	Down	0.0189114466145429	0.294945558575374
KORKOLA_EMBRYONIC_CARCINOMA_VS_SEMINOMA_UP	21	Up	0.019015000506653	0.294945558575374
KEGG_SELENOAMINO_ACID_METABOLISM	29	Down	0.0191355501499428	0.294945558575374
PLASARI_NFIC_TARGETS_BASAL_UP	43	Up	0.0192267412035986	0.294945558575374
HUPER_BREAST_BASAL_VS_LUMINAL_UP	47	Up	0.0192613572274843	0.294945558575374
NEWMAN_ERCC6_TARGETS_UP	29	Up	0.0194445908954075	0.294945558575374
PID_ER_NONGENOMIC_PATHWAY	62	Down	0.0194548274450627	0.294945558575374
REACTOME_PURINE_SALVAGE	17	Down	0.0194599124964618	0.294945558575374
PID_INTEGRIN_A4B1_PATHWAY	49	Down	0.0195092411187772	0.294945558575374
BIOCARTA_PDGF_PATHWAY	46	Down	0.0195294178070404	0.294945558575374
CHIANG_LIVER_CANCER_SUBCLASS_POLYSOMY7_UP	92	Up	0.0195517028480473	0.294945558575374
STEIN_ESRRA_TARGETS_RESPONSIVE_TO_ESTROGEN_DN	50	Down	0.0196056971950355	0.294945558575374
GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_UP	249	Down	0.0196319509977086	0.294945558575374
HOOI_ST7_TARGETS_DN	172	Up	0.0196671996086458	0.294945558575374
SMIRNOV_RESPONSE_TO_IR_6HR_DN	139	Down	0.0200065319755666	0.299084990672711
REACTOME_CHROMOSOME_MAINTENANCE	100	Down	0.0201423148455029	0.300164969495759
MODY_HIPPOCAMPUS_PRENATAL	65	Down	0.0202371354259077	0.30062964701883
MATZUK_PREOVULATORY_FOLLICLE	16	Up	0.020608021278381	0.305179600373265
BIOCARTA_BCR_PATHWAY	44	Down	0.0207864241865349	0.306859587053722
ZAIDI_OSTEOBLAST_TRANSCRIPTION_FACTORS	14	Up	0.0209020966744776	0.30760593361443
RAGHAVACHARI_PLATELET_SPECIFIC_GENES	118	Down	0.021121571601246	0.309600299188447
BENPORATH_PRC2_TARGETS	526	Up	0.0211686910749086	0.309600299188447
MCCABE_HOXC6_TARGETS_UP	11	Down	0.0212601058479247	0.309977592671594
YEMELYANOV_GR_TARGETS_DN	19	Up	0.0213985991079894	0.310462118518931
KORKOLA_CHORIOCARCINOMA	2	Down	0.0214247778656163	0.310462118518931
CHEN_ETV5_TARGETS_TESTIS	28	Down	0.0215211780979777	0.310905337415433
MITSIADES_RESPONSE_TO_APLIDIN_DN	408	Down	0.0216808520537597	0.312257149701101
BIOCARTA_IGF1_PATHWAY	36	Down	0.021814444309202	0.313226245947326
REACTOME_APOBEC3G_MEDIATED_RESISTANCE_TO_HIV1_INFECTION	8	Down	0.0220764194000316	0.316027288623482
PID_AURORA_B_PATHWAY	48	Down	0.0222083903051984	0.316955999401079
REACTOME_P38MAPK_EVENTS	15	Down	0.0223501545704681	0.318018464430395
HOEGERKORP_CD44_TARGETS_DIRECT_DN	20	Up	0.0225950530678199	0.319852476901234
OHASHI_AURKB_TARGETS	10	Down	0.0226144638621956	0.319852476901234
REACTOME_RAS_ACTIVATION_UOPN_CA2_INFUX_THROUGH_NMDA_RECEPTOR	16	Down	0.0227631569308831	0.320831152358705
LE_SKI_TARGETS_DN	10	Up	0.0228373468187943	0.320831152358705
STAMBOLSKY_RESPONSE_TO_VITAMIN_D3_DN	47	Up	0.022887404391381	0.320831152358705
REACTOME_GABA_SYNTHESIS_RELEASE_REUPTAKE_AND_DEGRADATION	22	Up	0.022958808770698	0.320879919031886
SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_UP	236	Down	0.023231313397663	0.322463209684656
MIKKELSEN_PLURIPOTENT_STATE_UP	12	Down	0.0232662084580117	0.322463209684656
BIOCARTA_INSULIN_PATHWAY	37	Down	0.0233300909219601	0.322463209684656
YAUCH_HEDGEHOG_SIGNALING_PARACRINE_DN	284	Up	0.023345134994105	0.322463209684656
CHUANG_OXIDATIVE_STRESS_RESPONSE_DN	19	Down	0.023497917453941	0.323388944843642
TERAO_AOX4_TARGETS_SKIN_DN	34	Up	0.023629248791813	0.323388944843642
REACTOME_VOLTAGE_GATED_POTASSIUM_CHANNELS	21	Up	0.0236307302453606	0.323388944843642
KIM_ALL_DISORDERS_DURATION_CORR_UP	9	Down	0.0237477396501308	0.323388944843642
ST_GAQ_PATHWAY	31	Down	0.0237895276596864	0.323388944843642
OLSSON_E2F3_TARGETS_DN	65	Down	0.0238228943280244	0.323388944843642
REACTOME_DNA_REPLICATION	206	Down	0.0240701618539793	0.3253132626973
PARK_APL_PATHOGENESIS_UP	13	Up	0.0241023797510701	0.3253132626973
REACTOME_SIGNALLING_TO_ERKS	41	Down	0.0242407819648211	0.325857348746483
REACTOME_LOSS_OF_NLP_FROM_MITOTIC_CENTROSOMES	95	Down	0.0243467977579447	0.325857348746483
DAIRKEE_CANCER_PRONE_RESPONSE_E2	49	Up	0.0243496283038756	0.325857348746483
CALVET_IRINOTECAN_SENSITIVE_VS_REVERTED_UP	6	Down	0.0245103000548013	0.326432012162392
PYEON_CANCER_HEAD_AND_NECK_VS_CERVICAL_UP	242	Down	0.024541656098786	0.326432012162392
HARRIS_BRAIN_CANCER_PROGENITORS	35	Up	0.0246473208764437	0.326432012162392
REACTOME_GLUCAGON_SIGNALING_IN_METABOLIC_REGULATION	28	Down	0.0246689729767091	0.326432012162392
PENG_GLUTAMINE_DEPRIVATION_UP	67	Down	0.0248499614354879	0.327908429668282
SASAI_RESISTANCE_TO_NEOPLASTIC_TRANSFROMATION	73	Up	0.0250854384341459	0.330093624409207
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_RED_DN	37	Up	0.0254537353303911	0.333403441993397
BIOCARTA_AT1R_PATHWAY	46	Down	0.0254781207789197	0.333403441993397
REACTOME_CREB_PHOSPHORYLATION_THROUGH_THE_ACTIVATION_OF_RAS	28	Down	0.0255745234513153	0.333740466254181
FIGUEROA_AML_METHYLATION_CLUSTER_4_DN	20	Up	0.0257618891950014	0.334394629687654
BIOCARTA_AKAP13_PATHWAY	18	Down	0.0257928658515356	0.334394629687654
PLASARI_NFIC_TARGETS_BASAL_DN	27	Up	0.0258370109729029	0.334394629687654
KONDO_COLON_CANCER_HCP_WITH_H3K27ME3	4	Down	0.025995627654211	0.335528265132494
RHEIN_ALL_GLUCOCORTICOID_THERAPY_DN	561	Down	0.0262645145319188	0.336530605487273
SA_G2_AND_M_PHASES	9	Down	0.02627953163225	0.336530605487273
PID_HEDGEHOG_GLI_PATHWAY	79	Down	0.0263170832783699	0.336530605487273
LIANG_SILENCED_BY_METHYLATION_DN	12	Down	0.0263977003795952	0.336530605487273
SEMBA_FHIT_TARGETS_DN	9	Down	0.0264737485875868	0.336530605487273
BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_DN	72	Up	0.0265256266665377	0.336530605487273
WONG_EMBRYONIC_STEM_CELL_CORE	440	Down	0.0266257813357771	0.336530605487273
RODRIGUES_DCC_TARGETS_UP	6	Up	0.0267326953514622	0.336530605487273
SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX6_UP	10	Up	0.0267586006479816	0.336530605487273
REACTOME_ENDOSOMAL_VACUOLAR_PATHWAY	16	Down	0.0267856705468278	0.336530605487273
ZWANG_CLASS_3_TRANSIENTLY_INDUCED_BY_EGF	289	Up	0.0273630539144476	0.342872855946552
LY_AGING_OLD_DN	76	Down	0.0278141611494802	0.346637641699808
PID_IL27_PATHWAY	15	Up	0.0278300613649382	0.346637641699808
REACTOME_CA_DEPENDENT_EVENTS	29	Down	0.0278836375626433	0.346637641699808
REACTOME_OPIOID_SIGNALLING	74	Down	0.0280010747618074	0.347183929592594
LOPEZ_EPITHELIOID_MESOTHELIOMA	26	Up	0.0282291083726693	0.349095046996047
MOLENAAR_TARGETS_OF_CCND1_AND_CDK4_DN	63	Down	0.0285729796294925	0.352424949790399
MEISSNER_NPC_ICP_WITH_H3_UNMETHYLATED	23	Up	0.0289074794740051	0.355622221445833
LI_CISPLATIN_RESISTANCE_DN	38	Up	0.0291567252043074	0.357182562878473
LUI_THYROID_CANCER_CLUSTER_3	39	Down	0.0291855354087829	0.357182562878473
REACTOME_DEPOSITION_OF_NEW_CENPA_CONTAINING_NUCLEOSOMES_AT_THE_CENTROMERE	43	Down	0.0292899697949298	0.357534411656972
WANG_SMARCE1_TARGETS_UP	367	Up	0.029619895642991	0.359417216651539
NIKOLSKY_BREAST_CANCER_22Q13_AMPLICON	26	Up	0.0296225770617384	0.359417216651539
LUI_THYROID_CANCER_CLUSTER_5	16	Down	0.0297892583186585	0.359417216651539
GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_UP	109	Down	0.0298027198498354	0.359417216651539
REACTOME_FORMATION_OF_THE_TERNARY_COMPLEX_AND_SUBSEQUENTLY_THE_43S_COMPLEX	64	Down	0.0298246293241751	0.359417216651539
LIU_TOPBP1_TARGETS	15	Up	0.0300085002231306	0.359962296744947
COLDREN_GEFITINIB_RESISTANCE_DN	285	Up	0.0300224269563701	0.359962296744947
GAVIN_FOXP3_TARGETS_CLUSTER_T7	144	Down	0.0300984562265568	0.359962296744947
REACTOME_ANTIGEN_ACTIVATES_B_CELL_RECEPTOR_LEADING_TO_GENERATION_OF_SECOND_MESSENGERS	34	Down	0.0302185477198121	0.36016611308419
TURJANSKI_MAPK14_TARGETS	10	Up	0.030267981984425	0.36016611308419
WANG_MLL_TARGETS	365	Up	0.0313287923930306	0.371634346685359
MARTINEZ_RESPONSE_TO_TRABECTEDIN	73	Down	0.0314510210262209	0.371634346685359
PID_ERBB2_ERBB3_PATHWAY	60	Down	0.0314997897709931	0.371634346685359
REACTOME_ACYL_CHAIN_REMODELLING_OF_PS	6	Down	0.0315464379807005	0.371634346685359
BHAT_ESR1_TARGETS_NOT_VIA_AKT1_DN	157	Up	0.031780315274203	0.373458232227202
MATZUK_SPERMATOZOA	136	Down	0.0319819449333886	0.374895056737786
HOLLMANN_APOPTOSIS_VIA_CD40_UP	292	Down	0.0321298409329044	0.374946833190638
CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN	252	Up	0.0321451031842101	0.374946833190638
PACHER_TARGETS_OF_IGF1_AND_IGF2_UP	44	Up	0.0324449576425184	0.376993808268449
DELASERNA_MYOD_TARGETS_UP	119	Down	0.0325320848712658	0.376993808268449
BIOCARTA_AKAP95_PATHWAY	25	Down	0.032628441249899	0.376993808268449
REACTOME_SEROTONIN_RECEPTORS	5	Up	0.0326790861932481	0.376993808268449
KATSANOU_ELAVL1_TARGETS_UP	256	Up	0.0327403364458147	0.376993808268449
GYORFFY_DOXORUBICIN_RESISTANCE	65	Up	0.0327994189666241	0.376993808268449
CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_UP	26	Up	0.032967334328089	0.378004095548283
REACTOME_ENOS_ACTIVATION_AND_REGULATION	31	Down	0.0330479112992852	0.378010491471726
KEGG_PHOSPHATIDYLINOSITOL_SIGNALING_SYSTEM	63	Down	0.0333076751447997	0.378466394814789
MIKKELSEN_NPC_ICP_WITH_H3K27ME3	8	Up	0.0333236621028152	0.378466394814789
PID_AURORA_A_PATHWAY	45	Down	0.0333281160548163	0.378466394814789
REACTOME_NEGATIVE_REGULATION_OF_THE_PI3K_AKT_NETWORK	21	Down	0.0337187064952067	0.381983619864164
ABDULRAHMAN_KIDNEY_CANCER_VHL_DN	23	Up	0.0338989825827424	0.382645255066261
PID_THROMBIN_PAR1_PATHWAY	51	Down	0.0340345725044091	0.382645255066261
BIOCARTA_CXCR4_PATHWAY	40	Down	0.0340641805790807	0.382645255066261
REACTOME_INHIBITION_OF_VOLTAGE_GATED_CA2_CHANNELS_VIA_GBETA_GAMMA_SUBUNITS	14	Down	0.0341013826727335	0.382645255066261
ZHONG_RESPONSE_TO_AZACITIDINE_AND_TSA_DN	92	Down	0.0342310525934077	0.382645255066261
BIOCARTA_NUCLEARRS_PATHWAY	16	Up	0.0343315441847743	0.382645255066261
BIOCARTA_CTLA4_PATHWAY	13	Down	0.034386369491308	0.382645255066261
KEGG_PROTEIN_EXPORT	31	Up	0.0344251129134549	0.382645255066261
MATTIOLI_MULTIPLE_MYELOMA_SUBGROUPS	21	Up	0.0346024352798333	0.383713390286227
ROZANOV_MMP14_TARGETS_DN	36	Up	0.0347005008085686	0.38389968576037
BIOCARTA_EPHA4_PATHWAY	26	Up	0.0355917409185826	0.392839682475197
MUELLER_COMMON_TARGETS_OF_AML_FUSIONS_UP	22	Down	0.0358393070721273	0.393664061500814
PUJANA_XPRSS_INT_NETWORK	304	Down	0.03604527995815	0.393664061500814
LOPEZ_MESOTHELIOMA_SURVIVAL_WORST_VS_BEST_DN	2	Up	0.0360703481327573	0.393664061500814
KUROKAWA_LIVER_CANCER_EARLY_RECURRENCE_UP	21	Up	0.0361747951852093	0.393664061500814
BIOCARTA_P27_PATHWAY	16	Down	0.0361945858334572	0.393664061500814
DACOSTA_ERCC3_ALLELE_XPCS_VS_TTD_DN	73	Up	0.0363872564158444	0.393664061500814
LEONARD_HYPOXIA	78	Up	0.0364459350807045	0.393664061500814
PUJANA_BRCA_CENTERED_NETWORK	190	Down	0.0365136436816105	0.393664061500814
REACTOME_PKA_MEDIATED_PHOSPHORYLATION_OF_CREB	17	Down	0.0365937161655476	0.393664061500814
MILI_PSEUDOPODIA_HAPTOTAXIS_UP	737	Down	0.0366368543461955	0.393664061500814
BERENJENO_TRANSFORMED_BY_RHOA_UP	724	Down	0.036674983196589	0.393664061500814
TARTE_PLASMA_CELL_VS_B_LYMPHOCYTE_DN	47	Down	0.0366947493212968	0.393664061500814
REACTOME_SYNTHESIS_SECRETION_AND_INACTIVATION_OF_GIP	8	Up	0.0367640643166142	0.393664061500814
BIOCARTA_SKP2E2F_PATHWAY	13	Down	0.0368330895815749	0.393664061500814
LEIN_MIDBRAIN_MARKERS	113	Up	0.0369305342144586	0.393814545438155
JACKSON_DNMT1_TARGETS_UP	116	Down	0.0373034263686272	0.396240634183901
PID_P38_GAMMA_DELTA_PATHWAY	13	Down	0.0373657925908819	0.396240634183901
MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_18	5	Down	0.0374096788412404	0.396240634183901
PRAMOONJAGO_SOX4_TARGETS_DN	65	Down	0.0379348551510232	0.40090437524258
REACTOME_AMINO_ACID_AND_OLIGOPEPTIDE_SLC_TRANSPORTERS	36	Up	0.0382773210729579	0.401377195242206
REACTOME_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR	111	Down	0.0382956598603162	0.401377195242206
REACTOME_DNA_STRAND_ELONGATION	31	Down	0.0384213589193019	0.401377195242206
JIANG_AGING_CEREBRAL_CORTEX_UP	88	Up	0.0384417092205808	0.401377195242206
REACTOME_DESTABILIZATION_OF_MRNA_BY_TRISTETRAPROLIN_TTP	19	Down	0.038442658447362	0.401377195242206
NAISHIRO_CTNNB1_TARGETS_WITH_LEF1_MOTIF	8	Up	0.0384893881127687	0.401377195242206
LE_EGR2_TARGETS_UP	154	Down	0.038646076189181	0.402123488805487
KIM_LRRC3B_TARGETS	45	Down	0.0390692542205272	0.405621697132048
GAUSSMANN_MLL_AF4_FUSION_TARGETS_B_DN	11	Up	0.0392170791249335	0.405621697132048
BIOCARTA_TPO_PATHWAY	36	Down	0.0392398635879225	0.405621697132048
GENTILE_RESPONSE_CLUSTER_D3	98	Down	0.0394716312679503	0.407126607226631
KEGG_STEROID_BIOSYNTHESIS	20	Down	0.0395764597624762	0.407318509625136
SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX2_UP	6	Up	0.0396640219956339	0.407332260668205
REACTOME_ACTIVATION_OF_NMDA_RECEPTOR_UPON_GLUTAMATE_BINDING_AND_POSTSYNAPTIC_EVENTS	40	Down	0.0399778447245639	0.409151772244684
BURTON_ADIPOGENESIS_PEAK_AT_16HR	57	Down	0.0400964719318691	0.409151772244684
HOLLEMAN_PREDNISOLONE_RESISTANCE_B_ALL_UP	30	Down	0.040101031022288	0.409151772244684
NOUSHMEHR_GBM_SILENCED_BY_METHYLATION	52	Up	0.0403139796651141	0.409168288477182
PODAR_RESPONSE_TO_ADAPHOSTIN_DN	25	Down	0.0403510080885576	0.409168288477182
CASTELLANO_HRAS_TARGETS_DN	8	Down	0.0404322345986359	0.409168288477182
PARK_HSC_MARKERS	50	Down	0.0405166375591041	0.409168288477182
REACTOME_IL_3_5_AND_GM_CSF_SIGNALING	50	Down	0.0405892337095319	0.409168288477182
RASHI_RESPONSE_TO_IONIZING_RADIATION_4	91	Down	0.0406833669886907	0.409168288477182
STONER_ESOPHAGEAL_CARCINOGENESIS_DN	8	Up	0.0407089533412945	0.409168288477182
KANG_CISPLATIN_RESISTANCE_DN	14	Up	0.0408923374245771	0.410138857736098
PID_CD8_TCR_DOWNSTREAM_PATHWAY	55	Down	0.0409827931101972	0.410175242907991
REACTOME_FGFR4_LIGAND_BINDING_AND_ACTIVATION	3	Up	0.0412799644388421	0.410949601532071
VERRECCHIA_RESPONSE_TO_TGFB1_C5	45	Up	0.0413697826682778	0.410949601532071
LEE_LIVER_CANCER_MYC_E2F1_DN	48	Up	0.0415155579416013	0.410949601532071
MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_9	15	Down	0.041519680245571	0.410949601532071
REACTOME_NEUROTRANSMITTER_RELEASE_CYCLE	38	Up	0.0416713711605841	0.410949601532071
NIKOLSKY_BREAST_CANCER_8Q23_Q24_AMPLICON	212	Up	0.041834336784962	0.410949601532071
SHEPARD_CRUSH_AND_BURN_MUTANT_DN	242	Down	0.0418912822449129	0.410949601532071
OHM_EMBRYONIC_CARCINOMA_DN	9	Up	0.0420300004283837	0.410949601532071
YU_BAP1_TARGETS	38	Down	0.0420884759649732	0.410949601532071
REACTOME_G_PROTEIN_BETA_GAMMA_SIGNALLING	23	Down	0.0421311506198196	0.410949601532071
KAPOSI_LIVER_CANCER_MET_DN	8	Up	0.0421635110344345	0.410949601532071
VANDESLUIS_COMMD1_TARGETS_GROUP_2_UP	21	Up	0.0422870635537873	0.410949601532071
HUMMERICH_BENIGN_SKIN_TUMOR_DN	27	Up	0.0423256605300906	0.410949601532071
REACTOME_BILE_ACID_AND_BILE_SALT_METABOLISM	61	Up	0.042420088942192	0.410949601532071
KEGG_SMALL_CELL_LUNG_CANCER	105	Down	0.0424688522367706	0.410949601532071
KIM_MYCL1_AMPLIFICATION_TARGETS_UP	10	Up	0.0425521605724725	0.410949601532071
LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_DN	120	Up	0.0425901017687385	0.410949601532071
KUNINGER_IGF1_VS_PDGFB_TARGETS_DN	68	Down	0.0426260170937161	0.410949601532071
ST_GRANULE_CELL_SURVIVAL_PATHWAY	36	Up	0.0430415528931892	0.414110582214717
PID_IL8_CXCR2_PATHWAY	53	Down	0.0432826525362598	0.414653782189775
YAO_HOXA10_TARGETS_VIA_PROGESTERONE_DN	23	Up	0.0435283598096647	0.414653782189775
GUILLAUMOND_KLF10_TARGETS_UP	63	Up	0.0435583476461164	0.414653782189775
JEON_SMAD6_TARGETS_UP	25	Up	0.0437285153475201	0.414653782189775
PUJANA_BREAST_CANCER_LIT_INT_NETWORK	126	Down	0.0437358468584758	0.414653782189775
MAGRANGEAS_MULTIPLE_MYELOMA_IGG_VS_IGA_UP	46	Up	0.0437693299023865	0.414653782189775
BIOCARTA_G1_PATHWAY	34	Down	0.0437899827569131	0.414653782189775
BIOCARTA_PGC1A_PATHWAY	26	Down	0.0438450677740992	0.414653782189775
ST_TYPE_I_INTERFERON_PATHWAY	8	Up	0.0439160013757371	0.414653782189775
KHETCHOUMIAN_TRIM24_TARGETS_DN	6	Up	0.0439757715658504	0.414653782189775
LI_WILMS_TUMOR_VS_FETAL_KIDNEY_2_UP	41	Down	0.0442168814048542	0.416096708678349
BIOCARTA_NDKDYNAMIN_PATHWAY	23	Down	0.0443778866577849	0.416781583640907
REACTOME_REGULATION_OF_WATER_BALANCE_BY_RENAL_AQUAPORINS	36	Down	0.0447245427823572	0.418214422868794
PID_TCR_CALCIUM_PATHWAY	29	Down	0.0447943846061612	0.418214422868794
SMID_BREAST_CANCER_LUMINAL_A_UP	95	Up	0.0447960410608826	0.418214422868794
NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_DN	91	Up	0.0452007755724611	0.421160678115003
TSUDA_ALVEOLAR_SOFT_PART_SARCOMA	17	Up	0.0453397669742822	0.421347819062625
LY_AGING_OLD_UP	9	Down	0.0455349712837415	0.421347819062625
MIKKELSEN_ES_ICP_WITH_H3K27ME3	65	Up	0.0456683089987879	0.421347819062625
JOHNSTONE_PARVB_TARGETS_1_DN	81	Down	0.0457808666935454	0.421347819062625
DUTERTRE_ESTRADIOL_RESPONSE_24HR_DN	711	Up	0.0458229538019291	0.421347819062625
MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_11	3	Down	0.0458408701497505	0.421347819062625
ELVIDGE_HIF1A_AND_HIF2A_TARGETS_UP	54	Up	0.0458452114729444	0.421347819062625
BIOCARTA_P53_PATHWAY	20	Down	0.0460375743704811	0.42221847706587
PID_RET_PATHWAY	55	Down	0.0461866802662746	0.42221847706587
MUELLER_COMMON_TARGETS_OF_AML_FUSIONS_DN	47	Up	0.0462080763427297	0.42221847706587
NIKOLSKY_OVERCONNECTED_IN_BREAST_CANCER	26	Up	0.0472011988804577	0.429638299000005
SA_PROGRAMMED_CELL_DEATH	12	Down	0.047202006177181	0.429638299000005
PID_INTEGRIN_A9B1_PATHWAY	26	Down	0.0473932282532184	0.430506176370035
REACTOME_CALNEXIN_CALRETICULIN_CYCLE	13	Up	0.0475027908937102	0.430506176370035
OXFORD_RALA_OR_RALB_TARGETS_DN	36	Up	0.047570750225478	0.430506176370035
KREPPEL_CD99_TARGETS_DN	14	Down	0.0480877281355448	0.43210597714754
REACTOME_DOWNSTREAM_SIGNAL_TRANSDUCTION	117	Down	0.0482244095590165	0.43210597714754
BIOCARTA_ARF_PATHWAY	23	Down	0.0482737571238305	0.43210597714754
CUI_GLUCOSE_DEPRIVATION	82	Up	0.0483157690548861	0.43210597714754
REACTOME_METABOLISM_OF_PORPHYRINS	16	Up	0.0483204593918875	0.43210597714754
BIOCARTA_CLASSIC_PATHWAY	5	Up	0.0483846321014881	0.43210597714754
BIOCARTA_EGF_PATHWAY	47	Down	0.0483878200489095	0.43210597714754
BIOCARTA_GH_PATHWAY	41	Down	0.0485598091932085	0.432354056512898
REACTOME_SIGNALING_BY_FGFR	126	Down	0.0485986460644261	0.432354056512898
BOYLAN_MULTIPLE_MYELOMA_C_D_UP	171	Down	0.0489925852514677	0.434883046228897
BIOCARTA_IL2_PATHWAY	34	Down	0.0490670329466558	0.434883046228897
WILLIAMS_ESR2_TARGETS_DN	18	Down	0.0492444144625382	0.435446091685007
LINDSTEDT_DENDRITIC_CELL_MATURATION_D	83	Down	0.0493149151252072	0.435446091685007
KOBAYASHI_EGFR_SIGNALING_6HR_UP	10	Up	0.0501003038208686	0.440222775143984
BIOCARTA_GSK3_PATHWAY	56	Down	0.050138878407569	0.440222775143984
GHANDHI_BYSTANDER_IRRADIATION_DN	21	Up	0.050213507464868	0.440222775143984
BAFNA_MUC4_TARGETS_UP	7	Down	0.050297719513522	0.440222775143984
REACTOME_PEPTIDE_CHAIN_ELONGATION	117	Down	0.0503218244237407	0.440222775143984
MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_30	6	Down	0.0505971985721138	0.441813615627847
IZADPANAH_STEM_CELL_ADIPOSE_VS_BONE_DN	170	Up	0.050785293622683	0.442522795133777
MOROSETTI_FACIOSCAPULOHUMERAL_MUSCULAR_DISTROPHY_DN	12	Up	0.0509400921421295	0.442522795133777
REACTOME_DOPAMINE_NEUROTRANSMITTER_RELEASE_CYCLE	14	Up	0.0509594412685806	0.442522795133777
REACTOME_KINESINS	28	Down	0.0513963595987574	0.444497449488888
REACTOME_INTERFERON_GAMMA_SIGNALING	62	Down	0.0516256729650101	0.444497449488888
MARTINELLI_IMMATURE_NEUTROPHIL_DN	9	Up	0.0517161536079875	0.444497449488888
LEE_LIVER_CANCER_MYC_DN	61	Up	0.0517849014439004	0.444497449488888
KEGG_RIBOSOME	116	Down	0.0518041992960143	0.444497449488888
NEMETH_INFLAMMATORY_RESPONSE_LPS_DN	43	Down	0.0519325237916171	0.444497449488888
REACTOME_PLC_BETA_MEDIATED_EVENTS	41	Down	0.0519937939054033	0.444497449488888
HONRADO_BREAST_CANCER_BRCA1_VS_BRCA2	22	Down	0.0521450489417189	0.444497449488888
FRIDMAN_IMMORTALIZATION_DN	49	Up	0.052167252040639	0.444497449488888
SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM6	52	Down	0.052249017260281	0.444497449488888
MAINA_VHL_TARGETS_UP	15	Up	0.0523009324742325	0.444497449488888
GEISS_RESPONSE_TO_DSRNA_UP	42	Down	0.0523159572218082	0.444497449488888
BIOCARTA_VITCB_PATHWAY	21	Up	0.0524846367700814	0.44513002531753
KEGG_ALLOGRAFT_REJECTION	20	Down	0.0528031217158404	0.447028578827294
LOPEZ_MESOTHELIOMA_SURVIVAL_UP	18	Down	0.0530898545599063	0.447034599403097
MOHANKUMAR_TLX1_TARGETS_UP	604	Down	0.0531514942574199	0.447034599403097
LOPEZ_MESOTHELIOMA_SURVIVAL_DN	34	Up	0.0531540964145328	0.447034599403097
MIKKELSEN_MCV6_HCP_WITH_H3K27ME3	316	Up	0.0532464058410335	0.447034599403097
REACTOME_COMPLEMENT_CASCADE	14	Up	0.053276985491944	0.447034599403097
SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_UP	566	Up	0.0536033760536731	0.448440038274297
VISALA_RESPONSE_TO_HEAT_SHOCK_AND_AGING_UP	25	Down	0.0537880743203403	0.448440038274297
CALVET_IRINOTECAN_SENSITIVE_VS_REVERTED_DN	7	Down	0.0537971364864701	0.448440038274297
FURUKAWA_DUSP6_TARGETS_PCI35_UP	93	Up	0.0538241959571394	0.448440038274297
ZHENG_IL22_SIGNALING_UP	56	Up	0.0541841371577719	0.448774896527383
CHIARADONNA_NEOPLASTIC_TRANSFORMATION_CDC25_UP	172	Down	0.0543301093730562	0.448774896527383
BUCKANOVICH_T_LYMPHOCYTE_HOMING_ON_TUMOR_DN	27	Up	0.0543538631017639	0.448774896527383
CAFFAREL_RESPONSE_TO_THC_8HR_3_UP	9	Up	0.0544753901388637	0.448774896527383
REACTOME_IL_2_SIGNALING	45	Down	0.054489023651793	0.448774896527383
HU_GENOTOXIC_DAMAGE_4HR	47	Down	0.0544942308428447	0.448774896527383
DURAND_STROMA_NS_UP	234	Up	0.0545293798913459	0.448774896527383
MORI_MATURE_B_LYMPHOCYTE_DN	94	Down	0.0548120664029198	0.449662568317023
MCMURRAY_TP53_HRAS_COOPERATION_RESPONSE_DN	122	Up	0.0548276120555896	0.449662568317023
CAIRO_PML_TARGETS_BOUND_BY_MYC_UP	31	Down	0.0549341035857462	0.449755121904792
BIOCARTA_AKT_PATHWAY	29	Down	0.0555225933552525	0.453786731851579
REACTOME_AMINE_COMPOUND_SLC_TRANSPORTERS	9	Up	0.0557326192155964	0.453972357895964
REACTOME_SIGNALING_BY_EGFR_IN_CANCER	143	Down	0.0557375037213504	0.453972357895964
WILLIAMS_ESR1_TARGETS_UP	35	Down	0.0560258592153575	0.454613587553247
CHOW_RASSF1_TARGETS_DN	37	Up	0.0560602741309316	0.454613587553247
PID_ECADHERIN_NASCENT_AJ_PATHWAY	65	Down	0.0561049368212411	0.454613587553247
FAELT_B_CLL_WITH_VH_REARRANGEMENTS_UP	111	Down	0.0562313458641553	0.454728365670189
HASLINGER_B_CLL_WITH_MUTATED_VH_GENES	22	Up	0.0564053806965281	0.454728365670189
LIN_MELANOMA_COPY_NUMBER_UP	101	Down	0.0564078793993926	0.454728365670189
OHM_METHYLATED_IN_ADULT_CANCERS	31	Up	0.0566025271645191	0.45552016750458
ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_2HR	9	Down	0.057090868148284	0.458536425477035
HOFMANN_CELL_LYMPHOMA_UP	74	Down	0.0573986682674401	0.458536425477035
MEISSNER_NPC_HCP_WITH_H3K4ME3_AND_H3K27ME3	149	Up	0.0574129431329604	0.458536425477035
JU_AGING_TERC_TARGETS_DN	3	Down	0.0574340290598258	0.458536425477035
KEGG_VALINE_LEUCINE_AND_ISOLEUCINE_BIOSYNTHESIS	14	Down	0.0574626511182059	0.458536425477035
CHIN_BREAST_CANCER_COPY_NUMBER_UP	33	Down	0.0576259216747213	0.458554810990676
REACTOME_MITOTIC_M_M_G1_PHASES	186	Down	0.057659093507295	0.458554810990676
BLUM_RESPONSE_TO_SALIRASIB_DN	518	Down	0.0578832756087394	0.459416417575818
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_13	205	Down	0.0581042565435934	0.459416417575818
SIG_IL4RECEPTOR_IN_B_LYPHOCYTES	34	Down	0.0582479654798054	0.459416417575818
PID_ECADHERIN_KERATINOCYTE_PATHWAY	32	Down	0.0584559773952593	0.459416417575818
CHEOK_RESPONSE_TO_MERCAPTOPURINE_AND_HD_MTX_DN	30	Down	0.0584664114940958	0.459416417575818
MIKKELSEN_MEF_HCP_WITH_H3K27ME3	378	Up	0.0585531054996945	0.459416417575818
GALI_TP53_TARGETS_APOPTOTIC_DN	8	Down	0.0585730921675121	0.459416417575818
OXFORD_RALB_TARGETS_DN	23	Down	0.0586943038140574	0.459416417575818
RIZ_ERYTHROID_DIFFERENTIATION_HEMGN	37	Down	0.0587153922741038	0.459416417575818
BIOCARTA_CTL_PATHWAY	20	Down	0.0589206484471148	0.459416417575818
IIZUKA_LIVER_CANCER_PROGRESSION_L0_L1_DN	37	Down	0.0589493137232169	0.459416417575818
KONG_E2F1_TARGETS	14	Down	0.0590038066982662	0.459416417575818
REACTOME_PACKAGING_OF_TELOMERE_ENDS	25	Down	0.0591259119986068	0.459416417575818
REACTOME_ORGANIC_CATION_ANION_ZWITTERION_TRANSPORT	4	Up	0.0591289546752958	0.459416417575818
SERVITJA_LIVER_HNF1A_TARGETS_DN	142	Up	0.0593345751366679	0.460257032751427
FARMER_BREAST_CANCER_CLUSTER_5	21	Up	0.0595281961535713	0.461001964966346
GAJATE_RESPONSE_TO_TRABECTEDIN_DN	33	Down	0.0598815697913742	0.462187274180008
LOPEZ_MESOTELIOMA_SURVIVAL_TIME_DN	8	Up	0.0601603854902775	0.462187274180008
REACTOME_GAP_JUNCTION_ASSEMBLY	7	Up	0.0602128119210393	0.462187274180008
RICKMAN_HEAD_AND_NECK_CANCER_D	9	Up	0.0602963371937096	0.462187274180008
GUTIERREZ_CHRONIC_LYMPHOCYTIC_LEUKEMIA_UP	11	Down	0.0603023834641236	0.462187274180008
MANN_RESPONSE_TO_AMIFOSTINE_DN	22	Down	0.060340165772909	0.462187274180008
REACTOME_INTERFERON_SIGNALING	157	Down	0.060474665997106	0.462187274180008
CHICAS_RB1_TARGETS_GROWING	335	Down	0.0605115405439573	0.462187274180008
PID_TRKR_PATHWAY	84	Down	0.0605617956641458	0.462187274180008
KEGG_LIMONENE_AND_PINENE_DEGRADATION	14	Up	0.0608737570842065	0.463818755589986
PID_CD8_TCR_PATHWAY	65	Down	0.0610882874954466	0.464703816632029
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_12	135	Down	0.0614439733652954	0.46665808710234
REACTOME_TRYPTOPHAN_CATABOLISM	8	Up	0.0617646811394626	0.468340856665844
REACTOME_SIGNALING_BY_ERBB2	127	Down	0.0620007587120987	0.468525873008129
WINNEPENNINCKX_MELANOMA_METASTASIS_UP	206	Down	0.0621294894162403	0.468525873008129
KIM_MYCL1_AMPLIFICATION_TARGETS_DN	30	Down	0.0621723197804175	0.468525873008129
VALK_AML_CLUSTER_7	36	Up	0.0623379120687073	0.468525873008129
BROWNE_HCMV_INFECTION_10HR_DN	78	Up	0.0627849157582422	0.468525873008129
PETRETTO_BLOOD_PRESSURE_UP	13	Down	0.0628159743212089	0.468525873008129
SEMENZA_HIF1_TARGETS	51	Up	0.0630270641783619	0.468525873008129
BOSCO_TH1_CYTOTOXIC_MODULE	81	Down	0.063069851562871	0.468525873008129
REACTOME_PEROXISOMAL_LIPID_METABOLISM	60	Up	0.0630737175766004	0.468525873008129
BIOCARTA_RB_PATHWAY	14	Down	0.0632495619289161	0.468525873008129
REACTOME_BIOSYNTHESIS_OF_THE_N_GLYCAN_PRECURSOR_DOLICHOL_LIPID_LINKED_OLIGOSACCHARIDE_LLO_AND_TRANSFER_TO_A_NASCENT_PROTEIN	31	Up	0.0632946450611145	0.468525873008129
YIH_RESPONSE_TO_ARSENITE_C5	12	Down	0.0633640116221706	0.468525873008129
BIOCARTA_NKCELLS_PATHWAY	36	Down	0.063383652640264	0.468525873008129
KAAB_FAILED_HEART_ATRIUM_UP	62	Up	0.0634280460688781	0.468525873008129
REACTOME_REGULATION_OF_INSULIN_SECRETION_BY_GLUCAGON_LIKE_PEPTIDE1	40	Down	0.0634467492846753	0.468525873008129
PARK_APL_PATHOGENESIS_DN	69	Down	0.063454968760501	0.468525873008129
REACTOME_THROMBIN_SIGNALLING_THROUGH_PROTEINASE_ACTIVATED_RECEPTORS_PARS	24	Down	0.0634751394422529	0.468525873008129
REACTOME_UNWINDING_OF_DNA	11	Down	0.0637400376046183	0.469747172611883
MIKKELSEN_ES_HCP_WITH_H3K27ME3	34	Up	0.0640054157082832	0.470882801206253
ZHOU_TNF_SIGNALING_4HR	78	Down	0.0640934888178706	0.470882801206253
RUAN_RESPONSE_TO_TNF_UP	18	Up	0.0642950844928455	0.471349754112907
RICKMAN_HEAD_AND_NECK_CANCER_C	104	Up	0.0643566027525032	0.471349754112907
MURAKAMI_UV_RESPONSE_1HR_DN	15	Down	0.0644744142098096	0.471481629608577
KEGG_REGULATION_OF_AUTOPHAGY	19	Up	0.064718890622716	0.471922845579203
ZHAN_MULTIPLE_MYELOMA_UP	107	Down	0.0647345478271219	0.471922845579203
BONOME_OVARIAN_CANCER_POOR_SURVIVAL_DN	31	Down	0.0648590490946635	0.472101922840047
REACTOME_REGULATION_OF_RHEB_GTPASE_ACTIVITY_BY_AMPK	10	Up	0.0651095392889675	0.473196097847819
NEMETH_INFLAMMATORY_RESPONSE_LPS_UP	112	Down	0.065434581106425	0.474815464025068
VALK_AML_CLUSTER_9	36	Down	0.0655333790314023	0.474815464025068
LIM_MAMMARY_LUMINAL_MATURE_UP	158	Up	0.0656540402084785	0.474961234218763
BOYAULT_LIVER_CANCER_SUBCLASS_G6_DN	26	Up	0.066074360013881	0.476918026212377
REACTOME_NUCLEOTIDE_BINDING_DOMAIN_LEUCINE_RICH_REPEAT_CONTAINING_RECEPTOR_NLR_SIGNALING_PATHWAYS	46	Up	0.0661947547799098	0.476918026212377
NIKOLSKY_BREAST_CANCER_10Q22_AMPLICON	11	Down	0.066227397374115	0.476918026212377
BEIER_GLIOMA_STEM_CELL_UP	54	Up	0.0665599474118716	0.478022468310357
REACTOME_PHOSPHOLIPASE_C_MEDIATED_CASCADE	43	Down	0.0665831465174036	0.478022468310357
PID_ANGIOPOIETIN_RECEPTOR_PATHWAY	65	Down	0.0669048299650244	0.479603060325911
WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_TBH	93	Down	0.0672351478712098	0.481240664459992
BRACHAT_RESPONSE_TO_METHOTREXATE_DN	41	Down	0.0673877669636514	0.481603345138108
KEGG_MATURITY_ONSET_DIABETES_OF_THE_YOUNG	4	Up	0.0677116069745718	0.482642956401114
YE_METASTATIC_LIVER_CANCER	42	Down	0.0677375698759396	0.482642956401114
FUJIWARA_PARK2_HEPATOCYTE_PROLIFERATION_DN	6	Up	0.0678953033880114	0.483038272899045
BARRIER_CANCER_RELAPSE_TUMOR_SAMPLE_DN	14	Down	0.068067406810343	0.483534480860241
LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_UP	240	Up	0.0682143332882985	0.48385061629718
CHEN_HOXA5_TARGETS_6HR_UP	10	Down	0.0689613653640596	0.484856168959602
CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_CDC25_DN	65	Up	0.0689890560733669	0.484856168959602
LI_WILMS_TUMOR_ANAPLASTIC_UP	22	Down	0.069007765717501	0.484856168959602
REACTOME_DIABETES_PATHWAYS	168	Up	0.069104827992932	0.484856168959602
FAELT_B_CLL_WITH_VH3_21_DN	68	Down	0.0691102396208722	0.484856168959602
BIOCARTA_EPO_PATHWAY	32	Down	0.069132103089581	0.484856168959602
ZHAN_LATE_DIFFERENTIATION_GENES_DN	15	Down	0.0691546007675589	0.484856168959602
KAAB_FAILED_HEART_VENTRICLE_DN	64	Down	0.0692204138990672	0.484856168959602
BIDUS_METASTASIS_UP	294	Down	0.0692798293919837	0.484856168959602
ZHAN_V1_LATE_DIFFERENTIATION_GENES_DN	24	Down	0.0695590437884205	0.485254458102586
SATO_SILENCED_BY_DEACETYLATION_IN_PANCREATIC_CANCER	54	Up	0.0695740915140474	0.485254458102586
GEISS_RESPONSE_TO_DSRNA_DN	33	Down	0.0697759363247473	0.485254458102586
WHITFIELD_CELL_CYCLE_G2	226	Down	0.069832497092499	0.485254458102586
HOFFMANN_IMMATURE_TO_MATURE_B_LYMPHOCYTE_UP	48	Down	0.069850345366164	0.485254458102586
REACTOME_EXTENSION_OF_TELOMERES	28	Down	0.0702258284416363	0.486397046532805
REACTOME_CTLA4_INHIBITORY_SIGNALING	20	Down	0.0702526652969126	0.486397046532805
HOELZEL_NF1_TARGETS_DN	128	Up	0.07032370507661	0.486397046532805
LEE_AGING_CEREBELLUM_UP	111	Down	0.0708564875495853	0.489083986488593
PETRETTO_BLOOD_PRESSURE_DN	13	Down	0.0709192486758438	0.489083986488593
GRADE_METASTASIS_DN	53	Down	0.0715396959910817	0.491892816166021
KIM_RESPONSE_TO_TSA_AND_DECITABINE_DN	14	Down	0.0715825705054833	0.491892816166021
DAZARD_UV_RESPONSE_CLUSTER_G5	22	Down	0.0719079798066175	0.491892816166021
FERRANDO_T_ALL_WITH_MLL_ENL_FUSION_DN	132	Down	0.0720745707097375	0.491892816166021
SHIN_B_CELL_LYMPHOMA_CLUSTER_7	34	Down	0.0721950640877497	0.491892816166021
PALOMERO_GSI_SENSITIVITY_UP	9	Down	0.0725509429875013	0.491892816166021
PID_AR_NONGENOMIC_PATHWAY	44	Down	0.072609978330053	0.491892816166021
WORSCHECH_TUMOR_REJECTION_DN	11	Down	0.0726398253806851	0.491892816166021
MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_24	19	Down	0.0726491981357454	0.491892816166021
ST_INTERLEUKIN_4_PATHWAY	31	Down	0.0728222034006954	0.491892816166021
REACTOME_AMINO_ACID_SYNTHESIS_AND_INTERCONVERSION_TRANSAMINATION	20	Up	0.0728790990953707	0.491892816166021
WANG_NEOPLASTIC_TRANSFORMATION_BY_CCND1_MYC	34	Up	0.0730157061779239	0.491892816166021
KANG_GIST_WITH_PDGFRA_DN	8	Down	0.0730231668215424	0.491892816166021
WANG_ESOPHAGUS_CANCER_VS_NORMAL_DN	156	Down	0.0730693304452354	0.491892816166021
GUILLAUMOND_KLF10_TARGETS_DN	36	Up	0.073100995898011	0.491892816166021
WHITFIELD_CELL_CYCLE_G1_S	171	Down	0.0731466174410534	0.491892816166021
GRUETZMANN_PANCREATIC_CANCER_UP	504	Down	0.0731769502906592	0.491892816166021
BARRIER_CANCER_RELAPSE_NORMAL_SAMPLE_UP	28	Up	0.0732008149374921	0.491892816166021
LU_TUMOR_ENDOTHELIAL_MARKERS_UP	38	Up	0.073399095698646	0.492524613750573
PID_LIS1_PATHWAY	49	Down	0.0737837360653103	0.494403360528406
SERVITJA_ISLET_HNF1A_TARGETS_DN	91	Up	0.0741006137305756	0.495323990185644
LUI_THYROID_CANCER_PAX8_PPARG_DN	67	Down	0.0741308342636008	0.495323990185644
BIOCARTA_IL2RB_PATHWAY	51	Down	0.0742566794424838	0.495464058878945
FONTAINE_FOLLICULAR_THYROID_ADENOMA_UP	102	Down	0.0743688177049199	0.495512404567054
TUOMISTO_TUMOR_SUPPRESSION_BY_COL13A1_DN	6	Up	0.0748617322003976	0.496844579466115
PID_PI3KCI_PATHWAY	54	Down	0.0748682179112394	0.496844579466115
REACTOME_NOREPINEPHRINE_NEUROTRANSMITTER_RELEASE_CYCLE	13	Up	0.0749714773790508	0.496844579466115
ENGELMANN_CANCER_PROGENITORS_DN	78	Up	0.0749894549448221	0.496844579466115
PID_EPHRINB_REV_PATHWAY	40	Up	0.0751367940666215	0.497123550659272
THILLAINADESAN_ZNF217_TARGETS_DN	13	Up	0.0752445632530381	0.497140303227066
REACTOME_ADP_SIGNALLING_THROUGH_P2RY12	15	Down	0.0754634481450952	0.497648089545955
LANDEMAINE_LUNG_METASTASIS	24	Up	0.0756845682589006	0.497648089545955
REACTOME_G2_M_DNA_DAMAGE_CHECKPOINT	12	Down	0.0757610334896163	0.497648089545955
SCHLINGEMANN_SKIN_CARCINOGENESIS_TPA_DN	64	Up	0.0757745572111982	0.497648089545955
BIOCARTA_PPARA_PATHWAY	94	Down	0.0758481423524741	0.497648089545955
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_5	47	Up	0.0762283823457841	0.499449206936871
PID_SYNDECAN_3_PATHWAY	19	Down	0.0763483167971593	0.499542172506621
TARTE_PLASMA_CELL_VS_B_LYMPHOCYTE_UP	117	Up	0.0764548848339859	0.499547546273512
MIKKELSEN_IPS_LCP_WITH_H3K27ME3	13	Up	0.0766854720990297	0.499704564507329
BIOCARTA_MPR_PATHWAY	54	Down	0.0766904761362856	0.499704564507329
VETTER_TARGETS_OF_PRKCA_AND_ETS1_DN	22	Up	0.0769442126468709	0.500008810309424
SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6	633	Down	0.0770579880562312	0.500008810309424
PEDRIOLI_MIR31_TARGETS_UP	265	Up	0.0770904087754929	0.500008810309424
STOSSI_RESPONSE_TO_ESTRADIOL	52	Down	0.077638962739285	0.500008810309424
REACTOME_G1_S_SPECIFIC_TRANSCRIPTION	21	Down	0.0776877770127113	0.500008810309424
VECCHI_GASTRIC_CANCER_EARLY_DN	390	Up	0.0777206996373917	0.500008810309424
LA_MEN1_TARGETS	33	Up	0.0778276367210767	0.500008810309424
WATTEL_AUTONOMOUS_THYROID_ADENOMA_UP	98	Up	0.0779428896218692	0.500008810309424
MCCOLLUM_GELDANAMYCIN_RESISTANCE_DN	9	Down	0.0779784403392998	0.500008810309424
JOHANSSON_GLIOMAGENESIS_BY_PDGFB_UP	91	Down	0.0780284808089103	0.500008810309424
LEE_LIVER_CANCER_MYC_UP	54	Down	0.0780289651020458	0.500008810309424
REACTOME_GLUTATHIONE_CONJUGATION	21	Down	0.0780651867868488	0.500008810309424
REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_24_HYDROXYCHOLESTEROL	37	Up	0.0781796208137475	0.500008810309424
KEGG_CELL_CYCLE	129	Down	0.0782189904357884	0.500008810309424
KEGG_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY_ARVC	68	Up	0.0787042117129169	0.501280758862005
FIGUEROA_AML_METHYLATION_CLUSTER_7_DN	2	Down	0.0787948893912982	0.501280758862005
REACTOME_ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S	76	Down	0.078814717664144	0.501280758862005
CHEOK_RESPONSE_TO_HD_MTX_DN	34	Down	0.0788424224882451	0.501280758862005
KUUSELO_PANCREATIC_CANCER_19Q13_AMPLIFICATION	57	Down	0.07899374958845	0.501567840128814
FUJII_YBX1_TARGETS_DN	260	Down	0.0794921180836174	0.504054719230884
BIOCARTA_G2_PATHWAY	32	Down	0.0796519870216446	0.504391403070039
PID_IL8_CXCR1_PATHWAY	39	Down	0.0800619722606282	0.506034502059883
REACTOME_NA_CL_DEPENDENT_NEUROTRANSMITTER_TRANSPORTERS	6	Up	0.0802364029447723	0.506034502059883
VANDESLUIS_COMMD1_TARGETS_GROUP_4_DN	28	Up	0.0802698627342167	0.506034502059883
PID_ERBB1_RECEPTOR_PROXIMAL_PATHWAY	47	Down	0.0803399399968062	0.506034502059883
REACTOME_NGF_SIGNALLING_VIA_TRKA_FROM_THE_PLASMA_MEMBRANE	184	Down	0.0804795472766325	0.506238856637566
BIOCARTA_ALK_PATHWAY	40	Up	0.0807057972181603	0.506986949545996
BRACHAT_RESPONSE_TO_CISPLATIN	24	Up	0.0808929825859484	0.507487981057132
TAKADA_GASTRIC_CANCER_COPY_NUMBER_DN	31	Up	0.08115440245505	0.507807859279981
THUM_MIR21_TARGETS_HEART_DISEASE_UP	41	Up	0.0811589614217582	0.507807859279981
TERAO_AOX4_TARGETS_HG_UP	52	Down	0.0814233511748999	0.508497934666043
POMEROY_MEDULLOBLASTOMA_PROGNOSIS_DN	64	Down	0.0815422715760185	0.508497934666043
PID_FCER1_PATHWAY	90	Down	0.0815921749527647	0.508497934666043
ASTON_MAJOR_DEPRESSIVE_DISORDER_DN	223	Up	0.0817823295190063	0.50900089822451
REACTOME_3_UTR_MEDIATED_TRANSLATIONAL_REGULATION	144	Down	0.0818883748202006	0.50900089822451
REACTOME_CELL_CELL_JUNCTION_ORGANIZATION	38	Up	0.0824205019668771	0.510406238999334
REICHERT_G1S_REGULATORS_AS_PI3K_TARGETS	10	Down	0.0824911560322478	0.510406238999334
BOWIE_RESPONSE_TO_TAMOXIFEN	29	Down	0.0825465722438078	0.510406238999334
MARIADASON_RESPONSE_TO_BUTYRATE_SULINDAC_6	81	Down	0.0825466483055655	0.510406238999334
BIOCARTA_IL6_PATHWAY	34	Down	0.0833040921018858	0.5144163805089
MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_6	7	Up	0.0834523726059261	0.514659279621925
YEGNASUBRAMANIAN_PROSTATE_CANCER	116	Up	0.0835943931994916	0.514862990188264
WEBER_METHYLATED_ICP_IN_SPERM_UP	6	Down	0.0838723218711994	0.515470825823597
HU_GENOTOXIN_ACTION_DIRECT_VS_INDIRECT_24HR	81	Down	0.0839748827708366	0.515470825823597
KEGG_GRAFT_VERSUS_HOST_DISEASE	20	Down	0.0840393675606331	0.515470825823597
KEGG_ABC_TRANSPORTERS	33	Up	0.0842929535989449	0.515470825823597
TERAMOTO_OPN_TARGETS_CLUSTER_1	14	Down	0.0843178063572947	0.515470825823597
PID_ERBB1_INTERNALIZATION_PATHWAY	59	Down	0.0846739149358062	0.515470825823597
BHAT_ESR1_TARGETS_VIA_AKT1_DN	124	Up	0.0847253407129658	0.515470825823597
ZWANG_CLASS_2_TRANSIENTLY_INDUCED_BY_EGF	50	Up	0.0849085483895967	0.515470825823597
COWLING_MYCN_TARGETS	78	Up	0.084951808612718	0.515470825823597
KUROZUMI_RESPONSE_TO_ONCOCYTIC_VIRUS_AND_CYCLIC_RGD	3	Down	0.0849648224656746	0.515470825823597
NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_DN	99	Up	0.0849651199109769	0.515470825823597
REACTOME_GLYCEROPHOSPHOLIPID_BIOSYNTHESIS	63	Down	0.0850024922346702	0.515470825823597
TOMLINS_PROSTATE_CANCER_UP	88	Up	0.0852541947326731	0.515838757118087
KEGG_COLORECTAL_CANCER	72	Down	0.0852815557386169	0.515838757118087
GUTIERREZ_WALDENSTROEMS_MACROGLOBULINEMIA_2	6	Down	0.0854742335011101	0.516343067850696
SEIKE_LUNG_CANCER_POOR_SURVIVAL	2	Down	0.0857801546431216	0.516748840199444
BIOCARTA_DEATH_PATHWAY	38	Down	0.0860051355377605	0.516748840199444
REACTOME_REGULATION_OF_PYRUVATE_DEHYDROGENASE_PDH_COMPLEX	21	Down	0.0860480109152345	0.516748840199444
KEGG_SNARE_INTERACTIONS_IN_VESICULAR_TRANSPORT	33	Up	0.0860790369653387	0.516748840199444
REACTOME_NEF_MEDIATED_DOWNREGULATION_OF_MHC_CLASS_I_COMPLEX_CELL_SURFACE_EXPRESSION	23	Down	0.0860883440383071	0.516748840199444
MANTOVANI_VIRAL_GPCR_SIGNALING_UP	90	Up	0.0862972552374967	0.516827943736582
BIOCARTA_ERK_PATHWAY	46	Down	0.0863203318391539	0.516827943736582
BIOCARTA_PLATELETAPP_PATHWAY	19	Up	0.0865690708660523	0.51766112755852
MIKKELSEN_IPS_ICP_WITH_H3K27ME3	54	Up	0.0869239295698486	0.519125971286934
BOYAULT_LIVER_CANCER_SUBCLASS_G12_UP	52	Down	0.0871677031199748	0.519268817653098
BIOCARTA_IL10_PATHWAY	14	Up	0.0872261244957963	0.519268817653098
REACTOME_SYNTHESIS_OF_PA	19	Down	0.0873555956712004	0.519268817653098
GARY_CD5_TARGETS_UP	667	Down	0.0873875338768444	0.519268817653098
REACTOME_SIGNALING_BY_FGFR_IN_DISEASE	151	Down	0.0875896985423612	0.519816251148385
HOUSTIS_ROS	40	Up	0.0877648489111172	0.520202191036534
MIKI_COEXPRESSED_WITH_CYP19A1	6	Up	0.0879910805507386	0.520289204184149
CHEOK_RESPONSE_TO_HD_MTX_UP	12	Down	0.0884392736771977	0.520289204184149
ABE_VEGFA_TARGETS	17	Down	0.0886141434457461	0.520289204184149
RAY_TUMORIGENESIS_BY_ERBB2_CDC25A_DN	226	Up	0.0886871666241347	0.520289204184149
FAELT_B_CLL_WITH_VH_REARRANGEMENTS_DN	66	Down	0.0888030742478614	0.520289204184149
BYSTRYKH_HEMATOPOIESIS_STEM_CELL_IL3RA	18	Up	0.088809239037308	0.520289204184149
NABA_COLLAGENS	35	Up	0.088871964053717	0.520289204184149
REACTOME_ACTIVATION_OF_CHAPERONE_GENES_BY_ATF6_ALPHA	19	Up	0.0890302684962772	0.520289204184149
GLINSKY_CANCER_DEATH_UP	11	Down	0.0891609111868534	0.520289204184149
REACTOME_PHOSPHOLIPID_METABOLISM	176	Down	0.0891980325374061	0.520289204184149
RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP	837	Down	0.0892263742704258	0.520289204184149
BURTON_ADIPOGENESIS_10	55	Down	0.0892555284081567	0.520289204184149
REACTOME_SHC_MEDIATED_SIGNALLING	19	Down	0.0892608338061811	0.520289204184149
BIOCARTA_SALMONELLA_PATHWAY	21	Up	0.0893823652586646	0.520289204184149
PUJANA_CHEK2_PCC_NETWORK	1089	Down	0.0894315905583254	0.520289204184149
REACTOME_SHC_RELATED_EVENTS	21	Down	0.0896720238441146	0.52104629844969
HOWLIN_CITED1_TARGETS_2_UP	20	Up	0.0899735134986493	0.52215586949339
LUI_TARGETS_OF_PAX8_PPARG_FUSION	60	Down	0.0902528625906724	0.522414813742132
TESAR_ALK_TARGETS_HUMAN_ES_5D_UP	5	Up	0.0903019853278587	0.522414813742132
BENPORATH_ES_WITH_H3K27ME3	936	Up	0.0905061490283311	0.522414813742132
PID_TRAIL_PATHWAY	27	Down	0.0905295062266813	0.522414813742132
DELACROIX_RARG_BOUND_MEF	545	Down	0.0905710695289597	0.522414813742132
YAGUE_PRETUMOR_DRUG_RESISTANCE_UP	13	Up	0.0909215492786423	0.523796827795495
SCHLESINGER_METHYLATED_IN_COLON_CANCER	4	Up	0.0915361048554764	0.52669495656184
ZHENG_FOXP3_TARGETS_IN_T_LYMPHOCYTE_DN	64	Down	0.0920449121609952	0.528455209621765
WAKABAYASHI_ADIPOGENESIS_PPARG_BOUND_36HR	37	Up	0.0920657573070941	0.528455209621765
REACTOME_MEIOTIC_SYNAPSIS	48	Down	0.0925290700073399	0.530470056692565
LUDWICZEK_TREATING_IRON_OVERLOAD	6	Up	0.0927303351624106	0.530979519160276
TRACEY_RESISTANCE_TO_IFNA2_UP	4	Up	0.0928820517674293	0.531204373546411
WANG_BARRETTS_ESOPHAGUS_DN	28	Down	0.0932252413796743	0.531935265952814
REACTOME_PYRUVATE_METABOLISM	27	Down	0.0932350550823307	0.531935265952814
REACTOME_TIE2_SIGNALING	19	Down	0.0941218761358516	0.53507406451646
BIOCARTA_PYK2_PATHWAY	42	Down	0.0943159924603498	0.53507406451646
PODAR_RESPONSE_TO_ADAPHOSTIN_UP	208	Up	0.0944089638679117	0.53507406451646
ABBUD_LIF_SIGNALING_2_DN	11	Up	0.0945344050677827	0.53507406451646
PID_REELIN_PATHWAY	40	Down	0.0945577697418853	0.53507406451646
XU_HGF_SIGNALING_NOT_VIA_AKT1_48HR_DN	35	Down	0.0946394873515548	0.53507406451646
REACTOME_FACILITATIVE_NA_INDEPENDENT_GLUCOSE_TRANSPORTERS	8	Up	0.0947904915865327	0.53507406451646
RICKMAN_METASTASIS_DN	348	Down	0.094872001211846	0.53507406451646
YANG_MUC2_TARGETS_DUODENUM_6MO_UP	2	Down	0.094877389486647	0.53507406451646
NIELSEN_SYNOVIAL_SARCOMA_UP	33	Up	0.0950397113998849	0.53507406451646
GOLDRATH_IMMUNE_MEMORY	82	Down	0.0951665459804804	0.53507406451646
BIOCARTA_EIF_PATHWAY	24	Down	0.0952458444640976	0.53507406451646
MARKS_HDAC_TARGETS_DN	14	Down	0.0952576816804282	0.53507406451646
PUJANA_BRCA2_PCC_NETWORK	652	Down	0.0955526681788298	0.53567807922723
REACTOME_TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES	63	Up	0.0956538733893049	0.53567807922723
AMIT_EGF_RESPONSE_240_MCF10A	41	Up	0.0957214577786515	0.53567807922723
VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_DN	108	Up	0.0958760611818675	0.53567807922723
PID_AR_PATHWAY	92	Down	0.096135662146516	0.53567807922723
MARSON_FOXP3_TARGETS_STIMULATED_UP	33	Down	0.0962155207287948	0.53567807922723
NIELSEN_GIST_VS_SYNOVIAL_SARCOMA_UP	51	Up	0.0962425105820839	0.53567807922723
BRUNEAU_SEPTATION_ATRIAL	8	Up	0.096272372833175	0.53567807922723
OHGUCHI_LIVER_HNF4A_TARGETS_UP	54	Up	0.0969975213662222	0.53863688079264
STONER_ESOPHAGEAL_CARCINOGENESIS_UP	51	Up	0.0970321730640425	0.53863688079264
VISALA_AGING_LYMPHOCYTE_UP	13	Up	0.0973396809527393	0.539058742016331
BIOCARTA_BCELLSURVIVAL_PATHWAY	21	Down	0.0974929640523109	0.539058742016331
HASLINGER_B_CLL_WITH_6Q21_DELETION	24	Down	0.0975547083548288	0.539058742016331
KEGG_PROGESTERONE_MEDIATED_OOCYTE_MATURATION	79	Down	0.0978066091387626	0.539058742016331
FUNG_IL2_SIGNALING_1	10	Up	0.0978234622532685	0.539058742016331
REACTOME_SIGNALLING_TO_P38_VIA_RIT_AND_RIN	17	Down	0.0978310961097335	0.539058742016331
TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN	202	Up	0.0979069434060144	0.539058742016331
REACTOME_HORMONE_SENSITIVE_LIPASE_HSL_MEDIATED_TRIACYLGLYCEROL_HYDROLYSIS	13	Down	0.0981246164415334	0.539628274819329
REACTOME_SYNTHESIS_OF_PIPS_AT_THE_PLASMA_MEMBRANE	32	Down	0.098260420453836	0.539746774678978
WHITFIELD_CELL_CYCLE_M_G1	216	Down	0.0985520697895234	0.5407200669985
KONDO_PROSTATE_CANCER_WITH_H3K27ME3	130	Up	0.0987671239340608	0.541271338125874
JOHNSTONE_PARVB_TARGETS_3_DN	1204	Down	0.099290916825223	0.543511345402495
MARKS_HDAC_TARGETS_UP	33	Down	0.0995157388301627	0.544111516474177
REACTOME_S_PHASE	115	Down	0.0997551163585243	0.544304817267655
HOQUE_METHYLATED_IN_CANCER	54	Up	0.0998444199728367	0.544304817267655
MULLIGHAN_MLL_SIGNATURE_2_UP	523	Down	0.0998967562597496	0.544304817267655
KEGG_NICOTINATE_AND_NICOTINAMIDE_METABOLISM	23	Up	0.10008451638186	0.54469960298146
MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_7	14	Down	0.100259658702599	0.54502488804497
REACTOME_ACTIVATION_OF_THE_AP1_FAMILY_OF_TRANSCRIPTION_FACTORS	9	Up	0.100709639645186	0.546242988411465
SMID_BREAST_CANCER_NORMAL_LIKE_DN	20	Up	0.100714996381538	0.546242988411465
BALLIF_DEVELOPMENTAL_DISABILITY_P16_P12_DELETION	12	Down	0.100837978226561	0.546282808649398
MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_8	15	Down	0.101158219221007	0.547389951431887
COURTOIS_SENESCENCE_TRIGGERS	8	Down	0.101622929908568	0.549275424357066
LEE_EARLY_T_LYMPHOCYTE_DN	64	Down	0.102044187939799	0.550921992945838
ALONSO_METASTASIS_DN	28	Up	0.10227236684182	0.551150595546488
PID_WNT_SIGNALING_PATHWAY	26	Up	0.1030010460573	0.551150595546488
ZHANG_TLX_TARGETS_36HR_DN	289	Down	0.103100015842486	0.551150595546488
BOHN_PRIMARY_IMMUNODEFICIENCY_SYNDROM_UP	62	Down	0.103270153684596	0.551150595546488
KEGG_CITRATE_CYCLE_TCA_CYCLE	40	Down	0.103448168602961	0.551150595546488
REACTOME_METAL_ION_SLC_TRANSPORTERS	19	Up	0.103559030934148	0.551150595546488
REACTOME_G1_PHASE	40	Down	0.103586690622639	0.551150595546488
OSMAN_BLADDER_CANCER_UP	537	Down	0.103634906065815	0.551150595546488
CHOI_ATL_STAGE_PREDICTOR	58	Down	0.103812261501051	0.551150595546488
MIKKELSEN_ES_HCP_WITH_H3_UNMETHYLATED	73	Up	0.103913092588159	0.551150595546488
PEREZ_TP53_AND_TP63_TARGETS	277	Up	0.103952887470489	0.551150595546488
BENPORATH_EED_TARGETS	899	Up	0.103963721504915	0.551150595546488
SAENZ_DETOX_PATHWAY_AND_CARCINOGENESIS_DN	20	Up	0.10401089376806	0.551150595546488
CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_DN	247	Up	0.104029643628788	0.551150595546488
GAUSSMANN_MLL_AF4_FUSION_TARGETS_E_UP	138	Up	0.104162522515497	0.551150595546488
REACTOME_GLOBAL_GENOMIC_NER_GG_NER	34	Down	0.104245428022805	0.551150595546488
SCHAVOLT_TARGETS_OF_TP53_AND_TP63	37	Up	0.104328802818945	0.551150595546488
TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_DN	474	Down	0.10434249829723	0.551150595546488
REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION	177	Up	0.104645626724245	0.551150595546488
KEGG_ERBB_SIGNALING_PATHWAY	81	Down	0.104664892484573	0.551150595546488
ROYLANCE_BREAST_CANCER_16Q_COPY_NUMBER_UP	76	Down	0.104833748565902	0.551150595546488
BIOCARTA_CK1_PATHWAY	24	Down	0.104990476387203	0.551150595546488
WHITFIELD_CELL_CYCLE_G2_M	302	Down	0.105079387488568	0.551150595546488
PID_TELOMERASE_PATHWAY	85	Down	0.10510623892606	0.551150595546488
SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_DN	111	Up	0.105108358275502	0.551150595546488
SMID_BREAST_CANCER_RELAPSE_IN_BRAIN_UP	35	Up	0.105119959057448	0.551150595546488
REACTOME_AMYLOIDS	40	Down	0.105500080704775	0.552530356152279
DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_DN	120	Up	0.105759945277943	0.553072218968275
REACTOME_BOTULINUM_NEUROTOXICITY	16	Up	0.105941182624416	0.553072218968275
NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_UP	126	Down	0.105954775225717	0.553072218968275
SWEET_KRAS_TARGETS_UP	119	Up	0.106517820378154	0.554866751424812
REACTOME_CD28_DEPENDENT_PI3K_AKT_SIGNALING	25	Down	0.106533476617761	0.554866751424812
MIKKELSEN_IPS_HCP_WITH_H3_UNMETHYLATED	74	Up	0.106751478537133	0.555389850891427
REACTOME_SIGNAL_AMPLIFICATION	27	Down	0.107419107845227	0.558068514376947
REACTOME_SIGNALING_BY_SCF_KIT	104	Down	0.107757790511473	0.558068514376947
PID_LYSOPHOSPHOLIPID_PATHWAY	91	Down	0.107898584861033	0.558068514376947
REACTOME_SYNTHESIS_SECRETION_AND_DEACYLATION_OF_GHRELIN	10	Up	0.108083986182583	0.558068514376947
REACTOME_MITOTIC_G1_G1_S_PHASES	147	Down	0.108119256350817	0.558068514376947
KALMA_E2F1_TARGETS	13	Down	0.108269419036775	0.558068514376947
FOURNIER_ACINAR_DEVELOPMENT_LATE_2	402	Down	0.108386687700398	0.558068514376947
KEGG_ENDOMETRIAL_CANCER	55	Down	0.108450581084842	0.558068514376947
LENAOUR_DENDRITIC_CELL_MATURATION_DN	183	Down	0.108523726584989	0.558068514376947
MAHADEVAN_IMATINIB_RESISTANCE_UP	24	Up	0.108529140556753	0.558068514376947
REACTOME_SYNTHESIS_OF_GLYCOSYLPHOSPHATIDYLINOSITOL_GPI	17	Up	0.108565826569097	0.558068514376947
MUELLER_PLURINET	382	Down	0.108898067802387	0.559167904672257
REACTOME_MEIOSIS	78	Down	0.109026139815224	0.55921768131066
PID_IL2_1PATHWAY	72	Down	0.109184206935913	0.559421034235633
BIOCARTA_MCM_PATHWAY	19	Down	0.109505594776818	0.560459837189259
FUJIWARA_PARK2_HEPATOCYTE_PROLIFERATION_UP	16	Up	0.110223422148932	0.563523210207312
KEGG_NEUROTROPHIN_SIGNALING_PATHWAY	133	Down	0.110518192247482	0.564419394786061
REACTOME_ADP_SIGNALLING_THROUGH_P2RY1	21	Down	0.110712691323454	0.56453757898243
BASSO_CD40_SIGNALING_UP	125	Down	0.110780342023013	0.56453757898243
KEGG_GNRH_SIGNALING_PATHWAY	88	Down	0.110940458219933	0.564744315335092
MARKS_ACETYLATED_NON_HISTONE_PROTEINS	19	Down	0.111440224108423	0.566677738092775
REACTOME_TRIGLYCERIDE_BIOSYNTHESIS	41	Down	0.111639527078253	0.56668350982942
CHEN_PDGF_TARGETS	30	Up	0.111681275963419	0.56668350982942
KANNAN_TP53_TARGETS_DN	31	Up	0.111842691194754	0.566893640776841
REACTOME_RNA_POL_I_PROMOTER_OPENING	29	Down	0.112224386179732	0.568080424553252
ELVIDGE_HYPOXIA_BY_DMOG_DN	79	Up	0.112317340502273	0.568080424553252
CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_UP	543	Up	0.112588050173693	0.568405623952385
PID_AVB3_OPN_PATHWAY	46	Down	0.112626558332463	0.568405623952385
WHITEHURST_PACLITAXEL_SENSITIVITY	46	Down	0.112742605767016	0.568405623952385
KEGG_CHEMOKINE_SIGNALING_PATHWAY	159	Down	0.113237831627509	0.569260167954364
ISHIDA_TARGETS_OF_SYT_SSX_FUSIONS	7	Up	0.11330196293106	0.569260167954364
REACTOME_PROSTACYCLIN_SIGNALLING_THROUGH_PROSTACYCLIN_RECEPTOR	15	Down	0.113307840661166	0.569260167954364
YANG_BREAST_CANCER_ESR1_BULK_UP	30	Up	0.113444904798436	0.569260167954364
LIU_VAV3_PROSTATE_CARCINOGENESIS_UP	116	Up	0.113514622822399	0.569260167954364
OUILLETTE_CLL_13Q14_DELETION_DN	102	Down	0.114068662283481	0.571431983697949
REACTOME_GAB1_SIGNALOSOME	59	Down	0.114567231774013	0.57332012224185
TSUNODA_CISPLATIN_RESISTANCE_DN	76	Up	0.114746760583524	0.57332012224185
REACTOME_ABC_FAMILY_PROTEINS_MEDIATED_TRANSPORT	28	Up	0.114830018600458	0.57332012224185
MIKKELSEN_DEDIFFERENTIATED_STATE_UP	7	Up	0.114939140764174	0.57332012224185
SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP	693	Down	0.115052386935917	0.57332012224185
PID_MET_PATHWAY	102	Down	0.11529519098124	0.573924638772791
ZHENG_GLIOBLASTOMA_PLASTICITY_DN	89	Up	0.116064710661113	0.577147045434839
MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_17	29	Down	0.116698925718333	0.577318467124266
SHIN_B_CELL_LYMPHOMA_CLUSTER_6	6	Down	0.116807020441128	0.577318467124266
GAURNIER_PSMD4_TARGETS	50	Down	0.116889675065194	0.577318467124266
GOLDRATH_HOMEOSTATIC_PROLIFERATION	250	Down	0.117100207734026	0.577318467124266
INAMURA_LUNG_CANCER_SCC_SUBTYPES_DN	6	Down	0.117189603126663	0.577318467124266
BOUDOUKHA_BOUND_BY_IGF2BP2	152	Down	0.117253264399743	0.577318467124266
MARIADASON_RESPONSE_TO_CURCUMIN_SULINDAC_7	24	Down	0.117264935502778	0.577318467124266
REACTOME_KERATAN_SULFATE_DEGRADATION	20	Down	0.117370107992701	0.577318467124266
TOMLINS_METASTASIS_DN	28	Up	0.117507800134991	0.577318467124266
PID_NFAT_TFPATHWAY	42	Down	0.117526685340819	0.577318467124266
BUSA_SAM68_TARGETS_DN	7	Up	0.117700293212452	0.577318467124266
HOLLEMAN_DAUNORUBICIN_B_ALL_DN	19	Down	0.117783547956063	0.577318467124266
PID_FAS_PATHWAY	43	Down	0.1179984825782	0.577318467124266
DELLA_RESPONSE_TO_TSA_AND_BUTYRATE	39	Up	0.118250851775034	0.577318467124266
MEISSNER_BRAIN_HCP_WITH_H3K4ME3_AND_H3K27ME3	1079	Up	0.118275967534286	0.577318467124266
TURASHVILI_BREAST_CARCINOMA_DUCTAL_VS_LOBULAR_DN	8	Up	0.118278076969555	0.577318467124266
SABATES_COLORECTAL_ADENOMA_DN	255	Up	0.118286463756042	0.577318467124266
BIOCARTA_MCALPAIN_PATHWAY	40	Down	0.118298957700315	0.577318467124266
KEGG_PYRUVATE_METABOLISM	51	Down	0.11858994623199	0.577802021829561
WANG_CISPLATIN_RESPONSE_AND_XPC_DN	322	Down	0.118642667479821	0.577802021829561
BHAT_ESR1_TARGETS_NOT_VIA_AKT1_UP	221	Up	0.118928825536124	0.578599147098505
REACTOME_N_GLYCAN_TRIMMING_IN_THE_ER_AND_CALNEXIN_CALRETICULIN_CYCLE	15	Up	0.119055140075088	0.57861777954189
MATZUK_SPERMATOCYTE	88	Down	0.119472878729282	0.578856653686735
WILCOX_RESPONSE_TO_PROGESTERONE_DN	112	Up	0.119497840156395	0.578856653686735
LEE_LIVER_CANCER_E2F1_UP	86	Up	0.119534719588743	0.578856653686735
KANG_AR_TARGETS_UP	29	Up	0.119594431413686	0.578856653686735
CHIANG_LIVER_CANCER_SUBCLASS_INTERFERON_UP	24	Up	0.119813650677434	0.579324141044216
KEEN_RESPONSE_TO_ROSIGLITAZONE_UP	40	Down	0.120352004050219	0.581332174982859
BIOCARTA_IGF1MTOR_PATHWAY	31	Down	0.120483147227983	0.581371182334006
THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_DN	332	Down	0.120655614933792	0.581470312213729
HINATA_NFKB_TARGETS_KERATINOCYTE_DN	37	Up	0.120754822732727	0.581470312213729
DAUER_STAT3_TARGETS_UP	73	Up	0.120872956518603	0.581470312213729
PID_P73PATHWAY	113	Down	0.121202606686371	0.581507152058321
BIOCARTA_TEL_PATHWAY	31	Down	0.121212550239345	0.581507152058321
WATANABE_ULCERATIVE_COLITIS_WITH_CANCER_UP	32	Up	0.121249903636208	0.581507152058321
KEGG_DORSO_VENTRAL_AXIS_FORMATION	25	Down	0.121501478566186	0.582122702582822
CHARAFE_BREAST_CANCER_BASAL_VS_MESENCHYMAL_UP	148	Up	0.122025203816337	0.58365919891051
ZHU_CMV_24_HR_DN	150	Up	0.122078817605978	0.58365919891051
NIELSEN_SCHWANNOMA_DN	37	Up	0.122192833980206	0.58365919891051
KERLEY_RESPONSE_TO_CISPLATIN_DN	5	Down	0.123602925269814	0.588842462770933
NABA_BASEMENT_MEMBRANES	44	Up	0.123761539491891	0.588842462770933
TSENG_IRS1_TARGETS_UP	158	Up	0.123779513448264	0.588842462770933
KEGG_OOCYTE_MEIOSIS	101	Down	0.123832771265131	0.588842462770933
WONG_ENDMETRIUM_CANCER_DN	115	Up	0.124117074044839	0.588842462770933
OHASHI_AURKA_TARGETS	8	Down	0.124176066539905	0.588842462770933
DELPUECH_FOXO3_TARGETS_DN	56	Down	0.124346706235475	0.588842462770933
KEGG_GLYCOSYLPHOSPHATIDYLINOSITOL_GPI_ANCHOR_BIOSYNTHESIS	23	Up	0.124386475458598	0.588842462770933
BIOCARTA_INTRINSIC_PATHWAY	19	Up	0.124399825962191	0.588842462770933
BERENJENO_TRANSFORMED_BY_RHOA_FOREVER_DN	60	Up	0.124860322848381	0.589377054765953
REACTOME_THROMBOXANE_SIGNALLING_THROUGH_TP_RECEPTOR	18	Down	0.124866004343861	0.589377054765953
CROONQUIST_STROMAL_STIMULATION_DN	11	Down	0.124897338728932	0.589377054765953
REACTOME_APOPTOTIC_CLEAVAGE_OF_CELL_ADHESION_PROTEINS	12	Up	0.125011813902516	0.589377054765953
REACTOME_SYNTHESIS_OF_SUBSTRATES_IN_N_GLYCAN_BIOSYTHESIS	17	Up	0.125147086440974	0.589426556677129
KORKOLA_EMBRYONIC_CARCINOMA_VS_SEMINOMA_DN	24	Up	0.125384640500331	0.58964459389019
ROSS_AML_WITH_PML_RARA_FUSION	113	Up	0.125657854675008	0.58964459389019
PANGAS_TUMOR_SUPPRESSION_BY_SMAD1_AND_SMAD5_UP	189	Down	0.125690025670903	0.58964459389019
NIKOLSKY_BREAST_CANCER_16Q24_AMPLICON	74	Down	0.12581001802197	0.58964459389019
REACTOME_TCA_CYCLE_AND_RESPIRATORY_ELECTRON_TRANSPORT	146	Down	0.125817474733555	0.58964459389019
REACTOME_SIGNALING_BY_FGFR3_MUTANTS	7	Up	0.126490748739671	0.59086792617456
REACTOME_FGFR2C_LIGAND_BINDING_AND_ACTIVATION	7	Up	0.126490748739671	0.59086792617456
DUTERTRE_ESTRADIOL_RESPONSE_6HR_DN	133	Up	0.126598322123956	0.59086792617456
KRIEG_HYPOXIA_NOT_VIA_KDM3A	979	Down	0.126602332449851	0.59086792617456
ENGELMANN_CANCER_PROGENITORS_UP	60	Down	0.126703896954875	0.59086792617456
REACTOME_CHYLOMICRON_MEDIATED_LIPID_TRANSPORT	12	Up	0.127195136935724	0.592048043492166
REACTOME_REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_ACTIVITY_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS	17	Up	0.12724626570994	0.592048043492166
ICHIBA_GRAFT_VERSUS_HOST_DISEASE_35D_DN	45	Up	0.127395543117799	0.592048043492166
REACTOME_EXTRINSIC_PATHWAY_FOR_APOPTOSIS	12	Down	0.127485468560487	0.592048043492166
GALLUZZI_PERMEABILIZE_MITOCHONDRIA	54	Down	0.127583596163214	0.592048043492166
THILLAINADESAN_ZNF217_TARGETS_UP	55	Down	0.127911010650067	0.592620730823283
MELLMAN_TUT1_TARGETS_UP	26	Down	0.127957905469887	0.592620730823283
ZHOU_PANCREATIC_ENDOCRINE_PROGENITOR	3	Up	0.128259264267722	0.59343463702323
VERRECCHIA_RESPONSE_TO_TGFB1_C1	47	Up	0.128609266692001	0.593660936918127
XU_HGF_TARGETS_REPRESSED_BY_AKT1_UP	10	Down	0.128638277572979	0.593660936918127
IVANOV_MUTATED_IN_COLON_CANCER	15	Up	0.128685181922981	0.593660936918127
KEGG_GLYCOSAMINOGLYCAN_DEGRADATION	24	Down	0.129106819565054	0.594741915509917
KIM_GERMINAL_CENTER_T_HELPER_DN	47	Up	0.129251401553453	0.594741915509917
VERHAAK_GLIOBLASTOMA_MESENCHYMAL	298	Down	0.129297194586936	0.594741915509917
LINDGREN_BLADDER_CANCER_CLUSTER_1_DN	499	Down	0.129682651990568	0.595934677046149
CONRAD_STEM_CELL	38	Down	0.130067157853668	0.596785544542218
KOBAYASHI_EGFR_SIGNALING_24HR_UP	146	Up	0.130756975187626	0.596785544542218
HUNSBERGER_EXERCISE_REGULATED_GENES	47	Down	0.130809384306093	0.596785544542218
DAZARD_UV_RESPONSE_CLUSTER_G3	12	Down	0.130913925131663	0.596785544542218
REACTOME_GLYCOPROTEIN_HORMONES	4	Up	0.131038387152351	0.596785544542218
REACTOME_PEPTIDE_HORMONE_BIOSYNTHESIS	4	Up	0.131038387152351	0.596785544542218
REACTOME_PHOSPHORYLATION_OF_THE_APC_C	22	Down	0.131084862600539	0.596785544542218
ZIRN_TRETINOIN_RESPONSE_WT1_DN	20	Down	0.131295364362684	0.596785544542218
HUANG_GATA2_TARGETS_DN	81	Up	0.131355010573129	0.596785544542218
PID_E2F_PATHWAY	86	Down	0.131430005980245	0.596785544542218
KAUFFMANN_MELANOMA_RELAPSE_UP	67	Down	0.131464532697099	0.596785544542218
BOYLAN_MULTIPLE_MYELOMA_C_D_DN	280	Up	0.131474380507074	0.596785544542218
BIOCARTA_DREAM_PATHWAY	18	Down	0.131515716887082	0.596785544542218
PID_HDAC_CLASSIII_PATHWAY	42	Down	0.131724120884919	0.596785544542218
BIOCARTA_SARS_PATHWAY	13	Up	0.131819289913709	0.596785544542218
WEST_ADRENOCORTICAL_TUMOR_MARKERS_UP	24	Down	0.131889100021608	0.596785544542218
KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	59	Down	0.132982476063587	0.601157145382187
BIOCARTA_AKAPCENTROSOME_PATHWAY	28	Down	0.13341223403044	0.602523320802867
HEIDENBLAD_AMPLICON_12P11_12_UP	44	Up	0.133746361266163	0.602550627597918
GAZDA_DIAMOND_BLACKFAN_ANEMIA_MYELOID_UP	36	Down	0.133798377541673	0.602550627597918
ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_DN	27	Down	0.133800933181672	0.602550627597918
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_DN	20	Down	0.134256910584097	0.603281856181981
VERRECCHIA_DELAYED_RESPONSE_TO_TGFB1	85	Up	0.134310055236634	0.603281856181981
SIG_CHEMOTAXIS	51	Down	0.134346425212414	0.603281856181981
ZHAN_VARIABLE_EARLY_DIFFERENTIATION_GENES_DN	46	Down	0.134816782763842	0.604793513154806
CHESLER_BRAIN_D6MIT150_QTL_CIS	8	Down	0.134939111529459	0.604793513154806
JAZAG_TGFB1_SIGNALING_UP	141	Down	0.135176813548735	0.604866471063371
INAMURA_LUNG_CANCER_SCC_UP	17	Up	0.135830590244695	0.604866471063371
NIELSEN_MALIGNAT_FIBROUS_HISTIOCYTOMA_DN	39	Up	0.135879880750635	0.604866471063371
WANG_ADIPOGENIC_GENES_REPRESSED_BY_SIRT1	46	Up	0.135918804834309	0.604866471063371
BIOCARTA_GATA3_PATHWAY	17	Down	0.135992330791806	0.604866471063371
CROSBY_E2F4_TARGETS	6	Down	0.136022476661862	0.604866471063371
ACEVEDO_LIVER_CANCER_WITH_H3K27ME3_DN	186	Down	0.136040960953333	0.604866471063371
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_UP	101	Up	0.136053705605111	0.604866471063371
REACTOME_MICRORNA_MIRNA_BIOGENESIS	24	Up	0.136188930542846	0.604866471063371
BORCZUK_MALIGNANT_MESOTHELIOMA_UP	445	Down	0.136342065679612	0.604866471063371
CHEN_LVAD_SUPPORT_OF_FAILING_HEART_UP	115	Up	0.136363842439138	0.604866471063371
GILDEA_METASTASIS	72	Up	0.136581930914418	0.605265517485657
GRADE_COLON_AND_RECTAL_CANCER_UP	416	Down	0.137021658029844	0.606485672151309
REACTOME_MRNA_DECAY_BY_3_TO_5_EXORIBONUCLEASE	10	Down	0.137232250258106	0.606485672151309
CHEOK_RESPONSE_TO_MERCAPTOPURINE_DN	18	Down	0.137293343725664	0.606485672151309
WILCOX_RESPONSE_TO_PROGESTERONE_UP	192	Down	0.137370802117252	0.606485672151309
REACTOME_TRAFFICKING_AND_PROCESSING_OF_ENDOSOMAL_TLR	31	Down	0.137506833137374	0.606519402185766
HOFFMANN_SMALL_PRE_BII_TO_IMMATURE_B_LYMPHOCYTE_UP	76	Down	0.137777150357117	0.607017166352223
KEGG_BASE_EXCISION_REPAIR	36	Down	0.137876676438598	0.607017166352223
HUMMERICH_MALIGNANT_SKIN_TUMOR_UP	42	Up	0.138422871672217	0.607343866682648
GAUSSMANN_MLL_AF4_FUSION_TARGETS_A_UP	304	Down	0.138425965057931	0.607343866682648
GRADE_COLON_CANCER_DN	41	Up	0.138449930774774	0.607343866682648
ZHAN_MULTIPLE_MYELOMA_CD1_UP	49	Up	0.138465144880866	0.607343866682648
WINZEN_DEGRADED_VIA_KHSRP	108	Up	0.138790324529783	0.607900932166148
PID_ERBB4_PATHWAY	53	Down	0.138855542223165	0.607900932166148
BIOCARTA_INTEGRIN_PATHWAY	62	Down	0.139164459262328	0.607900932166148
BIOCARTA_LEPTIN_PATHWAY	11	Up	0.139278349461052	0.607900932166148
KEGG_NUCLEOTIDE_EXCISION_REPAIR	48	Down	0.139281225613556	0.607900932166148
OHGUCHI_LIVER_HNF4A_TARGETS_DN	103	Up	0.13936424841997	0.607900932166148
LUI_THYROID_CANCER_CLUSTER_2	78	Up	0.139770361488603	0.609109951727084
YORDY_RECIPROCAL_REGULATION_BY_ETS1_AND_SP100_UP	32	Down	0.140069266254301	0.609800993321152
ZHAN_MULTIPLE_MYELOMA_CD1_AND_CD2_DN	67	Down	0.140187103883736	0.609800993321152
XU_AKT1_TARGETS_6HR	44	Down	0.140352204208295	0.609957509365213
SAMOLS_TARGETS_OF_KHSV_MIRNAS_DN	77	Up	0.140698406958212	0.610168133130915
REACTOME_CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM	268	Down	0.140700366521676	0.610168133130915
CAIRO_HEPATOBLASTOMA_DN	301	Up	0.140853383430191	0.610168133130915
KEGG_ARGININE_AND_PROLINE_METABOLISM	48	Up	0.140917322871683	0.610168133130915
REACTOME_NCAM1_INTERACTIONS	53	Up	0.141362855315165	0.611536747718717
FLECHNER_PBL_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP	225	Down	0.141717951932785	0.612511989872348
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_TURQUOISE_DN	76	Down	0.141883789041319	0.61266820788957
REACTOME_INTEGRATION_OF_PROVIRUS	11	Down	0.142128446212737	0.612927333529189
KAUFFMANN_DNA_REPLICATION_GENES	151	Down	0.142284636863798	0.612927333529189
LEI_HOXC8_TARGETS_UP	13	Up	0.142621290018603	0.612927333529189
NIELSEN_LEIOMYOSARCOMA_CNN1_UP	24	Up	0.14264655971119	0.612927333529189
PID_INSULIN_PATHWAY	60	Down	0.14272152455178	0.612927333529189
REACTOME_PROCESSIVE_SYNTHESIS_ON_THE_LAGGING_STRAND	16	Down	0.14284307492265	0.612927333529189
NOJIMA_SFRP2_TARGETS_DN	27	Down	0.142940157681677	0.612927333529189
BIOCARTA_VEGF_PATHWAY	42	Down	0.142981778482042	0.612927333529189
ZEMBUTSU_SENSITIVITY_TO_VINBLASTINE	29	Up	0.143150251802642	0.613093190857374
HAHTOLA_CTCL_CUTANEOUS	31	Up	0.144355572298726	0.617695401756506
SCHURINGA_STAT5A_TARGETS_UP	20	Up	0.144880262980906	0.619379513413393
KEGG_VIRAL_MYOCARDITIS	58	Down	0.145066381998755	0.619614456204446
PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_6	33	Up	0.145723881408859	0.621315343612162
RAMJAUN_APOPTOSIS_BY_TGFB1_VIA_SMAD4_DN	13	Down	0.145896884555695	0.621315343612162
ZHANG_TLX_TARGETS_UP	157	Down	0.14597423929741	0.621315343612162
KEGG_TIGHT_JUNCTION	106	Down	0.146138863885874	0.621315343612162
REACTOME_TRANSPORT_TO_THE_GOLGI_AND_SUBSEQUENT_MODIFICATION	34	Up	0.146354227136206	0.621315343612162
REACTOME_COSTIMULATION_BY_THE_CD28_FAMILY	49	Down	0.14640781858131	0.621315343612162
MARSON_BOUND_BY_E2F4_UNSTIMULATED	850	Down	0.14655269506223	0.621315343612162
ONDER_CDH1_TARGETS_1_UP	209	Up	0.14661088928871	0.621315343612162
REACTOME_AMINE_DERIVED_HORMONES	3	Up	0.146648308240381	0.621315343612162
REACTOME_MEIOTIC_RECOMBINATION	49	Down	0.14687325742211	0.621710813675671
ROVERSI_GLIOMA_COPY_NUMBER_DN	59	Down	0.147092196967184	0.622062914671475
GAZIN_EPIGENETIC_SILENCING_BY_KRAS	33	Down	0.147615904604066	0.622062914671475
SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_DN	129	Up	0.147629155199625	0.622062914671475
DOANE_BREAST_CANCER_ESR1_UP	138	Up	0.147656507532895	0.622062914671475
FARMER_BREAST_CANCER_CLUSTER_4	54	Up	0.147707550313954	0.622062914671475
MEINHOLD_OVARIAN_CANCER_LOW_GRADE_DN	30	Down	0.148013313119041	0.622062914671475
BIOCARTA_TCAPOPTOSIS_PATHWAY	1	Up	0.148158813790783	0.622062914671475
MEISSNER_BRAIN_ICP_WITH_H3K4ME3	55	Up	0.148344722920204	0.622062914671475
REACTOME_E2F_MEDIATED_REGULATION_OF_DNA_REPLICATION	39	Down	0.148421468642537	0.622062914671475
NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_UP	35	Down	0.148496566821081	0.622062914671475
HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_1_DN	60	Down	0.148539739439261	0.622062914671475
KEGG_HISTIDINE_METABOLISM	20	Up	0.148659001019375	0.622062914671475
TIEN_INTESTINE_PROBIOTICS_24HR_DN	316	Up	0.148668296076227	0.622062914671475
CROONQUIST_STROMAL_STIMULATION_UP	135	Up	0.149047909780991	0.62257013194621
BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_DN	50	Up	0.149053094672134	0.62257013194621
SMID_BREAST_CANCER_NORMAL_LIKE_UP	429	Up	0.149442123381406	0.623643631496254
ALCALAY_AML_BY_NPM1_LOCALIZATION_DN	212	Down	0.15035032835477	0.623932670741531
KEGG_LONG_TERM_POTENTIATION	62	Down	0.150425565746371	0.623932670741531
REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_7ALPHA_HYDROXYCHOLESTEROL	50	Up	0.150834392386334	0.623932670741531
MIKKELSEN_MEF_HCP_WITH_H3_UNMETHYLATED	174	Up	0.150874360989032	0.623932670741531
REACTOME_GLUCOSE_METABOLISM	71	Down	0.150938902462204	0.623932670741531
HEDVAT_ELF4_TARGETS_UP	15	Up	0.151055514236066	0.623932670741531
STAMBOLSKY_BOUND_BY_MUTATED_TP53	22	Down	0.151060193047739	0.623932670741531
KEGG_PRIMARY_IMMUNODEFICIENCY	21	Down	0.151422296385519	0.623932670741531
MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_23	20	Down	0.151466581111748	0.623932670741531
DAWSON_METHYLATED_IN_LYMPHOMA_TCL1	65	Up	0.151542650424337	0.623932670741531
LAU_APOPTOSIS_CDKN2A_UP	66	Down	0.151641588397323	0.623932670741531
KEGG_AUTOIMMUNE_THYROID_DISEASE	22	Down	0.151657393034608	0.623932670741531
QI_PLASMACYTOMA_DN	170	Up	0.151704625974876	0.623932670741531
REACTOME_SHC1_EVENTS_IN_EGFR_SIGNALING	23	Down	0.15173635169227	0.623932670741531
SASAKI_ADULT_T_CELL_LEUKEMIA	266	Down	0.151923896252536	0.623932670741531
MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_25	7	Up	0.151930277491044	0.623932670741531
TCGA_GLIOBLASTOMA_MUTATED	11	Down	0.151999932380573	0.623932670741531
TIEN_INTESTINE_PROBIOTICS_2HR_DN	133	Up	0.152212497379978	0.623932670741531
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_15	59	Up	0.152279018466973	0.623932670741531
BOYLAN_MULTIPLE_MYELOMA_C_CLUSTER_DN	44	Up	0.152318347789057	0.623932670741531
PAPASPYRIDONOS_UNSTABLE_ATEROSCLEROTIC_PLAQUE_UP	75	Down	0.152320164219143	0.623932670741531
GAUTSCHI_SRC_SIGNALING	8	Up	0.15250093789872	0.623932670741531
LI_WILMS_TUMOR_VS_FETAL_KIDNEY_2_DN	77	Up	0.152572736521067	0.623932670741531
KEEN_RESPONSE_TO_ROSIGLITAZONE_DN	172	Up	0.152681237802119	0.623932670741531
TIEN_INTESTINE_PROBIOTICS_24HR_UP	785	Down	0.153023963583299	0.624627335536506
FIGUEROA_AML_METHYLATION_CLUSTER_5_UP	12	Down	0.153115676238627	0.624627335536506
BOWIE_RESPONSE_TO_EXTRACELLULAR_MATRIX	28	Down	0.153433537545663	0.624935435165981
BROWN_MYELOID_CELL_DEVELOPMENT_UP	184	Down	0.153606040645827	0.624935435165981
REACTOME_REGULATION_OF_SIGNALING_BY_CBL	21	Down	0.153701800376735	0.624935435165981
KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP	167	Down	0.153800361639707	0.624935435165981
GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_UP	310	Up	0.153862722482775	0.624935435165981
BIOCARTA_ETC_PATHWAY	14	Down	0.154044098272428	0.624935435165981
SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_DN	86	Down	0.154117227343008	0.624935435165981
NIKOLSKY_BREAST_CANCER_6P24_P22_AMPLICON	22	Down	0.155035817105452	0.62794174910325
GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_UP	300	Up	0.15512447527593	0.62794174910325
BENPORATH_CYCLING_GENES	834	Down	0.155494230375387	0.628899609840176
WEBER_METHYLATED_LCP_IN_SPERM_UP	4	Up	0.155710958396444	0.628976560536914
SEITZ_NEOPLASTIC_TRANSFORMATION_BY_8P_DELETION_DN	34	Down	0.155779546110963	0.628976560536914
SANA_RESPONSE_TO_IFNG_DN	130	Down	0.155913453115801	0.628979634943677
REACTOME_PI3K_EVENTS_IN_ERBB4_SIGNALING	57	Down	0.15621511032667	0.629273070531955
PARK_OSTEOBLAST_DIFFERENTIATION_BY_PHENYLAMIL_DN	8	Down	0.156413739067538	0.629273070531955
YAMANAKA_GLIOBLASTOMA_SURVIVAL_UP	14	Up	0.156483561287884	0.629273070531955
KEGG_ALANINE_ASPARTATE_AND_GLUTAMATE_METABOLISM	30	Up	0.156519021565421	0.629273070531955
PID_MAPK_TRK_PATHWAY	46	Down	0.156726904179501	0.629524610231687
BIOCARTA_ACE2_PATHWAY	15	Up	0.156848108857472	0.629524610231687
WIERENGA_STAT5A_TARGETS_GROUP2	60	Up	0.157083198604251	0.629863644938543
MONNIER_POSTRADIATION_TUMOR_ESCAPE_UP	584	Down	0.157318481274369	0.629863644938543
FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_UP	236	Down	0.158070936699975	0.629863644938543
PID_HDAC_CLASSI_PATHWAY	80	Down	0.158168723905864	0.629863644938543
PID_ILK_PATHWAY	63	Down	0.158354545181923	0.629863644938543
MIYAGAWA_TARGETS_OF_EWSR1_ETS_FUSIONS_DN	315	Up	0.158420803366515	0.629863644938543
PATIL_LIVER_CANCER	1004	Down	0.158526735092959	0.629863644938543
YANG_BREAST_CANCER_ESR1_UP	50	Up	0.158761569297346	0.629863644938543
PIONTEK_PKD1_TARGETS_DN	25	Down	0.158777884855242	0.629863644938543
BENPORATH_SUZ12_TARGETS	869	Up	0.158874648574176	0.629863644938543
CHO_NR4A1_TARGETS	44	Up	0.158924177889981	0.629863644938543
GREENBAUM_E2A_TARGETS_DN	29	Up	0.158930483090894	0.629863644938543
SMID_BREAST_CANCER_LUMINAL_B_DN	548	Up	0.158987312963831	0.629863644938543
REACTOME_TRNA_AMINOACYLATION	45	Down	0.159139322160001	0.629863644938543
ST_WNT_CA2_CYCLIC_GMP_PATHWAY	16	Down	0.159236320397169	0.629863644938543
BIOCARTA_IL3_PATHWAY	25	Down	0.159491240168403	0.629863644938543
REACTOME_SHC1_EVENTS_IN_ERBB4_SIGNALING	28	Down	0.159686964504407	0.629863644938543
CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_DN	165	Up	0.159703799631316	0.629863644938543
ODONNELL_METASTASIS_UP	108	Up	0.159773433019931	0.629863644938543
REACTOME_REPAIR_SYNTHESIS_FOR_GAP_FILLING_BY_DNA_POL_IN_TC_NER	15	Down	0.159813392809051	0.629863644938543
BIOCARTA_HER2_PATHWAY	32	Down	0.159862544168009	0.629863644938543
REACTOME_PLATELET_AGGREGATION_PLUG_FORMATION	36	Down	0.15997447771374	0.629863644938543
YAMAZAKI_TCEB3_TARGETS_DN	320	Down	0.159999232414533	0.629863644938543
BIOCARTA_EPONFKB_PATHWAY	16	Down	0.160626137740323	0.631687406800735
RAFFEL_VEGFA_TARGETS_DN	3	Up	0.160763596802181	0.631687406800735
ROSS_AML_OF_FAB_M7_TYPE	98	Up	0.160863664348282	0.631687406800735
KASLER_HDAC7_TARGETS_2_DN	54	Down	0.16112109695675	0.631972709930852
LI_INDUCED_T_TO_NATURAL_KILLER_UP	389	Down	0.161296263017143	0.631972709930852
BREDEMEYER_RAG_SIGNALING_VIA_ATM_NOT_VIA_NFKB_UP	84	Down	0.161560328429498	0.631972709930852
ACEVEDO_LIVER_CANCER_WITH_H3K9ME3_DN	137	Down	0.161615481921802	0.631972709930852
WEINMANN_ADAPTATION_TO_HYPOXIA_UP	55	Up	0.161676737385182	0.631972709930852
GENTLES_LEUKEMIC_STEM_CELL_DN	13	Down	0.161805490551909	0.631972709930852
GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_DN	2368	Down	0.16207356987792	0.631972709930852
REACTOME_ACYL_CHAIN_REMODELLING_OF_PG	8	Down	0.162276479471359	0.631972709930852
WAGNER_APO2_SENSITIVITY	17	Down	0.1625000647065	0.631972709930852
BIOCARTA_CDK5_PATHWAY	16	Down	0.162768732573722	0.631972709930852
HOLLEMAN_ASPARAGINASE_RESISTANCE_ALL_UP	32	Down	0.162872570207228	0.631972709930852
AMUNDSON_POOR_SURVIVAL_AFTER_GAMMA_RADIATION_2G	218	Down	0.163089608984087	0.631972709930852
REACTOME_PROTEOLYTIC_CLEAVAGE_OF_SNARE_COMPLEX_PROTEINS	15	Up	0.163511257590352	0.631972709930852
NIKOLSKY_BREAST_CANCER_7P22_AMPLICON	50	Up	0.163563558787915	0.631972709930852
TAVOR_CEBPA_TARGETS_DN	41	Down	0.163790084629422	0.631972709930852
REACTOME_INFLUENZA_VIRAL_RNA_TRANSCRIPTION_AND_REPLICATION	136	Down	0.163879901945415	0.631972709930852
KRIGE_AMINO_ACID_DEPRIVATION	39	Up	0.163972948065847	0.631972709930852
BIOCARTA_LYM_PATHWAY	6	Down	0.16400466971108	0.631972709930852
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_YELLOW_DN	28	Down	0.164187869506216	0.631972709930852
REACTOME_PI3K_AKT_ACTIVATION	57	Down	0.164236470070292	0.631972709930852
REACTOME_SIGNALING_BY_CONSTITUTIVELY_ACTIVE_EGFR	27	Down	0.164248854088876	0.631972709930852
MARZEC_IL2_SIGNALING_DN	48	Up	0.164420787658814	0.631972709930852
ST_GA12_PATHWAY	37	Up	0.164445928022724	0.631972709930852
JI_CARCINOGENESIS_BY_KRAS_AND_STK11_UP	10	Down	0.164511719435315	0.631972709930852
ROZANOV_MMP14_TARGETS_SUBSET	75	Up	0.164619865536965	0.631972709930852
REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS	53	Up	0.164681590222357	0.631972709930852
BIOCARTA_CDMAC_PATHWAY	25	Down	0.164786113583593	0.631972709930852
SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP	124	Down	0.165207946004341	0.631972709930852
CAFFAREL_RESPONSE_TO_THC_24HR_3_UP	18	Up	0.165266034788558	0.631972709930852
KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP	155	Down	0.165292248695971	0.631972709930852
BIOCARTA_BIOPEPTIDES_PATHWAY	55	Down	0.165480107232092	0.631972709930852
WENG_POR_TARGETS_LIVER_DN	24	Up	0.165599685310595	0.631972709930852
RORIE_TARGETS_OF_EWSR1_FLI1_FUSION_DN	27	Up	0.165624657668405	0.631972709930852
VANOEVELEN_MYOGENESIS_SIN3A_TARGETS	334	Down	0.165660119258191	0.631972709930852
MIKKELSEN_NPC_WITH_LCP_H3K27ME3	5	Down	0.165735017738417	0.631972709930852
REACTOME_IRAK2_MEDIATED_ACTIVATION_OF_TAK1_COMPLEX_UPON_TLR7_8_OR_9_STIMULATION	10	Up	0.165752368248164	0.631972709930852
WELCSH_BRCA1_TARGETS_DN	218	Down	0.165985192036135	0.632000288591055
WALLACE_PROSTATE_CANCER_DN	9	Up	0.166231647896131	0.632000288591055
BIOCARTA_PAR1_PATHWAY	49	Down	0.166330067750451	0.632000288591055
PID_PS1_PATHWAY	70	Down	0.166454723011622	0.632000288591055
PID_TNF_PATHWAY	54	Up	0.166529439482417	0.632000288591055
DANG_MYC_TARGETS_UP	200	Down	0.166666744422256	0.632000288591055
AIYAR_COBRA1_TARGETS_UP	44	Down	0.167186383365312	0.632000288591055
BUSA_SAM68_TARGETS_UP	10	Down	0.16722711158714	0.632000288591055
LOCKWOOD_AMPLIFIED_IN_LUNG_CANCER	331	Down	0.167383504019666	0.632000288591055
CHESLER_BRAIN_D6MIT150_QTL_TRANS	6	Up	0.167412839186752	0.632000288591055
BIOCARTA_NO2IL12_PATHWAY	8	Up	0.167420906235456	0.632000288591055
KEGG_PANCREATIC_CANCER	80	Down	0.167431600820938	0.632000288591055
JOHNSTONE_PARVB_TARGETS_2_DN	489	Down	0.167587413577625	0.632000288591055
BIOCARTA_ARAP_PATHWAY	21	Up	0.167632591364224	0.632000288591055
BIOCARTA_TCRA_PATHWAY	7	Down	0.168055307221274	0.632729236168749
REACTOME_NONSENSE_MEDIATED_DECAY_ENHANCED_BY_THE_EXON_JUNCTION_COMPLEX	148	Down	0.168093816975398	0.632729236168749
LINDGREN_BLADDER_CANCER_HIGH_RECURRENCE	92	Up	0.168606984034586	0.63362813191921
CHIANG_LIVER_CANCER_SUBCLASS_INTERFERON_DN	116	Up	0.168782583001544	0.63362813191921
REACTOME_GABA_B_RECEPTOR_ACTIVATION	26	Down	0.168881049849386	0.63362813191921
REACTOME_SPHINGOLIPID_DE_NOVO_BIOSYNTHESIS	34	Down	0.168995906843008	0.63362813191921
MARTINEZ_RESPONSE_TO_TRABECTEDIN_UP	78	Down	0.169084010279256	0.63362813191921
MULLIGAN_NTF3_SIGNALING_VIA_INSR_AND_IGF1R_DN	16	Up	0.16913739931205	0.63362813191921
REACTOME_PYRUVATE_METABOLISM_AND_CITRIC_ACID_TCA_CYCLE	52	Down	0.169465850841027	0.634355530406508
REACTOME_GAP_JUNCTION_TRAFFICKING	17	Up	0.169754747298681	0.63467282399412
SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX5_UP	15	Up	0.16984286981393	0.63467282399412
KEGG_T_CELL_RECEPTOR_SIGNALING_PATHWAY	97	Down	0.170142521222685	0.63467282399412
REACTOME_SIGNALLING_BY_NGF	278	Down	0.170216234909317	0.63467282399412
ZHANG_TLX_TARGETS_36HR_UP	332	Down	0.170231747158957	0.63467282399412
NABA_MATRISOME	579	Up	0.170585270180744	0.63467282399412
REACTOME_LAGGING_STRAND_SYNTHESIS	20	Down	0.170672448221937	0.63467282399412
KERLEY_RESPONSE_TO_CISPLATIN_UP	64	Up	0.170715677920931	0.63467282399412
OXFORD_RALA_OR_RALB_TARGETS_UP	65	Down	0.170759771231272	0.63467282399412
KANG_IMMORTALIZED_BY_TERT_UP	122	Up	0.17125879652657	0.635732531198324
PETROVA_ENDOTHELIUM_LYMPHATIC_VS_BLOOD_UP	171	Down	0.171314037302173	0.635732531198324
MATTHEWS_AP1_TARGETS	20	Down	0.172465915087059	0.638983633312113
REACTOME_RECRUITMENT_OF_NUMA_TO_MITOTIC_CENTROSOMES	13	Down	0.172866202838829	0.638983633312113
REACTOME_P2Y_RECEPTORS	5	Up	0.172921424359467	0.638983633312113
GUTIERREZ_WALDENSTROEMS_MACROGLOBULINEMIA_1_UP	14	Down	0.172945677575804	0.638983633312113
REACTOME_ACETYLCHOLINE_NEUROTRANSMITTER_RELEASE_CYCLE	11	Up	0.173094479898364	0.638983633312113
PEREZ_TP63_TARGETS	480	Up	0.173332057838434	0.638983633312113
ALONSO_METASTASIS_EMT_UP	50	Up	0.173421173481032	0.638983633312113
REACTOME_PI_METABOLISM	46	Down	0.173505719724456	0.638983633312113
REACTOME_NOD1_2_SIGNALING_PATHWAY	32	Up	0.173556492502612	0.638983633312113
REACTOME_G_ALPHA1213_SIGNALLING_EVENTS	81	Down	0.173666948449439	0.638983633312113
KEGG_GLYCEROPHOSPHOLIPID_METABOLISM	59	Down	0.173857736889151	0.638983633312113
PID_ERBB1_DOWNSTREAM_PATHWAY	155	Down	0.173907820086841	0.638983633312113
MIKKELSEN_MCV6_ICP_WITH_H3K4ME3_AND_H3K27ME3	38	Up	0.173948550474043	0.638983633312113
FOURNIER_ACINAR_DEVELOPMENT_EARLY_DN	11	Down	0.174673803362227	0.640562684146942
REACTOME_INTERFERON_ALPHA_BETA_SIGNALING	62	Down	0.17479889767003	0.640562684146942
KIM_PTEN_TARGETS_UP	25	Up	0.174827675803392	0.640562684146942
BIOCARTA_PLCE_PATHWAY	17	Down	0.175002565044582	0.640562684146942
KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_DN	89	Down	0.17505639822898	0.640562684146942
YUAN_ZNF143_PARTNERS	29	Down	0.175287601398979	0.640911987830166
HOEGERKORP_CD44_TARGETS_TEMPORAL_UP	12	Up	0.17557441730533	0.640911987830166
REACTOME_INTEGRIN_ALPHAIIB_BETA3_SIGNALING	32	Down	0.175742836968627	0.640911987830166
LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_DN	226	Down	0.175754146788469	0.640911987830166
PID_FOXO_PATHWAY	60	Down	0.175914199241706	0.640911987830166
REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT	159	Up	0.175965886582499	0.640911987830166
CHNG_MULTIPLE_MYELOMA_HYPERPLOID_UP	72	Down	0.176107047001372	0.640931964587426
CROMER_TUMORIGENESIS_UP	84	Up	0.176993939558234	0.643663872573592
VERRECCHIA_EARLY_RESPONSE_TO_TGFB1	138	Up	0.177529639106063	0.645115396259264
ONGUSAHA_TP53_TARGETS	42	Up	0.178271946031843	0.646686395299779
BIOCARTA_MITOCHONDRIA_PATHWAY	23	Down	0.17832090525398	0.646686395299779
MIKKELSEN_MCV6_ICP_WITH_H3K27ME3	67	Up	0.178476967238768	0.646686395299779
MATZUK_LUTEAL_GENES	9	Down	0.178509538414672	0.646686395299779
REACTOME_THE_NLRP3_INFLAMMASOME	11	Up	0.178855929235516	0.647199808494885
DEN_INTERACT_WITH_LCA5	33	Down	0.178949632605406	0.647199808494885
IKEDA_MIR133_TARGETS_UP	70	Down	0.179062267083576	0.647199808494885
PILON_KLF1_TARGETS_DN	2514	Down	0.179657843643953	0.648680820976912
ZHENG_FOXP3_TARGETS_UP	37	Down	0.179878637501045	0.648680820976912
GERHOLD_RESPONSE_TO_TZD_DN	12	Up	0.180016273000672	0.648680820976912
XU_HGF_TARGETS_INDUCED_BY_AKT1_6HR	30	Down	0.180221971822214	0.648680820976912
HOWLIN_CITED1_TARGETS_2_DN	46	Up	0.180261527507957	0.648680820976912
STEIN_ESR1_TARGETS	93	Down	0.180307163898584	0.648680820976912
VERRECCHIA_RESPONSE_TO_TGFB1_C4	44	Up	0.18043323428528	0.648680820976912
BONOME_OVARIAN_CANCER_POOR_SURVIVAL_UP	48	Up	0.181205620867572	0.649996698738619
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_17	229	Down	0.181556906566704	0.649996698738619
IWANAGA_E2F1_TARGETS_INDUCED_BY_SERUM	39	Down	0.181580697475383	0.649996698738619
AMIT_SERUM_RESPONSE_240_MCF10A	101	Up	0.18159691910857	0.649996698738619
SANSOM_WNT_PATHWAY_REQUIRE_MYC	73	Up	0.181873713059635	0.649996698738619
BURTON_ADIPOGENESIS_11	107	Up	0.181969452367234	0.649996698738619
SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX4_DN	46	Up	0.181995885635143	0.649996698738619
WANG_TARGETS_OF_MLL_CBP_FUSION_DN	54	Down	0.1819959519358	0.649996698738619
KEGG_HYPERTROPHIC_CARDIOMYOPATHY_HCM	77	Up	0.182037602123453	0.649996698738619
CHEOK_RESPONSE_TO_MERCAPTOPURINE_AND_LD_MTX_UP	18	Down	0.18235520940544	0.650638979781948
REACTOME_ALPHA_LINOLENIC_ACID_ALA_METABOLISM	24	Up	0.18269204628604	0.65134885030585
NIELSEN_LIPOSARCOMA_UP	17	Up	0.183602541349624	0.653763155209546
VECCHI_GASTRIC_CANCER_EARLY_UP	511	Down	0.183735406359301	0.653763155209546
MA_MYELOID_DIFFERENTIATION_UP	60	Down	0.183784392489051	0.653763155209546
PID_HNF3A_PATHWAY	34	Up	0.184021090619789	0.654112589983358
RADAEVA_RESPONSE_TO_IFNA1_UP	71	Down	0.184255888025966	0.654454748146365
FLOTHO_PEDIATRIC_ALL_THERAPY_RESPONSE_UP	61	Down	0.184795321738179	0.655253255285266
REACTOME_TIGHT_JUNCTION_INTERACTIONS	16	Up	0.184844905913274	0.655253255285266
XU_AKT1_TARGETS_48HR	8	Down	0.184997700459587	0.655253255285266
RANKIN_ANGIOGENIC_TARGETS_OF_VHL_HIF2A_UP	6	Up	0.185035529752444	0.655253255285266
REACTOME_ADHERENS_JUNCTIONS_INTERACTIONS	22	Up	0.185449668860224	0.655518470145383
HIRSCH_CELLULAR_TRANSFORMATION_SIGNATURE_DN	194	Down	0.185759756668897	0.655518470145383
VERNOCHET_ADIPOGENESIS	13	Up	0.185859262624551	0.655518470145383
REACTOME_ELEVATION_OF_CYTOSOLIC_CA2_LEVELS	5	Down	0.185898481858611	0.655518470145383
TESAR_JAK_TARGETS_MOUSE_ES_D3_DN	4	Down	0.186035166032939	0.655518470145383
BIOCARTA_AHSP_PATHWAY	8	Up	0.186165278020171	0.655518470145383
BIOCARTA_AMI_PATHWAY	19	Up	0.186198644438881	0.655518470145383
BOYLAN_MULTIPLE_MYELOMA_D_DN	92	Down	0.186225263782651	0.655518470145383
YAMASHITA_METHYLATED_IN_PROSTATE_CANCER	74	Up	0.186359294116268	0.655518470145383
KEGG_PENTOSE_PHOSPHATE_PATHWAY	26	Down	0.186808267178933	0.656608820054525
CHANG_POU5F1_TARGETS_UP	33	Up	0.18785468021557	0.659795917723684
REACTOME_G1_S_TRANSITION	117	Down	0.188012713602796	0.659860370772367
KAYO_AGING_MUSCLE_UP	301	Up	0.188154530524245	0.65986785612215
WANG_BARRETTS_ESOPHAGUS_AND_ESOPHAGUS_CANCER_UP	38	Up	0.188521374675278	0.660294274723079
TESAR_ALK_TARGETS_EPISC_4D_UP	4	Up	0.188577828968722	0.660294274723079
HELLER_SILENCED_BY_METHYLATION_DN	129	Up	0.188695442607146	0.660294274723079
BIOCARTA_ACTINY_PATHWAY	27	Up	0.188929151044917	0.660317437830538
CAFFAREL_RESPONSE_TO_THC_DN	62	Down	0.188981620649214	0.660317437830538
PID_IL3_PATHWAY	38	Down	0.189347065206573	0.660553513491755
SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP	419	Down	0.189382568352857	0.660553513491755
SCHLOSSER_SERUM_RESPONSE_UP	221	Down	0.18954570197963	0.660553513491755
REACTOME_NEUROTRANSMITTER_RECEPTOR_BINDING_AND_DOWNSTREAM_TRANSMISSION_IN_THE_POSTSYNAPTIC_CELL	97	Down	0.189671334047853	0.660553513491755
BIOCARTA_CHEMICAL_PATHWAY	28	Down	0.189855397902273	0.660553513491755
REACTOME_ACTIVATION_OF_KAINATE_RECEPTORS_UPON_GLUTAMATE_BINDING	25	Down	0.189888160737046	0.660553513491755
PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_4	134	Up	0.190442670508632	0.66199497828019
KEGG_GLYCOLYSIS_GLUCONEOGENESIS	66	Down	0.191232847094366	0.663786135502464
REACTOME_OTHER_SEMAPHORIN_INTERACTIONS	23	Up	0.191364473801571	0.663786135502464
HU_ANGIOGENESIS_UP	47	Up	0.191633734470656	0.663786135502464
DAIRKEE_CANCER_PRONE_RESPONSE_BPA_E2	185	Down	0.191645625738649	0.663786135502464
KARLSSON_TGFB1_TARGETS_UP	173	Down	0.191777358003828	0.663786135502464
SHIPP_DLBCL_VS_FOLLICULAR_LYMPHOMA_UP	77	Down	0.191801031956152	0.663786135502464
KYNG_DNA_DAMAGE_BY_4NQO_OR_GAMMA_RADIATION	23	Up	0.192365682830368	0.665252917782325
SU_LIVER	50	Up	0.19328139776253	0.667930741060856
OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_DN	57	Up	0.193753729982084	0.668274670477553
REACTOME_SMOOTH_MUSCLE_CONTRACTION	34	Down	0.193782124913736	0.668274670477553
JOHNSTONE_PARVB_TARGETS_1_UP	12	Up	0.193869423205211	0.668274670477553
SASAI_TARGETS_OF_CXCR6_AND_PTCH1_DN	5	Down	0.19407223778837	0.668274670477553
REACTOME_TANDEM_PORE_DOMAIN_POTASSIUM_CHANNELS	4	Down	0.19426414099546	0.668274670477553
KYNG_WERNER_SYNDROM_AND_NORMAL_AGING_UP	117	Down	0.194329458426031	0.668274670477553
TAVAZOIE_METASTASIS	132	Up	0.194508873392907	0.668274670477553
KANG_CISPLATIN_RESISTANCE_UP	21	Down	0.194512631648314	0.668274670477553
ZHOU_TNF_SIGNALING_30MIN	96	Down	0.194702645679132	0.668305263607774
STEARMAN_TUMOR_FIELD_EFFECT_UP	27	Down	0.194804476712088	0.668305263607774
VALK_AML_WITH_11Q23_REARRANGED	16	Down	0.194954892736189	0.668335931266876
GRADE_COLON_CANCER_UP	1199	Down	0.195748385599825	0.670569523983737
CHEN_LUNG_CANCER_SURVIVAL	42	Up	0.196363916225455	0.672066790565645
HOOI_ST7_TARGETS_UP	130	Up	0.196469991060787	0.672066790565645
BIOCARTA_CCR3_PATHWAY	37	Down	0.196619611874738	0.672091929447367
SAKAI_TUMOR_INFILTRATING_MONOCYTES_DN	111	Down	0.196839297480833	0.672356356687964
ZHAN_LATE_DIFFERENTIATION_GENES_UP	48	Down	0.197478453524786	0.672911886929386
LEIN_ASTROCYTE_MARKERS	43	Down	0.197748012776428	0.672911886929386
MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_16	17	Down	0.19777963866348	0.672911886929386
TARTE_PLASMA_CELL_VS_PLASMABLAST_DN	436	Down	0.198041214266389	0.672911886929386
NUTT_GBM_VS_AO_GLIOMA_UP	89	Down	0.198065058066512	0.672911886929386
MIZUSHIMA_AUTOPHAGOSOME_FORMATION	34	Up	0.198107497288753	0.672911886929386
LEE_CALORIE_RESTRICTION_MUSCLE_UP	46	Down	0.198116204055332	0.672911886929386
KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_DN	99	Down	0.198198400843235	0.672911886929386
MARTINELLI_IMMATURE_NEUTROPHIL_UP	1	Down	0.198415892568603	0.672911886929386
CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_3	883	Up	0.198480949989548	0.672911886929386
ZHANG_PROLIFERATING_VS_QUIESCENT	80	Up	0.198702257919143	0.672911886929386
PENG_GLUTAMINE_DEPRIVATION_DN	491	Down	0.198833704901091	0.672911886929386
EHLERS_ANEUPLOIDY_UP	49	Down	0.198853724418591	0.672911886929386
KEGG_GAP_JUNCTION	80	Down	0.199276723731762	0.67383224340923
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_MAGENTA_UP	96	Up	0.199410981432283	0.67383224340923
CROONQUIST_NRAS_VS_STROMAL_STIMULATION_DN	184	Down	0.199758751725318	0.674052588965372
KEGG_PROSTATE_CANCER	93	Down	0.199892999202166	0.674052588965372
BIOCARTA_CHREBP2_PATHWAY	41	Down	0.200188700952779	0.674052588965372
FARMER_BREAST_CANCER_CLUSTER_8	9	Up	0.200214865864677	0.674052588965372
LIU_LIVER_CANCER	46	Up	0.200318482734065	0.674052588965372
KRASNOSELSKAYA_ILF3_TARGETS_UP	78	Down	0.200332310522308	0.674052588965372
CAIRO_HEPATOBLASTOMA_CLASSES_UP	775	Down	0.200945338657326	0.675634006987336
SCHLESINGER_H3K27ME3_IN_NORMAL_AND_METHYLATED_IN_CANCER	29	Up	0.20112710562356	0.675764187031078
GNATENKO_PLATELET_SIGNATURE	92	Down	0.201291092204794	0.675834484417516
ZHENG_RESPONSE_TO_ARSENITE_UP	24	Down	0.201463676946866	0.67593352975639
KIM_ALL_DISORDERS_DURATION_CORR_DN	185	Down	0.201721735202316	0.675987698498348
BYSTROEM_CORRELATED_WITH_IL5_DN	97	Down	0.201766015004799	0.675987698498348
VALK_AML_WITH_CEBPA	46	Up	0.201996007194082	0.676278623660415
MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_22	17	Up	0.202235693066548	0.676485761808188
HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS	123	Up	0.202344280574718	0.676485761808188
REACTOME_KERATAN_SULFATE_KERATIN_METABOLISM	37	Down	0.202495877193744	0.676513807541193
LEE_LIVER_CANCER_MYC_E2F1_UP	88	Up	0.203073912240392	0.677965485105025
PID_THROMBIN_PAR4_PATHWAY	19	Down	0.203563774507656	0.678830248337729
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_RED_UP	26	Up	0.203808220264518	0.678830248337729
FLOTHO_PEDIATRIC_ALL_THERAPY_RESPONSE_DN	32	Down	0.203922069121053	0.678830248337729
CHUNG_BLISTER_CYTOTOXICITY_DN	70	Down	0.204053312837531	0.678830248337729
DUNNE_TARGETS_OF_AML1_MTG8_FUSION_UP	46	Up	0.204358222666156	0.678830248337729
FRASOR_RESPONSE_TO_ESTRADIOL_UP	38	Up	0.204556232058012	0.678830248337729
WEBER_METHYLATED_HCP_IN_SPERM_UP	19	Down	0.204608785668889	0.678830248337729
BIOCARTA_EIF2_PATHWAY	16	Down	0.204702420227241	0.678830248337729
STEGER_ADIPOGENESIS_DN	30	Up	0.204781385109147	0.678830248337729
MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_29	6	Up	0.205106664864215	0.678830248337729
REACTOME_METABOLISM_OF_RNA	318	Down	0.205161098512359	0.678830248337729
FARDIN_HYPOXIA_9	8	Up	0.205192310027692	0.678830248337729
BIOCARTA_CELL2CELL_PATHWAY	16	Down	0.205201014950524	0.678830248337729
TOOKER_GEMCITABINE_RESISTANCE_DN	170	Down	0.205705844533491	0.680024079479504
TSUNODA_CISPLATIN_RESISTANCE_UP	17	Up	0.206625510097735	0.681548045287219
RAMJAUN_APOPTOSIS_BY_TGFB1_VIA_MAPK1_DN	8	Down	0.206637522221494	0.681548045287219
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_1	107	Up	0.206741761976808	0.681548045287219
LINDVALL_IMMORTALIZED_BY_TERT_DN	127	Up	0.207195962068931	0.681548045287219
MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_5	9	Down	0.207341328034529	0.681548045287219
KEGG_OLFACTORY_TRANSDUCTION	28	Down	0.207394114369206	0.681548045287219
REACTOME_INTERACTIONS_OF_VPR_WITH_HOST_CELLULAR_PROTEINS	36	Down	0.207421699299599	0.681548045287219
REACTOME_INTRINSIC_PATHWAY_FOR_APOPTOSIS	36	Down	0.207494157952049	0.681548045287219
BRACHAT_RESPONSE_TO_CAMPTOTHECIN_DN	71	Down	0.207730501085407	0.681548045287219
MARSON_FOXP3_CORE_DIRECT_TARGETS	32	Down	0.207774162743571	0.681548045287219
ZHAN_MULTIPLE_MYELOMA_CD1_VS_CD2_UP	76	Up	0.207960862112696	0.681548045287219
REACTOME_INHIBITION_OF_THE_PROTEOLYTIC_ACTIVITY_OF_APC_C_REQUIRED_FOR_THE_ONSET_OF_ANAPHASE_BY_MITOTIC_SPINDLE_CHECKPOINT_COMPONENTS	20	Down	0.207964300868753	0.681548045287219
KEGG_VASCULAR_SMOOTH_MUSCLE_CONTRACTION	90	Down	0.208121825428874	0.681548045287219
VILIMAS_NOTCH1_TARGETS_UP	42	Down	0.208200566973985	0.681548045287219
REACTOME_SIGNALING_BY_THE_B_CELL_RECEPTOR_BCR	149	Down	0.208355679540258	0.681548045287219
HAN_JNK_SINGALING_UP	57	Down	0.208531115834424	0.681548045287219
ACEVEDO_LIVER_CANCER_WITH_H3K27ME3_UP	347	Up	0.208619490576909	0.681548045287219
NAKAMURA_ADIPOGENESIS_LATE_DN	54	Up	0.208871054830995	0.68189831584079
WESTON_VEGFA_TARGETS_12HR	59	Up	0.209886217387255	0.68459823311414
KEGG_TYROSINE_METABOLISM	46	Up	0.209987900038609	0.68459823311414
REACTOME_TRANSLOCATION_OF_ZAP_70_TO_IMMUNOLOGICAL_SYNAPSE	4	Down	0.210205470711136	0.684834926647868
AZARE_STAT3_TARGETS	39	Up	0.210454732596362	0.685174470561828
REACTOME_SHC_MEDIATED_CASCADE	19	Down	0.210757011435626	0.685585365793311
BAELDE_DIABETIC_NEPHROPATHY_UP	95	Down	0.210961131342984	0.685585365793311
BIOCARTA_RANKL_PATHWAY	17	Up	0.211080132554851	0.685585365793311
GRANDVAUX_IRF3_TARGETS_DN	18	Down	0.211161453689515	0.685585365793311
PID_RETINOIC_ACID_PATHWAY	40	Down	0.211599543753834	0.686379903654953
SA_B_CELL_RECEPTOR_COMPLEXES	31	Down	0.211696765373681	0.686379903654953
REACTOME_PURINE_CATABOLISM	10	Up	0.212138392029961	0.686648596563477
ZHAN_MULTIPLE_MYELOMA_HP_UP	54	Up	0.212408877723913	0.686648596563477
TSENG_ADIPOGENIC_POTENTIAL_UP	50	Up	0.212507210482663	0.686648596563477
MARSON_FOXP3_TARGETS_UP	105	Down	0.21251531170558	0.686648596563477
LY_AGING_PREMATURE_DN	44	Down	0.212537879330398	0.686648596563477
GOERING_BLOOD_HDL_CHOLESTEROL_QTL_CIS	14	Down	0.212706785905565	0.686648596563477
LU_TUMOR_VASCULATURE_UP	47	Up	0.212797109519249	0.686648596563477
KEGG_STEROID_HORMONE_BIOSYNTHESIS	24	Up	0.213039404435574	0.686753663138998
KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP	1628	Down	0.213197499776253	0.686753663138998
LIANG_SILENCED_BY_METHYLATION_UP	45	Up	0.213626819231444	0.686753663138998
CHEMELLO_SOLEUS_VS_EDL_MYOFIBERS_DN	30	Down	0.21376981344179	0.686753663138998
GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_DN	8	Down	0.213781721588315	0.686753663138998
ST_GA13_PATHWAY	47	Down	0.214190318507023	0.686753663138998
DING_LUNG_CANCER_MUTATED_FREQUENTLY	19	Down	0.214303161425226	0.686753663138998
ST_ADRENERGIC	44	Down	0.214442074289155	0.686753663138998
GRAHAM_CML_DIVIDING_VS_NORMAL_DIVIDING_DN	8	Up	0.21444721248022	0.686753663138998
REACTOME_FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION	117	Down	0.214480729084834	0.686753663138998
AMIT_EGF_RESPONSE_480_HELA	269	Down	0.214512970722319	0.686753663138998
REACTOME_ACTIVATION_OF_CHAPERONES_BY_ATF6_ALPHA	21	Up	0.214592884489016	0.686753663138998
ICHIBA_GRAFT_VERSUS_HOST_DISEASE_35D_UP	126	Down	0.214840013520211	0.686753663138998
KARLSSON_TGFB1_TARGETS_DN	330	Up	0.214864926782269	0.686753663138998
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_0	92	Up	0.215150476257393	0.686776323755244
RUAN_RESPONSE_TO_TNF_TROGLITAZONE_DN	53	Up	0.215294054501954	0.686776323755244
REACTOME_BRANCHED_CHAIN_AMINO_ACID_CATABOLISM	44	Down	0.215326358472316	0.686776323755244
BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_A	972	Up	0.215600521033225	0.686776323755244
TESAR_ALK_AND_JAK_TARGETS_MOUSE_ES_D4_DN	2	Up	0.215701290259141	0.686776323755244
PID_HIF1A_PATHWAY	24	Up	0.215744298148345	0.686776323755244
ZHAN_MULTIPLE_MYELOMA_CD2_DN	74	Down	0.216255704264627	0.687504802444322
BASSO_HAIRY_CELL_LEUKEMIA_UP	4	Down	0.216308745155443	0.687504802444322
RIZ_ERYTHROID_DIFFERENTIATION_APOBEC2	34	Up	0.216628729744322	0.687504802444322
RUIZ_TNC_TARGETS_DN	187	Down	0.216662290201583	0.687504802444322
JIANG_CORE_DUPLICON_GENES	10	Up	0.216700815165029	0.687504802444322
REACTOME_REMOVAL_OF_THE_FLAP_INTERMEDIATE_FROM_THE_C_STRAND	11	Down	0.216970883935043	0.687816223567217
PENG_GLUCOSE_DEPRIVATION_DN	261	Down	0.217121224042706	0.687816223567217
REACTOME_SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX	88	Down	0.217496979449096	0.687816223567217
BONOME_OVARIAN_CANCER_SURVIVAL_SUBOPTIMAL_DEBULKING	692	Down	0.217508809131131	0.687816223567217
EINAV_INTERFERON_SIGNATURE_IN_CANCER	29	Down	0.217566460087179	0.687816223567217
TESAR_ALK_TARGETS_EPISC_3D_UP	7	Up	0.217672577102665	0.687816223567217
ZHAN_MULTIPLE_MYELOMA_DN	70	Up	0.218102571571693	0.688714270123449
PID_INTEGRIN2_PATHWAY	16	Down	0.218462562794276	0.689288702476789
ZHANG_INTERFERON_RESPONSE	32	Down	0.21857630743231	0.689288702476789
WANG_TUMOR_INVASIVENESS_UP	561	Down	0.21877802390121	0.689464566317087
PID_NFKAPPAB_CANONICAL_PATHWAY	32	Down	0.219031693728697	0.68964248700139
BIOCARTA_MYOSIN_PATHWAY	42	Down	0.219126454908782	0.68964248700139
YANG_BCL3_TARGETS_DN	10	Up	0.219429015833409	0.690134933952747
MEISSNER_NPC_HCP_WITH_H3_UNMETHYLATED	499	Up	0.219684657994398	0.690479257728235
NAKAMURA_CANCER_MICROENVIRONMENT_UP	45	Up	0.220437575403937	0.690597639732975
REACTOME_SIGNAL_TRANSDUCTION_BY_L1	43	Down	0.220518116283354	0.690597639732975
PID_S1P_S1P1_PATHWAY	37	Up	0.220545956282129	0.690597639732975
PID_AMB2_NEUTROPHILS_PATHWAY	51	Down	0.220576171204349	0.690597639732975
DEMAGALHAES_AGING_UP	79	Down	0.220724868156055	0.690597639732975
CHICAS_RB1_TARGETS_SENESCENT	719	Down	0.221094185972056	0.690597639732975
REACTOME_CELL_JUNCTION_ORGANIZATION	69	Up	0.221116240666137	0.690597639732975
NAKAYAMA_FGF2_TARGETS	54	Up	0.221233171956419	0.690597639732975
NOUZOVA_METHYLATED_IN_APL	91	Up	0.221249772506006	0.690597639732975
HANSON_HRAS_SIGNALING_VIA_NFKB	27	Up	0.221283868754769	0.690597639732975
RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_UP	315	Down	0.221330403589273	0.690597639732975
DAZARD_UV_RESPONSE_CLUSTER_G24	38	Down	0.221581975263239	0.690926238378575
ZHAN_MULTIPLE_MYELOMA_HP_DN	57	Down	0.22174950647333	0.690992525448556
NIKOLSKY_BREAST_CANCER_12Q24_AMPLICON	18	Up	0.221960407267745	0.691002516590494
RHODES_UNDIFFERENTIATED_CANCER	130	Down	0.222058169441803	0.691002516590494
VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN	143	Up	0.222314222312817	0.691002516590494
SCHWAB_TARGETS_OF_BMYB_POLYMORPHIC_VARIANTS_UP	15	Down	0.222448252132666	0.691002516590494
ZWANG_EGF_PERSISTENTLY_UP	67	Down	0.222484087157947	0.691002516590494
CROMER_METASTASIS_DN	133	Down	0.222833681288451	0.691633581081895
SMID_BREAST_CANCER_ERBB2_UP	190	Up	0.223370279931961	0.691938507506487
ST_FAS_SIGNALING_PATHWAY	79	Up	0.223898797608291	0.691938507506487
RICKMAN_HEAD_AND_NECK_CANCER_E	77	Up	0.22408199703736	0.691938507506487
JIANG_HYPOXIA_VIA_VHL	44	Down	0.224182625743575	0.691938507506487
SHARMA_ASTROCYTOMA_WITH_NF1_SYNDROM	4	Up	0.224281944872283	0.691938507506487
REACTOME_STRIATED_MUSCLE_CONTRACTION	27	Down	0.224366660966783	0.691938507506487
ONDER_CDH1_TARGETS_2_UP	385	Up	0.224379808809552	0.691938507506487
YAN_ESCAPE_FROM_ANOIKIS	39	Down	0.224451234489739	0.691938507506487
REACTOME_THE_ROLE_OF_NEF_IN_HIV1_REPLICATION_AND_DISEASE_PATHOGENESIS	49	Down	0.224548437402534	0.691938507506487
KEGG_FC_EPSILON_RI_SIGNALING_PATHWAY	61	Down	0.224559160656701	0.691938507506487
LINDGREN_BLADDER_CANCER_CLUSTER_3_UP	416	Down	0.224654515826262	0.691938507506487
RODWELL_AGING_KIDNEY_NO_BLOOD_DN	160	Down	0.224689600024333	0.691938507506487
PID_NEPHRIN_NEPH1_PATHWAY	34	Down	0.22532229357323	0.693200910485472
ABRAMSON_INTERACT_WITH_AIRE	68	Down	0.225393014078257	0.693200910485472
LEIN_OLIGODENDROCYTE_MARKERS	81	Up	0.226195589749327	0.69332425801314
BASAKI_YBX1_TARGETS_UP	372	Down	0.226356180542432	0.69332425801314
OUYANG_PROSTATE_CANCER_MARKERS	50	Up	0.226418474017618	0.69332425801314
MANALO_HYPOXIA_DN	336	Down	0.22659498553872	0.69332425801314
VALK_AML_CLUSTER_2	36	Up	0.226941711480802	0.69332425801314
ST_PAC1_RECEPTOR_PATHWAY	7	Down	0.226996376059707	0.69332425801314
LUI_THYROID_CANCER_PAX8_PPARG_UP	82	Down	0.227009991432625	0.69332425801314
SLEBOS_HEAD_AND_NECK_CANCER_WITH_HPV_UP	87	Down	0.227140516360734	0.69332425801314
REACTOME_SIGNALING_BY_PDGF	162	Down	0.227183488712479	0.69332425801314
REACTOME_CD28_CO_STIMULATION	34	Down	0.22730025689552	0.69332425801314
BOYAULT_LIVER_CANCER_SUBCLASS_G123_DN	73	Up	0.227312531052859	0.69332425801314
DANG_REGULATED_BY_MYC_DN	367	Up	0.227326540012653	0.69332425801314
REACTOME_PLATELET_HOMEOSTASIS	61	Down	0.227453198076592	0.69332425801314
IVANOVA_HEMATOPOIESIS_STEM_CELL_SHORT_TERM	44	Down	0.227556857413049	0.69332425801314
GAL_LEUKEMIC_STEM_CELL_UP	162	Up	0.227699586925175	0.69332425801314
MCBRYAN_PUBERTAL_BREAST_5_6WK_UP	135	Up	0.227781381972141	0.69332425801314
MORI_SMALL_PRE_BII_LYMPHOCYTE_DN	144	Down	0.22832550085229	0.693897743507883
REACTOME_MRNA_PROCESSING	187	Down	0.22847341814306	0.693897743507883
PID_A6B1_A6B4_INTEGRIN_PATHWAY	56	Down	0.228524141011341	0.693897743507883
SESTO_RESPONSE_TO_UV_C6	56	Down	0.22886972799722	0.693897743507883
LEE_NAIVE_T_LYMPHOCYTE	17	Down	0.229130333401631	0.693897743507883
RIZ_ERYTHROID_DIFFERENTIATION_6HR	37	Up	0.229137611912236	0.693897743507883
DING_LUNG_CANCER_EXPRESSION_BY_COPY_NUMBER	138	Down	0.229153385430326	0.693897743507883
BIOCARTA_CARDIACEGF_PATHWAY	25	Down	0.229237120692061	0.693897743507883
CHAN_INTERFERON_PRODUCING_DENDRITIC_CELL	2	Down	0.229748590954186	0.693897743507883
REACTOME_METABOLISM_OF_MRNA	270	Down	0.229767975447846	0.693897743507883
REACTOME_UNFOLDED_PROTEIN_RESPONSE	108	Up	0.229861410226247	0.693897743507883
KEGG_P53_SIGNALING_PATHWAY	86	Down	0.229922576749311	0.693897743507883
REACTOME_PLATELET_ADHESION_TO_EXPOSED_COLLAGEN	41	Up	0.230029052513352	0.693897743507883
BOSCO_INTERFERON_INDUCED_ANTIVIRAL_MODULE	78	Down	0.230038063847971	0.693897743507883
MALONEY_RESPONSE_TO_17AAG_DN	156	Down	0.230282255835727	0.693897743507883
CAFFAREL_RESPONSE_TO_THC_8HR_5_UP	18	Up	0.230319996151643	0.693897743507883
REACTOME_DOWNREGULATION_OF_SMAD2_3_SMAD4_TRANSCRIPTIONAL_ACTIVITY	29	Down	0.23052139040607	0.694061853587174
CORRE_MULTIPLE_MYELOMA_UP	91	Up	0.230885934448394	0.694430662336597
BERENJENO_TRANSFORMED_BY_RHOA_REVERSIBLY_DN	58	Up	0.231025679877283	0.694430662336597
BIOCARTA_IL12_PATHWAY	15	Up	0.231121461715984	0.694430662336597
SHIN_B_CELL_LYMPHOMA_CLUSTER_2	31	Up	0.231231886506238	0.694430662336597
HATADA_METHYLATED_IN_LUNG_CANCER_DN	78	Up	0.231835512321708	0.695397908852709
ZHANG_BREAST_CANCER_PROGENITORS_UP	605	Down	0.231852391069413	0.695397908852709
RUNNE_GENDER_EFFECT_UP	17	Down	0.23199557670446	0.695397908852709
NIKOLSKY_BREAST_CANCER_5P15_AMPLICON	23	Down	0.23226937066507	0.695777112886359
REACTOME_IRAK1_RECRUITS_IKK_COMPLEX	10	Up	0.232418162842456	0.695781623110116
PID_TGFBR_PATHWAY	76	Down	0.232797356654342	0.696475435614382
REACTOME_RESPIRATORY_ELECTRON_TRANSPORT_ATP_SYNTHESIS_BY_CHEMIOSMOTIC_COUPLING_AND_HEAT_PRODUCTION_BY_UNCOUPLING_PROTEINS_	98	Down	0.233235042245747	0.697343252891715
KEGG_NON_HOMOLOGOUS_END_JOINING	12	Up	0.233772131211002	0.697484721104676
DE_YY1_TARGETS_UP	14	Up	0.233883690834337	0.697484721104676
YOSHIOKA_LIVER_CANCER_EARLY_RECURRENCE_DN	75	Up	0.234101563889655	0.697484721104676
REACTOME_REGULATORY_RNA_PATHWAYS	27	Up	0.23419160435406	0.697484721104676
REACTOME_SIGNAL_REGULATORY_PROTEIN_SIRP_FAMILY_INTERACTIONS	11	Down	0.234230637486444	0.697484721104676
JEON_SMAD6_TARGETS_DN	29	Down	0.234284580606335	0.697484721104676
LIN_APC_TARGETS	118	Down	0.234402286482549	0.697484721104676
MCBRYAN_PUBERTAL_BREAST_4_5WK_UP	335	Up	0.234463534528837	0.697484721104676
BIOCARTA_RAB_PATHWAY	25	Up	0.235126805091819	0.697873568089384
BANDRES_RESPONSE_TO_CARMUSTIN_WITHOUT_MGMT_24HR_DN	15	Up	0.235481818662192	0.697873568089384
HOFMANN_CELL_LYMPHOMA_DN	47	Down	0.235509598898607	0.697873568089384
KEGG_RNA_POLYMERASE	28	Up	0.235569392072999	0.697873568089384
REACTOME_POL_SWITCHING	14	Down	0.235730916882911	0.697873568089384
CORRE_MULTIPLE_MYELOMA_DN	89	Up	0.235782536360714	0.697873568089384
JAEGER_METASTASIS_UP	68	Down	0.235843032914606	0.697873568089384
REACTOME_PD1_SIGNALING	8	Down	0.236035955135658	0.697873568089384
BERNARD_PPAPDC1B_TARGETS_UP	77	Down	0.236432743021543	0.697873568089384
GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP	22	Down	0.236449580224181	0.697873568089384
HAEGERSTRAND_RESPONSE_TO_IMATINIB	30	Up	0.236540865799728	0.697873568089384
REACTOME_VIRAL_MESSENGER_RNA_SYNTHESIS	15	Up	0.236663073185975	0.697873568089384
HUPER_BREAST_BASAL_VS_LUMINAL_DN	67	Down	0.236689664601247	0.697873568089384
DORN_ADENOVIRUS_INFECTION_48HR_DN	75	Up	0.236703156652502	0.697873568089384
WAGSCHAL_EHMT2_TARGETS_UP	13	Up	0.236944433621834	0.697873568089384
REACTOME_PI3K_EVENTS_IN_ERBB2_SIGNALING	60	Down	0.23715050049776	0.697873568089384
XU_RESPONSE_TO_TRETINOIN_AND_NSC682994_DN	18	Down	0.237209931789902	0.697873568089384
REACTOME_ARMS_MEDIATED_ACTIVATION	21	Down	0.237255220619342	0.697873568089384
PID_INTEGRIN3_PATHWAY	70	Up	0.237401105825495	0.697873568089384
KUNINGER_IGF1_VS_PDGFB_TARGETS_UP	118	Up	0.237615478346286	0.698069353052149
HOFFMAN_CLOCK_TARGETS_DN	5	Down	0.237811658141994	0.698169209926901
VANDESLUIS_COMMD1_TARGETS_GROUP_3_UP	96	Up	0.23802915327015	0.698169209926901
LUI_THYROID_CANCER_CLUSTER_4	8	Up	0.238141713866927	0.698169209926901
JAATINEN_HEMATOPOIETIC_STEM_CELL_DN	196	Up	0.23824063641028	0.698169209926901
KEGG_AMINOACYL_TRNA_BIOSYNTHESIS	42	Down	0.238637023048031	0.698897270228703
BIOCARTA_CERAMIDE_PATHWAY	31	Down	0.238907712888926	0.699256527687291
BIOCARTA_PTDINS_PATHWAY	36	Up	0.23927108136479	0.699791986675171
BIOCARTA_NFAT_PATHWAY	73	Down	0.239386928549339	0.699791986675171
MA_PITUITARY_FETAL_VS_ADULT_DN	30	Down	0.239871981367343	0.700776277043492
GAUSSMANN_MLL_AF4_FUSION_TARGETS_D_UP	40	Up	0.240126658668561	0.701086733961855
ACOSTA_PROLIFERATION_INDEPENDENT_MYC_TARGETS_UP	137	Down	0.240351247478777	0.701104631962941
TCGA_GLIOBLASTOMA_COPY_NUMBER_UP	104	Down	0.240429615533439	0.701104631962941
GOZGIT_ESR1_TARGETS_UP	197	Up	0.240776423482487	0.701682803535637
DOANE_BREAST_CANCER_CLASSES_DN	46	Down	0.241212893778835	0.702521399637002
GALIE_TUMOR_ANGIOGENESIS	8	Down	0.241566480357392	0.702796575432069
ROESSLER_LIVER_CANCER_METASTASIS_DN	60	Up	0.241604919242523	0.702796575432069
BOYAULT_LIVER_CANCER_SUBCLASS_G5_DN	36	Down	0.2422861621666	0.704344510815397
MCCLUNG_COCAIN_REWARD_4WK	106	Down	0.242696306603885	0.704648838796477
ZHAN_MULTIPLE_MYELOMA_MS_DN	69	Down	0.242835770349872	0.704648838796477
TOYOTA_TARGETS_OF_MIR34B_AND_MIR34C	599	Down	0.242838338179649	0.704648838796477
MCBRYAN_PUBERTAL_BREAST_3_4WK_DN	38	Down	0.243140848433996	0.705093534685204
PEDRIOLI_MIR31_TARGETS_DN	545	Up	0.243666801716649	0.706185258472055
WANG_LSD1_TARGETS_DN	36	Down	0.244079082508515	0.706946404518837
REACTOME_PLATELET_SENSITIZATION_BY_LDL	21	Down	0.244562835563907	0.707229328989582
NAGY_STAGA_COMPONENTS_HUMAN	18	Down	0.244658742931442	0.707229328989582
ZEMBUTSU_SENSITIVITY_TO_METHOTREXATE	27	Up	0.244707146504253	0.707229328989582
KUMAR_TARGETS_OF_MLL_AF9_FUSION	470	Down	0.244871624020203	0.707229328989582
PHESSE_TARGETS_OF_APC_AND_MBD2_DN	15	Down	0.244925313765232	0.707229328989582
REACTOME_IL_6_SIGNALING	10	Up	0.24533509962988	0.707979847679629
LEE_LIVER_CANCER_MYC_TGFA_DN	64	Up	0.245510186194633	0.708021322633103
BIOCARTA_IL22BP_PATHWAY	12	Up	0.245649226883077	0.708021322633103
REACTOME_PRE_NOTCH_TRANSCRIPTION_AND_TRANSLATION	29	Down	0.246254804985344	0.709333962652904
KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_4NQO_IN_OLD	15	Down	0.246524778384074	0.709366174572156
HALMOS_CEBPA_TARGETS_DN	60	Up	0.24656631216077	0.709366174572156
TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_UP	122	Up	0.247554701585657	0.710804469078474
CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_2	482	Down	0.248133407236637	0.710804469078474
BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP	607	Down	0.248164685302086	0.710804469078474
CREIGHTON_AKT1_SIGNALING_VIA_MTOR_UP	58	Down	0.248189567551239	0.710804469078474
ZHU_CMV_ALL_DN	200	Up	0.248309717848436	0.710804469078474
PID_CERAMIDE_PATHWAY	61	Down	0.248395380100188	0.710804469078474
KEGG_EPITHELIAL_CELL_SIGNALING_IN_HELICOBACTER_PYLORI_INFECTION	76	Up	0.248503011339947	0.710804469078474
AMUNDSON_GENOTOXIC_SIGNATURE	159	Down	0.248599368763938	0.710804469078474
BROWNE_HCMV_INFECTION_14HR_DN	411	Down	0.248790256376494	0.710804469078474
DIRMEIER_LMP1_RESPONSE_LATE_DN	42	Down	0.248813786992042	0.710804469078474
REACTOME_ZINC_TRANSPORTERS	12	Up	0.249006230186399	0.710804469078474
REACTOME_SYNTHESIS_OF_PIPS_AT_THE_EARLY_ENDOSOME_MEMBRANE	15	Down	0.249078308169681	0.710804469078474
SAGIV_CD24_TARGETS_UP	31	Up	0.249133464342501	0.710804469078474
SCHLOSSER_MYC_TARGETS_REPRESSED_BY_SERUM	214	Down	0.249283811266888	0.710804469078474
MIKKELSEN_MCV6_LCP_WITH_H3K27ME3	17	Up	0.2493232441285	0.710804469078474
REACTOME_EARLY_PHASE_OF_HIV_LIFE_CYCLE	14	Down	0.249722101969482	0.711512189206171
DAZARD_RESPONSE_TO_UV_SCC_DN	194	Down	0.250042825263358	0.711996568139905
WEST_ADRENOCORTICAL_TUMOR_UP	437	Down	0.250797420144104	0.712649933756803
REACTOME_G_PROTEIN_ACTIVATION	18	Down	0.250943854170148	0.712649933756803
REACTOME_APC_C_CDC20_MEDIATED_DEGRADATION_OF_CYCLIN_B	26	Down	0.251010073617796	0.712649933756803
DURCHDEWALD_SKIN_CARCINOGENESIS_UP	122	Down	0.251316986475302	0.712649933756803
OZANNE_AP1_TARGETS_UP	24	Down	0.251329176330157	0.712649933756803
REACTOME_HYALURONAN_METABOLISM	21	Up	0.251957585185492	0.712649933756803
BYSTROEM_CORRELATED_WITH_IL5_UP	77	Down	0.252131285095744	0.712649933756803
VALK_AML_CLUSTER_5	43	Down	0.252136500851074	0.712649933756803
REACTOME_RNA_POL_III_TRANSCRIPTION_TERMINATION	20	Up	0.252207631134954	0.712649933756803
DORN_ADENOVIRUS_INFECTION_24HR_UP	15	Up	0.252207816156498	0.712649933756803
SEIDEN_ONCOGENESIS_BY_MET	132	Down	0.25234076989784	0.712649933756803
WANG_RECURRENT_LIVER_CANCER_UP	23	Down	0.252601463343961	0.712649933756803
MATTIOLI_MULTIPLE_MYELOMA_WITH_14Q32_TRANSLOCATIONS	63	Down	0.252744410203467	0.712649933756803
DAZARD_UV_RESPONSE_CLUSTER_G6	238	Down	0.252761437156914	0.712649933756803
REACTOME_NEF_MEDIATES_DOWN_MODULATION_OF_CELL_SURFACE_RECEPTORS_BY_RECRUITING_THEM_TO_CLATHRIN_ADAPTERS	34	Down	0.252823844962552	0.712649933756803
MATZUK_SPERMATID_DIFFERENTIATION	64	Down	0.252829362873847	0.712649933756803
JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_UP	72	Down	0.253163244858144	0.712649933756803
SUNG_METASTASIS_STROMA_DN	63	Down	0.253512482709218	0.712649933756803
BIOCARTA_ATM_PATHWAY	25	Down	0.253596668543837	0.712649933756803
BURTON_ADIPOGENESIS_5	199	Down	0.253666354023013	0.712649933756803
STEIN_ESTROGEN_RESPONSE_NOT_VIA_ESRRA	18	Down	0.253946778931103	0.712649933756803
FOSTER_KDM1A_TARGETS_DN	305	Down	0.254596577536504	0.712649933756803
REACTOME_SIGNAL_ATTENUATION	15	Up	0.25503537296736	0.712649933756803
BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_UP	115	Up	0.255049165344747	0.712649933756803
REACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL	37	Down	0.255060138746617	0.712649933756803
SENESE_HDAC1_TARGETS_DN	379	Up	0.255083291336239	0.712649933756803
WILLIAMS_ESR2_TARGETS_UP	33	Down	0.255272734532554	0.712649933756803
VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP	274	Up	0.255302448936666	0.712649933756803
ZHENG_FOXP3_TARGETS_DN	9	Up	0.255599448471659	0.712649933756803
XU_HGF_TARGETS_INDUCED_BY_AKT1_48HR_UP	28	Up	0.255619444208184	0.712649933756803
KEGG_GLYCINE_SERINE_AND_THREONINE_METABOLISM	29	Down	0.255644277673014	0.712649933756803
KAUFFMANN_DNA_REPAIR_GENES	246	Down	0.255882016204391	0.712649933756803
GENTILE_UV_RESPONSE_CLUSTER_D4	97	Down	0.256036811861867	0.712649933756803
SATO_SILENCED_EPIGENETICALLY_IN_PANCREATIC_CANCER	47	Up	0.256217489572191	0.712649933756803
TURJANSKI_MAPK8_AND_MAPK9_TARGETS	9	Down	0.25626880779128	0.712649933756803
FLECHNER_PBL_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP	90	Down	0.256475128932338	0.712649933756803
TANG_SENESCENCE_TP53_TARGETS_UP	40	Up	0.256478116479359	0.712649933756803
DOANE_BREAST_CANCER_CLASSES_UP	91	Up	0.25670781241225	0.712649933756803
RAFFEL_VEGFA_TARGETS_UP	14	Up	0.256885518231185	0.712649933756803
OUYANG_PROSTATE_CANCER_PROGRESSION_UP	37	Down	0.256984827557343	0.712649933756803
AMUNDSON_DNA_DAMAGE_RESPONSE_TP53	26	Up	0.25700147730367	0.712649933756803
KIM_MYCN_AMPLIFICATION_TARGETS_DN	211	Up	0.257020009981085	0.712649933756803
BAKER_HEMATOPOIESIS_STAT3_TARGETS	19	Up	0.257109309686383	0.712649933756803
SESTO_RESPONSE_TO_UV_C8	144	Up	0.25719946960275	0.712649933756803
REACTOME_SIGNALING_BY_ERBB4	118	Down	0.257210604363807	0.712649933756803
TOMLINS_METASTASIS_UP	25	Down	0.257211714025265	0.712649933756803
IZADPANAH_STEM_CELL_ADIPOSE_VS_BONE_UP	213	Down	0.257424525140477	0.712821486965775
REACTOME_POST_CHAPERONIN_TUBULIN_FOLDING_PATHWAY	18	Down	0.257859512188632	0.71321950669576
DITTMER_PTHLH_TARGETS_UP	194	Down	0.257977955689023	0.71321950669576
REACTOME_INTERACTION_BETWEEN_L1_AND_ANKYRINS	15	Up	0.258193177321665	0.71321950669576
WHITESIDE_CISPLATIN_RESISTANCE_UP	18	Down	0.258194063393317	0.71321950669576
REACTOME_APC_CDC20_MEDIATED_DEGRADATION_OF_NEK2A	25	Down	0.258323153250729	0.71321950669576
VALK_AML_CLUSTER_16	23	Down	0.25857031322765	0.713484906359473
BIOCARTA_IL4_PATHWAY	18	Down	0.258854620982126	0.713852439882991
ABE_INNER_EAR	57	Down	0.259169756669869	0.714304510214973
DONATO_CELL_CYCLE_TRETINOIN	6	Up	0.259504993627778	0.714590867018041
REACTOME_TRANSMEMBRANE_TRANSPORT_OF_SMALL_MOLECULES	287	Up	0.259576191321541	0.714590867018041
REACTOME_BILE_SALT_AND_ORGANIC_ANION_SLC_TRANSPORTERS	4	Up	0.259821731631566	0.714850238921094
NIKOLSKY_BREAST_CANCER_20P13_AMPLICON	9	Down	0.260545091566809	0.715575986576948
CHNG_MULTIPLE_MYELOMA_HYPERPLOID_DN	37	Up	0.260596489013438	0.715575986576948
MCCLUNG_CREB1_TARGETS_UP	123	Down	0.260602328585499	0.715575986576948
WANG_RESPONSE_TO_PACLITAXEL_VIA_MAPK8_UP	24	Down	0.260691421020095	0.715575986576948
MATTIOLI_MGUS_VS_MULTIPLE_MYELOMA	25	Up	0.260867366099301	0.71564311118066
WELCSH_BRCA1_TARGETS_UP	339	Down	0.26153495473544	0.717058111532338
REACTOME_TGF_BETA_RECEPTOR_SIGNALING_IN_EMT_EPITHELIAL_TO_MESENCHYMAL_TRANSITION	25	Down	0.261723727967584	0.717159449488901
STANHILL_HRAS_TRANSFROMATION_UP	25	Up	0.261999801389076	0.717499745948983
KEGG_BASAL_CELL_CARCINOMA	47	Up	0.262979623858501	0.719765783955712
PENG_LEUCINE_DEPRIVATION_DN	285	Down	0.263300919084223	0.720227875943179
REACTOME_SIGNALING_BY_ACTIVATED_POINT_MUTANTS_OF_FGFR1	6	Up	0.263553308868562	0.720341754193731
WANG_TNF_TARGETS	22	Up	0.26364752180376	0.720341754193731
DELASERNA_MYOD_TARGETS_DN	113	Down	0.264087988887405	0.720842217411725
HUMMERICH_MALIGNANT_SKIN_TUMOR_DN	30	Up	0.264135876024491	0.720842217411725
MIKKELSEN_IPS_WITH_HCP_H3K27ME3	74	Up	0.264898339867778	0.721919738127476
REACTOME_ACTIVATED_AMPK_STIMULATES_FATTY_ACID_OXIDATION_IN_MUSCLE	22	Up	0.265045599418796	0.721919738127476
SMID_BREAST_CANCER_RELAPSE_IN_LIVER_UP	3	Down	0.265072601316104	0.721919738127476
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINED_IN_MONOCYTE_DN	2	Up	0.265153869334273	0.721919738127476
ENK_UV_RESPONSE_KERATINOCYTE_UP	706	Down	0.265343787897021	0.721919738127476
SEITZ_NEOPLASTIC_TRANSFORMATION_BY_8P_DELETION_UP	129	Up	0.265505997833236	0.721919738127476
SMID_BREAST_CANCER_BASAL_DN	902	Up	0.265600445568491	0.721919738127476
ZHENG_IL22_SIGNALING_DN	76	Up	0.266106164048113	0.722878389283085
KEGG_TGF_BETA_SIGNALING_PATHWAY	81	Up	0.266295865437665	0.722977970303177
KYNG_DNA_DAMAGE_BY_GAMMA_RADIATION	117	Up	0.266640837033934	0.723498744484954
RAMPON_ENRICHED_LEARNING_ENVIRONMENT_EARLY_DN	15	Up	0.266904542855454	0.723798542163699
FINETTI_BREAST_CANCERS_KINOME_BLUE	36	Up	0.267700354490197	0.724828734906209
AGUIRRE_PANCREATIC_CANCER_COPY_NUMBER_DN	334	Up	0.267728844822614	0.724828734906209
SCHLESINGER_METHYLATED_DE_NOVO_IN_CANCER	123	Up	0.267744738021028	0.724828734906209
MAINA_VHL_TARGETS_DN	48	Up	0.268085197440129	0.725072587325052
REACTOME_POST_TRANSLATIONAL_MODIFICATION_SYNTHESIS_OF_GPI_ANCHORED_PROTEINS	27	Up	0.268141788750395	0.725072587325052
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREEN_UP	55	Down	0.269193171071174	0.725745215184869
WANG_CLIM2_TARGETS_UP	379	Down	0.269347526993632	0.725745215184869
LAMB_CCND1_TARGETS	34	Down	0.269473263252467	0.725745215184869
GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_DN	41	Up	0.26960567289346	0.725745215184869
DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN	742	Down	0.269743231672522	0.725745215184869
MEINHOLD_OVARIAN_CANCER_LOW_GRADE_UP	26	Down	0.269861505792348	0.725745215184869
REACTOME_GLUCONEOGENESIS	38	Down	0.270247864641281	0.725745215184869
BIOCARTA_ERYTH_PATHWAY	8	Up	0.270897270663377	0.725745215184869
THUM_MIR21_TARGETS_HEART_DISEASE_DN	18	Up	0.270932484711418	0.725745215184869
SCHLOSSER_MYC_TARGETS_AND_SERUM_RESPONSE_DN	67	Down	0.270947984205828	0.725745215184869
BURTON_ADIPOGENESIS_PEAK_AT_8HR	71	Down	0.270972285462951	0.725745215184869
TURJANSKI_MAPK11_TARGETS	5	Up	0.271014755115879	0.725745215184869
MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP	27	Up	0.271016855631115	0.725745215184869
LOPEZ_MESOTHELIOMA_SURVIVAL_WORST_VS_BEST_UP	24	Down	0.271093035111124	0.725745215184869
REACTOME_RESOLUTION_OF_AP_SITES_VIA_THE_MULTIPLE_NUCLEOTIDE_PATCH_REPLACEMENT_PATHWAY	18	Down	0.271216504736937	0.725745215184869
DORSAM_HOXA9_TARGETS_UP	57	Down	0.271448639798411	0.725745215184869
TURASHVILI_BREAST_NORMAL_DUCTAL_VS_LOBULAR_DN	23	Down	0.271485202415208	0.725745215184869
LIM_MAMMARY_STEM_CELL_DN	557	Up	0.271631023331375	0.725745215184869
REACTOME_ANTIGEN_PRESENTATION_FOLDING_ASSEMBLY_AND_PEPTIDE_LOADING_OF_CLASS_I_MHC	39	Up	0.27175659358201	0.725745215184869
OUYANG_PROSTATE_CANCER_PROGRESSION_DN	24	Down	0.271902330399526	0.725745215184869
BOGNI_TREATMENT_RELATED_MYELOID_LEUKEMIA_DN	55	Up	0.271915715566403	0.725745215184869
HANN_RESISTANCE_TO_BCL2_INHIBITOR_DN	46	Up	0.272059538072055	0.725745215184869
YANG_MUC2_TARGETS_DUODENUM_3MO_DN	19	Down	0.27218047583568	0.725745215184869
KEGG_PRION_DISEASES	34	Down	0.27219480437341	0.725745215184869
HENDRICKS_SMARCA4_TARGETS_UP	83	Up	0.272365378392543	0.725745215184869
PID_TCR_PATHWAY	67	Down	0.272384899771967	0.725745215184869
YAGI_AML_SURVIVAL	202	Down	0.272730227152881	0.726255689442057
HSIAO_HOUSEKEEPING_GENES	613	Down	0.273047289547192	0.726666613400149
DUTTA_APOPTOSIS_VIA_NFKB	31	Down	0.273245008873539	0.726666613400149
DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_UP	1823	Down	0.273346014397135	0.726666613400149
GERHOLD_ADIPOGENESIS_DN	101	Down	0.273712384805766	0.727188457438024
NEWMAN_ERCC6_TARGETS_DN	72	Up	0.273984257736272	0.727188457438024
MIKKELSEN_NPC_HCP_WITH_H3K4ME3_AND_H3K27ME3	186	Up	0.274114685725452	0.727188457438024
MANTOVANI_NFKB_TARGETS_UP	63	Up	0.274329208746291	0.727188457438024
REACTOME_PI_3K_CASCADE	62	Down	0.274422662828031	0.727188457438024
KORKOLA_TERATOMA	50	Down	0.274540809331076	0.727188457438024
PID_CXCR4_PATHWAY	128	Down	0.274756235631191	0.727188457438024
MORI_LARGE_PRE_BII_LYMPHOCYTE_DN	74	Down	0.274875982342022	0.727188457438024
PID_SYNDECAN_1_PATHWAY	57	Up	0.274927727558068	0.727188457438024
ONO_FOXP3_TARGETS_DN	33	Down	0.275135901008062	0.727331839038661
JOHANSSON_BRAIN_CANCER_EARLY_VS_LATE_DN	64	Up	0.275521286974608	0.727571921938904
DARWICHE_PAPILLOMA_RISK_HIGH_VS_LOW_DN	50	Up	0.275534751978979	0.727571921938904
SMID_BREAST_CANCER_RELAPSE_IN_PLEURA_DN	25	Up	0.275819230188524	0.727635044704416
PID_NOTCH_PATHWAY	70	Down	0.275866715720917	0.727635044704416
BHAT_ESR1_TARGETS_VIA_AKT1_UP	334	Up	0.276433466884512	0.728632896279495
BRUNO_HEMATOPOIESIS	87	Down	0.276588441562282	0.728632896279495
REACTOME_TRANSCRIPTIONAL_ACTIVITY_OF_SMAD2_SMAD3_SMAD4_HETEROTRIMER	51	Down	0.276933975202928	0.728632896279495
IVANOVA_HEMATOPOIESIS_EARLY_PROGENITOR	725	Down	0.277157017457287	0.728632896279495
KEGG_AMYOTROPHIC_LATERAL_SCLEROSIS_ALS	50	Up	0.2774213661613	0.728632896279495
JIANG_AGING_HYPOTHALAMUS_UP	70	Down	0.277653607882347	0.728632896279495
CEBALLOS_TARGETS_OF_TP53_AND_MYC_UP	41	Down	0.277675606792037	0.728632896279495
CHANDRAN_METASTASIS_TOP50_DN	60	Up	0.27784544600891	0.728632896279495
CHANG_POU5F1_TARGETS_DN	6	Up	0.277981774770971	0.728632896279495
REACTOME_RESPIRATORY_ELECTRON_TRANSPORT	79	Down	0.278018448543906	0.728632896279495
RIGGI_EWING_SARCOMA_PROGENITOR_UP	583	Up	0.2780297010249	0.728632896279495
YAGI_AML_RELAPSE_PROGNOSIS	53	Down	0.278334970388757	0.728632896279495
REACTOME_PERK_REGULATED_GENE_EXPRESSION	31	Up	0.278395749651984	0.728632896279495
KEGG_ECM_RECEPTOR_INTERACTION	85	Up	0.278404398345573	0.728632896279495
KIM_BIPOLAR_DISORDER_OLIGODENDROCYTE_DENSITY_CORR_UP	894	Down	0.278582552507178	0.728695447421877
RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP	532	Down	0.278795770765027	0.728842015113989
PID_FGF_PATHWAY	79	Down	0.279107224841825	0.728842015113989
TESAR_JAK_TARGETS_MOUSE_ES_D3_UP	3	Up	0.279254325748782	0.728842015113989
REACTOME_REGULATION_OF_BETA_CELL_DEVELOPMENT	9	Down	0.27934450620872	0.728842015113989
CHIARETTI_T_ALL_RELAPSE_PROGNOSIS	24	Down	0.279410010451193	0.728842015113989
WEBER_METHYLATED_LCP_IN_FIBROBLAST_UP	3	Up	0.279716613076382	0.729015748630567
KEGG_PRIMARY_BILE_ACID_BIOSYNTHESIS	49	Up	0.27985779644753	0.729015748630567
PIEPOLI_LGI1_TARGETS_DN	30	Up	0.27993957832681	0.729015748630567
MASSARWEH_TAMOXIFEN_RESISTANCE_UP	763	Up	0.280174833628022	0.729093712811836
GEORGANTAS_HSC_MARKERS	102	Down	0.280278192732069	0.729093712811836
NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_DN	16	Up	0.280904808301292	0.729848178266995
KEGG_TYPE_I_DIABETES_MELLITUS	25	Down	0.280984821949275	0.729848178266995
KIM_RESPONSE_TO_TSA_AND_DECITABINE_UP	140	Up	0.281092583099058	0.729848178266995
WONG_ENDMETRIUM_CANCER_UP	19	Up	0.2812631267968	0.729848178266995
KOINUMA_COLON_CANCER_MSI_DN	10	Down	0.281370018811521	0.729848178266995
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP	251	Up	0.281639885565004	0.729848178266995
KEGG_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY	92	Down	0.281821671305178	0.729848178266995
REACTOME_MEMBRANE_TRAFFICKING	158	Up	0.281946515959466	0.729848178266995
VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP	169	Up	0.281981722977268	0.729848178266995
AUJLA_IL22_AND_IL17A_SIGNALING	5	Down	0.282175686549137	0.729848178266995
WESTON_VEGFA_TARGETS_6HR	79	Up	0.282273653385934	0.729848178266995
SU_SALIVARY_GLAND	15	Up	0.282463851856708	0.729848178266995
SU_TESTIS	86	Down	0.282576697301087	0.729848178266995
KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	48	Down	0.28275370344413	0.729906281459055
REACTOME_BASE_EXCISION_REPAIR	20	Down	0.283639283563944	0.731656981322646
REACTOME_SYNTHESIS_OF_DNA	97	Down	0.2839067249243	0.731656981322646
WINNEPENNINCKX_MELANOMA_METASTASIS_DN	37	Up	0.284033058647879	0.731656981322646
BIOCARTA_FREE_PATHWAY	13	Down	0.284116397216104	0.731656981322646
HWANG_PROSTATE_CANCER_MARKERS	37	Up	0.284206299899885	0.731656981322646
HUMMEL_BURKITTS_LYMPHOMA_DN	14	Up	0.285338847367841	0.733433610431543
PID_IL1_PATHWAY	41	Down	0.285530402519936	0.733433610431543
ABBUD_LIF_SIGNALING_2_UP	34	Up	0.285649275437534	0.733433610431543
BROWNE_HCMV_INFECTION_2HR_UP	35	Up	0.285895707099944	0.733433610431543
KEGG_MELANOMA	68	Down	0.285953126125532	0.733433610431543
PID_KIT_PATHWAY	74	Down	0.286020555965977	0.733433610431543
MARTORIATI_MDM4_TARGETS_NEUROEPITHELIUM_DN	157	Up	0.28616593894535	0.733433610431543
KEGG_TRYPTOPHAN_METABOLISM	49	Up	0.286278772691451	0.733433610431543
REACTOME_SYNTHESIS_OF_PIPS_AT_THE_LATE_ENDOSOME_MEMBRANE	13	Down	0.286426238944866	0.733433610431543
MATZUK_IMPLANTATION_AND_UTERINE	21	Down	0.287081525692389	0.733433610431543
WANG_IMMORTALIZED_BY_HOXA9_AND_MEIS1_UP	52	Up	0.287119138769956	0.733433610431543
NABA_ECM_AFFILIATED	93	Up	0.287189371260515	0.733433610431543
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_UP	176	Up	0.287444502518219	0.733433610431543
SCHWAB_TARGETS_OF_BMYB_POLYMORPHIC_VARIANTS_DN	24	Up	0.287604163204728	0.733433610431543
AFFAR_YY1_TARGETS_UP	313	Up	0.287625199066423	0.733433610431543
SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_DN	37	Up	0.287681363830003	0.733433610431543
BIOCARTA_GLEEVEC_PATHWAY	39	Down	0.287693071176701	0.733433610431543
CHIBA_RESPONSE_TO_TSA_UP	92	Up	0.287791649051641	0.733433610431543
AMIT_EGF_RESPONSE_60_MCF10A	50	Up	0.287989635769549	0.733433610431543
BYSTRYKH_SCP2_QTL	5	Up	0.288084760248538	0.733433610431543
MOOTHA_VOXPHOS	95	Down	0.288156812227126	0.733433610431543
SUH_COEXPRESSED_WITH_ID1_AND_ID2_UP	21	Up	0.288385211902121	0.73359969775395
PROVENZANI_METASTASIS_DN	190	Down	0.288532649963345	0.73359969775395
PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP	278	Up	0.288799575293202	0.733883374763359
REACTOME_G_BETA_GAMMA_SIGNALLING_THROUGH_PLC_BETA	15	Down	0.289092221371065	0.734232071912318
DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	1217	Down	0.289837163424854	0.735728511563143
BROWNE_HCMV_INFECTION_4HR_UP	72	Down	0.290050880776363	0.735875596556144
SMID_BREAST_CANCER_LUMINAL_A_DN	26	Down	0.290318121925253	0.736158243679492
ST_WNT_BETA_CATENIN_PATHWAY	40	Down	0.290613954642686	0.736292638677692
BYSTRYKH_HEMATOPOIESIS_STEM_CELL_AND_BRAIN_QTL_TRANS	231	Up	0.290682847403449	0.736292638677692
BROWNE_INTERFERON_RESPONSIVE_GENES	104	Down	0.291280289671796	0.737410551130528
REACTOME_CLASS_C_3_METABOTROPIC_GLUTAMATE_PHEROMONE_RECEPTORS	3	Down	0.292645664956222	0.74037531060209
GOUYER_TUMOR_INVASIVENESS	13	Up	0.292765269634562	0.74037531060209
ZHAN_MULTIPLE_MYELOMA_LB_UP	54	Up	0.292921561286051	0.74037531060209
XU_RESPONSE_TO_TRETINOIN_UP	25	Up	0.293155548950514	0.740570488364827
SIMBULAN_UV_RESPONSE_NORMAL_DN	61	Up	0.293355116226611	0.740678551071358
NIKOLSKY_BREAST_CANCER_15Q26_AMPLICON	34	Up	0.293545982155083	0.74076454043836
REACTOME_INCRETIN_SYNTHESIS_SECRETION_AND_INACTIVATION	14	Up	0.294346065774	0.742386980628071
VANDESLUIS_COMMD1_TARGETS_GROUP_3_DN	34	Down	0.294636795749604	0.742723704973921
MARSON_BOUND_BY_FOXP3_STIMULATED	1204	Down	0.294901935305642	0.742883205591694
COLLER_MYC_TARGETS_UP	34	Down	0.295014583761646	0.742883205591694
REACTOME_METABOLISM_OF_CARBOHYDRATES	235	Down	0.295451266127332	0.743586457744015
VALK_AML_CLUSTER_8	33	Up	0.295932520469168	0.744050454679091
BIOCARTA_ATRBRCA_PATHWAY	21	Up	0.296381388470259	0.744050454679091
PLASARI_TGFB1_TARGETS_1HR_UP	41	Down	0.296445512308154	0.744050454679091
GOLUB_ALL_VS_AML_UP	41	Down	0.29648545990093	0.744050454679091
ALCALA_APOPTOSIS	140	Down	0.296540314078978	0.744050454679091
KEGG_N_GLYCAN_BIOSYNTHESIS	46	Up	0.296714670495415	0.744050454679091
REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA	169	Down	0.296738157623922	0.744050454679091
RIZ_ERYTHROID_DIFFERENTIATION	93	Down	0.297027920905523	0.744381908943072
ITO_PTTG1_TARGETS_UP	18	Up	0.29761571918209	0.744734912121303
REACTOME_CIRCADIAN_REPRESSION_OF_EXPRESSION_BY_REV_ERBA	27	Down	0.297649207026698	0.744734912121303
WEBER_METHYLATED_LCP_IN_SPERM_DN	5	Down	0.297663339434811	0.744734912121303
NAKAMURA_LUNG_CANCER_DIFFERENTIATION_MARKERS	13	Up	0.298316584154967	0.744734912121303
LE_EGR2_TARGETS_DN	132	Down	0.298337265765316	0.744734912121303
PID_HNF3B_PATHWAY	45	Up	0.298473657045295	0.744734912121303
BRACHAT_RESPONSE_TO_CAMPTOTHECIN_UP	39	Up	0.298534163209826	0.744734912121303
SPIRA_SMOKERS_LUNG_CANCER_UP	55	Up	0.298638055126492	0.744734912121303
WEIGEL_OXIDATIVE_STRESS_BY_TBH_AND_H2O2	70	Down	0.298738826486002	0.744734912121303
REACTOME_BMAL1_CLOCK_NPAS2_ACTIVATES_CIRCADIAN_EXPRESSION	38	Down	0.29874527063291	0.744734912121303
LENAOUR_DENDRITIC_CELL_MATURATION_UP	140	Up	0.299241469909328	0.745293486329559
FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP	814	Down	0.299324028884266	0.745293486329559
CHUNG_BLISTER_CYTOTOXICITY_UP	163	Down	0.299442641205229	0.745293486329559
REACTOME_ABORTIVE_ELONGATION_OF_HIV1_TRANSCRIPT_IN_THE_ABSENCE_OF_TAT	24	Up	0.299910715497573	0.745790819115717
BOYAULT_LIVER_CANCER_SUBCLASS_G123_UP	85	Down	0.299958204132062	0.745790819115717
TSAI_RESPONSE_TO_IONIZING_RADIATION	224	Down	0.300144426722386	0.745861268719912
VANTVEER_BREAST_CANCER_METASTASIS_DN	165	Down	0.300359290651145	0.74600278077603
REACTOME_RNA_POL_III_TRANSCRIPTION_INITIATION_FROM_TYPE_3_PROMOTER	27	Up	0.300681687087777	0.746411082397614
WEBER_METHYLATED_HCP_IN_FIBROBLAST_DN	35	Down	0.30105154117288	0.746558842393437
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN	164	Up	0.301398433527875	0.746558842393437
REACTOME_IL1_SIGNALING	43	Up	0.301462151904508	0.746558842393437
GAL_LEUKEMIC_STEM_CELL_DN	259	Down	0.301585944346012	0.746558842393437
CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_UP	495	Up	0.301596645644075	0.746558842393437
REACTOME_MITOCHONDRIAL_TRNA_AMINOACYLATION	34	Down	0.301689422127238	0.746558842393437
GEORGES_TARGETS_OF_MIR192_AND_MIR215	1142	Down	0.301938764398422	0.74673258886654
AMIT_EGF_RESPONSE_40_MCF10A	72	Down	0.302075778434369	0.74673258886654
MILI_PSEUDOPODIA_HAPTOTAXIS_DN	945	Down	0.302384011177858	0.746973206657328
GRANDVAUX_IRF3_TARGETS_UP	17	Down	0.302579996654351	0.746973206657328
TESAR_ALK_TARGETS_HUMAN_ES_4D_DN	4	Up	0.303062973867872	0.746973206657328
TESAR_ALK_TARGETS_HUMAN_ES_5D_DN	4	Up	0.303062973867872	0.746973206657328
LIU_IL13_MEMORY_MODEL_UP	24	Up	0.303115046778563	0.746973206657328
GOTTWEIN_TARGETS_OF_KSHV_MIR_K12_11	82	Down	0.30312185375997	0.746973206657328
BOYLAN_MULTIPLE_MYELOMA_D_UP	107	Down	0.303661918858022	0.74763396630764
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_10	92	Down	0.303706515949272	0.74763396630764
KIM_ALL_DISORDERS_OLIGODENDROCYTE_NUMBER_CORR_UP	956	Down	0.304086325914208	0.74817906438475
ZHAN_MULTIPLE_MYELOMA_MS_UP	65	Up	0.304445159544759	0.748660372896838
EBAUER_MYOGENIC_TARGETS_OF_PAX3_FOXO1_FUSION	64	Up	0.304598907008409	0.748660372896838
STREICHER_LSM1_TARGETS_DN	35	Down	0.305555254165108	0.750620395567328
WONG_PROTEASOME_GENE_MODULE	64	Down	0.306340186056878	0.752157504642772
REACTOME_CITRIC_ACID_CYCLE_TCA_CYCLE	29	Down	0.306664090057102	0.75256164230117
BOQUEST_STEM_CELL_CULTURED_VS_FRESH_UP	594	Up	0.307020243835915	0.753044460997334
BENPORATH_ES_2	54	Up	0.307603567753999	0.753465335254254
HINATA_NFKB_TARGETS_FIBROBLAST_UP	108	Up	0.308002522377149	0.753465335254254
ZAMORA_NOS2_TARGETS_UP	104	Down	0.308063615815097	0.753465335254254
HOSHIDA_LIVER_CANCER_SUBCLASS_S1	354	Down	0.308071781003767	0.753465335254254
ELVIDGE_HYPOXIA_DN	218	Up	0.308266765970678	0.753465335254254
CHESLER_BRAIN_QTL_TRANS	11	Down	0.308286624356394	0.753465335254254
KEGG_ACUTE_MYELOID_LEUKEMIA	64	Down	0.308308317749042	0.753465335254254
REACTOME_RAP1_SIGNALLING	18	Down	0.308604896904113	0.753800172169095
KOYAMA_SEMA3B_TARGETS_DN	523	Down	0.308781475524396	0.753818221605222
KYNG_WERNER_SYNDROM_DN	42	Down	0.308931430361497	0.753818221605222
RICKMAN_HEAD_AND_NECK_CANCER_F	56	Up	0.30945107525947	0.754696375594081
DACOSTA_UV_RESPONSE_VIA_ERCC3_XPCS_UP	37	Up	0.310008525973343	0.755340372553164
OSADA_ASCL1_TARGETS_DN	43	Up	0.31003492429733	0.755340372553164
DELPUECH_FOXO3_TARGETS_UP	117	Up	0.310797580346067	0.756808128636506
SAGIV_CD24_TARGETS_DN	66	Down	0.311270076406267	0.757552406179147
CAFFAREL_RESPONSE_TO_THC_24HR_5_UP	53	Down	0.311473586612772	0.757552406179147
REACTOME_PIP3_ACTIVATES_AKT_SIGNALING	44	Down	0.311588659689416	0.757552406179147
CROMER_METASTASIS_UP	128	Up	0.311853985898618	0.757552406179147
SANSOM_APC_TARGETS_DN	420	Up	0.311975749939333	0.757552406179147
YIH_RESPONSE_TO_ARSENITE_C4	23	Down	0.31206540694848	0.757552406179147
CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_5	612	Up	0.312366453236192	0.757893746835014
REACTOME_PROSTANOID_LIGAND_RECEPTORS	5	Down	0.312641450801383	0.758171567549145
PID_IFNG_PATHWAY	50	Down	0.312891230372207	0.758327910466785
REACTOME_FORMATION_OF_FIBRIN_CLOT_CLOTTING_CASCADE	13	Down	0.313310488427769	0.758327910466785
WANG_METHYLATED_IN_BREAST_CANCER	88	Up	0.313773951492681	0.758327910466785
PID_FRA_PATHWAY	65	Up	0.314010919760867	0.758327910466785
FIGUEROA_AML_METHYLATION_CLUSTER_6_DN	34	Up	0.314033796666633	0.758327910466785
NIELSEN_SCHWANNOMA_UP	9	Down	0.314481801040574	0.758327910466785
REACTOME_INHIBITION_OF_REPLICATION_INITIATION_OF_DAMAGED_DNA_BY_RB1_E2F1	13	Down	0.314519121974619	0.758327910466785
REACTOME_INSULIN_SYNTHESIS_AND_PROCESSING	30	Up	0.314546218058323	0.758327910466785
CHIN_BREAST_CANCER_COPY_NUMBER_DN	18	Down	0.314707463482299	0.758327910466785
JIANG_AGING_CEREBRAL_CORTEX_DN	97	Down	0.314827743992073	0.758327910466785
STREICHER_LSM1_TARGETS_UP	57	Up	0.314883618799278	0.758327910466785
MANTOVANI_NFKB_TARGETS_DN	12	Down	0.31501416433794	0.758327910466785
KEGG_HEMATOPOIETIC_CELL_LINEAGE	48	Down	0.315129596948998	0.758327910466785
REACTOME_REGULATION_OF_APOPTOSIS	67	Up	0.315181675226775	0.758327910466785
PID_P53_REGULATION_PATHWAY	74	Down	0.31539818006142	0.758327910466785
PIONTEK_PKD1_TARGETS_UP	59	Up	0.31542927379165	0.758327910466785
BURTON_ADIPOGENESIS_6	275	Down	0.315469189344959	0.758327910466785
BOYLAN_MULTIPLE_MYELOMA_PCA1_UP	107	Up	0.315595400503323	0.758327910466785
WIKMAN_ASBESTOS_LUNG_CANCER_DN	29	Down	0.315895644654846	0.758477620886528
CHASSOT_SKIN_WOUND	12	Down	0.315978822587783	0.758477620886528
SHEPARD_BMYB_MORPHOLINO_DN	261	Down	0.316185445569786	0.758588138583885
TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_DN	130	Up	0.316471287603726	0.758888508954316
MEISSNER_ES_ICP_WITH_H3K4ME3	64	Up	0.317418695327242	0.760228581145496
BOYAULT_LIVER_CANCER_SUBCLASS_G12_DN	17	Up	0.317423754871159	0.760228581145496
FORTSCHEGGER_PHF8_TARGETS_DN	1077	Down	0.317512910795949	0.760228581145496
GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_DN	31	Down	0.317732292304501	0.760368464461228
BAUS_TFF2_TARGETS_UP	27	Down	0.317950468015397	0.760412464333031
REACTOME_ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES	81	Down	0.318072614208736	0.760412464333031
HUANG_GATA2_TARGETS_UP	189	Down	0.318589679835736	0.760916052142943
WIELAND_UP_BY_HBV_INFECTION	117	Down	0.319436742748118	0.760916052142943
REACTOME_MUSCLE_CONTRACTION	52	Down	0.319442416621917	0.760916052142943
DISTECHE_ESCAPED_FROM_X_INACTIVATION	30	Down	0.319559536936427	0.760916052142943
ST_ERK1_ERK2_MAPK_PATHWAY	51	Down	0.31965464413147	0.760916052142943
SASSON_RESPONSE_TO_GONADOTROPHINS_UP	155	Down	0.319780979894061	0.760916052142943
VICENT_METASTASIS_UP	21	Up	0.31985606436309	0.760916052142943
SCHLOSSER_SERUM_RESPONSE_AUGMENTED_BY_MYC	138	Down	0.319913195650705	0.760916052142943
REACTOME_CS_DS_DEGRADATION	14	Down	0.31996204196462	0.760916052142943
REACTOME_RNA_POL_III_CHAIN_ELONGATION	18	Up	0.319965248525199	0.760916052142943
DAIRKEE_CANCER_PRONE_RESPONSE_BPA	81	Down	0.320447547179992	0.760916052142943
LIM_MAMMARY_LUMINAL_MATURE_DN	146	Up	0.320588090362451	0.760916052142943
FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_DN	31	Up	0.320662210787253	0.760916052142943
WONG_ENDOMETRIAL_CANCER_LATE	3	Up	0.320700076099954	0.760916052142943
PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_1	78	Up	0.320735800191738	0.760916052142943
WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_DN	496	Down	0.320860452131402	0.760916052142943
REACTOME_REGULATION_OF_HYPOXIA_INDUCIBLE_FACTOR_HIF_BY_OXYGEN	25	Up	0.321343511577683	0.761494272358425
REACTOME_RORA_ACTIVATES_CIRCADIAN_EXPRESSION	31	Down	0.321538375688705	0.761494272358425
MAYBURD_RESPONSE_TO_L663536_UP	37	Up	0.321587864808437	0.761494272358425
SMID_BREAST_CANCER_RELAPSE_IN_PLEURA_UP	6	Up	0.321865464637222	0.761733671430424
REACTOME_GABA_RECEPTOR_ACTIVATION	31	Down	0.322011461017476	0.761733671430424
BAKKER_FOXO3_TARGETS_DN	241	Down	0.323114927282227	0.763475736964638
GENTILE_UV_HIGH_DOSE_DN	447	Down	0.32318079121416	0.763475736964638
KEGG_INSULIN_SIGNALING_PATHWAY	126	Down	0.323232742152683	0.763475736964638
GAUSSMANN_MLL_AF4_FUSION_TARGETS_B_UP	48	Up	0.323513762086537	0.763757627234783
TERAMOTO_OPN_TARGETS_CLUSTER_6	40	Down	0.323841269394567	0.763955828325657
SHIN_B_CELL_LYMPHOMA_CLUSTER_3	36	Up	0.32392115244206	0.763955828325657
REACTOME_PROLONGED_ERK_ACTIVATION_EVENTS	23	Down	0.324173829334354	0.764170244398945
VANHARANTA_UTERINE_FIBROID_WITH_7Q_DELETION_UP	82	Down	0.325228711002535	0.766155491082411
REACTOME_SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE	143	Down	0.325533212311601	0.766155491082411
REACTOME_SIGNALING_BY_INSULIN_RECEPTOR	102	Up	0.325736641926869	0.766155491082411
KEGG_CYTOKINE_CYTOKINE_RECEPTOR_INTERACTION	135	Up	0.325738617137643	0.766155491082411
MODY_HIPPOCAMPUS_POSTNATAL	97	Down	0.325826922435344	0.766155491082411
CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_1	687	Down	0.326669178172486	0.767753829694938
MIDORIKAWA_AMPLIFIED_IN_LIVER_CANCER	79	Up	0.327132889809345	0.768461348313945
NATSUME_RESPONSE_TO_INTERFERON_BETA_DN	87	Down	0.327447558740872	0.768818224399541
TRAYNOR_RETT_SYNDROM_DN	27	Down	0.327828000591635	0.769329098258759
FOSTER_TOLERANT_MACROPHAGE_DN	595	Down	0.328012978108882	0.769380987381508
BIOCARTA_SPRY_PATHWAY	27	Down	0.328443694980479	0.770008940490216
HONMA_DOCETAXEL_RESISTANCE	65	Down	0.328696876736931	0.770025339161479
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_11	173	Up	0.328857052103831	0.770025339161479
ADDYA_ERYTHROID_DIFFERENTIATION_BY_HEMIN	90	Up	0.329147403071741	0.770025339161479
NADLER_HYPERGLYCEMIA_AT_OBESITY	85	Up	0.329423814479123	0.770025339161479
MIKKELSEN_ES_ICP_WITH_H3K4ME3_AND_H3K27ME3	157	Up	0.329682011419484	0.770025339161479
GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN	129	Down	0.330211113625283	0.770025339161479
MEISSNER_ES_ICP_WITH_H3K4ME3_AND_H3K27ME3	14	Up	0.330276321540862	0.770025339161479
FOURNIER_ACINAR_DEVELOPMENT_EARLY_UP	29	Up	0.330514911209888	0.770025339161479
KEGG_TASTE_TRANSDUCTION	34	Down	0.330602032590351	0.770025339161479
BILANGES_SERUM_RESPONSE_TRANSLATION	47	Down	0.330657964632839	0.770025339161479
PLASARI_TGFB1_TARGETS_1HR_DN	7	Up	0.330829501966728	0.770025339161479
LOPEZ_MESOTHELIOMA_SURVIVAL_OVERALL_DN	39	Up	0.33109329266965	0.770025339161479
RICKMAN_TUMOR_DIFFERENTIATED_MODERATELY_VS_POORLY_DN	20	Down	0.331104380395417	0.770025339161479
LABBE_TARGETS_OF_TGFB1_AND_WNT3A_UP	167	Up	0.331321778397486	0.770025339161479
CHEOK_RESPONSE_TO_MERCAPTOPURINE_UP	22	Up	0.33150623236826	0.770025339161479
HASLINGER_B_CLL_WITH_CHROMOSOME_12_TRISOMY	27	Down	0.331551869487926	0.770025339161479
WHITE_NEUROBLASTOMA_WITH_1P36.3_DELETION	28	Up	0.331729928328535	0.770025339161479
PETRETTO_CARDIAC_HYPERTROPHY	65	Up	0.33176043317226	0.770025339161479
ONKEN_UVEAL_MELANOMA_UP	1155	Down	0.331801109518972	0.770025339161479
REACTOME_REGULATION_OF_MITOTIC_CELL_CYCLE	88	Down	0.331809838369644	0.770025339161479
VANHARANTA_UTERINE_FIBROID_WITH_7Q_DELETION_DN	54	Up	0.332005945675257	0.770025339161479
MAHADEVAN_RESPONSE_TO_MP470_DN	37	Up	0.332500010476587	0.770025339161479
WEI_MIR34A_TARGETS	194	Down	0.332530806116483	0.770025339161479
SMID_BREAST_CANCER_RELAPSE_IN_LUNG_UP	47	Up	0.332753061285709	0.770025339161479
BIOCARTA_IL7_PATHWAY	23	Down	0.332807201618072	0.770025339161479
KIM_PTEN_TARGETS_DN	6	Up	0.332853631420882	0.770025339161479
ZHANG_RESPONSE_TO_CANTHARIDIN_DN	107	Down	0.332912040484167	0.770025339161479
HESS_TARGETS_OF_HOXA9_AND_MEIS1_UP	78	Down	0.333121940861355	0.770025339161479
NIELSEN_GIST_VS_SYNOVIAL_SARCOMA_DN	18	Up	0.33331559398081	0.770025339161479
JI_RESPONSE_TO_FSH_DN	133	Down	0.33334077446766	0.770025339161479
KIM_ALL_DISORDERS_OLIGODENDROCYTE_NUMBER_CORR_DN	51	Up	0.33380159514723	0.770409247474297
REACTOME_ENERGY_DEPENDENT_REGULATION_OF_MTOR_BY_LKB1_AMPK	19	Up	0.334034793583074	0.770409247474297
DAZARD_RESPONSE_TO_UV_NHEK_UP	323	Down	0.33466288201122	0.770409247474297
PEART_HDAC_PROLIFERATION_CLUSTER_UP	92	Down	0.334750369072516	0.770409247474297
OXFORD_RALA_TARGETS_UP	25	Up	0.33494024489474	0.770409247474297
BRACHAT_RESPONSE_TO_METHOTREXATE_UP	33	Up	0.335185475613077	0.770409247474297
PID_BARD1_PATHWAY	34	Down	0.335750747284808	0.770409247474297
ITO_PTTG1_TARGETS_DN	16	Up	0.3358044615406	0.770409247474297
MARCINIAK_ER_STRESS_RESPONSE_VIA_CHOP	34	Up	0.335825194506049	0.770409247474297
HASLINGER_B_CLL_WITH_17P13_DELETION	33	Up	0.335853340382549	0.770409247474297
VERHAAK_GLIOBLASTOMA_CLASSICAL	300	Down	0.336098175815826	0.770409247474297
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINDED_IN_ERYTHROCYTE_UP	72	Up	0.336186448077284	0.770409247474297
BIOCARTA_BARRESTIN_SRC_PATHWAY	30	Down	0.336274914451839	0.770409247474297
BIOCARTA_HSP27_PATHWAY	18	Up	0.336317777443002	0.770409247474297
MCBRYAN_PUBERTAL_BREAST_6_7WK_DN	105	Down	0.336610957031094	0.770409247474297
LABBE_TGFB1_TARGETS_UP	141	Down	0.336719492838354	0.770409247474297
YANG_MUC2_TARGETS_DUODENUM_6MO_DN	17	Down	0.336770860145115	0.770409247474297
SCHEIDEREIT_IKK_INTERACTING_PROTEINS	82	Down	0.336999603946012	0.770409247474297
VISALA_RESPONSE_TO_HEAT_SHOCK_AND_AGING_DN	24	Up	0.33701438828668	0.770409247474297
KEGG_BIOSYNTHESIS_OF_UNSATURATED_FATTY_ACIDS	33	Up	0.337287374179836	0.770409247474297
SHAFFER_IRF4_TARGETS_IN_PLASMA_CELL_VS_MATURE_B_LYMPHOCYTE	97	Up	0.33737384091818	0.770409247474297
BYSTRYKH_HEMATOPOIESIS_STEM_CELL_FGF3	8	Up	0.337569199977884	0.770409247474297
CERVERA_SDHB_TARGETS_2	145	Up	0.33789554708659	0.770409247474297
MILI_PSEUDOPODIA_CHEMOTAXIS_UP	91	Down	0.33807711922218	0.770409247474297
REACTOME_ACTIVATED_NOTCH1_TRANSMITS_SIGNAL_TO_THE_NUCLEUS	24	Up	0.338460158161025	0.770409247474297
BAE_BRCA1_TARGETS_DN	50	Down	0.338517384576755	0.770409247474297
HOLLEMAN_PREDNISOLONE_RESISTANCE_ALL_UP	24	Down	0.3386266108457	0.770409247474297
MEDINA_SMARCA4_TARGETS	66	Up	0.338978433215568	0.770409247474297
CHANDRAN_METASTASIS_DN	365	Up	0.339014693188808	0.770409247474297
REACTOME_METABOLISM_OF_POLYAMINES	18	Down	0.339062639255795	0.770409247474297
REACTOME_METABOLISM_OF_NUCLEOTIDES	81	Down	0.339173841798514	0.770409247474297
STARK_PREFRONTAL_CORTEX_22Q11_DELETION_UP	315	Down	0.339314840399588	0.770409247474297
CAFFAREL_RESPONSE_TO_THC_8HR_5_DN	26	Up	0.339377584418316	0.770409247474297
DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_DN	152	Up	0.33939412136601	0.770409247474297
CAIRO_PML_TARGETS_BOUND_BY_MYC_DN	21	Down	0.339412393071435	0.770409247474297
OLSSON_E2F3_TARGETS_UP	30	Up	0.3395426870419	0.770409247474297
KEGG_FRUCTOSE_AND_MANNOSE_METABOLISM	51	Down	0.339588895526603	0.770409247474297
BRUINS_UVC_RESPONSE_MIDDLE	118	Up	0.339704162254225	0.770409247474297
FARMER_BREAST_CANCER_CLUSTER_7	26	Up	0.340051766069241	0.770827515792271
LOPES_METHYLATED_IN_COLON_CANCER_DN	36	Down	0.340388180201456	0.771220030346129
PID_VEGFR1_2_PATHWAY	102	Down	0.340700020681671	0.771556518552355
HIRSCH_CELLULAR_TRANSFORMATION_SIGNATURE_UP	336	Up	0.340939512362871	0.771728920173551
TANAKA_METHYLATED_IN_ESOPHAGEAL_CARCINOMA	108	Up	0.341331845887155	0.772246954009062
BROWNE_HCMV_INFECTION_4HR_DN	418	Up	0.342233380936878	0.773915984464247
HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_1_UP	48	Up	0.342665872854501	0.774523245629024
CASTELLANO_HRAS_TARGETS_UP	8	Down	0.343736142292988	0.776523602771925
FOURNIER_ACINAR_DEVELOPMENT_LATE_DN	54	Up	0.343879631032783	0.776523602771925
OSAWA_TNF_TARGETS	24	Up	0.344586537589582	0.777748114464017
DANG_REGULATED_BY_MYC_UP	103	Down	0.345083458896081	0.778329003032786
KEGG_LINOLEIC_ACID_METABOLISM	17	Down	0.345173425350061	0.778329003032786
KAMIKUBO_MYELOID_CEBPA_NETWORK	21	Up	0.345791113064139	0.778849042890291
WACKER_HYPOXIA_TARGETS_OF_VHL	20	Up	0.34615070519396	0.778849042890291
LIU_VAV3_PROSTATE_CARCINOGENESIS_DN	24	Up	0.346221623357046	0.778849042890291
REACTOME_RAF_MAP_KINASE_CASCADE	14	Down	0.346254629638567	0.778849042890291
DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY	45	Up	0.346299825862032	0.778849042890291
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP	283	Up	0.346393276696126	0.778849042890291
WU_CELL_MIGRATION	246	Up	0.347139639621859	0.779312750660041
CAMPS_COLON_CANCER_COPY_NUMBER_DN	65	Down	0.347220055932008	0.779312750660041
WENDT_COHESIN_TARGETS_UP	42	Down	0.347275035862938	0.779312750660041
FUNG_IL2_SIGNALING_2	7	Up	0.347374320291213	0.779312750660041
BIOCARTA_COMP_PATHWAY	8	Up	0.347424354972491	0.779312750660041
MCBRYAN_PUBERTAL_BREAST_3_4WK_UP	290	Up	0.347703022851052	0.779527267308067
REACTOME_DESTABILIZATION_OF_MRNA_BY_KSRP	19	Down	0.347850016825869	0.779527267308067
MORI_MATURE_B_LYMPHOCYTE_UP	103	Down	0.348184673899895	0.779887589831003
REACTOME_NEURONAL_SYSTEM	201	Up	0.348340985297082	0.779887589831003
BILANGES_SERUM_SENSITIVE_GENES	107	Down	0.348681042074816	0.780225060354013
BURTON_ADIPOGENESIS_1	56	Up	0.348822042224317	0.780225060354013
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_6	82	Up	0.349530557594808	0.781297899626462
KOBAYASHI_RESPONSE_TO_ROMIDEPSIN	21	Down	0.3496324639734	0.781297899626462
PID_CD40_PATHWAY	34	Down	0.350300061730019	0.7821441495481
YOKOE_CANCER_TESTIS_ANTIGENS	62	Down	0.350366308798566	0.7821441495481
HASLINGER_B_CLL_WITH_11Q23_DELETION	32	Down	0.350507867187411	0.7821441495481
UDAYAKUMAR_MED1_TARGETS_UP	180	Down	0.351036511182304	0.782953956008123
CHICAS_RB1_TARGETS_LOW_SERUM	122	Down	0.351553593988761	0.783737224163712
BIOCARTA_FAS_PATHWAY	31	Up	0.351858963637288	0.783802984348402
CADWELL_ATG16L1_TARGETS_UP	68	Up	0.351939970216224	0.783802984348402
SARTIPY_NORMAL_AT_INSULIN_RESISTANCE_DN	23	Up	0.352080849446933	0.783802984348402
LANDIS_ERBB2_BREAST_TUMORS_324_DN	247	Up	0.352260711661637	0.783834009368617
PID_ATM_PATHWAY	39	Down	0.352593108699468	0.784051598445961
PID_S1P_S1P3_PATHWAY	38	Down	0.3528347744915	0.784051598445961
BANDRES_RESPONSE_TO_CARMUSTIN_WITHOUT_MGMT_48HR_UP	19	Up	0.353163567041601	0.784051598445961
HUANG_DASATINIB_RESISTANCE_UP	156	Up	0.353221781986701	0.784051598445961
REACTOME_TRANSCRIPTION_COUPLED_NER_TC_NER	47	Down	0.353292996188114	0.784051598445961
TIEN_INTESTINE_PROBIOTICS_6HR_UP	100	Down	0.353481196138644	0.784051598445961
MCCABE_HOXC6_TARGETS_CANCER_DN	28	Down	0.353520301585499	0.784051598445961
PID_NFAT_3PATHWAY	70	Down	0.354723869667082	0.786351741110885
KEGG_GLYCOSPHINGOLIPID_BIOSYNTHESIS_GLOBO_SERIES	11	Down	0.354900816703075	0.786374980349591
REACTOME_METABOLISM_OF_NON_CODING_RNA	54	Down	0.355342800034583	0.786833994733719
GRADE_COLON_VS_RECTAL_CANCER_DN	80	Down	0.355542608840593	0.786833994733719
SAKAI_TUMOR_INFILTRATING_MONOCYTES_UP	39	Up	0.355607658500527	0.786833994733719
KEGG_SULFUR_METABOLISM	7	Down	0.355920984039789	0.786852648718999
LEE_LIVER_CANCER_CIPROFIBRATE_UP	68	Up	0.356011837994365	0.786852648718999
SETLUR_PROSTATE_CANCER_TMPRSS2_ERG_FUSION_DN	22	Up	0.356259223827806	0.786852648718999
RASHI_NFKB1_TARGETS	33	Up	0.356282348774331	0.786852648718999
RODRIGUES_NTN1_TARGETS_UP	21	Up	0.35654853810963	0.78698257134887
JUBAN_TARGETS_OF_SPI1_AND_FLI1_UP	169	Down	0.356802370030958	0.78698257134887
MCBRYAN_PUBERTAL_BREAST_5_6WK_DN	202	Down	0.356840954239898	0.78698257134887
DORN_ADENOVIRUS_INFECTION_32HR_DN	72	Up	0.357749430118857	0.788443191578597
KYNG_WERNER_SYNDROM_AND_NORMAL_AGING_DN	325	Down	0.35791078411756	0.788443191578597
CHEN_LIVER_METABOLISM_QTL_CIS	141	Up	0.358036617096681	0.788443191578597
LI_CYTIDINE_ANALOG_PATHWAY	13	Down	0.358368888797807	0.788443191578597
XU_GH1_EXOGENOUS_TARGETS_DN	217	Up	0.358374317764914	0.788443191578597
KAMIKUBO_MYELOID_MN1_NETWORK	29	Down	0.358611274319755	0.788443191578597
NAKAYAMA_FRA2_TARGETS	63	Down	0.358671553493312	0.788443191578597
LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_LARGE_VS_TINY_UP	66	Down	0.358918714227727	0.788619537679898
PID_P38_MK2_PATHWAY	23	Down	0.359210976566958	0.788894771409721
IWANAGA_E2F1_TARGETS_NOT_INDUCED_BY_SERUM	6	Up	0.359389196659894	0.788919407537797
DACOSTA_LOW_DOSE_UV_RESPONSE_VIA_ERCC3_XPCS_DN	34	Up	0.359802076254496	0.78945889838655
KYNG_DNA_DAMAGE_BY_UV	81	Down	0.360142717243946	0.789695041901569
BROWNE_HCMV_INFECTION_16HR_UP	343	Up	0.360244033720974	0.789695041901569
GALE_APL_WITH_FLT3_MUTATED_DN	29	Down	0.361584816606488	0.792266546219411
LEE_CALORIE_RESTRICTION_NEOCORTEX_UP	123	Down	0.362025187965676	0.792863693996223
BAUS_TFF2_TARGETS_DN	8	Up	0.362421977167712	0.793364884216993
BIOCARTA_NTHI_PATHWAY	53	Down	0.363853987230835	0.795233612451174
ZHENG_FOXP3_TARGETS_IN_THYMUS_UP	310	Down	0.364242910090766	0.795233612451174
NUTT_GBM_VS_AO_GLIOMA_DN	67	Up	0.364757574833365	0.795233612451174
SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX2_DN	9	Down	0.364952942076462	0.795233612451174
LEE_LIVER_CANCER_CIPROFIBRATE_DN	54	Down	0.365009917246189	0.795233612451174
TAKAO_RESPONSE_TO_UVB_RADIATION_UP	109	Down	0.365175790012787	0.795233612451174
DARWICHE_PAPILLOMA_PROGRESSION_RISK	74	Up	0.365251188051755	0.795233612451174
BIOCARTA_DNAFRAGMENT_PATHWAY	10	Down	0.365503489664004	0.795233612451174
IGARASHI_ATF4_TARGETS_DN	120	Up	0.365815837763761	0.795233612451174
VALK_AML_CLUSTER_10	40	Down	0.366197712355146	0.795233612451174
ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_UP	1144	Down	0.36635156939947	0.795233612451174
NIKOLSKY_BREAST_CANCER_8Q12_Q22_AMPLICON	180	Up	0.366661047825394	0.795233612451174
REACTOME_SYNTHESIS_OF_PIPS_AT_THE_GOLGI_MEMBRANE	17	Down	0.366956067137197	0.795233612451174
MILI_PSEUDOPODIA	53	Down	0.367090878575328	0.795233612451174
YOSHIOKA_LIVER_CANCER_EARLY_RECURRENCE_UP	40	Down	0.36735916260435	0.795233612451174
PEPPER_CHRONIC_LYMPHOCYTIC_LEUKEMIA_DN	20	Up	0.367415383708936	0.795233612451174
GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_UP	34	Down	0.367417746134401	0.795233612451174
BOYERINAS_ONCOFETAL_TARGETS_OF_LET7A1	33	Up	0.367508189346214	0.795233612451174
SHEN_SMARCA2_TARGETS_UP	619	Down	0.367797701414197	0.795233612451174
REACTOME_SULFUR_AMINO_ACID_METABOLISM	23	Down	0.367906995181036	0.795233612451174
ZEILSTRA_CD44_TARGETS_UP	6	Down	0.367924575540893	0.795233612451174
WANG_TARGETS_OF_MLL_CBP_FUSION_UP	55	Down	0.367932067795497	0.795233612451174
PRAMOONJAGO_SOX4_TARGETS_UP	75	Up	0.368183576143813	0.795233612451174
BARRIER_COLON_CANCER_RECURRENCE_UP	60	Up	0.368224796016994	0.795233612451174
NAGASHIMA_NRG1_SIGNALING_UP	230	Up	0.368241091708185	0.795233612451174
FARMER_BREAST_CANCER_CLUSTER_1	20	Down	0.368402743521212	0.795233612451174
MEISSNER_BRAIN_HCP_WITH_H3K4ME2_AND_H3K27ME3	83	Up	0.368428273137866	0.795233612451174
CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_UP	256	Up	0.368438164337552	0.795233612451174
SCHEIDEREIT_IKK_TARGETS	25	Down	0.368452482910774	0.795233612451174
REACTOME_SMAD2_SMAD3_SMAD4_HETEROTRIMER_REGULATES_TRANSCRIPTION	34	Down	0.368700310167246	0.795233612451174
BONCI_TARGETS_OF_MIR15A_AND_MIR16_1	134	Up	0.368834299872621	0.795233612451174
BIOCARTA_FEEDER_PATHWAY	11	Down	0.368894951763633	0.795233612451174
BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_24HR_DN	38	Up	0.368975286550107	0.795233612451174
REACTOME_RECEPTOR_LIGAND_BINDING_INITIATES_THE_SECOND_PROTEOLYTIC_CLEAVAGE_OF_NOTCH_RECEPTOR	13	Up	0.369296152573184	0.795233612451174
GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_DN	239	Down	0.369372332413673	0.795233612451174
RORIE_TARGETS_OF_EWSR1_FLI1_FUSION_UP	50	Up	0.369463358802656	0.795233612451174
DORN_ADENOVIRUS_INFECTION_12HR_UP	50	Up	0.369504186987792	0.795233612451174
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINED_IN_GRANULOCYTE_DN	4	Up	0.370493679406257	0.796916342101662
HOFMANN_MYELODYSPLASTIC_SYNDROM_LOW_RISK_DN	56	Down	0.370623455460912	0.796916342101662
BIERIE_INFLAMMATORY_RESPONSE_TGFB1	7	Down	0.371349480164354	0.798114169379622
IIZUKA_LIVER_CANCER_PROGRESSION_L1_G1_UP	28	Up	0.371658122833407	0.798276315583737
REACTOME_DEADENYLATION_OF_MRNA	25	Up	0.371762890407329	0.798276315583737
BILANGES_RAPAMYCIN_SENSITIVE_GENES	49	Down	0.373323999038358	0.800814743881187
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREEN_DN	35	Down	0.373549569897312	0.800814743881187
CAVARD_LIVER_CANCER_MALIGNANT_VS_BENIGN	68	Down	0.373664514217355	0.800814743881187
ROETH_TERT_TARGETS_UP	12	Down	0.373691002384351	0.800814743881187
MCCLUNG_DELTA_FOSB_TARGETS_2WK	76	Up	0.373792656701528	0.800814743881187
REACTOME_PURINE_METABOLISM	37	Down	0.375826485949221	0.804807035187725
REACTOME_CYCLIN_E_ASSOCIATED_EVENTS_DURING_G1_S_TRANSITION_	70	Down	0.376212967599421	0.805269623443436
GHANDHI_DIRECT_IRRADIATION_UP	119	Up	0.376631055606966	0.805795145115945
REACTOME_DESTABILIZATION_OF_MRNA_BY_AUF1_HNRNP_D0	62	Up	0.377082106555168	0.805795145115945
AMIT_SERUM_RESPONSE_120_MCF10A	94	Up	0.377156934711822	0.805795145115945
GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_DN	70	Down	0.377767138465895	0.805795145115945
REACTOME_IONOTROPIC_ACTIVITY_OF_KAINATE_RECEPTORS	10	Down	0.377926787712763	0.805795145115945
WIERENGA_STAT5A_TARGETS_DN	239	Down	0.378127305235153	0.805795145115945
NGO_MALIGNANT_GLIOMA_1P_LOH	39	Down	0.378174016117438	0.805795145115945
GAVIN_FOXP3_TARGETS_CLUSTER_P4	123	Down	0.378463025277334	0.805795145115945
MCGOWAN_RSP6_TARGETS_DN	6	Up	0.378521514587562	0.805795145115945
WEBER_METHYLATED_HCP_IN_FIBROBLAST_UP	3	Down	0.378821419918922	0.805795145115945
MORI_EMU_MYC_LYMPHOMA_BY_ONSET_TIME_DN	29	Up	0.378842212720657	0.805795145115945
GHANDHI_BYSTANDER_IRRADIATION_UP	92	Up	0.379182043163506	0.805795145115945
REACTOME_SIGNALING_BY_GPCR	343	Down	0.379224829667772	0.805795145115945
REACTOME_SYNTHESIS_OF_PE	10	Down	0.379262545362184	0.805795145115945
JIANG_TIP30_TARGETS_UP	75	Up	0.379560611339202	0.805795145115945
REACTOME_CYTOSOLIC_TRNA_AMINOACYLATION	35	Down	0.379675781018739	0.805795145115945
IIZUKA_LIVER_CANCER_PROGRESSION_G1_G2_UP	15	Up	0.37969572371359	0.805795145115945
ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_DN	86	Down	0.379766044537458	0.805795145115945
SWEET_LUNG_CANCER_KRAS_DN	561	Up	0.37995993248534	0.805795145115945
REACTOME_CONVERSION_FROM_APC_C_CDC20_TO_APC_C_CDH1_IN_LATE_ANAPHASE	19	Down	0.380309825146754	0.805795145115945
GROSS_ELK3_TARGETS_DN	48	Down	0.380495265483549	0.805795145115945
PID_IGF1_PATHWAY	50	Down	0.380513695557103	0.805795145115945
PID_CDC42_PATHWAY	95	Up	0.380532431327546	0.805795145115945
VALK_AML_CLUSTER_11	67	Down	0.380552279583758	0.805795145115945
SCHAEFFER_SOX9_TARGETS_IN_PROSTATE_DEVELOPMENT_UP	38	Up	0.381109831454637	0.806614177326033
ZHONG_SECRETOME_OF_LUNG_CANCER_AND_MACROPHAGE	103	Down	0.381580772146487	0.807097195696788
OSMAN_BLADDER_CANCER_DN	569	Down	0.381749124069953	0.807097195696788
GEORGES_CELL_CYCLE_MIR192_TARGETS	74	Down	0.381880452984604	0.807097195696788
YOSHIMURA_MAPK8_TARGETS_DN	528	Down	0.38202144995301	0.807097195696788
SETLUR_PROSTATE_CANCER_TMPRSS2_ERG_FUSION_UP	108	Down	0.382459914932754	0.807662332651913
DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_UP	144	Down	0.382704333868823	0.807817369614084
REACTOME_INTRINSIC_PATHWAY	8	Down	0.383107555319641	0.807857883969201
YAMAZAKI_TCEB3_TARGETS_UP	267	Up	0.38317159988274	0.807857883969201
PID_WNT_CANONICAL_PATHWAY	29	Down	0.383236561806727	0.807857883969201
BILANGES_RAPAMYCIN_SENSITIVE_VIA_TSC1_AND_TSC2	122	Down	0.383775210745609	0.808042886601204
PID_HDAC_CLASSII_PATHWAY	51	Down	0.384185995267977	0.808042886601204
LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_LARGE_VS_TINY_DN	53	Down	0.384191165961241	0.808042886601204
REACTOME_INFLUENZA_LIFE_CYCLE	182	Down	0.384322627871753	0.808042886601204
PID_DNA_PK_PATHWAY	17	Up	0.384531596232755	0.808042886601204
FREDERICK_PRKCI_TARGETS	11	Up	0.384737308338205	0.808042886601204
REACTOME_KERATAN_SULFATE_BIOSYNTHESIS	22	Down	0.384776124579386	0.808042886601204
KIM_MYC_AMPLIFICATION_TARGETS_UP	254	Down	0.384884938887726	0.808042886601204
PID_GMCSF_PATHWAY	49	Down	0.384920098326969	0.808042886601204
MULLIGHAN_NPM1_MUTATED_SIGNATURE_1_DN	173	Up	0.385034830173436	0.808042886601204
PID_ARF_3PATHWAY	31	Up	0.385657055257653	0.808698403094651
WARTERS_RESPONSE_TO_IR_SKIN	104	Up	0.385888302145717	0.808698403094651
NADLER_OBESITY_UP	94	Down	0.385924221560672	0.808698403094651
REACTOME_MRNA_SPLICING	136	Down	0.386031943052167	0.808698403094651
BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_48HR_UP	26	Up	0.386642086048801	0.809617559616372
DEMAGALHAES_AGING_DN	29	Up	0.387070626491507	0.810155799532956
PID_EPHA_FWDPATHWAY	35	Up	0.387564667118445	0.810820265053377
NIELSEN_LIPOSARCOMA_DN	26	Down	0.387740220640212	0.810820265053377
SESTO_RESPONSE_TO_UV_C1	108	Down	0.388055977684839	0.810820265053377
IRITANI_MAD1_TARGETS_DN	70	Down	0.388074644217969	0.810820265053377
MULLIGHAN_MLL_SIGNATURE_1_UP	486	Down	0.388321345512719	0.81097702749871
GENTILE_UV_RESPONSE_CLUSTER_D1	48	Down	0.388963651263326	0.811642786058602
REACTOME_RNA_POL_III_TRANSCRIPTION	34	Up	0.388983756908695	0.811642786058602
SMIRNOV_RESPONSE_TO_IR_2HR_UP	72	Up	0.389645611212836	0.812664842105711
OKAMOTO_LIVER_CANCER_MULTICENTRIC_OCCURRENCE_DN	4	Down	0.390324632474757	0.812857809499582
MOSERLE_IFNA_RESPONSE	40	Down	0.390335617469077	0.812857809499582
BOYLAN_MULTIPLE_MYELOMA_C_DN	72	Down	0.390370860410524	0.812857809499582
PID_FAK_PATHWAY	98	Down	0.390426411887077	0.812857809499582
CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_DN	408	Up	0.391053781703098	0.813482093625056
WALLACE_JAK2_TARGETS_UP	29	Down	0.391132254620491	0.813482093625056
HOLLEMAN_ASPARAGINASE_RESISTANCE_B_ALL_UP	34	Down	0.391242869753625	0.813482093625056
GRESHOCK_CANCER_COPY_NUMBER_UP	394	Down	0.391625101671745	0.813845610349748
DAIRKEE_TERT_TARGETS_UP	475	Down	0.391870895235124	0.813845610349748
TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_DN	84	Up	0.391985318629912	0.813845610349748
KAYO_AGING_MUSCLE_DN	188	Down	0.392106818195602	0.813845610349748
KRISHNAN_FURIN_TARGETS_DN	19	Up	0.392353767183697	0.814000525329726
NADELLA_PRKAR1A_TARGETS_UP	12	Up	0.392899547981032	0.81469828771182
BIOCARTA_NKT_PATHWAY	11	Up	0.393035012213217	0.81469828771182
OUELLET_OVARIAN_CANCER_INVASIVE_VS_LMP_DN	14	Up	0.394280038460159	0.815908155126129
HOLLEMAN_DAUNORUBICIN_B_ALL_UP	16	Down	0.394574750114774	0.815908155126129
FUJIWARA_PARK2_IN_LIVER_CANCER_DN	6	Up	0.394977785699683	0.815908155126129
CHANGOLKAR_H2AFY_TARGETS_DN	40	Up	0.394997750201947	0.815908155126129
JAZAG_TGFB1_SIGNALING_VIA_SMAD4_UP	144	Up	0.39519309018783	0.815908155126129
COLLIS_PRKDC_SUBSTRATES	26	Down	0.395247262756381	0.815908155126129
REACTOME_TRAFFICKING_OF_GLUR2_CONTAINING_AMPA_RECEPTORS	12	Up	0.395257490623175	0.815908155126129
ELLWOOD_MYC_TARGETS_DN	52	Up	0.395295293708776	0.815908155126129
SEMBA_FHIT_TARGETS_UP	27	Up	0.395443911537468	0.815908155126129
WIERENGA_STAT5A_TARGETS_UP	304	Up	0.395576610771629	0.815908155126129
KIM_WT1_TARGETS_DN	625	Down	0.39586276391032	0.815908155126129
LEE_NEURAL_CREST_STEM_CELL_UP	204	Up	0.396203304075536	0.815908155126129
PUIFFE_INVASION_INHIBITED_BY_ASCITES_UP	145	Down	0.396551664128314	0.815908155126129
NAKAMURA_ALVEOLAR_EPITHELIUM	3	Up	0.396722581569764	0.815908155126129
SA_FAS_SIGNALING	8	Down	0.396846460941697	0.815908155126129
KEGG_CELL_ADHESION_MOLECULES_CAMS	74	Down	0.397007096521998	0.815908155126129
BROWNE_HCMV_INFECTION_18HR_DN	287	Down	0.397030817926465	0.815908155126129
LEE_LIVER_CANCER_SURVIVAL_UP	222	Up	0.397034251317503	0.815908155126129
FIGUEROA_AML_METHYLATION_CLUSTER_1_DN	75	Down	0.397041074793903	0.815908155126129
KEGG_GLUTATHIONE_METABOLISM	50	Down	0.397429285811951	0.815908155126129
HAHTOLA_MYCOSIS_FUNGOIDES_SKIN_UP	203	Down	0.397430112166851	0.815908155126129
KLEIN_PRIMARY_EFFUSION_LYMPHOMA_DN	49	Up	0.397767051306415	0.815908155126129
CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN	852	Down	0.39785189084003	0.815908155126129
KEGG_O_GLYCAN_BIOSYNTHESIS	19	Down	0.397977566110868	0.815908155126129
REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS	508	Down	0.398081742778555	0.815908155126129
PAL_PRMT5_TARGETS_DN	27	Up	0.398250559303815	0.815908155126129
PID_ATR_PATHWAY	45	Down	0.398508797325645	0.815908155126129
REACTOME_REGULATION_OF_AMPK_ACTIVITY_VIA_LKB1	16	Up	0.398732708997508	0.815908155126129
VALK_AML_WITH_EVI1	29	Down	0.399149451019017	0.815908155126129
BENNETT_SYSTEMIC_LUPUS_ERYTHEMATOSUS	28	Down	0.399250322956305	0.815908155126129
BIOCARTA_MET_PATHWAY	58	Down	0.399665819775414	0.815908155126129
LIU_NASOPHARYNGEAL_CARCINOMA	96	Down	0.39968774678546	0.815908155126129
DEBOSSCHER_NFKB_TARGETS_REPRESSED_BY_GLUCOCORTICOIDS	15	Down	0.399793698291621	0.815908155126129
SCHLOSSER_SERUM_RESPONSE_DN	1048	Down	0.399836463042968	0.815908155126129
BIOCARTA_P38MAPK_PATHWAY	57	Up	0.400096312443976	0.815908155126129
HUMMEL_BURKITTS_LYMPHOMA_UP	76	Down	0.400461514026011	0.815908155126129
DELYS_THYROID_CANCER_DN	286	Up	0.400471678007857	0.815908155126129
KIM_ALL_DISORDERS_CALB1_CORR_DN	23	Down	0.400962496326832	0.815908155126129
TERAMOTO_OPN_TARGETS_CLUSTER_4	29	Up	0.401119295120869	0.815908155126129
LU_AGING_BRAIN_DN	246	Down	0.401164518597987	0.815908155126129
NIELSEN_LEIOMYOSARCOMA_CNN1_DN	29	Down	0.401246499992979	0.815908155126129
RAMASWAMY_METASTASIS_DN	97	Down	0.40171049768829	0.815908155126129
BIOCARTA_TID_PATHWAY	28	Up	0.402002486360583	0.815908155126129
WANG_RECURRENT_LIVER_CANCER_DN	16	Up	0.402052585773868	0.815908155126129
WAESCH_ANAPHASE_PROMOTING_COMPLEX	17	Up	0.402387617907557	0.815908155126129
RASHI_RESPONSE_TO_IONIZING_RADIATION_1	79	Up	0.402407792929234	0.815908155126129
GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_UP	285	Up	0.402490672161579	0.815908155126129
UEDA_CENTRAL_CLOCK	130	Up	0.402676271645634	0.815908155126129
AMIT_EGF_RESPONSE_120_MCF10A	74	Up	0.402839600676962	0.815908155126129
PUJANA_BREAST_CANCER_WITH_BRCA1_MUTATED_DN	12	Down	0.40306340647912	0.815908155126129
MCCABE_HOXC6_TARGETS_CANCER_UP	33	Down	0.403110937498954	0.815908155126129
KEGG_FOCAL_ADHESION	210	Down	0.403366817499016	0.815908155126129
SCHMAHL_PDGF_SIGNALING	10	Down	0.403392884522484	0.815908155126129
YANAGIHARA_ESX1_TARGETS	49	Down	0.403560745168485	0.815908155126129
REACTOME_SEMA3A_PAK_DEPENDENT_AXON_REPULSION	32	Up	0.40383698387943	0.815908155126129
SANSOM_APC_TARGETS_REQUIRE_MYC	255	Down	0.403851336689151	0.815908155126129
GAJATE_RESPONSE_TO_TRABECTEDIN_UP	103	Up	0.404002926206121	0.815908155126129
ABE_VEGFA_TARGETS_2HR	36	Down	0.404038681105104	0.815908155126129
ZHAN_MULTIPLE_MYELOMA_SPIKED	32	Down	0.404091226369191	0.815908155126129
REACTOME_INFLAMMASOMES	18	Up	0.404118050762811	0.815908155126129
DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_DN	170	Down	0.404154335943087	0.815908155126129
FRIDMAN_SENESCENCE_UP	132	Up	0.404918288925171	0.81644505071789
WUNDER_INFLAMMATORY_RESPONSE_AND_CHOLESTEROL_UP	92	Down	0.405026707980248	0.81644505071789
REACTOME_SIGNALING_BY_NOTCH1	68	Up	0.405187443206007	0.81644505071789
KORKOLA_YOLK_SAC_TUMOR_UP	34	Down	0.405359288847182	0.81644505071789
HUANG_DASATINIB_RESISTANCE_DN	84	Up	0.405391759168213	0.81644505071789
KIM_GERMINAL_CENTER_T_HELPER_UP	86	Down	0.405612430810663	0.81644505071789
MARTENS_TRETINOIN_RESPONSE_UP	658	Up	0.40563008764498	0.81644505071789
WEIGEL_OXIDATIVE_STRESS_RESPONSE	90	Down	0.406176400801549	0.816801870138475
HATADA_METHYLATED_IN_LUNG_CANCER_UP	491	Up	0.406304058989923	0.816801870138475
REACTOME_ACTIVATION_OF_CHAPERONE_GENES_BY_XBP1S	69	Up	0.406392351902365	0.816801870138475
REACTOME_PYRIMIDINE_METABOLISM	23	Down	0.406577459358853	0.816801870138475
YANG_BREAST_CANCER_ESR1_DN	42	Up	0.406717650735355	0.816801870138475
GROSS_HYPOXIA_VIA_ELK3_UP	350	Down	0.40732079557142	0.816801870138475
MEISSNER_BRAIN_HCP_WITH_H3_UNMETHYLATED	23	Up	0.407321315188394	0.816801870138475
TIAN_BHLHA15_TARGETS	18	Up	0.407385927670453	0.816801870138475
BOQUEST_STEM_CELL_UP	354	Up	0.407595182391679	0.816801870138475
MATZUK_POST-IMPLANTATION_AND_POST-PARTUM	18	Up	0.407729348812039	0.816801870138475
BIOCARTA_RAC1_PATHWAY	32	Up	0.407745346300686	0.816801870138475
REACTOME_SIGNALING_BY_BMP	25	Up	0.40815346472122	0.816801870138475
GHO_ATF5_TARGETS_DN	38	Up	0.408175323079043	0.816801870138475
RODRIGUES_THYROID_CARCINOMA_UP	19	Up	0.408516197193645	0.816801870138475
GOZGIT_ESR1_TARGETS_DN	940	Up	0.40873466733238	0.816801870138475
BARRIER_COLON_CANCER_RECURRENCE_DN	41	Down	0.40878779112219	0.816801870138475
REACTOME_GLUCAGON_TYPE_LIGAND_RECEPTORS	15	Down	0.408814767487718	0.816801870138475
BOYAULT_LIVER_CANCER_SUBCLASS_G3_UP	303	Down	0.409256724155607	0.816801870138475
VERRECCHIA_RESPONSE_TO_TGFB1_C2	76	Up	0.409383799558177	0.816801870138475
PAPASPYRIDONOS_UNSTABLE_ATEROSCLEROTIC_PLAQUE_DN	59	Up	0.409605757339985	0.816801870138475
DER_IFN_BETA_RESPONSE_UP	156	Down	0.409689563163953	0.816801870138475
STANELLE_E2F1_TARGETS	42	Down	0.409903284497238	0.816801870138475
FRASOR_RESPONSE_TO_SERM_OR_FULVESTRANT_UP	40	Down	0.410030695660398	0.816801870138475
SMITH_TERT_TARGETS_DN	142	Down	0.410095065886783	0.816801870138475
KAPOSI_LIVER_CANCER_MET_UP	35	Down	0.410129982211783	0.816801870138475
REACTOME_G_ALPHA_Z_SIGNALLING_EVENTS	34	Down	0.410579595586471	0.81735272210303
KEGG_THYROID_CANCER	36	Down	0.411415458212366	0.818585689470104
NAGASHIMA_NRG1_SIGNALING_DN	68	Up	0.412168337989309	0.818585689470104
PETRETTO_LEFT_VENTRICLE_MASS_QTL_CIS_UP	6	Down	0.41217963857639	0.818585689470104
FOSTER_KDM1A_TARGETS_UP	282	Up	0.412223637415587	0.818585689470104
PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_3	23	Up	0.412288668276839	0.818585689470104
GYORFFY_MITOXANTRONE_RESISTANCE	73	Up	0.412291546874655	0.818585689470104
NOUZOVA_TRETINOIN_AND_H4_ACETYLATION	192	Up	0.412411926532356	0.818585689470104
ONGUSAHA_BRCA1_TARGETS_DN	46	Up	0.413182240314408	0.819770223958532
KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_4NQO_IN_WS	60	Down	0.413605768035721	0.820005928601391
KEGG_LEUKOCYTE_TRANSENDOTHELIAL_MIGRATION	87	Down	0.413648206574326	0.820005928601391
HSIAO_LIVER_SPECIFIC_GENES	239	Up	0.414159752760431	0.82067561746656
MIKKELSEN_ES_LCP_WITH_H3K4ME3	147	Down	0.414339246501384	0.820687044223287
LIM_MAMMARY_LUMINAL_PROGENITOR_DN	28	Up	0.414646927503267	0.820694415721342
CHAUHAN_RESPONSE_TO_METHOXYESTRADIOL_DN	168	Down	0.414907929335297	0.820694415721342
ST_PHOSPHOINOSITIDE_3_KINASE_PATHWAY	48	Down	0.415073309078719	0.820694415721342
WESTON_VEGFA_TARGETS	139	Up	0.415400723151667	0.820694415721342
MARIADASON_RESPONSE_TO_BUTYRATE_SULINDAC_4	25	Down	0.415474928940772	0.820694415721342
GARCIA_TARGETS_OF_FLI1_AND_DAX1_DN	226	Down	0.415511679922729	0.820694415721342
BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_UP	41	Up	0.415559069095142	0.820694415721342
PID_SHP2_PATHWAY	76	Down	0.415901547293052	0.821027542587705
PUJANA_BRCA1_PCC_NETWORK	2096	Down	0.416156366256989	0.821187416122814
SNIJDERS_AMPLIFIED_IN_HEAD_AND_NECK_TUMORS	49	Up	0.416372231230422	0.821270321641968
BHATTACHARYA_EMBRYONIC_STEM_CELL	169	Down	0.417690077852358	0.823444054204992
GARCIA_TARGETS_OF_FLI1_AND_DAX1_UP	88	Up	0.417933040172399	0.823444054204992
UEDA_PERIFERAL_CLOCK	233	Up	0.418033534559032	0.823444054204992
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_2	102	Up	0.418171525410198	0.823444054204992
WARTERS_IR_RESPONSE_5GY	56	Up	0.418362765088328	0.82347737594886
CHANGOLKAR_H2AFY_TARGETS_UP	75	Down	0.418776691213115	0.82394880853426
GUO_HEX_TARGETS_UP	124	Down	0.419036732563787	0.824117204259504
BERENJENO_TRANSFORMED_BY_RHOA_FOREVER_UP	29	Up	0.419557950117523	0.824798899856504
FERRANDO_T_ALL_WITH_MLL_ENL_FUSION_UP	143	Down	0.419765799165688	0.824864240956203
DASU_IL6_SIGNALING_UP	107	Down	0.420397664072753	0.825671908028854
ONGUSAHA_BRCA1_TARGETS_UP	21	Up	0.4205263782213	0.825671908028854
MARTENS_TRETINOIN_RESPONSE_DN	993	Down	0.421305060467105	0.825826697609292
DER_IFN_GAMMA_RESPONSE_DN	11	Down	0.421515362435724	0.825826697609292
ROVERSI_GLIOMA_LOH_REGIONS	89	Up	0.421618097495024	0.825826697609292
JOSEPH_RESPONSE_TO_SODIUM_BUTYRATE_UP	48	Down	0.421626476867156	0.825826697609292
COLINA_TARGETS_OF_4EBP1_AND_4EBP2	502	Down	0.421649030835308	0.825826697609292
REACTOME_TCR_SIGNALING	43	Down	0.421654105553263	0.825826697609292
MOOTHA_FFA_OXYDATION	96	Up	0.421911639625691	0.825831033974623
KEGG_PATHWAYS_IN_CANCER	337	Down	0.422080926850151	0.825831033974623
DUTERTRE_ESTRADIOL_RESPONSE_6HR_UP	272	Down	0.422570411968935	0.825831033974623
OXFORD_RALA_AND_RALB_TARGETS_DN	23	Up	0.422767916149211	0.825831033974623
CAIRO_LIVER_DEVELOPMENT_DN	229	Up	0.422818095945832	0.825831033974623
GUO_TARGETS_OF_IRS1_AND_IRS2	156	Down	0.423007840076476	0.825831033974623
REACTOME_EGFR_DOWNREGULATION	30	Up	0.423220069979117	0.825831033974623
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_MAGENTA_DN	14	Down	0.423240192928145	0.825831033974623
REACTOME_LIPOPROTEIN_METABOLISM	27	Up	0.423351295780808	0.825831033974623
NUYTTEN_EZH2_TARGETS_DN	1272	Down	0.423404480162265	0.825831033974623
VALK_AML_CLUSTER_3	59	Up	0.423925388274163	0.826175429813089
LEIN_LOCALIZED_TO_PROXIMAL_DENDRITES	50	Down	0.423936403278179	0.826175429813089
ZHAN_VARIABLE_EARLY_DIFFERENTIATION_GENES_UP	24	Down	0.424105719156804	0.826175429813089
PID_S1P_S1P4_PATHWAY	15	Up	0.425188345717624	0.827943011199527
NAGY_TFTC_COMPONENTS_HUMAN	22	Down	0.425508395146641	0.828138856578067
NAM_FXYD5_TARGETS_DN	22	Up	0.425750055130825	0.828138856578067
HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_2NM_DN	26	Up	0.425814835442025	0.828138856578067
ST_STAT3_PATHWAY	14	Down	0.426211265385551	0.828455195352223
HAHTOLA_MYCOSIS_FUNGOIDES_SKIN_DN	27	Down	0.426337809930362	0.828455195352223
RIGGINS_TAMOXIFEN_RESISTANCE_UP	94	Up	0.426503606074642	0.828455195352223
REACTOME_REVERSIBLE_HYDRATION_OF_CARBON_DIOXIDE	8	Up	0.426748925680101	0.828591009006494
DITTMER_PTHLH_TARGETS_DN	117	Up	0.427093904634219	0.828920133727218
REACTOME_APOPTOSIS_INDUCED_DNA_FRAGMENTATION	15	Down	0.427846505030289	0.829802051526521
KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_GAMMA_IN_OLD	34	Down	0.427947104027327	0.829802051526521
CAIRO_HEPATOBLASTOMA_CLASSES_DN	227	Up	0.42807527509952	0.829802051526521
BOYAULT_LIVER_CANCER_SUBCLASS_G23_DN	20	Down	0.428545324122234	0.830372482015354
SENESE_HDAC3_TARGETS_UP	722	Down	0.428830887717163	0.830585122417334
BIOCARTA_STRESS_PATHWAY	32	Up	0.429212906054202	0.830984331229529
TRAYNOR_RETT_SYNDROM_UP	60	Down	0.429581845369313	0.831033227216591
KIM_MYC_AMPLIFICATION_TARGETS_DN	150	Up	0.429589995948966	0.831033227216591
KONDO_HYPOXIA	5	Up	0.430615464245191	0.831449021407555
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_8	55	Up	0.430865403583671	0.831449021407555
PUIFFE_INVASION_INHIBITED_BY_ASCITES_DN	208	Down	0.430916311106466	0.831449021407555
PASQUALUCCI_LYMPHOMA_BY_GC_STAGE_UP	400	Up	0.430971438528008	0.831449021407555
CHEN_HOXA5_TARGETS_6HR_DN	10	Down	0.431067747589065	0.831449021407555
KINNEY_DNMT1_METHYLATION_TARGETS	3	Down	0.431160866537622	0.831449021407555
REACTOME_REGULATION_OF_GENE_EXPRESSION_IN_BETA_CELLS	6	Down	0.431193993543986	0.831449021407555
LUCAS_HNF4A_TARGETS_UP	82	Up	0.431317402690336	0.831449021407555
KEGG_BETA_ALANINE_METABOLISM	32	Up	0.431452081132921	0.831449021407555
REACTOME_GASTRIN_CREB_SIGNALLING_PATHWAY_VIA_PKC_AND_MAPK	119	Down	0.431732937232252	0.831449021407555
PID_HEDGEHOG_2PATHWAY	29	Down	0.431740992699562	0.831449021407555
PID_IL12_2PATHWAY	59	Down	0.432419964703936	0.832417242567805
WANG_LMO4_TARGETS_UP	477	Down	0.43275709087095	0.832726882800149
MILICIC_FAMILIAL_ADENOMATOUS_POLYPOSIS_DN	3	Up	0.433990847186852	0.834760896624874
DAIRKEE_TERT_TARGETS_DN	196	Up	0.434678113787838	0.835592338405111
HOLLEMAN_DAUNORUBICIN_ALL_DN	10	Down	0.434887029137231	0.835592338405111
KIM_ALL_DISORDERS_CALB1_CORR_UP	723	Down	0.434953759555074	0.835592338405111
WAMUNYOKOLI_OVARIAN_CANCER_GRADES_1_2_DN	99	Down	0.435594919921105	0.836258622269064
JACKSON_DNMT1_TARGETS_DN	46	Up	0.435654629425099	0.836258622269064
WANG_CLASSIC_ADIPOGENIC_TARGETS_OF_PPARG	21	Down	0.435886642161114	0.836340047372434
BENPORATH_ES_CORE_NINE	14	Down	0.436231376327306	0.836340047372434
REACTOME_TRANSLATION	191	Down	0.436320107479948	0.836340047372434
NIELSEN_LEIOMYOSARCOMA_DN	28	Up	0.436405211001916	0.836340047372434
WONG_IFNA2_RESISTANCE_UP	38	Down	0.43720221379129	0.837193262896657
VALK_AML_WITH_T_8_21_TRANSLOCATION	9	Up	0.437204864429732	0.837193262896657
REACTOME_GENERATION_OF_SECOND_MESSENGER_MOLECULES	16	Down	0.43745609169842	0.837201622213442
BURTON_ADIPOGENESIS_4	82	Up	0.437641644649072	0.837201622213442
YANG_BREAST_CANCER_ESR1_BULK_DN	29	Down	0.437945869918527	0.837201622213442
REACTOME_ACTIVATION_OF_BH3_ONLY_PROTEINS	21	Down	0.438104776313482	0.837201622213442
ST_MYOCYTE_AD_PATHWAY	38	Up	0.438251582225723	0.837201622213442
JIANG_VHL_TARGETS	204	Down	0.438272568106232	0.837201622213442
REACTOME_GRB2_EVENTS_IN_ERBB2_SIGNALING	27	Down	0.43925585715229	0.837982701695817
FRIDMAN_SENESCENCE_DN	32	Up	0.439300330744896	0.837982701695817
NOUSHMEHR_GBM_GERMLINE_MUTATED	7	Up	0.439338496568904	0.837982701695817
OXFORD_RALB_TARGETS_UP	26	Up	0.439534079716844	0.837982701695817
KLEIN_TARGETS_OF_BCR_ABL1_FUSION	37	Down	0.439568402794715	0.837982701695817
REACTOME_COLLAGEN_FORMATION	54	Up	0.440365506677476	0.838970909031899
SIG_PIP3_SIGNALING_IN_B_LYMPHOCYTES	45	Down	0.440468510336905	0.838970909031899
JOHNSTONE_PARVB_TARGETS_3_UP	635	Down	0.440851999983943	0.838970909031899
REACTOME_SYNTHESIS_OF_PC	13	Down	0.441043534803236	0.838970909031899
FUKUSHIMA_TNFSF11_TARGETS	13	Up	0.441150967313822	0.838970909031899
PID_ALK1_PATHWAY	30	Down	0.441257860769727	0.838970909031899
DELASERNA_TARGETS_OF_MYOD_AND_SMARCA4	15	Down	0.441511876308539	0.838970909031899
LINDGREN_BLADDER_CANCER_CLUSTER_2A_DN	206	Down	0.441533890353097	0.838970909031899
ONKEN_UVEAL_MELANOMA_DN	811	Down	0.441685150457734	0.838970909031899
DODD_NASOPHARYNGEAL_CARCINOMA_DN	1746	Down	0.442692493655949	0.840546358533241
NIKOLSKY_BREAST_CANCER_7P15_AMPLICON	11	Up	0.443251096380949	0.841268854682043
FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP	732	Down	0.443737337335795	0.841301914466554
PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_5	12	Down	0.443840909208076	0.841301914466554
KEGG_DRUG_METABOLISM_CYTOCHROME_P450	45	Up	0.444234602303326	0.841301914466554
KRISHNAN_FURIN_TARGETS_UP	18	Down	0.444412972248523	0.841301914466554
KONDO_PROSTATE_CANCER_HCP_WITH_H3K27ME3	101	Up	0.444420654323475	0.841301914466554
HADDAD_T_LYMPHOCYTE_AND_NK_PROGENITOR_UP	146	Up	0.444569567123379	0.841301914466554
ICHIBA_GRAFT_VERSUS_HOST_DISEASE_D7_DN	38	Down	0.444610416401428	0.841301914466554
RASHI_RESPONSE_TO_IONIZING_RADIATION_2	182	Up	0.444693243103934	0.841301914466554
MITSIADES_RESPONSE_TO_APLIDIN_UP	624	Up	0.445518697452326	0.84193694507233
REACTOME_GAMMA_CARBOXYLATION_TRANSPORT_AND_AMINO_TERMINAL_CLEAVAGE_OF_PROTEINS	8	Up	0.445718024291004	0.84193694507233
RIZ_ERYTHROID_DIFFERENTIATION_12HR	54	Up	0.445961913567302	0.84193694507233
REACTOME_TRAF6_MEDIATED_IRF7_ACTIVATION_IN_TLR7_8_OR_9_SIGNALING	28	Down	0.446621364373202	0.84193694507233
JEPSEN_SMRT_TARGETS	37	Down	0.447217107272987	0.84193694507233
BIOCARTA_CARM_ER_PATHWAY	38	Up	0.447420114870205	0.84193694507233
TOMIDA_METASTASIS_UP	53	Down	0.447539313922139	0.84193694507233
GHANDHI_DIRECT_IRRADIATION_DN	29	Up	0.447850128277747	0.84193694507233
MARSON_BOUND_BY_FOXP3_UNSTIMULATED	1501	Down	0.448336407083123	0.84193694507233
REACTOME_FATTY_ACID_TRIACYLGLYCEROL_AND_KETONE_BODY_METABOLISM	223	Down	0.448463056247042	0.84193694507233
KEGG_INOSITOL_PHOSPHATE_METABOLISM	48	Down	0.448942820982433	0.84193694507233
MARTINEZ_RESPONSE_TO_TRABECTEDIN_DN	396	Down	0.449026771105325	0.84193694507233
STEIN_ESRRA_TARGETS_RESPONSIVE_TO_ESTROGEN_UP	40	Down	0.449084000560404	0.84193694507233
PID_TCR_RAS_PATHWAY	16	Down	0.449109160229127	0.84193694507233
HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_4NM_DN	12	Up	0.449174367334806	0.84193694507233
BOYLAN_MULTIPLE_MYELOMA_PCA3_DN	91	Down	0.449307215081568	0.84193694507233
VALK_AML_CLUSTER_15	54	Up	0.449395961567742	0.84193694507233
NGUYEN_NOTCH1_TARGETS_UP	42	Up	0.449455506487558	0.84193694507233
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_YELLOW_UP	51	Down	0.449621022981698	0.84193694507233
VALK_AML_CLUSTER_12	38	Up	0.449638989796543	0.84193694507233
PETRETTO_HEART_MASS_QTL_CIS_DN	28	Up	0.449721053436767	0.84193694507233
RIZ_ERYTHROID_DIFFERENTIATION_HBZ	47	Down	0.44986599002737	0.84193694507233
RAMPON_ENRICHED_LEARNING_ENVIRONMENT_LATE_UP	39	Up	0.449935460945798	0.84193694507233
BOYLAN_MULTIPLE_MYELOMA_PCA1_DN	10	Up	0.450081708937033	0.84193694507233
PID_DELTA_NP63_PATHWAY	72	Up	0.450127471454135	0.84193694507233
DURCHDEWALD_SKIN_CARCINOGENESIS_DN	373	Down	0.450144792456422	0.84193694507233
SERVITJA_ISLET_HNF1A_TARGETS_UP	242	Up	0.450511373163787	0.84193694507233
RODRIGUES_NTN1_AND_DCC_TARGETS	41	Down	0.45064172407622	0.84193694507233
JI_METASTASIS_REPRESSED_BY_STK11	40	Down	0.451174522730176	0.84193694507233
HOEGERKORP_CD44_TARGETS_TEMPORAL_DN	28	Down	0.451373010938815	0.84193694507233
ISSAEVA_MLL2_TARGETS	94	Up	0.451575559856618	0.84193694507233
NAKAMURA_BRONCHIAL_AND_BRONCHIOLAR_EPITHELIA	10	Up	0.451611090765536	0.84193694507233
MATZUK_EARLY_ANTRAL_FOLLICLE	19	Down	0.451928571224173	0.84193694507233
XU_CREBBP_TARGETS_DN	66	Up	0.452191920934714	0.84193694507233
KEGG_LEISHMANIA_INFECTION	69	Down	0.452235334156754	0.84193694507233
NIELSEN_MALIGNAT_FIBROUS_HISTIOCYTOMA_UP	36	Down	0.452547264910121	0.84193694507233
SMID_BREAST_CANCER_RELAPSE_IN_LIVER_DN	9	Up	0.452615242143098	0.84193694507233
MORI_SMALL_PRE_BII_LYMPHOCYTE_UP	121	Up	0.452798233716387	0.84193694507233
REACTOME_ASSOCIATION_OF_LICENSING_FACTORS_WITH_THE_PRE_REPLICATIVE_COMPLEX	15	Up	0.452828376687739	0.84193694507233
PID_NETRIN_PATHWAY	51	Down	0.452967760818002	0.84193694507233
KEGG_DILATED_CARDIOMYOPATHY	83	Up	0.453245293328332	0.84193694507233
NAKAMURA_ADIPOGENESIS_EARLY_DN	50	Up	0.453296465744724	0.84193694507233
CHENG_RESPONSE_TO_NICKEL_ACETATE	57	Up	0.453322162427388	0.84193694507233
EBAUER_TARGETS_OF_PAX3_FOXO1_FUSION_DN	53	Up	0.453570152418266	0.84193694507233
REACTOME_MRNA_CAPPING	29	Up	0.453661939476497	0.84193694507233
POS_HISTAMINE_RESPONSE_NETWORK	53	Down	0.454022313902491	0.84193694507233
REACTOME_CRMPS_IN_SEMA3A_SIGNALING	28	Up	0.454187497587222	0.84193694507233
SHIN_B_CELL_LYMPHOMA_CLUSTER_9	10	Up	0.454312455709695	0.84193694507233
GROSS_HYPOXIA_VIA_ELK3_AND_HIF1A_UP	215	Up	0.454602511977351	0.84193694507233
BREUHAHN_GROWTH_FACTOR_SIGNALING_IN_LIVER_CANCER	27	Up	0.454714138838548	0.84193694507233
PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_7	529	Down	0.454722935399022	0.84193694507233
WOOD_EBV_EBNA1_TARGETS_DN	63	Down	0.454752473324195	0.84193694507233
MATHEW_FANCONI_ANEMIA_GENES	11	Down	0.454890555281754	0.84193694507233
PID_REG_GR_PATHWAY	85	Down	0.454913469166606	0.84193694507233
GRATIAS_RETINOBLASTOMA_16Q24	27	Down	0.454913589063548	0.84193694507233
MARIADASON_RESPONSE_TO_BUTYRATE_CURCUMIN_SULINDAC_TSA_1	16	Up	0.45521590089372	0.84193694507233
NOUSHMEHR_GBM_SOMATIC_MUTATED	22	Up	0.45522158764475	0.84193694507233
BROWNE_HCMV_INFECTION_8HR_DN	53	Up	0.455435182846527	0.84193694507233
HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP	634	Up	0.455927719838061	0.84193694507233
UDAYAKUMAR_MED1_TARGETS_DN	379	Up	0.456006960881442	0.84193694507233
SMID_BREAST_CANCER_RELAPSE_IN_BRAIN_DN	168	Up	0.45614248926399	0.84193694507233
REACTOME_NUCLEAR_SIGNALING_BY_ERBB4	42	Up	0.456468579609929	0.84193694507233
SENESE_HDAC1_AND_HDAC2_TARGETS_UP	280	Down	0.456613779193193	0.84193694507233
PURBEY_TARGETS_OF_CTBP1_AND_SATB1_DN	235	Down	0.456725860226786	0.84193694507233
ZHONG_SECRETOME_OF_LUNG_CANCER_AND_FIBROBLAST	199	Down	0.456839478765438	0.84193694507233
IKEDA_MIR1_TARGETS_UP	78	Down	0.456852628794514	0.84193694507233
IKEDA_MIR133_TARGETS_DN	10	Down	0.457077534200568	0.84193694507233
REACTOME_PHASE_II_CONJUGATION	47	Down	0.457148235417131	0.84193694507233
JAZAG_TGFB1_SIGNALING_DN	36	Down	0.457421757121593	0.842112385285427
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINED_IN_MONOCYTE_UP	34	Up	0.457681586399906	0.842262490905008
BYSTRYKH_HEMATOPOIESIS_STEM_CELL_AND_BRAIN_QTL_CIS	97	Up	0.45838153644833	0.842949249585581
REACTOME_PHOSPHORYLATION_OF_CD3_AND_TCR_ZETA_CHAINS	6	Down	0.458433974742123	0.842949249585581
BOYLAN_MULTIPLE_MYELOMA_D_CLUSTER_DN	52	Down	0.458590087094611	0.842949249585581
REACTOME_INWARDLY_RECTIFYING_K_CHANNELS	20	Down	0.459210629918185	0.843568878673722
BIOCARTA_RHO_PATHWAY	47	Down	0.459433892610906	0.843568878673722
BAKER_HEMATOPOESIS_STAT1_TARGETS	11	Down	0.459497907303196	0.843568878673722
SA_MMP_CYTOKINE_CONNECTION	9	Down	0.459641467761677	0.843568878673722
MCCOLLUM_GELDANAMYCIN_RESISTANCE_UP	27	Up	0.460076749288925	0.844039830540148
DORN_ADENOVIRUS_INFECTION_48HR_UP	20	Down	0.460440525930593	0.84426541915238
MATZUK_FERTILIZATION	8	Down	0.46055715181111	0.84426541915238
PID_HIF1_TFPATHWAY	94	Up	0.461055941904002	0.844810415542475
HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_2_DN	46	Down	0.461212121440314	0.844810415542475
REACTOME_SIGNALING_BY_FGFR1_FUSION_MUTANTS	31	Down	0.461564537707286	0.845128246561713
MANN_RESPONSE_TO_AMIFOSTINE_UP	29	Down	0.461821469044993	0.845271065388822
KYNG_ENVIRONMENTAL_STRESS_RESPONSE_DN	22	Down	0.462566213236883	0.846306270848581
REACTOME_REGULATION_OF_IFNA_SIGNALING	15	Up	0.463017791103651	0.846466462388027
TRACEY_RESISTANCE_TO_IFNA2_DN	40	Up	0.463294933656275	0.846466462388027
HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_2NM_UP	114	Up	0.463470740311044	0.846466462388027
PID_NCADHERIN_PATHWAY	60	Down	0.463710395235449	0.846466462388027
RICKMAN_METASTASIS_UP	413	Down	0.463823386421913	0.846466462388027
HOLLEMAN_ASPARAGINASE_RESISTANCE_B_ALL_DN	26	Down	0.463834233412827	0.846466462388027
HOFFMANN_IMMATURE_TO_MATURE_B_LYMPHOCYTE_DN	53	Up	0.464004266590702	0.846466462388027
STEARMAN_LUNG_CANCER_EARLY_VS_LATE_DN	62	Down	0.464385484626055	0.846466462388027
NING_CHRONIC_OBSTRUCTIVE_PULMONARY_DISEASE_UP	200	Down	0.464503072141981	0.846466462388027
MONNIER_POSTRADIATION_TUMOR_ESCAPE_DN	580	Down	0.46453415951087	0.846466462388027
MARTENS_BOUND_BY_PML_RARA_FUSION	596	Down	0.464860960718134	0.846466462388027
IRITANI_MAD1_TARGETS_UP	17	Up	0.464881069199941	0.846466462388027
LEE_LIVER_CANCER_ACOX1_UP	86	Up	0.465112496666424	0.846466462388027
REACTOME_RIP_MEDIATED_NFKB_ACTIVATION_VIA_DAI	30	Down	0.465267276922304	0.846466462388027
RAO_BOUND_BY_SALL4_ISOFORM_B	648	Up	0.465392063105381	0.846466462388027
LOPEZ_MBD_TARGETS	1304	Down	0.465520717460646	0.846466462388027
PENG_RAPAMYCIN_RESPONSE_UP	332	Down	0.465921001546616	0.846741477760537
GAVIN_FOXP3_TARGETS_CLUSTER_P2	86	Up	0.466065143479403	0.846741477760537
SESTO_RESPONSE_TO_UV_C3	41	Down	0.466229700735318	0.846741477760537
SASSON_RESPONSE_TO_GONADOTROPHINS_DN	160	Up	0.466430858123049	0.846741477760537
PATTERSON_DOCETAXEL_RESISTANCE	54	Down	0.466657309692791	0.846741477760537
KEGG_PEROXISOME	117	Up	0.466753723313774	0.846741477760537
MIZUKAMI_HYPOXIA_UP	13	Up	0.466926661635521	0.846741477760537
PEDERSEN_TARGETS_OF_611CTF_ISOFORM_OF_ERBB2	101	Up	0.467124051640897	0.846774374501764
REACTOME_G_ALPHA_S_SIGNALLING_EVENTS	63	Down	0.467482099468136	0.847098365127532
WANG_METASTASIS_OF_BREAST_CANCER	28	Up	0.467800117747793	0.847132447586926
NAKAMURA_LUNG_CANCER	21	Up	0.467994823252207	0.847132447586926
PID_PI3KCI_AKT_PATHWAY	50	Down	0.468038884039347	0.847132447586926
GAVIN_IL2_RESPONSIVE_FOXP3_TARGETS_DN	6	Down	0.468648413227638	0.847736483655375
TIEN_INTESTINE_PROBIOTICS_2HR_UP	62	Up	0.468881303847417	0.847736483655375
HAHTOLA_MYCOSIS_FUNGOIDES_CD4_DN	172	Down	0.468910972013441	0.847736483655375
WU_HBX_TARGETS_1_UP	16	Up	0.46951394418587	0.848501863938045
WHITESIDE_CISPLATIN_RESISTANCE_DN	26	Up	0.470398974220516	0.848613927391833
OKAWA_NEUROBLASTOMA_1P36_31_DELETION	29	Up	0.470536835540418	0.848613927391833
REACTOME_APC_C_CDC20_MEDIATED_DEGRADATION_OF_MITOTIC_PROTEINS	76	Down	0.470749456945757	0.848613927391833
EHRLICH_ICF_SYNDROM_DN	15	Up	0.471078514576695	0.848613927391833
NABA_MATRISOME_ASSOCIATED	399	Up	0.471102862441305	0.848613927391833
REACTOME_SCFSKP2_MEDIATED_DEGRADATION_OF_P27_P21	60	Down	0.471191346435253	0.848613927391833
PHONG_TNF_TARGETS_UP	90	Up	0.471234832625248	0.848613927391833
HOELZEL_NF1_TARGETS_UP	170	Up	0.471262680520714	0.848613927391833
IIZUKA_LIVER_CANCER_EARLY_RECURRENCE	21	Up	0.471370764327458	0.848613927391833
REACTOME_SIGNALING_BY_ROBO_RECEPTOR	32	Down	0.471372342395464	0.848613927391833
REACTOME_SPHINGOLIPID_METABOLISM	68	Down	0.471984612141483	0.849009650380752
DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN	448	Up	0.472098704068943	0.849009650380752
REACTOME_CDT1_ASSOCIATION_WITH_THE_CDC6_ORC_ORIGIN_COMPLEX	60	Up	0.472196858568485	0.849009650380752
REACTOME_REGULATION_OF_GLUCOKINASE_BY_GLUCOKINASE_REGULATORY_PROTEIN	28	Down	0.47240535012766	0.849009650380752
HAMAI_APOPTOSIS_VIA_TRAIL_UP	825	Down	0.472490764363039	0.849009650380752
MONTERO_THYROID_CANCER_POOR_SURVIVAL_DN	13	Up	0.472835333064588	0.849009737224954
TIMOFEEVA_GROWTH_STRESS_VIA_STAT1_DN	28	Down	0.472850257967581	0.849009737224954
HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_DN	101	Up	0.473332467085768	0.849477347431064
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_UP	229	Up	0.473470333570278	0.849477347431064
REACTOME_SIGNALING_BY_FGFR_MUTANTS	48	Down	0.473929726838833	0.849978750792197
APPEL_IMATINIB_RESPONSE	38	Down	0.474610302537997	0.850601194971928
REACTOME_CELL_EXTRACELLULAR_MATRIX_INTERACTIONS	20	Down	0.474673385286674	0.850601194971928
HAHTOLA_SEZARY_SYNDROM_UP	118	Down	0.475017900098475	0.850601194971928
ROPERO_HDAC2_TARGETS	146	Up	0.475068667059886	0.850601194971928
KANG_DOXORUBICIN_RESISTANCE_DN	29	Down	0.475177085844817	0.850601194971928
MARIADASON_RESPONSE_TO_BUTYRATE_CURCUMIN_SULINDAC_TSA_2	12	Up	0.475948680247049	0.85153943933027
CROMER_TUMORIGENESIS_DN	50	Up	0.476061739896537	0.85153943933027
APPIERTO_RESPONSE_TO_FENRETINIDE_DN	85	Down	0.476463734760631	0.851656160009059
GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_DN	1044	Down	0.476487559463154	0.851656160009059
REACTOME_JNK_C_JUN_KINASES_PHOSPHORYLATION_AND_ACTIVATION_MEDIATED_BY_ACTIVATED_HUMAN_TAK1	17	Up	0.476709194614228	0.851730043629959
NABA_SECRETED_FACTORS	163	Up	0.476924165244573	0.851746769120906
ZHU_CMV_ALL_UP	189	Down	0.477079159842066	0.851746769120906
CHIBA_RESPONSE_TO_TSA_DN	39	Up	0.477694801590812	0.852523703330183
RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN	426	Down	0.478213734936355	0.853127524108513
BIOCARTA_RNA_PATHWAY	15	Down	0.478505268424188	0.853325363546948
HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_2_UP	79	Up	0.47919879659931	0.854239666088731
REACTOME_GLYCOLYSIS	34	Down	0.479391596811954	0.854260997110399
VERHAAK_GLIOBLASTOMA_PRONEURAL	278	Up	0.47992009219985	0.854619456357244
BURTON_ADIPOGENESIS_8	154	Down	0.479954576146437	0.854619456357244
BASSO_CD40_SIGNALING_DN	81	Up	0.480332587709436	0.854623489179039
KEGG_UBIQUITIN_MEDIATED_PROTEOLYSIS	132	Down	0.480667665277274	0.854623489179039
RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_UP	146	Down	0.480800275680812	0.854623489179039
MALONEY_RESPONSE_TO_17AAG_UP	73	Up	0.48083142614146	0.854623489179039
HOWLIN_PUBERTAL_MAMMARY_GLAND	71	Down	0.481019425055686	0.854623489179039
PUJANA_ATM_PCC_NETWORK	1795	Down	0.481042306885492	0.854623489179039
PURBEY_TARGETS_OF_CTBP1_NOT_SATB1_DN	519	Down	0.481924174638265	0.855237824105811
WALLACE_PROSTATE_CANCER_UP	55	Up	0.482231855795658	0.855237824105811
ZUCCHI_METASTASIS_DN	54	Up	0.482325087048237	0.855237824105811
MOOTHA_GLYCOLYSIS	33	Down	0.482434382706405	0.855237824105811
KEGG_AMINO_SUGAR_AND_NUCLEOTIDE_SUGAR_METABOLISM	47	Down	0.482456367546423	0.855237824105811
MARTIN_INTERACT_WITH_HDAC	54	Down	0.48247434403937	0.855237824105811
GENTILE_UV_RESPONSE_CLUSTER_D5	55	Up	0.483553015992991	0.855507298937152
REACTOME_RECYCLING_PATHWAY_OF_L1	34	Down	0.483556687724616	0.855507298937152
LU_IL4_SIGNALING	115	Up	0.483680085466857	0.855507298937152
SASAKI_TARGETS_OF_TP73_AND_TP63	22	Down	0.483763467933356	0.855507298937152
HASLINGER_B_CLL_WITH_13Q14_DELETION	50	Down	0.48382612275092	0.855507298937152
KYNG_DNA_DAMAGE_BY_GAMMA_AND_UV_RADIATION	126	Down	0.48384582995022	0.855507298937152
WILENSKY_RESPONSE_TO_DARAPLADIB	20	Down	0.483894052235409	0.855507298937152
DANG_BOUND_BY_MYC	1465	Down	0.484262743789841	0.85577467735014
HEIDENBLAD_AMPLICON_12P11_12_DN	33	Up	0.484535368733983	0.85577467735014
BROWNE_HCMV_INFECTION_6HR_UP	115	Up	0.484866850796393	0.85577467735014
REACTOME_RNA_POL_I_TRANSCRIPTION_INITIATION	25	Up	0.485026914635099	0.85577467735014
MARCHINI_TRABECTEDIN_RESISTANCE_DN	124	Up	0.4852390503092	0.85577467735014
MCBRYAN_PUBERTAL_BREAST_4_5WK_DN	283	Down	0.485246461388449	0.85577467735014
RICKMAN_HEAD_AND_NECK_CANCER_B	72	Up	0.485344712586292	0.85577467735014
FLECHNER_PBL_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN	73	Down	0.485494524830308	0.85577467735014
REACTOME_REGULATION_OF_THE_FANCONI_ANEMIA_PATHWAY	9	Up	0.486161431787699	0.856053997854436
REACTOME_IL_7_SIGNALING	12	Down	0.486185279133991	0.856053997854436
BARIS_THYROID_CANCER_UP	32	Down	0.486579742765735	0.856053997854436
HAHTOLA_MYCOSIS_FUNGOIDES_DN	14	Down	0.486584721057242	0.856053997854436
CHENG_TAF7L_TARGETS	5	Up	0.486630548078849	0.856053997854436
AZARE_NEOPLASTIC_TRANSFORMATION_BY_STAT3_UP	176	Up	0.486821140154572	0.856053997854436
WU_APOPTOSIS_BY_CDKN1A_NOT_VIA_TP53	17	Down	0.486921484385027	0.856053997854436
PID_ENDOTHELIN_PATHWAY	97	Up	0.487903404681845	0.856263702129703
STARK_PREFRONTAL_CORTEX_22Q11_DELETION_DN	651	Down	0.487968137388952	0.856263702129703
INGA_TP53_TARGETS	24	Down	0.48821412771029	0.856263702129703
KEGG_LONG_TERM_DEPRESSION	58	Down	0.488274200389858	0.856263702129703
WANG_METASTASIS_OF_BREAST_CANCER_ESR1_DN	45	Down	0.488284568828233	0.856263702129703
HU_ANGIOGENESIS_DN	77	Down	0.488432208686855	0.856263702129703
DOANE_BREAST_CANCER_ESR1_DN	36	Up	0.488545597109328	0.856263702129703
AMIT_EGF_RESPONSE_20_HELA	13	Down	0.488640226891021	0.856263702129703
KEGG_BLADDER_CANCER	49	Down	0.488672087413564	0.856263702129703
HINATA_NFKB_TARGETS_KERATINOCYTE_UP	109	Up	0.488979270914169	0.856288666076453
LABBE_WNT3A_TARGETS_UP	167	Down	0.489048861362039	0.856288666076453
REACTOME_THE_ACTIVATION_OF_ARYLSULFATASES	12	Down	0.48932564510279	0.856455853080985
BROWNE_HCMV_INFECTION_1HR_UP	74	Up	0.489518564098455	0.856476184000407
KEGG_PATHOGENIC_ESCHERICHIA_COLI_INFECTION	78	Down	0.489904186694261	0.856480314389455
ACEVEDO_FGFR1_TARGETS_IN_PROSTATE_CANCER_MODEL_UP	365	Down	0.490063166415585	0.856480314389455
JOHNSTONE_PARVB_TARGETS_2_UP	202	Down	0.490154821211716	0.856480314389455
BIOCARTA_GRANULOCYTES_PATHWAY	7	Up	0.490246141005311	0.856480314389455
LIU_SOX4_TARGETS_UP	204	Down	0.490540479242762	0.856530986391843
WORSCHECH_TUMOR_REJECTION_UP	66	Down	0.490637775016158	0.856530986391843
SMID_BREAST_CANCER_LUMINAL_B_UP	201	Up	0.491041536343605	0.856919179049572
MIKKELSEN_IPS_ICP_WITH_H3K4ME3_AND_H327ME3	145	Up	0.491565865006553	0.857517410004046
KHETCHOUMIAN_TRIM24_TARGETS_UP	78	Up	0.492153071041237	0.857657287873364
KORKOLA_CHORIOCARCINOMA_DN	17	Down	0.492367379879051	0.857657287873364
BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_UP	270	Down	0.492514692903181	0.857657287873364
BIOCARTA_VDR_PATHWAY	16	Down	0.492851749827776	0.857657287873364
MATZUK_MATERNAL_EFFECT	10	Down	0.493009576744831	0.857657287873364
REACTOME_TRAF6_MEDIATED_IRF7_ACTIVATION	17	Up	0.493185301068499	0.857657287873364
REACTOME_TRANSCRIPTIONAL_REGULATION_OF_WHITE_ADIPOCYTE_DIFFERENTIATION	80	Down	0.493401539249065	0.857657287873364
KAN_RESPONSE_TO_ARSENIC_TRIOXIDE	142	Up	0.493406642391217	0.857657287873364
HASEGAWA_TUMORIGENESIS_BY_RET_C634R	38	Up	0.4934404103871	0.857657287873364
MOOTHA_PYR	10	Down	0.493589351049687	0.857657287873364
ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN	137	Up	0.493853421259528	0.857657287873364
PID_LKB1_PATHWAY	62	Down	0.493956255610075	0.857657287873364
MIKKELSEN_IPS_LCP_WITH_H3K4ME3	186	Down	0.494129779391801	0.857657287873364
SHIPP_DLBCL_CURED_VS_FATAL_DN	86	Down	0.494331468684381	0.857657287873364
AGARWAL_AKT_PATHWAY_TARGETS	10	Down	0.494546886556734	0.857657287873364
VETTER_TARGETS_OF_PRKCA_AND_ETS1_UP	17	Down	0.494818179851251	0.857657287873364
PLASARI_TGFB1_SIGNALING_VIA_NFIC_1HR_UP	47	Up	0.494838121371192	0.857657287873364
REACTOME_GABA_A_RECEPTOR_ACTIVATION	5	Up	0.494915333250367	0.857657287873364
KYNG_NORMAL_AGING_UP	24	Down	0.495095559701665	0.857657287873364
VANLOO_SP3_TARGETS_UP	6	Up	0.495301079258419	0.857698789742218
REACTOME_BIOLOGICAL_OXIDATIONS	79	Down	0.495859072781529	0.858077633145438
LEE_BMP2_TARGETS_UP	910	Up	0.495883136851618	0.858077633145438
MIKKELSEN_MEF_ICP_WITH_H3K4ME3_AND_H3K27ME3	34	Up	0.496350953415112	0.858231689693608
NATSUME_RESPONSE_TO_INTERFERON_BETA_UP	111	Up	0.496643670011497	0.858231689693608
DAZARD_UV_RESPONSE_CLUSTER_G4	51	Down	0.496676182232993	0.858231689693608
NGUYEN_NOTCH1_TARGETS_DN	137	Up	0.496698865288384	0.858231689693608
ODONNELL_TARGETS_OF_MYC_AND_TFRC_UP	123	Up	0.497171175508321	0.85873368669152
LIEN_BREAST_CARCINOMA_METAPLASTIC	63	Up	0.497527971731487	0.858780987921261
LABBE_WNT3A_TARGETS_DN	115	Down	0.497562143086472	0.858780987921261
BOYLAN_MULTIPLE_MYELOMA_C_UP	62	Down	0.497906320608986	0.859061160904619
GRADE_COLON_AND_RECTAL_CANCER_DN	146	Up	0.498266968714894	0.859109211614321
DAVICIONI_MOLECULAR_ARMS_VS_ERMS_UP	459	Down	0.498900263593734	0.859109211614321
GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_DN	426	Down	0.498915353782126	0.859109211614321
HOFFMANN_PRE_BI_TO_LARGE_PRE_BII_LYMPHOCYTE_UP	50	Up	0.498927192695186	0.859109211614321
TURASHVILI_BREAST_CARCINOMA_DUCTAL_VS_LOBULAR_UP	25	Down	0.499669368632651	0.859109211614321
LEIN_LOCALIZED_TO_DISTAL_AND_PROXIMAL_DENDRITES	27	Down	0.499715093528858	0.859109211614321
MODY_HIPPOCAMPUS_NEONATAL	69	Up	0.499816003283591	0.859109211614321
RASHI_RESPONSE_TO_IONIZING_RADIATION_6	71	Down	0.499849933576364	0.859109211614321
HASINA_NOL7_TARGETS_DN	21	Up	0.500124843879939	0.859109211614321
HUTTMANN_B_CLL_POOR_SURVIVAL_UP	359	Down	0.500129520841756	0.859109211614321
MATZUK_MALE_REPRODUCTION_SERTOLI	26	Down	0.500398806925385	0.859109211614321
MIKKELSEN_ES_LCP_WITH_H3K27ME3	10	Up	0.500497229459236	0.859109211614321
REACTOME_ADENYLATE_CYCLASE_ACTIVATING_PATHWAY	9	Up	0.500498553240818	0.859109211614321
KOBAYASHI_EGFR_SIGNALING_6HR_DN	41	Up	0.500658733511911	0.859109211614321
YANG_BREAST_CANCER_ESR1_LASER_UP	63	Down	0.500855840627437	0.859109211614321
OUELLET_OVARIAN_CANCER_INVASIVE_VS_LMP_UP	169	Down	0.500888619102181	0.859109211614321
REACTOME_TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM	65	Down	0.501025799745439	0.859109211614321
REACTOME_POTASSIUM_CHANNELS	51	Up	0.501340596743301	0.859337075114425
BIOCARTA_PROTEASOME_PATHWAY	33	Down	0.501600237785327	0.859470265976745
CERIBELLI_PROMOTERS_INACTIVE_AND_BOUND_BY_NFY	22	Up	0.502003016228674	0.859679092605024
PID_TCPTP_PATHWAY	63	Down	0.50244676167436	0.859679092605024
REACTOME_FORMATION_OF_INCISION_COMPLEX_IN_GG_NER	21	Down	0.50253777754734	0.859679092605024
LEE_CALORIE_RESTRICTION_MUSCLE_DN	69	Down	0.50300778835461	0.859679092605024
SANA_TNF_SIGNALING_DN	114	Up	0.503068362910635	0.859679092605024
LEI_HOXC8_TARGETS_DN	25	Up	0.503226181441147	0.859679092605024
OZANNE_AP1_TARGETS_DN	7	Up	0.503338873040319	0.859679092605024
MIKKELSEN_NPC_LCP_WITH_H3K4ME3	90	Down	0.503542825740618	0.859679092605024
REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION	72	Up	0.50357596751557	0.859679092605024
MORI_IMMATURE_B_LYMPHOCYTE_UP	80	Down	0.503598558819961	0.859679092605024
REACTOME_TGF_BETA_RECEPTOR_SIGNALING_ACTIVATES_SMADS	34	Down	0.50372390523512	0.859679092605024
SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_DN	5	Up	0.504501413241869	0.860372464176096
DARWICHE_PAPILLOMA_RISK_LOW_UP	187	Down	0.504704802065673	0.860372464176096
WAKASUGI_HAVE_ZNF143_BINDING_SITES	59	Up	0.504830963569974	0.860372464176096
XU_HGF_TARGETS_REPRESSED_BY_AKT1_DN	89	Up	0.505052439412876	0.860372464176096
KEGG_GLYCOSAMINOGLYCAN_BIOSYNTHESIS_HEPARAN_SULFATE	19	Down	0.505356963755803	0.860372464176096
KEGG_WNT_SIGNALING_PATHWAY	145	Down	0.505552408286025	0.860372464176096
BIOCARTA_TNFR1_PATHWAY	32	Up	0.505955164203318	0.860372464176096
CHEN_NEUROBLASTOMA_COPY_NUMBER_GAINS	51	Down	0.506021772857952	0.860372464176096
ELVIDGE_HYPOXIA_BY_DMOG_UP	167	Up	0.506032611687413	0.860372464176096
BIOCARTA_DC_PATHWAY	20	Down	0.506051842972098	0.860372464176096
RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP	431	Down	0.506133589742881	0.860372464176096
TAKADA_GASTRIC_CANCER_COPY_NUMBER_UP	13	Down	0.506532705120348	0.860725554185926
REACTOME_OPSINS	3	Down	0.506716631457948	0.860725554185926
SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_DN	559	Up	0.507556790408073	0.860725554185926
FINAK_BREAST_CANCER_SDPP_SIGNATURE	12	Down	0.507729867220152	0.860725554185926
PID_MYC_PATHWAY	36	Down	0.507898686785609	0.860725554185926
GROSS_ELK3_TARGETS_UP	42	Down	0.508006449024205	0.860725554185926
ZHENG_BOUND_BY_FOXP3	672	Down	0.508175369242595	0.860725554185926
MCBRYAN_TERMINAL_END_BUD_DN	11	Down	0.50818508822971	0.860725554185926
KIM_MYCN_AMPLIFICATION_TARGETS_UP	136	Down	0.508262040576112	0.860725554185926
IWANAGA_CARCINOGENESIS_BY_KRAS_DN	180	Down	0.508286011296919	0.860725554185926
KEGG_AXON_GUIDANCE	131	Up	0.508345532637327	0.860725554185926
FIGUEROA_AML_METHYLATION_CLUSTER_5_DN	41	Down	0.509398307976997	0.862112050221334
LIU_TARGETS_OF_VMYB_VS_CMYB_DN	56	Up	0.509529391240043	0.862112050221334
AMUNDSON_GAMMA_RADIATION_RESISTANCE	40	Up	0.509739524036922	0.862158793967211
FIGUEROA_AML_METHYLATION_CLUSTER_3_DN	58	Up	0.510228154087415	0.862479487424862
PID_RHOA_REG_PATHWAY	55	Up	0.510362562336929	0.862479487424862
KAAB_HEART_ATRIUM_VS_VENTRICLE_DN	377	Up	0.51069909407361	0.862479487424862
PASTURAL_RIZ1_TARGETS_UP	32	Down	0.511010033599969	0.862479487424862
REACTOME_GROWTH_HORMONE_RECEPTOR_SIGNALING	26	Up	0.511375812052846	0.862479487424862
LEE_AGING_MUSCLE_DN	96	Down	0.511748752566589	0.862479487424862
MIKKELSEN_ES_LCP_WITH_H3K4ME3_AND_H3K27ME3	5	Down	0.511860917273707	0.862479487424862
REACTOME_PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION	222	Down	0.51186499830827	0.862479487424862
SEIDEN_MET_SIGNALING	30	Up	0.511933926841954	0.862479487424862
ZHOU_PANCREATIC_EXOCRINE_PROGENITOR	3	Up	0.511937574198344	0.862479487424862
WANG_TUMOR_INVASIVENESS_DN	299	Down	0.511965965425854	0.862479487424862
GRAESSMANN_APOPTOSIS_BY_SERUM_DEPRIVATION_UP	749	Up	0.512452727859561	0.862479487424862
RODWELL_AGING_KIDNEY_NO_BLOOD_UP	260	Up	0.512474084571801	0.862479487424862
GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_DN	111	Down	0.512485165368668	0.862479487424862
HU_GENOTOXIC_DAMAGE_24HR	59	Up	0.513283031064402	0.86351461493883
SIMBULAN_PARP1_TARGETS_UP	47	Up	0.513772378336348	0.863986553100168
REN_ALVEOLAR_RHABDOMYOSARCOMA_DN	627	Down	0.513929342551116	0.863986553100168
REACTOME_HOST_INTERACTIONS_OF_HIV_FACTORS	158	Down	0.514150264784107	0.864050462767741
REACTOME_HS_GAG_DEGRADATION	29	Down	0.514526411531899	0.864375095333104
RAHMAN_TP53_TARGETS_PHOSPHORYLATED	45	Down	0.514723562006502	0.864398900433245
LAIHO_COLORECTAL_CANCER_SERRATED_DN	129	Down	0.515018647554155	0.864587097031212
DAZARD_RESPONSE_TO_UV_NHEK_DN	463	Down	0.515249764975825	0.86466781163261
REACTOME_CDC6_ASSOCIATION_WITH_THE_ORC_ORIGIN_COMPLEX	11	Up	0.516180566978646	0.865557094415357
ROESSLER_LIVER_CANCER_METASTASIS_UP	157	Down	0.516203034472955	0.865557094415357
REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH	86	Up	0.516505816284394	0.865557094415357
REACTOME_VEGF_LIGAND_RECEPTOR_INTERACTIONS	10	Down	0.516585355763204	0.865557094415357
GREGORY_SYNTHETIC_LETHAL_WITH_IMATINIB	201	Down	0.516695809960056	0.865557094415357
ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP	576	Up	0.517139083742597	0.865950757042926
REACTOME_NITRIC_OXIDE_STIMULATES_GUANYLATE_CYCLASE	13	Up	0.517454244002766	0.865950757042926
BARRIER_CANCER_RELAPSE_TUMOR_SAMPLE_UP	15	Up	0.517513391929693	0.865950757042926
PID_SMAD2_3PATHWAY	21	Down	0.517664042736923	0.865950757042926
WANG_BARRETTS_ESOPHAGUS_AND_ESOPHAGUS_CANCER_DN	36	Up	0.51812563535634	0.866416106698531
LEE_DOUBLE_POLAR_THYMOCYTE	25	Up	0.518591416641395	0.866496060594379
JIANG_AGING_HYPOTHALAMUS_DN	64	Up	0.518604093898231	0.866496060594379
LIN_SILENCED_BY_TUMOR_MICROENVIRONMENT	136	Up	0.518723721287236	0.866496060594379
REACTOME_ACYL_CHAIN_REMODELLING_OF_PC	12	Down	0.519116526800066	0.866498687003549
MAHADEVAN_RESPONSE_TO_MP470_UP	14	Down	0.51919736068591	0.866498687003549
LI_WILMS_TUMOR	43	Up	0.519275567931212	0.866498687003549
HAN_SATB1_TARGETS_DN	633	Up	0.519689144371898	0.8665159485749
ROETH_TERT_TARGETS_DN	9	Up	0.519771080580215	0.8665159485749
ZHU_CMV_24_HR_UP	153	Down	0.519836197769108	0.8665159485749
DAVICIONI_RHABDOMYOSARCOMA_PAX_FOXO1_FUSION_DN	34	Up	0.520209883782787	0.866832977421477
NIKOLSKY_BREAST_CANCER_17P11_AMPLICON	7	Up	0.52057384696305	0.867079083041165
LEE_NEURAL_CREST_STEM_CELL_DN	187	Up	0.520724673706136	0.867079083041165
DARWICHE_SKIN_TUMOR_PROMOTER_UP	164	Down	0.520969866668296	0.867181694905226
RAMALHO_STEMNESS_UP	285	Down	0.521161219044332	0.867194645567251
SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP	249	Up	0.521523583642524	0.867492045467353
KAMMINGA_SENESCENCE	47	Up	0.521951416512535	0.86785648049342
REACTOME_GAP_JUNCTION_DEGRADATION	11	Up	0.522136360795892	0.86785648049342
MOROSETTI_FACIOSCAPULOHUMERAL_MUSCULAR_DISTROPHY_UP	32	Up	0.522367403776521	0.86785648049342
HUTTMANN_B_CLL_POOR_SURVIVAL_DN	71	Down	0.522477525512973	0.86785648049342
NIELSEN_LEIOMYOSARCOMA_UP	34	Up	0.523597334112015	0.869410828240828
LIU_CMYB_TARGETS_UP	246	Down	0.52425482078457	0.870196687767501
REACTOME_TRANSPORT_OF_VITAMINS_NUCLEOSIDES_AND_RELATED_MOLECULES	22	Down	0.524896769294537	0.870440504156515
ABDULRAHMAN_KIDNEY_CANCER_VHL_UP	5	Down	0.525269939792931	0.870440504156515
THEODOROU_MAMMARY_TUMORIGENESIS	33	Down	0.525378233372148	0.870440504156515
GENTILE_UV_RESPONSE_CLUSTER_D7	55	Down	0.525467866482925	0.870440504156515
SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX5_DN	18	Down	0.525957850633197	0.870440504156515
ROY_WOUND_BLOOD_VESSEL_DN	29	Up	0.525975746453846	0.870440504156515
PID_CONE_PATHWAY	15	Up	0.52606554500331	0.870440504156515
KEGG_LYSINE_DEGRADATION	64	Down	0.526167176195397	0.870440504156515
SENESE_HDAC3_TARGETS_DN	686	Down	0.526174615240312	0.870440504156515
REACTOME_RNA_POL_I_TRANSCRIPTION	57	Down	0.52646219811557	0.870440504156515
RUTELLA_RESPONSE_TO_HGF_UP	520	Down	0.526574277063054	0.870440504156515
MOREAUX_B_LYMPHOCYTE_MATURATION_BY_TACI_UP	152	Up	0.526612819830508	0.870440504156515
GAVIN_FOXP3_TARGETS_CLUSTER_P7	129	Down	0.527604899662278	0.871775287164953
WANG_LSD1_TARGETS_UP	26	Down	0.527811527075444	0.871811767099439
CHESLER_BRAIN_HIGHEST_GENETIC_VARIANCE	49	Down	0.528556939595721	0.872737847832991
REACTOME_NEP_NS2_INTERACTS_WITH_THE_CELLULAR_EXPORT_MACHINERY	31	Down	0.528986543707834	0.873077974623731
REACTOME_SYNTHESIS_SECRETION_AND_INACTIVATION_OF_GLP1	13	Up	0.529965117499073	0.873077974623731
FUNG_IL2_TARGETS_WITH_STAT5_BINDING_SITES	6	Up	0.530027135090593	0.873077974623731
KEGG_METABOLISM_OF_XENOBIOTICS_BY_CYTOCHROME_P450	47	Up	0.530167865372618	0.873077974623731
BIOCARTA_STEM_PATHWAY	6	Down	0.530198634928122	0.873077974623731
REACTOME_CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL	105	Up	0.530253061729022	0.873077974623731
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_UP	163	Down	0.530408889852907	0.873077974623731
BIOCARTA_GLYCOLYSIS_PATHWAY	24	Down	0.530595336257735	0.873077974623731
TAKAO_RESPONSE_TO_UVB_RADIATION_DN	137	Down	0.530681576954774	0.873077974623731
AKL_HTLV1_INFECTION_DN	105	Up	0.530993498054526	0.873077974623731
MIKKELSEN_ES_ICP_WITH_H3K4ME3	868	Up	0.531030688326294	0.873077974623731
RIZ_ERYTHROID_DIFFERENTIATION_CCNE1	49	Down	0.531148459821572	0.873077974623731
HO_LIVER_CANCER_VASCULAR_INVASION	20	Down	0.531165558651271	0.873077974623731
NUYTTEN_NIPP1_TARGETS_DN	1127	Down	0.531617027720474	0.873229654400686
BOQUEST_STEM_CELL_CULTURED_VS_FRESH_DN	22	Down	0.531923709776573	0.873229654400686
PID_RAC1_PATHWAY	69	Up	0.532058451438018	0.873229654400686
REACTOME_RNA_POL_III_TRANSCRIPTION_INITIATION_FROM_TYPE_2_PROMOTER	24	Up	0.532150797530528	0.873229654400686
HU_GENOTOXIN_ACTION_DIRECT_VS_INDIRECT_4HR	53	Up	0.532182086159944	0.873229654400686
BIOCARTA_CDC42RAC_PATHWAY	27	Down	0.533164032368391	0.873686937009588
MOOTHA_GLYCOGEN_METABOLISM	18	Up	0.533199669930685	0.873686937009588
TSENG_ADIPOGENIC_POTENTIAL_DN	73	Up	0.533322619394948	0.873686937009588
PID_ARF6_PATHWAY	52	Up	0.533474593647693	0.873686937009588
BACOLOD_RESISTANCE_TO_ALKYLATING_AGENTS_DN	121	Up	0.533528916479292	0.873686937009588
REACTOME_HEMOSTASIS	428	Down	0.53357045158185	0.873686937009588
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREY_UP	38	Up	0.534123228013984	0.873893530690023
PID_IL5_PATHWAY	19	Down	0.534142915703485	0.873893530690023
SENGUPTA_NASOPHARYNGEAL_CARCINOMA_DN	273	Up	0.534612546299181	0.873893530690023
PHONG_TNF_RESPONSE_VIA_P38_COMPLETE	331	Down	0.53504594744022	0.873893530690023
ZHANG_RESPONSE_TO_CANTHARIDIN_UP	15	Down	0.535349967583303	0.873893530690023
REACTOME_GLUTAMATE_NEUROTRANSMITTER_RELEASE_CYCLE	23	Up	0.535539409003412	0.873893530690023
BECKER_TAMOXIFEN_RESISTANCE_DN	119	Down	0.535773677851757	0.873893530690023
SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_DN	858	Down	0.536336954346515	0.873893530690023
ZERBINI_RESPONSE_TO_SULINDAC_UP	10	Up	0.536422581938791	0.873893530690023
WOOD_EBV_EBNA1_TARGETS_UP	173	Down	0.536805506066923	0.873893530690023
BIOCARTA_TCYTOTOXIC_PATHWAY	4	Down	0.536853643782317	0.873893530690023
BIOCARTA_THELPER_PATHWAY	4	Down	0.536853643782317	0.873893530690023
LIU_PROSTATE_CANCER_UP	168	Up	0.536912352415417	0.873893530690023
ST_JAK_STAT_PATHWAY	9	Down	0.537142044242624	0.873893530690023
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLACK_UP	73	Down	0.53746033244441	0.873893530690023
BIOCARTA_TGFB_PATHWAY	26	Up	0.537592401300161	0.873893530690023
KEGG_REGULATION_OF_ACTIN_CYTOSKELETON	209	Down	0.537835639586379	0.873893530690023
BLALOCK_ALZHEIMERS_DISEASE_UP	2200	Down	0.538189202817607	0.873893530690023
REACTOME_L1CAM_INTERACTIONS	91	Down	0.53823457373814	0.873893530690023
WONG_ADULT_TISSUE_STEM_MODULE	932	Up	0.538460255851801	0.873893530690023
MULLIGHAN_MLL_SIGNATURE_1_DN	294	Up	0.538689326330543	0.873893530690023
HELLER_HDAC_TARGETS_UP	472	Up	0.538713119543221	0.873893530690023
HOLLEMAN_DAUNORUBICIN_ALL_UP	20	Down	0.538774965188215	0.873893530690023
TERAMOTO_OPN_TARGETS_CLUSTER_8	6	Up	0.538924554744063	0.873893530690023
KAAB_FAILED_HEART_ATRIUM_DN	240	Down	0.539498094776081	0.873893530690023
DAVIES_MULTIPLE_MYELOMA_VS_MGUS_UP	24	Up	0.539559688449853	0.873893530690023
CHIANG_LIVER_CANCER_SUBCLASS_UNANNOTATED_DN	251	Down	0.539624378354246	0.873893530690023
TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_UP	129	Up	0.539642913788084	0.873893530690023
NIKOLSKY_BREAST_CANCER_19Q13.4_AMPLICON	4	Down	0.539757030614349	0.873893530690023
KORKOLA_EMBRYONAL_CARCINOMA_DN	18	Down	0.540128318071608	0.873893530690023
KORKOLA_SEMINOMA_DN	18	Down	0.540128318071608	0.873893530690023
MCBRYAN_PUBERTAL_TGFB1_TARGETS_DN	76	Down	0.540252844902082	0.873893530690023
KIM_WT1_TARGETS_12HR_UP	219	Down	0.540276591978242	0.873893530690023
LEE_LIVER_CANCER_ACOX1_DN	53	Up	0.540358095443989	0.873893530690023
LIN_TUMOR_ESCAPE_FROM_IMMUNE_ATTACK	23	Down	0.540386243722977	0.873893530690023
GERHOLD_RESPONSE_TO_TZD_UP	6	Up	0.54041777532561	0.873893530690023
REACTOME_NUCLEOTIDE_EXCISION_REPAIR	52	Down	0.540541256705387	0.873893530690023
PEREZ_TP53_TARGETS	1351	Up	0.541055593397196	0.874048964329334
BRUINS_UVC_RESPONSE_LATE	1595	Down	0.541142261504921	0.874048964329334
SU_THYMUS	9	Down	0.541508508925216	0.874048964329334
VILIMAS_NOTCH1_TARGETS_DN	10	Down	0.541588104053008	0.874048964329334
MARSON_FOXP3_TARGETS_DN	75	Down	0.54169682921099	0.874048964329334
PENG_RAPAMYCIN_RESPONSE_DN	354	Down	0.541870833359849	0.874048964329334
WANG_IMMORTALIZED_BY_HOXA9_AND_MEIS1_DN	23	Down	0.541932560652121	0.874048964329334
LUND_SILENCED_BY_METHYLATION	24	Up	0.542216625512883	0.874208648096538
KEGG_HUNTINGTONS_DISEASE	179	Down	0.542864227452005	0.874866918796097
REACTOME_CYTOCHROME_P450_ARRANGED_BY_SUBSTRATE_TYPE	19	Up	0.543039436460343	0.874866918796097
NEBEN_AML_WITH_FLT3_OR_NRAS_DN	19	Down	0.543180498058627	0.874866918796097
GROSS_HYPOXIA_VIA_HIF1A_ONLY	8	Up	0.543455588904792	0.874919242217191
ANASTASSIOU_CANCER_MESENCHYMAL_TRANSITION_SIGNATURE	113	Up	0.543720337323742	0.874919242217191
REACTOME_INITIAL_TRIGGERING_OF_COMPLEMENT	7	Up	0.543931316151228	0.874919242217191
MAGRANGEAS_MULTIPLE_MYELOMA_IGLL_VS_IGLK_DN	44	Down	0.544170840233604	0.874919242217191
MA_PITUITARY_FETAL_VS_ADULT_UP	35	Down	0.544315747234433	0.874919242217191
KEGG_PROXIMAL_TUBULE_BICARBONATE_RECLAMATION	19	Down	0.544953410873028	0.874919242217191
CAIRO_HEPATOBLASTOMA_UP	294	Down	0.544974941425175	0.874919242217191
REACTOME_ADVANCED_GLYCOSYLATION_ENDPRODUCT_RECEPTOR_SIGNALING	10	Up	0.545013861795101	0.874919242217191
PHONG_TNF_RESPONSE_VIA_P38_PARTIAL	241	Up	0.545016928186803	0.874919242217191
REACTOME_DOWNSTREAM_SIGNALING_EVENTS_OF_B_CELL_RECEPTOR_BCR	115	Down	0.545146755930412	0.874919242217191
KEGG_ASTHMA	5	Down	0.545459722951948	0.874919242217191
REACTOME_PYRIMIDINE_CATABOLISM	10	Up	0.545495299424296	0.874919242217191
SCHUHMACHER_MYC_TARGETS_DN	5	Down	0.545678245428202	0.874919242217191
KRIEG_KDM3A_TARGETS_NOT_HYPOXIA	261	Up	0.545805886285788	0.874919242217191
WALLACE_PROSTATE_CANCER_RACE_DN	136	Down	0.546195068647148	0.875246100505131
UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN	54	Up	0.546429956102693	0.875325572271659
REACTOME_SYNTHESIS_OF_VERY_LONG_CHAIN_FATTY_ACYL_COAS	15	Up	0.546907217535784	0.875411521993643
SMITH_TERT_TARGETS_UP	224	Up	0.546988581924452	0.875411521993643
KRASNOSELSKAYA_ILF3_TARGETS_DN	70	Up	0.547096421035698	0.875411521993643
FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN	598	Down	0.547236443569308	0.875411521993643
RUTELLA_RESPONSE_TO_HGF_DN	335	Down	0.547410168494755	0.875411521993643
GROSS_HYPOXIA_VIA_HIF1A_UP	156	Down	0.54812217416058	0.875744987552585
IVANOVA_HEMATOPOIESIS_LATE_PROGENITOR	672	Down	0.548177993339964	0.875744987552585
ROSS_AML_WITH_CBFB_MYH11_FUSION	73	Up	0.548350905654102	0.875744987552585
ZIRN_TRETINOIN_RESPONSE_DN	7	Up	0.548360218708837	0.875744987552585
NELSON_RESPONSE_TO_ANDROGEN_DN	27	Up	0.549207816187881	0.876556776357345
LIU_SMARCA4_TARGETS	92	Up	0.54927418296542	0.876556776357345
SILIGAN_BOUND_BY_EWS_FLT1_FUSION	65	Up	0.5494251936482	0.876556776357345
REACTOME_NUCLEAR_EVENTS_KINASE_AND_TRANSCRIPTION_FACTOR_ACTIVATION	48	Down	0.54993946043205	0.877081030074612
YAMASHITA_LIVER_CANCER_STEM_CELL_UP	85	Up	0.550675985978344	0.877959283753526
PARK_HSC_AND_MULTIPOTENT_PROGENITORS	92	Down	0.551096003585892	0.878332496943236
PID_INTEGRIN4_PATHWAY	11	Up	0.552138987787351	0.879291164509656
MOREAUX_MULTIPLE_MYELOMA_BY_TACI_DN	230	Down	0.55221941488502	0.879291164509656
WILLIAMS_ESR1_TARGETS_DN	7	Down	0.552500200687526	0.879291164509656
PID_NECTIN_PATHWAY	45	Down	0.552794179277117	0.879291164509656
ROZANOV_MMP14_TARGETS_UP	370	Up	0.552845821396128	0.879291164509656
ROYLANCE_BREAST_CANCER_16Q_COPY_NUMBER_DN	41	Up	0.552891882371079	0.879291164509656
FERRARI_RESPONSE_TO_FENRETINIDE_DN	10	Up	0.553000433903088	0.879291164509656
ENK_UV_RESPONSE_KERATINOCYTE_DN	686	Down	0.553361490576401	0.879400291885223
RUAN_RESPONSE_TO_TNF_DN	115	Up	0.553441377598385	0.879400291885223
HOSHIDA_LIVER_CANCER_SURVIVAL_UP	133	Up	0.553780483962861	0.879456012593071
SWEET_LUNG_CANCER_KRAS_UP	626	Down	0.553883365311857	0.879456012593071
ST_T_CELL_SIGNAL_TRANSDUCTION	53	Up	0.55407798526484	0.879456012593071
ZHAN_MULTIPLE_MYELOMA_CD1_VS_CD2_DN	70	Down	0.55471330644664	0.879456012593071
ZHENG_FOXP3_TARGETS_IN_THYMUS_DN	15	Up	0.554803160465837	0.879456012593071
ASTIER_INTEGRIN_SIGNALING	70	Up	0.554879372306968	0.879456012593071
LIU_SOX4_TARGETS_DN	449	Down	0.554880367447931	0.879456012593071
WANG_RESPONSE_TO_BEXAROTENE_UP	34	Down	0.554971047154821	0.879456012593071
VANDESLUIS_NORMAL_EMBRYOS_UP	7	Up	0.555358934095869	0.879456012593071
BILD_CTNNB1_ONCOGENIC_SIGNATURE	123	Down	0.555432073432402	0.879456012593071
HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_4NM_UP	28	Up	0.55603933984213	0.879456012593071
SIMBULAN_UV_RESPONSE_IMMORTALIZED_DN	72	Down	0.556142924754719	0.879456012593071
TONG_INTERACT_WITH_PTTG1	68	Down	0.556317058239758	0.879456012593071
MARIADASON_REGULATED_BY_HISTONE_ACETYLATION_DN	83	Up	0.556346645837139	0.879456012593071
LABBE_TARGETS_OF_TGFB1_AND_WNT3A_DN	129	Down	0.556385787795247	0.879456012593071
ROSS_AML_WITH_MLL_FUSIONS	89	Down	0.556636436259127	0.879456012593071
PID_SMAD2_3NUCLEAR_PATHWAY	130	Down	0.556887014510294	0.879456012593071
KEGG_HEDGEHOG_SIGNALING_PATHWAY	47	Up	0.556960160853505	0.879456012593071
DING_LUNG_CANCER_BY_MUTATION_RATE	36	Up	0.557118192360503	0.879456012593071
PASINI_SUZ12_TARGETS_DN	512	Up	0.557199797987101	0.879456012593071
HOWLIN_CITED1_TARGETS_1_DN	80	Up	0.557466392872757	0.879582912468572
HOSHIDA_LIVER_CANCER_LATE_RECURRENCE_UP	77	Up	0.557705743428833	0.879666755244677
ZEMBUTSU_SENSITIVITY_TO_CYCLOPHOSPHAMIDE	21	Up	0.558467091141308	0.880315797123831
IKEDA_MIR1_TARGETS_DN	10	Up	0.558489933103328	0.880315797123831
MATZUK_OVULATION	21	Down	0.558975877802927	0.880774765027635
VALK_AML_CLUSTER_4	37	Up	0.559372529712099	0.880774765027635
KLEIN_PRIMARY_EFFUSION_LYMPHOMA_UP	58	Down	0.559518840337806	0.880774765027635
MURAKAMI_UV_RESPONSE_6HR_UP	54	Down	0.559850256747957	0.880774765027635
BIOCARTA_MTA3_PATHWAY	30	Down	0.559881917645869	0.880774765027635
SANSOM_APC_TARGETS	289	Down	0.559899792417017	0.880774765027635
REACTOME_PROTEIN_FOLDING	63	Down	0.560507935868345	0.881050267698264
BIOCARTA_KERATINOCYTE_PATHWAY	58	Up	0.560567610900202	0.881050267698264
POMEROY_MEDULLOBLASTOMA_DESMOPLASIC_VS_CLASSIC_DN	94	Up	0.560659891654904	0.881050267698264
REACTOME_ORC1_REMOVAL_FROM_CHROMATIN	71	Down	0.560842179946711	0.881050267698264
HOSHIDA_LIVER_CANCER_SURVIVAL_DN	122	Up	0.56114399044478	0.881050267698264
KEGG_FC_GAMMA_R_MEDIATED_PHAGOCYTOSIS	93	Down	0.561193957558018	0.881050267698264
BIOCARTA_CBL_PATHWAY	19	Down	0.561636697325842	0.881347461463145
REACTOME_ADAPTIVE_IMMUNE_SYSTEM	511	Down	0.56175639425604	0.881347461463145
FIGUEROA_AML_METHYLATION_CLUSTER_2_UP	80	Up	0.562013961268468	0.881458815747757
GALE_APL_WITH_FLT3_MUTATED_UP	80	Up	0.56232086280501	0.881572807222816
FARDIN_HYPOXIA_11	47	Up	0.562459873194235	0.881572807222816
YAUCH_HEDGEHOG_SIGNALING_PARACRINE_UP	185	Up	0.562774857923475	0.881595362815868
BIOCARTA_FIBRINOLYSIS_PATHWAY	6	Up	0.562911615629062	0.881595362815868
BROWNE_HCMV_INFECTION_10HR_UP	195	Up	0.56329795045387	0.881595362815868
DORSEY_GAB2_TARGETS	57	Up	0.563365186360964	0.881595362815868
SASAI_TARGETS_OF_CXCR6_AND_PTCH1_UP	13	Up	0.563407366710649	0.881595362815868
REACTOME_NOTCH_HLH_TRANSCRIPTION_PATHWAY	14	Down	0.564053885228558	0.881783123200358
HADDAD_T_LYMPHOCYTE_AND_NK_PROGENITOR_DN	51	Up	0.564061148172618	0.881783123200358
HOLLEMAN_ASPARAGINASE_RESISTANCE_ALL_DN	34	Up	0.56415338721392	0.881783123200358
LIAN_NEUTROPHIL_GRANULE_CONSTITUENTS	18	Down	0.56453756051306	0.881783123200358
NICK_RESPONSE_TO_PROC_TREATMENT_DN	58	Down	0.564605177484239	0.881783123200358
NIKOLSKY_BREAST_CANCER_21Q22_AMPLICON	18	Down	0.564647321693709	0.881783123200358
ROZANOV_MMP14_CORRELATED	21	Down	0.565675823338923	0.882519350657725
MOOTHA_PGC	632	Down	0.565726124724413	0.882519350657725
BIOCARTA_PARKIN_PATHWAY	11	Down	0.565844248579892	0.882519350657725
ROSS_AML_WITH_AML1_ETO_FUSION	93	Down	0.565991977157654	0.882519350657725
HENDRICKS_SMARCA4_TARGETS_DN	44	Up	0.566183550264391	0.882519350657725
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_LIGHTYELLOW_UP	19	Up	0.566306029805937	0.882519350657725
MARTINEZ_RB1_TARGETS_DN	691	Up	0.566497975255369	0.882519350657725
ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP	544	Up	0.56661329181729	0.882519350657725
PILON_KLF1_TARGETS_UP	665	Up	0.567169471275711	0.883003717525887
PID_PTP1B_PATHWAY	69	Down	0.567298112339345	0.883003717525887
MOTAMED_RESPONSE_TO_ANDROGEN_DN	5	Down	0.567782219269049	0.883066985250346
DOANE_RESPONSE_TO_ANDROGEN_UP	253	Up	0.567821375983395	0.883066985250346
CHESLER_BRAIN_QTL_CIS	76	Down	0.567899555713495	0.883066985250346
MATZUK_MEIOTIC_AND_DNA_REPAIR	41	Up	0.568194006278314	0.883218390563359
GRAHAM_CML_DIVIDING_VS_NORMAL_DIVIDING_UP	20	Down	0.56843084691726	0.883218390563359
MOOTHA_HUMAN_MITODB_6_2002	538	Down	0.568619723536668	0.883218390563359
MURAKAMI_UV_RESPONSE_24HR	25	Down	0.568983518839123	0.883218390563359
PID_INTEGRIN5_PATHWAY	20	Down	0.569417855913961	0.883218390563359
KUROKAWA_LIVER_CANCER_CHEMOTHERAPY_UP	17	Down	0.569479966304412	0.883218390563359
REACTOME_UNBLOCKING_OF_NMDA_RECEPTOR_GLUTAMATE_BINDING_AND_ACTIVATION	11	Down	0.569521873735704	0.883218390563359
REACTOME_NEPHRIN_INTERACTIONS	28	Down	0.569569385752639	0.883218390563359
FONTAINE_THYROID_TUMOR_UNCERTAIN_MALIGNANCY_DN	24	Down	0.569699241470947	0.883218390563359
LANDIS_BREAST_CANCER_PROGRESSION_UP	49	Up	0.570005968669046	0.883218390563359
KEGG_PPAR_SIGNALING_PATHWAY	64	Down	0.57005352938774	0.883218390563359
COATES_MACROPHAGE_M1_VS_M2_DN	107	Up	0.570413544129753	0.883486420481624
ONDER_CDH1_TARGETS_3_DN	57	Up	0.570899037312213	0.883948558591575
HAHTOLA_MYCOSIS_FUNGOIDES_UP	24	Down	0.572401913934613	0.885849255866976
REACTOME_COMMON_PATHWAY	3	Down	0.572501646520296	0.885849255866976
WATANABE_COLON_CANCER_MSI_VS_MSS_DN	77	Up	0.57283105228156	0.8859895528493
SASSON_FSH_RESPONSE	23	Up	0.572967418279977	0.8859895528493
URS_ADIPOCYTE_DIFFERENTIATION_UP	117	Up	0.573627209430592	0.886401387646567
TSAI_DNAJB4_TARGETS_UP	19	Down	0.573786545257	0.886401387646567
ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP	282	Down	0.57416587222807	0.886401387646567
IIZUKA_LIVER_CANCER_PROGRESSION_G2_G3_DN	11	Up	0.574230126552717	0.886401387646567
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_GRANULOCYTE_UP	75	Down	0.574286976788718	0.886401387646567
OKUMURA_INFLAMMATORY_RESPONSE_LPS	248	Up	0.574359578235847	0.886401387646567
SARTIPY_BLUNTED_BY_INSULIN_RESISTANCE_UP	21	Up	0.574730408411754	0.886616884889746
WAMUNYOKOLI_OVARIAN_CANCER_GRADES_1_2_UP	203	Up	0.574903885179084	0.886616884889746
BERNARD_PPAPDC1B_TARGETS_DN	73	Down	0.575062264035178	0.886616884889746
KEGG_RETINOL_METABOLISM	26	Up	0.575422119811061	0.886749883460398
XU_GH1_AUTOCRINE_TARGETS_UP	274	Up	0.575523950611681	0.886749883460398
LASTOWSKA_COAMPLIFIED_WITH_MYCN	39	Up	0.575837078776016	0.886842388575088
ZHANG_TLX_TARGETS_60HR_UP	430	Down	0.576094772925301	0.886842388575088
FEVR_CTNNB1_TARGETS_UP	882	Up	0.576147182586144	0.886842388575088
TURJANSKI_MAPK7_TARGETS	10	Down	0.576532154507494	0.886926876132357
JAZAG_TGFB1_SIGNALING_VIA_SMAD4_DN	70	Down	0.576577569136848	0.886926876132357
INGRAM_SHH_TARGETS_UP	179	Up	0.577709784462629	0.887521399440436
PID_ECADHERIN_STABILIZATION_PATHWAY	69	Up	0.577726714329797	0.887521399440436
GUTIERREZ_MULTIPLE_MYELOMA_UP	44	Down	0.577748371594355	0.887521399440436
ZHAN_V1_LATE_DIFFERENTIATION_GENES_UP	43	Down	0.577789516054139	0.887521399440436
KEGG_RENAL_CELL_CARCINOMA	76	Down	0.578025133035018	0.887521399440436
BROWNE_HCMV_INFECTION_6HR_DN	237	Down	0.578091309500047	0.887521399440436
HEIDENBLAD_AMPLIFIED_IN_SOFT_TISSUE_CANCER	13	Down	0.578361681337688	0.88761873248067
GENTILE_UV_RESPONSE_CLUSTER_D8	77	Down	0.578530499006771	0.88761873248067
BIOCARTA_MONOCYTE_PATHWAY	6	Down	0.579333179834617	0.887938300261999
JIANG_HYPOXIA_CANCER	107	Down	0.579816922758249	0.887938300261999
WANG_RESPONSE_TO_PACLITAXEL_VIA_MAPK8_DN	5	Up	0.579929585570441	0.887938300261999
BIOCARTA_ARENRF2_PATHWAY	16	Up	0.58013781891834	0.887938300261999
STAEGE_EWING_FAMILY_TUMOR	36	Up	0.580200904203668	0.887938300261999
LI_CYTIDINE_ANALOGS_CYCTOTOXICITY	18	Down	0.580280143904256	0.887938300261999
KEGG_CYTOSOLIC_DNA_SENSING_PATHWAY	39	Up	0.580769281515839	0.887938300261999
REACTOME_VITAMIN_B5_PANTOTHENATE_METABOLISM	12	Down	0.580983323118625	0.887938300261999
REACTOME_DOUBLE_STRAND_BREAK_REPAIR	25	Down	0.581173705395275	0.887938300261999
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_GRANULOCYTE_DN	6	Down	0.581184381177953	0.887938300261999
WEBER_METHYLATED_LCP_IN_FIBROBLAST_DN	6	Down	0.581269124371015	0.887938300261999
WEBER_METHYLATED_HCP_IN_SPERM_DN	19	Down	0.581319922278502	0.887938300261999
SASSON_RESPONSE_TO_FORSKOLIN_UP	156	Down	0.581353083414885	0.887938300261999
HOLLEMAN_VINCRISTINE_RESISTANCE_B_ALL_UP	52	Up	0.581680371966524	0.887938300261999
MOREAUX_B_LYMPHOCYTE_MATURATION_BY_TACI_DN	102	Down	0.581730502983899	0.887938300261999
DELACROIX_RAR_TARGETS_UP	75	Down	0.581746197991297	0.887938300261999
SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX6_DN	5	Down	0.582056224420221	0.88812454914765
KORKOLA_EMBRYONAL_CARCINOMA_UP	58	Up	0.582305628735718	0.888207259363774
WANG_ESOPHAGUS_CANCER_PROGRESSION_UP	19	Down	0.582618060145763	0.888207259363774
SU_KIDNEY	16	Up	0.582726720796828	0.888207259363774
KEGG_NOD_LIKE_RECEPTOR_SIGNALING_PATHWAY	57	Up	0.582862511436854	0.888207259363774
NIKOLSKY_BREAST_CANCER_14Q22_AMPLICON	36	Down	0.583054936652833	0.888213969928405
REACTOME_EFFECTS_OF_PIP2_HYDROLYSIS	17	Up	0.583581532382223	0.888575009531925
HOFFMANN_SMALL_PRE_BII_TO_IMMATURE_B_LYMPHOCYTE_DN	77	Down	0.58366813179034	0.888575009531925
NAKAMURA_METASTASIS	73	Down	0.584053410513866	0.888594044576836
BERENJENO_TRANSFORMED_BY_RHOA_DN	627	Up	0.584056839206409	0.888594044576836
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_9	76	Up	0.58464668767961	0.888743456077
HUI_MAPK14_TARGETS_UP	42	Down	0.584792530552437	0.888743456077
KEGG_STARCH_AND_SUCROSE_METABOLISM	32	Down	0.58496280531889	0.888743456077
MARTORIATI_MDM4_TARGETS_FETAL_LIVER_UP	297	Down	0.585039638594809	0.888743456077
REACTOME_GRB2_SOS_PROVIDES_LINKAGE_TO_MAPK_SIGNALING_FOR_INTERGRINS_	16	Down	0.585193279033903	0.888743456077
REACTOME_CELL_CYCLE_CHECKPOINTS	121	Down	0.585283846709472	0.888743456077
LEE_INTRATHYMIC_T_PROGENITOR	33	Up	0.585504293928109	0.888792507878017
LOPES_METHYLATED_IN_COLON_CANCER_UP	21	Down	0.586025603938299	0.889170051980559
SANA_RESPONSE_TO_IFNG_UP	86	Down	0.586192692604596	0.889170051980559
DORN_ADENOVIRUS_INFECTION_24HR_DN	79	Up	0.58648737804111	0.889170051980559
CARD_MIR302A_TARGETS	109	Down	0.586505902195475	0.889170051980559
LIU_BREAST_CANCER	57	Down	0.586957465950197	0.889306440439935
FORTSCHEGGER_PHF8_TARGETS_UP	354	Down	0.586972371145579	0.889306440439935
YAGI_AML_WITH_11Q23_REARRANGED	486	Down	0.587338040927894	0.889575154005569
REACTOME_PLATELET_CALCIUM_HOMEOSTASIS	12	Down	0.587848458444608	0.890062858234721
CHEN_HOXA5_TARGETS_9HR_UP	339	Down	0.588185238691406	0.890272854102992
BROWN_MYELOID_CELL_DEVELOPMENT_DN	146	Up	0.588866131333452	0.890272854102992
VANHARANTA_UTERINE_FIBROID_DN	86	Up	0.588940494412968	0.890272854102992
REACTOME_CD28_DEPENDENT_VAV1_PATHWAY	16	Down	0.589226269319006	0.890272854102992
FRASOR_RESPONSE_TO_ESTRADIOL_DN	144	Up	0.58965254016207	0.890272854102992
WIERENGA_STAT5A_TARGETS_GROUP1	224	Up	0.589687905691812	0.890272854102992
NIKOLSKY_BREAST_CANCER_1Q32_AMPLICON	8	Down	0.589755438632204	0.890272854102992
REACTOME_NOTCH1_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION	48	Up	0.589776979209725	0.890272854102992
SWEET_KRAS_ONCOGENIC_SIGNATURE	129	Down	0.589810333167193	0.890272854102992
AMIT_DELAYED_EARLY_GENES	21	Down	0.589969900258975	0.890272854102992
SCHUHMACHER_MYC_TARGETS_UP	132	Down	0.590060183360811	0.890272854102992
GOLUB_ALL_VS_AML_DN	21	Up	0.590408562961533	0.890499313180529
PID_UPA_UPAR_PATHWAY	44	Down	0.590591341992997	0.890499313180529
IWANAGA_CARCINOGENESIS_BY_KRAS_UP	240	Up	0.590918369463404	0.890499313180529
KREPPEL_CD99_TARGETS_UP	5	Down	0.590964298649653	0.890499313180529
BIOCARTA_NO1_PATHWAY	43	Down	0.591466333990998	0.890661759973126
MIKKELSEN_DEDIFFERENTIATED_STATE_DN	10	Up	0.591491591516532	0.890661759973126
DOUGLAS_BMI1_TARGETS_DN	493	Up	0.591889020830519	0.890661759973126
REACTOME_CHEMOKINE_RECEPTORS_BIND_CHEMOKINES	21	Down	0.592313715298267	0.890661759973126
NING_CHRONIC_OBSTRUCTIVE_PULMONARY_DISEASE_DN	182	Down	0.592725941898584	0.890661759973126
MARSHALL_VIRAL_INFECTION_RESPONSE_UP	7	Down	0.59320240121063	0.890661759973126
NIELSEN_SYNOVIAL_SARCOMA_DN	17	Down	0.593434982979004	0.890661759973126
PID_HIF2PATHWAY	44	Up	0.593516894948941	0.890661759973126
RODRIGUES_NTN1_TARGETS_DN	237	Up	0.59353227890165	0.890661759973126
PARK_OSTEOBLAST_DIFFERENTIATION_BY_PHENYLAMIL_UP	14	Up	0.593711277821459	0.890661759973126
GABRIELY_MIR21_TARGETS	457	Up	0.593878603925451	0.890661759973126
LIU_IL13_MEMORY_MODEL_DN	21	Up	0.594192055274223	0.890661759973126
REACTOME_GLYCOGEN_BREAKDOWN_GLYCOGENOLYSIS	17	Down	0.594383508392157	0.890661759973126
GAVIN_PDE3B_TARGETS	14	Down	0.594550230367251	0.890661759973126
RADAEVA_RESPONSE_TO_IFNA1_DN	15	Up	0.59487285029945	0.890661759973126
REACTOME_NEGATIVE_REGULATORS_OF_RIG_I_MDA5_SIGNALING	37	Down	0.594880608562062	0.890661759973126
REACTOME_GPCR_DOWNSTREAM_SIGNALING	251	Down	0.595023733924747	0.890661759973126
LE_NEURONAL_DIFFERENTIATION_UP	33	Up	0.595309624195397	0.890661759973126
STEINER_ERYTHROCYTE_MEMBRANE_GENES	19	Up	0.595426178666199	0.890661759973126
ABBUD_LIF_SIGNALING_1_UP	43	Up	0.595470499233541	0.890661759973126
HOSHIDA_LIVER_CANCER_SUBCLASS_S2	182	Down	0.595679057734108	0.890661759973126
THUM_SYSTOLIC_HEART_FAILURE_DN	315	Up	0.595807109436669	0.890661759973126
MORI_PRE_BI_LYMPHOCYTE_DN	99	Down	0.596275238991827	0.890661759973126
ST_G_ALPHA_S_PATHWAY	17	Up	0.596315166817545	0.890661759973126
HOFFMANN_PRE_BI_TO_LARGE_PRE_BII_LYMPHOCYTE_DN	85	Down	0.596356574513674	0.890661759973126
REACTOME_GLUCOSE_TRANSPORT	35	Down	0.596379488941982	0.890661759973126
HOLLEMAN_VINCRISTINE_RESISTANCE_B_ALL_DN	18	Down	0.59649961126613	0.890661759973126
BENPORATH_MYC_MAX_TARGETS	1088	Down	0.596600192430672	0.890661759973126
BOYLAN_MULTIPLE_MYELOMA_D_CLUSTER_UP	32	Up	0.596614899608565	0.890661759973126
REACTOME_REGULATED_PROTEOLYSIS_OF_P75NTR	13	Down	0.596804043774703	0.890661759973126
REACTOME_ION_TRANSPORT_BY_P_TYPE_ATPASES	24	Down	0.596949349522003	0.890661759973126
ZHAN_MULTIPLE_MYELOMA_CD1_AND_CD2_UP	136	Up	0.597105375494261	0.890661759973126
COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP	148	Up	0.597730744966209	0.891313143693299
LU_TUMOR_ENDOTHELIAL_MARKERS_DN	3	Down	0.59811279976109	0.891601409299902
RODWELL_AGING_KIDNEY_DN	156	Down	0.599146439750327	0.892348250825524
REACTOME_SEMAPHORIN_INTERACTIONS	83	Down	0.599151480734839	0.892348250825524
SIG_INSULIN_RECEPTOR_PATHWAY_IN_CARDIAC_MYOCYTES	69	Down	0.599758532182577	0.892348250825524
EHLERS_ANEUPLOIDY_DN	14	Down	0.599972961281389	0.892348250825524
NADERI_BREAST_CANCER_PROGNOSIS_DN	18	Up	0.600074196994557	0.892348250825524
WEST_ADRENOCORTICAL_TUMOR_MARKERS_DN	19	Up	0.600836670326331	0.892348250825524
REACTOME_A_TETRASACCHARIDE_LINKER_SEQUENCE_IS_REQUIRED_FOR_GAG_SYNTHESIS	21	Up	0.600919316548215	0.892348250825524
LEIN_NEURON_MARKERS	82	Down	0.601459432764456	0.892348250825524
KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_UV_IN_OLD	33	Down	0.601537012836723	0.892348250825524
MIKKELSEN_NPC_ICP_WITH_H3K4ME3	690	Up	0.601622398716067	0.892348250825524
PID_TAP63_PATHWAY	74	Up	0.601703982581284	0.892348250825524
KEGG_CYSTEINE_AND_METHIONINE_METABOLISM	31	Down	0.60193157638589	0.892348250825524
PID_AJDISS_2PATHWAY	77	Up	0.602032318737185	0.892348250825524
ZHAN_MULTIPLE_MYELOMA_PR_DN	81	Up	0.602351392438463	0.892348250825524
CHEN_ETV5_TARGETS_SERTOLI	19	Up	0.602354855838851	0.892348250825524
MAYBURD_RESPONSE_TO_L663536_DN	129	Up	0.60245677246978	0.892348250825524
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREY_DN	94	Down	0.60270792765486	0.892348250825524
MULLIGAN_NTF3_SIGNALING_VIA_INSR_AND_IGF1R_UP	36	Up	0.602841964223336	0.892348250825524
BIOCARTA_TALL1_PATHWAY	20	Up	0.602949464994251	0.892348250825524
KEGG_PARKINSONS_DISEASE	111	Down	0.602978516611082	0.892348250825524
ZHANG_TARGETS_OF_EWSR1_FLI1_FUSION	149	Down	0.603106860650445	0.892348250825524
CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_DN	76	Up	0.603367092439049	0.892348250825524
MARZEC_IL2_SIGNALING_UP	143	Down	0.603533696786965	0.892348250825524
STEARMAN_LUNG_CANCER_EARLY_VS_LATE_UP	183	Down	0.603585104916373	0.892348250825524
YAGI_AML_FAB_MARKERS	319	Up	0.603740959953148	0.892348250825524
AMUNDSON_RESPONSE_TO_ARSENITE	326	Down	0.603832143856541	0.892348250825524
PID_HIV_NEF_PATHWAY	41	Up	0.604005372251673	0.892348250825524
BILBAN_B_CLL_LPL_DN	74	Down	0.604123229959367	0.892348250825524
QI_HYPOXIA	202	Down	0.604153433506822	0.892348250825524
ZHANG_BREAST_CANCER_PROGENITORS_DN	225	Up	0.604441302085703	0.892348250825524
REACTOME_FRS2_MEDIATED_CASCADE	30	Down	0.604522753194645	0.892348250825524
REACTOME_FORMATION_OF_TUBULIN_FOLDING_INTERMEDIATES_BY_CCT_TRIC	21	Down	0.604658499342189	0.892348250825524
KEGG_PROPANOATE_METABOLISM	46	Down	0.605242399246389	0.892739033657111
BIOCARTA_HIVNEF_PATHWAY	71	Up	0.605301254192152	0.892739033657111
CHARAFE_BREAST_CANCER_BASAL_VS_MESENCHYMAL_DN	84	Up	0.60586367071922	0.893289631859424
REACTOME_XENOBIOTICS	3	Up	0.606217941301996	0.893370140311031
REACTOME_CLASS_A1_RHODOPSIN_LIKE_RECEPTORS	99	Up	0.60629650081227	0.893370140311031
BIOCARTA_IL17_PATHWAY	4	Down	0.606882297051988	0.8936911953829
YIH_RESPONSE_TO_ARSENITE_C1	40	Down	0.607057630510339	0.8936911953829
EHRLICH_ICF_SYNDROM_UP	15	Down	0.607081931833981	0.8936911953829
DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_UP	534	Up	0.607620376487563	0.8939246378059
MORI_PLASMA_CELL_DN	59	Down	0.607766889074703	0.8939246378059
TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_DN	69	Up	0.608173778612442	0.8939246378059
REACTOME_DOWNREGULATION_OF_TGF_BETA_RECEPTOR_SIGNALING	27	Down	0.608343149888017	0.8939246378059
MAHADEVAN_IMATINIB_RESISTANCE_DN	20	Up	0.608836436980003	0.8939246378059
BIOCARTA_CASPASE_PATHWAY	23	Up	0.60901192281067	0.8939246378059
GENTILE_UV_RESPONSE_CLUSTER_D9	37	Down	0.60972796943234	0.8939246378059
NIELSEN_GIST	147	Down	0.609830504400737	0.8939246378059
ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_UP	46	Up	0.609851409307099	0.8939246378059
DORN_ADENOVIRUS_INFECTION_32HR_UP	16	Down	0.609895422109916	0.8939246378059
SHAFFER_IRF4_TARGETS_IN_ACTIVATED_DENDRITIC_CELL	107	Up	0.610007768109829	0.8939246378059
WINTER_HYPOXIA_METAGENE	303	Up	0.610064107265506	0.8939246378059
BIOCARTA_MTOR_PATHWAY	33	Down	0.610113832912701	0.8939246378059
GAVIN_FOXP3_TARGETS_CLUSTER_P3	211	Down	0.610242068656385	0.8939246378059
DALESSIO_TSA_RESPONSE	30	Up	0.610396946254047	0.8939246378059
XU_RESPONSE_TO_TRETINOIN_AND_NSC682994_UP	26	Down	0.610799957465904	0.8939246378059
WENG_POR_DOSAGE	25	Up	0.610857764112799	0.8939246378059
NELSON_RESPONSE_TO_ANDROGEN_UP	135	Up	0.610905795911944	0.8939246378059
REACTOME_ANDROGEN_BIOSYNTHESIS	5	Up	0.611096460579189	0.8939246378059
XU_GH1_EXOGENOUS_TARGETS_UP	99	Down	0.611236401655177	0.8939246378059
BERENJENO_ROCK_SIGNALING_NOT_VIA_RHOA_DN	94	Up	0.611269513314485	0.8939246378059
KEGG_CALCIUM_SIGNALING_PATHWAY	115	Down	0.611403578482401	0.8939246378059
PID_P38_ALPHA_BETA_PATHWAY	47	Down	0.611617371462932	0.893960539229856
RAMASWAMY_METASTASIS_UP	105	Up	0.612399144763504	0.894394693371478
OXFORD_RALA_TARGETS_DN	29	Up	0.612477324060679	0.894394693371478
YAGUE_PRETUMOR_DRUG_RESISTANCE_DN	24	Up	0.612666604212294	0.894394693371478
REACTOME_MRNA_DECAY_BY_5_TO_3_EXORIBONUCLEASE	15	Down	0.612769989539977	0.894394693371478
PID_S1P_META_PATHWAY	25	Down	0.61286105470861	0.894394693371478
LUI_THYROID_CANCER_CLUSTER_1	88	Down	0.613164634793157	0.894561375776057
BROWNE_HCMV_INFECTION_20HR_UP	426	Up	0.613555684020629	0.894855526802548
REACTOME_SIGNALING_BY_ILS	114	Down	0.614070564459042	0.895024870971113
REACTOME_CELL_CELL_COMMUNICATION	117	Up	0.614192633141616	0.895024870971113
LAIHO_COLORECTAL_CANCER_SERRATED_UP	154	Down	0.614240184523359	0.895024870971113
BORLAK_LIVER_CANCER_EGF_UP	106	Up	0.615232770561609	0.895844059734419
NUMATA_CSF3_SIGNALING_VIA_STAT3	24	Down	0.615550791922248	0.895844059734419
KIM_WT1_TARGETS_8HR_UP	267	Down	0.615555194047418	0.895844059734419
BENPORATH_MYC_TARGETS_WITH_EBOX	312	Down	0.615674645879843	0.895844059734419
GU_PDEF_TARGETS_UP	101	Up	0.615750563496541	0.895844059734419
BIOCARTA_LAIR_PATHWAY	8	Up	0.616087656595309	0.896058525171256
REACTOME_ACYL_CHAIN_REMODELLING_OF_PE	11	Down	0.617123133139714	0.89707634436855
WANG_PROSTATE_CANCER_ANDROGEN_INDEPENDENT	129	Up	0.617167256392419	0.89707634436855
HUMMERICH_SKIN_CANCER_PROGRESSION_DN	178	Down	0.617798048766434	0.897717004728586
KIM_WT1_TARGETS_8HR_DN	145	Up	0.618769207676368	0.898479869709131
JOHANSSON_GLIOMAGENESIS_BY_PDGFB_DN	24	Down	0.618934081480997	0.898479869709131
REACTOME_STEROID_HORMONES	24	Down	0.619288541175376	0.898479869709131
SCIAN_CELL_CYCLE_TARGETS_OF_TP53_AND_TP73_UP	14	Down	0.619375995897318	0.898479869709131
LIM_MAMMARY_STEM_CELL_UP	646	Up	0.619460602796272	0.898479869709131
LIU_PROSTATE_CANCER_DN	608	Up	0.619544656008906	0.898479869709131
REACTOME_HOMOLOGOUS_RECOMBINATION_REPAIR_OF_REPLICATION_INDEPENDENT_DOUBLE_STRAND_BREAKS	19	Down	0.619654406331996	0.898479869709131
KOINUMA_TARGETS_OF_SMAD2_OR_SMAD3	1168	Down	0.620575592665144	0.899539459880374
LIU_VMYB_TARGETS_UP	206	Down	0.620900750102502	0.899734706590252
GERHOLD_ADIPOGENESIS_UP	63	Up	0.621675521784751	0.900246365562208
WEBER_METHYLATED_ICP_IN_SPERM_DN	14	Up	0.621930150390917	0.900246365562208
CASORELLI_APL_SECONDARY_VS_DE_NOVO_UP	46	Up	0.622325507751418	0.900246365562208
HARRIS_HYPOXIA	114	Up	0.62248481103618	0.900246365562208
LEI_MYB_TARGETS	443	Up	0.622601939095746	0.900246365562208
REACTOME_HIV_INFECTION	233	Down	0.623041687516472	0.900246365562208
BIOCARTA_SODD_PATHWAY	10	Up	0.623290289452609	0.900246365562208
SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_UP	226	Down	0.623378540906083	0.900246365562208
FARMER_BREAST_CANCER_CLUSTER_6	21	Up	0.623393779968995	0.900246365562208
LU_EZH2_TARGETS_UP	400	Down	0.623412383152765	0.900246365562208
REACTOME_MYOGENESIS	28	Up	0.623419012136078	0.900246365562208
WU_ALZHEIMER_DISEASE_DN	29	Down	0.623540666409726	0.900246365562208
TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_UP	371	Down	0.624053422241928	0.900496106675621
CONCANNON_APOPTOSIS_BY_EPOXOMICIN_DN	201	Down	0.624393424043557	0.900496106675621
RODWELL_AGING_KIDNEY_UP	554	Down	0.624447416354856	0.900496106675621
ZHAN_MULTIPLE_MYELOMA_SUBGROUPS	36	Up	0.624637233648525	0.900496106675621
NIELSEN_GIST_AND_SYNOVIAL_SARCOMA_DN	18	Up	0.624666753085523	0.900496106675621
SENESE_HDAC1_AND_HDAC2_TARGETS_DN	327	Down	0.625044164849833	0.900765294310741
WEBER_METHYLATED_ICP_IN_FIBROBLAST	20	Down	0.625754186131084	0.901390126028866
REACTOME_FORMATION_OF_ATP_BY_CHEMIOSMOTIC_COUPLING	18	Down	0.625864091448364	0.901390126028866
GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_DN	70	Up	0.626050170089058	0.901390126028866
BIOCARTA_PITX2_PATHWAY	22	Up	0.626448055341084	0.901454457746952
ZHAN_MULTIPLE_MYELOMA_CD1_DN	56	Up	0.62651032076541	0.901454457746952
BROWNE_HCMV_INFECTION_18HR_UP	247	Up	0.626785085500883	0.901454457746952
YAMASHITA_LIVER_CANCER_WITH_EPCAM_DN	14	Up	0.626976793989822	0.901454457746952
REACTOME_TOLL_RECEPTOR_CASCADES	152	Down	0.627149088186708	0.901454457746952
KIM_HYPOXIA	37	Up	0.627239797335782	0.901454457746952
BACOLOD_RESISTANCE_TO_ALKYLATING_AGENTS_UP	44	Up	0.627738993490173	0.901897507678703
BALDWIN_PRKCI_TARGETS_UP	47	Down	0.628368474401956	0.902266879141645
REACTOME_DEFENSINS	22	Down	0.628865079211394	0.902266879141645
REACTOME_BETA_DEFENSINS	22	Down	0.628865079211394	0.902266879141645
WOO_LIVER_CANCER_RECURRENCE_UP	197	Up	0.628943405703323	0.902266879141645
BASAKI_YBX1_TARGETS_DN	550	Up	0.629078123688608	0.902266879141645
SUZUKI_RESPONSE_TO_TSA_AND_DECITABINE_1A	21	Down	0.629142061789284	0.902266879141645
SCHRAMM_INHBA_TARGETS_DN	32	Down	0.629425702822935	0.902399702620802
ZWANG_TRANSIENTLY_UP_BY_2ND_EGF_PULSE_ONLY	1250	Up	0.629654573817761	0.902453946212107
SHIN_B_CELL_LYMPHOMA_CLUSTER_5	12	Down	0.630233276408328	0.902915002435536
IIZUKA_LIVER_CANCER_PROGRESSION_G2_G3_UP	38	Up	0.630538452910195	0.902915002435536
PARK_TRETINOIN_RESPONSE_AND_RARA_PLZF_FUSION	33	Up	0.630995385737722	0.902915002435536
BAKKER_FOXO3_TARGETS_UP	99	Up	0.631139742819174	0.902915002435536
CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN	622	Down	0.63126352939122	0.902915002435536
GAZDA_DIAMOND_BLACKFAN_ANEMIA_PROGENITOR_UP	61	Down	0.631452230403227	0.902915002435536
PID_BETA_CATENIN_DEG_PATHWAY	22	Down	0.631577195672966	0.902915002435536
PID_TOLL_ENDOGENOUS_PATHWAY	39	Down	0.63187630029981	0.902915002435536
REACTOME_EICOSANOID_LIGAND_BINDING_RECEPTORS	6	Down	0.631894921044512	0.902915002435536
KEGG_CARDIAC_MUSCLE_CONTRACTION	71	Up	0.632484337721247	0.902915002435536
REACTOME_GLUCURONIDATION	11	Up	0.632506163758206	0.902915002435536
LIU_IL13_PRIMING_MODEL	26	Up	0.632569142447438	0.902915002435536
PID_BETA_CATENIN_NUC_PATHWAY	95	Up	0.632733445154944	0.902915002435536
KONDO_COLON_CANCER_HCP_WITH_H3K27ME1	29	Down	0.632763494845437	0.902915002435536
ONO_AML1_TARGETS_UP	19	Down	0.632843262714661	0.902915002435536
SILIGAN_TARGETS_OF_EWS_FLI1_FUSION_DN	44	Down	0.63319174693265	0.903030264685807
SAMOLS_TARGETS_OF_KHSV_MIRNAS_UP	28	Up	0.633479859331043	0.903030264685807
SENESE_HDAC2_TARGETS_UP	157	Down	0.633788436403455	0.903030264685807
DE_YY1_TARGETS_DN	147	Down	0.634021146495882	0.903030264685807
CEBALLOS_TARGETS_OF_TP53_AND_MYC_DN	48	Up	0.634423752027877	0.903030264685807
ZHAN_MULTIPLE_MYELOMA_CD2_UP	74	Down	0.63451024406939	0.903030264685807
NAGY_PCAF_COMPONENTS_HUMAN	12	Down	0.634871206959771	0.903030264685807
GOUYER_TATI_TARGETS_UP	6	Up	0.63493402177517	0.903030264685807
REACTOME_ACTIVATION_OF_GENES_BY_ATF4	24	Up	0.63494199591889	0.903030264685807
HADDAD_B_LYMPHOCYTE_PROGENITOR	487	Down	0.635024278703258	0.903030264685807
RODRIGUES_THYROID_CARCINOMA_DN	146	Up	0.635026786470417	0.903030264685807
SOUCEK_MYC_TARGETS	6	Down	0.635989031497005	0.903171818643237
PID_GLYPICAN_1PATHWAY	29	Up	0.636084006387513	0.903171818643237
KEGG_RNA_DEGRADATION	58	Down	0.636231245847425	0.903171818643237
REACTOME_APC_C_CDH1_MEDIATED_DEGRADATION_OF_CDC20_AND_OTHER_APC_C_CDH1_TARGETED_PROTEINS_IN_LATE_MITOSIS_EARLY_G1	72	Down	0.636260176848528	0.903171818643237
GALI_TP53_TARGETS_APOPTOTIC_UP	9	Up	0.636288693697638	0.903171818643237
MMS_MOUSE_LYMPH_HIGH_4HRS_UP	58	Down	0.636384070420713	0.903171818643237
SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM4	281	Up	0.636464645271663	0.903171818643237
PID_RAC1_REG_PATHWAY	45	Up	0.636939804619172	0.903480486433933
YANG_BCL3_TARGETS_UP	514	Up	0.637279886654606	0.903480486433933
KIM_TIAL1_TARGETS	46	Up	0.637308633365147	0.903480486433933
GRANDVAUX_IFN_RESPONSE_NOT_VIA_IRF3	19	Up	0.637447176393797	0.903480486433933
RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN	530	Up	0.638194841021919	0.903665391317551
YORDY_RECIPROCAL_REGULATION_BY_ETS1_AND_SP100_DN	148	Up	0.638203816338008	0.903665391317551
REACTOME_TRIF_MEDIATED_TLR3_SIGNALING	111	Down	0.638385917061401	0.903665391317551
GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_DN	6	Up	0.638459424980649	0.903665391317551
BAELDE_DIABETIC_NEPHROPATHY_DN	663	Up	0.63853409742125	0.903665391317551
REACTOME_DOWNSTREAM_TCR_SIGNALING	27	Down	0.639138181023486	0.904220191655881
LINSLEY_MIR16_TARGETS	293	Down	0.639308941602592	0.904220191655881
FINETTI_BREAST_CANCERS_KINOME_GRAY	28	Down	0.639792085371082	0.904557048216996
BILD_SRC_ONCOGENIC_SIGNATURE	99	Up	0.639992527893734	0.904557048216996
BOYLAN_MULTIPLE_MYELOMA_PCA3_UP	95	Down	0.640232482925469	0.904557048216996
ALONSO_METASTASIS_UP	316	Up	0.640486722841903	0.904557048216996
PID_LPA4_PATHWAY	20	Down	0.640504514455091	0.904557048216996
MARTINEZ_RB1_AND_TP53_TARGETS_DN	762	Up	0.641035880151777	0.904872041092212
REACTOME_CGMP_EFFECTS	10	Up	0.64111065231491	0.904872041092212
REACTOME_TRANSPORT_OF_ORGANIC_ANIONS	4	Down	0.641990307303201	0.905685871699354
TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_TOP20_DN	28	Down	0.642217231853826	0.905685871699354
MURATA_VIRULENCE_OF_H_PILORI	20	Down	0.642350634025396	0.905685871699354
RAO_BOUND_BY_SALL4	337	Down	0.642613157769061	0.905685871699354
REACTOME_IMMUNE_SYSTEM	838	Down	0.642645859851023	0.905685871699354
BURTON_ADIPOGENESIS_9	129	Down	0.643161731136858	0.90614256423815
KESHELAVA_MULTIPLE_DRUG_RESISTANCE	131	Down	0.643466899739247	0.90630221656774
REACTOME_ACTIVATION_OF_THE_PRE_REPLICATIVE_COMPLEX	30	Down	0.644754179613397	0.907815812885029
MURAKAMI_UV_RESPONSE_1HR_UP	22	Up	0.644928548335847	0.907815812885029
GRABARCZYK_BCL11B_TARGETS_DN	75	Down	0.645118053313938	0.907815812885029
SMID_BREAST_CANCER_RELAPSE_IN_LUNG_DN	42	Up	0.645910020787675	0.908659600417205
DAVICIONI_MOLECULAR_ARMS_VS_ERMS_DN	273	Down	0.646160632439956	0.908694118461598
LIAN_LIPA_TARGETS_6M	67	Up	0.646485680455356	0.908694118461598
AMIT_EGF_RESPONSE_240_HELA	82	Up	0.64663755589685	0.908694118461598
STAMBOLSKY_TARGETS_OF_MUTATED_TP53_UP	48	Down	0.646703985238758	0.908694118461598
BILD_MYC_ONCOGENIC_SIGNATURE	318	Up	0.647415069840227	0.909231672855303
QI_HYPOXIA_TARGETS_OF_HIF1A_AND_FOXA2	62	Up	0.647471496080702	0.909231672855303
BIOCARTA_NFKB_PATHWAY	38	Down	0.648249303000973	0.910053404866745
INAMURA_LUNG_CANCER_SCC_DN	18	Down	0.648950683689737	0.910461969226805
BIOCARTA_INFLAM_PATHWAY	11	Down	0.649499699303107	0.910461969226805
GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP	82	Down	0.649570139218426	0.910461969226805
SPIRA_SMOKERS_LUNG_CANCER_DN	61	Up	0.649577180290576	0.910461969226805
GENTILE_UV_LOW_DOSE_DN	104	Down	0.64968494131302	0.910461969226805
THUM_SYSTOLIC_HEART_FAILURE_UP	489	Up	0.649696718514725	0.910461969226805
STARK_BRAIN_22Q11_DELETION	13	Down	0.650546605141087	0.911333776384038
HEIDENBLAD_AMPLIFIED_IN_BONE_CANCER	8	Up	0.65091857058733	0.911333776384038
KORKOLA_CORRELATED_WITH_POU5F1	38	Up	0.651001055265035	0.911333776384038
PID_MYC_REPRESS_PATHWAY	104	Up	0.651090494347191	0.911333776384038
LI_DCP2_BOUND_MRNA	105	Down	0.652230596058908	0.911930404066915
PID_CASPASE_PATHWAY	59	Up	0.652348611951686	0.911930404066915
PARK_TRETINOIN_RESPONSE	13	Up	0.652370155725382	0.911930404066915
DAZARD_RESPONSE_TO_UV_SCC_UP	173	Down	0.652456674830203	0.911930404066915
GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_UP	889	Down	0.652481957185896	0.911930404066915
MIKHAYLOVA_OXIDATIVE_STRESS_RESPONSE_VIA_VHL_UP	12	Down	0.653365978712268	0.912895854314331
KUWANO_RNA_STABILIZED_BY_NO	9	Down	0.653869554849736	0.913329324988218
PID_VEGF_VEGFR_PATHWAY	10	Down	0.655468028084739	0.914481636584504
PANGAS_TUMOR_SUPPRESSION_BY_SMAD1_AND_SMAD5_DN	204	Up	0.65574697609617	0.914481636584504
REACTOME_SOS_MEDIATED_SIGNALLING	19	Down	0.656027704416839	0.914481636584504
REACTOME_CLEAVAGE_OF_GROWING_TRANSCRIPT_IN_THE_TERMINATION_REGION_	59	Down	0.656134313015925	0.914481636584504
NIKOLSKY_MUTATED_AND_AMPLIFIED_IN_BREAST_CANCER	134	Up	0.656209300081778	0.914481636584504
ZEILSTRA_CD44_TARGETS_DN	5	Down	0.656305031051144	0.914481636584504
REACTOME_PRE_NOTCH_EXPRESSION_AND_PROCESSING	49	Down	0.656359656363957	0.914481636584504
POS_RESPONSE_TO_HISTAMINE_UP	16	Down	0.65654236418119	0.914481636584504
STARK_HYPPOCAMPUS_22Q11_DELETION_DN	21	Up	0.656594645591478	0.914481636584504
ZEMBUTSU_SENSITIVITY_TO_NIMUSTINE	19	Down	0.656630336853225	0.914481636584504
FINETTI_BREAST_CANCER_KINOME_GREEN	19	Down	0.65734004477937	0.914698563160448
HILLION_HMGA1B_TARGETS	141	Down	0.657441078321053	0.914698563160448
KYNG_RESPONSE_TO_H2O2_VIA_ERCC6_UP	83	Down	0.657504634929928	0.914698563160448
REACTOME_TRANSPORT_OF_MATURE_MRNA_DERIVED_FROM_AN_INTRONLESS_TRANSCRIPT	37	Down	0.657560609757172	0.914698563160448
DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP	388	Up	0.658880834761953	0.916251925580231
MAEKAWA_ATF2_TARGETS	23	Down	0.659065208112114	0.916251925580231
REACTOME_G2_M_CHECKPOINTS	42	Down	0.659617940606088	0.916422395538447
JI_CARCINOGENESIS_BY_KRAS_AND_STK11_DN	24	Down	0.659808189854671	0.916422395538447
REACTOME_NUCLEAR_RECEPTOR_TRANSCRIPTION_PATHWAY	34	Down	0.660471113860078	0.916422395538447
HOFMANN_MYELODYSPLASTIC_SYNDROM_HIGH_RISK_DN	27	Down	0.660543331939052	0.916422395538447
KORKOLA_CHORIOCARCINOMA_UP	12	Down	0.66055654425034	0.916422395538447
WEST_ADRENOCORTICAL_TUMOR_DN	731	Up	0.660709350025061	0.916422395538447
CHIARETTI_T_ALL_REFRACTORY_TO_THERAPY	38	Down	0.660769233142361	0.916422395538447
MCGOWAN_RSP6_TARGETS_UP	15	Up	0.660896652448509	0.916422395538447
KEGG_VALINE_LEUCINE_AND_ISOLEUCINE_DEGRADATION	71	Down	0.660972981144364	0.916422395538447
KASLER_HDAC7_TARGETS_1_DN	24	Down	0.661145746462408	0.916422395538447
FLECHNER_PBL_KIDNEY_TRANSPLANT_OK_VS_DONOR_DN	64	Down	0.661457470899028	0.916422395538447
KRIGE_RESPONSE_TO_TOSEDOSTAT_24HR_UP	972	Down	0.661680979928041	0.916422395538447
HOEGERKORP_CD44_TARGETS_DIRECT_UP	31	Down	0.66170973564387	0.916422395538447
JISON_SICKLE_CELL_DISEASE_UP	245	Down	0.662700817105793	0.917103065303801
HOLLEMAN_PREDNISOLONE_RESISTANCE_ALL_DN	12	Up	0.662738852500184	0.917103065303801
ZHU_SKIL_TARGETS_DN	10	Down	0.662783629328361	0.917103065303801
REACTOME_TRANSPORT_OF_RIBONUCLEOPROTEINS_INTO_THE_HOST_NUCLEUS	31	Down	0.663226220179974	0.917149785546736
KAYO_CALORIE_RESTRICTION_MUSCLE_DN	131	Up	0.663368450730917	0.917149785546736
GROSS_HYPOXIA_VIA_HIF1A_DN	169	Up	0.663544741954311	0.917149785546736
STEGMEIER_PRE-MITOTIC_CELL_CYCLE_REGULATORS	11	Up	0.663848351002946	0.917149785546736
HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP	79	Up	0.664004385530073	0.917149785546736
BAKER_HEMATOPOESIS_STAT5_TARGETS	10	Up	0.664093621736886	0.917149785546736
HASINA_NOL7_TARGETS_UP	13	Down	0.664220453032796	0.917149785546736
PLASARI_TGFB1_SIGNALING_VIA_NFIC_10HR_DN	37	Up	0.664370568615777	0.917149785546736
REACTOME_REGULATION_OF_ORNITHINE_DECARBOXYLASE_ODC	51	Down	0.66509376050436	0.917562549159792
WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_H2O2	54	Up	0.665104545500633	0.917562549159792
NIKOLSKY_BREAST_CANCER_20Q12_Q13_AMPLICON	137	Up	0.665342957549291	0.917562549159792
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_14	204	Up	0.665446505804709	0.917562549159792
REACTOME_PKB_MEDIATED_EVENTS	33	Up	0.665692592386205	0.91763402580462
BILD_HRAS_ONCOGENIC_SIGNATURE	391	Down	0.666203132879695	0.917639775896955
GU_PDEF_TARGETS_DN	41	Up	0.666352550097179	0.917639775896955
MISSIAGLIA_REGULATED_BY_METHYLATION_UP	172	Down	0.666439140947432	0.917639775896955
PLASARI_TGFB1_TARGETS_10HR_UP	301	Down	0.666661128993459	0.917639775896955
SMID_BREAST_CANCER_RELAPSE_IN_BONE_UP	129	Up	0.667096419355469	0.917639775896955
RUAN_RESPONSE_TO_TROGLITAZONE_DN	21	Up	0.66739991359662	0.917639775896955
BOCHKIS_FOXA2_TARGETS	526	Up	0.667689251568248	0.917639775896955
BIOCARTA_PS1_PATHWAY	23	Down	0.667942987334635	0.917639775896955
BROWNE_HCMV_INFECTION_12HR_UP	170	Up	0.668133785000323	0.917639775896955
WIERENGA_PML_INTERACTOME	78	Down	0.668195283964645	0.917639775896955
KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	24	Up	0.668279278982809	0.917639775896955
MASSARWEH_RESPONSE_TO_ESTRADIOL	76	Down	0.668329420867197	0.917639775896955
ODONNELL_METASTASIS_DN	30	Up	0.668345988136919	0.917639775896955
GRADE_COLON_VS_RECTAL_CANCER_UP	48	Up	0.668416271985907	0.917639775896955
ZWANG_EGF_INTERVAL_DN	284	Up	0.669051671710673	0.917952252488881
PID_P75_NTR_PATHWAY	85	Down	0.669191273888149	0.917952252488881
ULE_SPLICING_VIA_NOVA2	78	Down	0.669226832678177	0.917952252488881
WANG_RESPONSE_TO_ANDROGEN_UP	40	Up	0.669922851283615	0.918241550509913
CROONQUIST_IL6_DEPRIVATION_UP	28	Down	0.670017760074996	0.918241550509913
BAFNA_MUC4_TARGETS_DN	7	Up	0.670053692104138	0.918241550509913
OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_UP	106	Down	0.67021525532561	0.918241550509913
LINDSTEDT_DENDRITIC_CELL_MATURATION_A	79	Down	0.670758972668772	0.918643853687579
FARMER_BREAST_CANCER_APOCRINE_VS_LUMINAL	439	Down	0.670987735040996	0.918643853687579
TCGA_GLIOBLASTOMA_COPY_NUMBER_DN	34	Down	0.671431948580008	0.918643853687579
LI_ADIPOGENESIS_BY_ACTIVATED_PPARG	17	Up	0.671457884882631	0.918643853687579
AGUIRRE_PANCREATIC_CANCER_COPY_NUMBER_UP	419	Down	0.671563376430984	0.918643853687579
LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP	98	Down	0.671675671176312	0.918643853687579
BREDEMEYER_RAG_SIGNALING_NOT_VIA_ATM_UP	69	Up	0.67220845792398	0.919106441456695
DARWICHE_PAPILLOMA_RISK_HIGH_VS_LOW_UP	9	Up	0.67317691406797	0.919955502280359
SENGUPTA_EBNA1_ANTICORRELATED	194	Down	0.673296933774392	0.919955502280359
FONTAINE_FOLLICULAR_THYROID_ADENOMA_DN	88	Up	0.673413659374573	0.919955502280359
AMUNDSON_POOR_SURVIVAL_AFTER_GAMMA_RADIATION_8G	131	Down	0.674102800031157	0.920068363421571
KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_GAMMA_IN_WS	40	Down	0.674184694782193	0.920068363421571
PID_P38_MKK3_6PATHWAY	34	Up	0.674252196760116	0.920068363421571
KYNG_RESPONSE_TO_H2O2	94	Down	0.674463600434656	0.920068363421571
DASU_IL6_SIGNALING_DN	24	Down	0.674538724169458	0.920068363421571
GOUYER_TATI_TARGETS_DN	15	Up	0.674664862593633	0.920068363421571
KORKOLA_EMBRYONAL_CARCINOMA	13	Down	0.675272330158579	0.920550496994501
BROWNE_HCMV_INFECTION_12HR_DN	176	Down	0.675517420594759	0.920550496994501
SYED_ESTRADIOL_RESPONSE	38	Down	0.675603000228606	0.920550496994501
ELVIDGE_HIF1A_TARGETS_DN	119	Up	0.675930018927903	0.920698872976839
CHANDRAN_METASTASIS_TOP50_UP	56	Down	0.67610169143875	0.920698872976839
BROWNE_HCMV_INFECTION_8HR_UP	168	Up	0.676635371096136	0.920949592430129
GALINDO_IMMUNE_RESPONSE_TO_ENTEROTOXIN	118	Down	0.676862471557678	0.920949592430129
MCBRYAN_TERMINAL_END_BUD_UP	14	Down	0.67728342112464	0.920949592430129
BURTON_ADIPOGENESIS_PEAK_AT_0HR	128	Up	0.677356752315045	0.920949592430129
HOFMANN_MYELODYSPLASTIC_SYNDROM_LOW_RISK_UP	33	Down	0.677421240142219	0.920949592430129
KRIGE_RESPONSE_TO_TOSEDOSTAT_6HR_UP	1230	Down	0.677676376975723	0.920949592430129
NAKAMURA_METASTASIS_MODEL_DN	53	Down	0.677915540036306	0.920949592430129
MULLIGHAN_NPM1_MUTATED_SIGNATURE_2_DN	91	Down	0.678033143923551	0.920949592430129
KYNG_DNA_DAMAGE_DN	280	Down	0.678176466929772	0.920949592430129
REACTOME_ROLE_OF_SECOND_MESSENGERS_IN_NETRIN1_SIGNALING	6	Up	0.678429323223546	0.920949592430129
REACTOME_NUCLEOTIDE_LIKE_PURINERGIC_RECEPTORS	8	Up	0.678657690975249	0.920949592430129
PID_RANBP2_PATHWAY	17	Down	0.679050952914616	0.920949592430129
REACTOME_FGFR1_LIGAND_BINDING_AND_ACTIVATION	8	Up	0.679113681070837	0.920949592430129
NADELLA_PRKAR1A_TARGETS_DN	18	Up	0.679505402389822	0.920949592430129
BROWNE_HCMV_INFECTION_24HR_UP	210	Down	0.679652875443296	0.920949592430129
BASSO_HAIRY_CELL_LEUKEMIA_DN	99	Down	0.679757548149771	0.920949592430129
DORN_ADENOVIRUS_INFECTION_12HR_DN	59	Down	0.679815520990896	0.920949592430129
REACTOME_HIV_LIFE_CYCLE	124	Down	0.679976596590984	0.920949592430129
KANNAN_TP53_TARGETS_UP	80	Down	0.679989876883211	0.920949592430129
BIOCARTA_UCALPAIN_PATHWAY	33	Down	0.680414012911715	0.92125990168958
LU_EZH2_TARGETS_DN	573	Up	0.681453903222061	0.922403506825507
DER_IFN_GAMMA_RESPONSE_UP	124	Down	0.682078892249148	0.922985014891142
INGRAM_SHH_TARGETS_DN	98	Up	0.682650780560383	0.923048209045929
MILI_PSEUDOPODIA_CHEMOTAXIS_DN	694	Down	0.682862192603921	0.923048209045929
KRIGE_RESPONSE_TO_TOSEDOSTAT_24HR_DN	1268	Down	0.683202299067434	0.923048209045929
CHEBOTAEV_GR_TARGETS_DN	183	Up	0.68333174333727	0.923048209045929
HOFMANN_MYELODYSPLASTIC_SYNDROM_HIGH_RISK_UP	16	Down	0.683347444065702	0.923048209045929
KYNG_NORMAL_AGING_DN	41	Down	0.683409984466342	0.923048209045929
STARK_HYPPOCAMPUS_22Q11_DELETION_UP	77	Up	0.683685408760744	0.923048209045929
REACTOME_METABOLISM_OF_STEROID_HORMONES_AND_VITAMINS_A_AND_D	27	Down	0.684230455655284	0.923048209045929
TSENG_IRS1_TARGETS_DN	197	Up	0.684422460426345	0.923048209045929
RAMJAUN_APOPTOSIS_BY_TGFB1_VIA_MAPK1_UP	11	Up	0.684802322416314	0.923048209045929
WAMUNYOKOLI_OVARIAN_CANCER_LMP_DN	290	Up	0.685017096730258	0.923048209045929
MARTINEZ_RB1_AND_TP53_TARGETS_UP	769	Down	0.685137416226507	0.923048209045929
WALLACE_PROSTATE_CANCER_RACE_UP	266	Down	0.685147798015541	0.923048209045929
BIOCARTA_CCR5_PATHWAY	19	Up	0.685195176302965	0.923048209045929
LI_LUNG_CANCER	68	Down	0.685649214271237	0.923048209045929
ZEMBUTSU_SENSITIVITY_TO_CISPLATIN	19	Up	0.686134257879967	0.923048209045929
HEDENFALK_BREAST_CANCER_BRACX_UP	27	Down	0.686334751336313	0.923048209045929
PETROVA_PROX1_TARGETS_DN	88	Down	0.686367521096272	0.923048209045929
MATZUK_CENTRAL_FOR_FEMALE_FERTILITY	25	Down	0.686704174047126	0.923048209045929
NEBEN_AML_WITH_FLT3_OR_NRAS_UP	8	Up	0.686714618172678	0.923048209045929
WEST_ADRENOCORTICAL_CARCINOMA_VS_ADENOMA_UP	24	Up	0.687021804805487	0.923048209045929
REACTOME_NRAGE_SIGNALS_DEATH_THROUGH_JNK	52	Down	0.687064817956504	0.923048209045929
RANKIN_ANGIOGENIC_TARGETS_OF_VHL_HIF2A_DN	19	Down	0.687984556176231	0.923048209045929
SESTO_RESPONSE_TO_UV_C2	94	Up	0.688123732249278	0.923048209045929
LEE_LIVER_CANCER_E2F1_DN	59	Up	0.688193136185517	0.923048209045929
REACTOME_PI3K_CASCADE	63	Up	0.688210994125834	0.923048209045929
REACTOME_FGFR_LIGAND_BINDING_AND_ACTIVATION	11	Up	0.688326768086411	0.923048209045929
CHIANG_LIVER_CANCER_SUBCLASS_POLYSOMY7_DN	41	Up	0.688494019428236	0.923048209045929
GROSS_HIF1A_TARGETS_DN	43	Down	0.688592792017741	0.923048209045929
JOSEPH_RESPONSE_TO_SODIUM_BUTYRATE_DN	85	Down	0.688631218170072	0.923048209045929
HEDENFALK_BREAST_CANCER_HEREDITARY_VS_SPORADIC	77	Down	0.688680266756687	0.923048209045929
REACTOME_ASSOCIATION_OF_TRIC_CCT_WITH_TARGET_PROTEINS_DURING_BIOSYNTHESIS	34	Down	0.689305205733253	0.923048209045929
TOMIDA_LUNG_CANCER_POOR_SURVIVAL	3	Up	0.689462271947943	0.923048209045929
WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_WITH_H4K20ME1_MARK	249	Down	0.689676057766424	0.923048209045929
KEGG_PROTEASOME	45	Up	0.689741619267501	0.923048209045929
VANTVEER_BREAST_CANCER_ESR1_DN	318	Down	0.690032685318726	0.923048209045929
MATZUK_SPERMATOGONIA	20	Down	0.690057424827781	0.923048209045929
TIAN_TNF_SIGNALING_NOT_VIA_NFKB	43	Down	0.690309847919742	0.923048209045929
GALIE_TUMOR_STEMNESS_GENES	9	Up	0.690411406476241	0.923048209045929
REACTOME_TAK1_ACTIVATES_NFKB_BY_PHOSPHORYLATION_AND_ACTIVATION_OF_IKKS_COMPLEX	24	Up	0.690581480289756	0.923048209045929
ST_B_CELL_ANTIGEN_RECEPTOR	56	Down	0.690590795649393	0.923048209045929
REACTOME_REGULATION_OF_IFNG_SIGNALING	17	Down	0.690754312325508	0.923048209045929
BIOCARTA_IL1R_PATHWAY	33	Up	0.690758698962388	0.923048209045929
KEGG_GLYCOSPHINGOLIPID_BIOSYNTHESIS_LACTO_AND_NEOLACTO_SERIES	17	Down	0.690867854339217	0.923048209045929
JAERVINEN_AMPLIFIED_IN_LARYNGEAL_CANCER	59	Down	0.690929511865881	0.923048209045929
PID_PDGFRB_PATHWAY	177	Down	0.691113783953313	0.923048209045929
REACTOME_MRNA_SPLICING_MINOR_PATHWAY	51	Up	0.691856718474973	0.92356814684367
REACTOME_RNA_POL_II_TRANSCRIPTION	121	Down	0.691897152096205	0.92356814684367
REACTOME_REGULATION_OF_INSULIN_SECRETION	91	Up	0.692118670924048	0.92356814684367
GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP	102	Down	0.692285099062962	0.92356814684367
REACTOME_HORMONE_LIGAND_BINDING_RECEPTORS	2	Up	0.692582318690182	0.923703803922196
MCDOWELL_ACUTE_LUNG_INJURY_DN	48	Down	0.693026489264215	0.924035319018953
PID_IL6_7_PATHWAY	63	Down	0.6936002276505	0.924219438144573
NAGASHIMA_EGF_SIGNALING_UP	81	Down	0.693639176860238	0.924219438144573
MARTORIATI_MDM4_TARGETS_NEUROEPITHELIUM_UP	229	Up	0.693830969746058	0.924219438144573
FAELT_B_CLL_WITH_VH3_21_UP	78	Down	0.69412661972298	0.924219438144573
BRUNEAU_HEART_GREAT_VESSELS_AND_VALVULOGENESIS	11	Down	0.694142795625941	0.924219438144573
RUIZ_TNC_TARGETS_UP	244	Up	0.694512459792183	0.92424710316455
DACOSTA_LOW_DOSE_UV_RESPONSE_VIA_ERCC3_XPCS_UP	15	Down	0.694554872191819	0.92424710316455
KEGG_ARACHIDONIC_ACID_METABOLISM	36	Up	0.694850800660619	0.924380507553017
SHARMA_PILOCYTIC_ASTROCYTOMA_LOCATION_DN	8	Up	0.695384875662743	0.924830560988401
TURASHVILI_BREAST_NORMAL_DUCTAL_VS_LOBULAR_UP	102	Down	0.6956788960903	0.924903223263951
FUJIWARA_PARK2_IN_LIVER_CANCER_UP	8	Down	0.695831087104167	0.924903223263951
HOLLEMAN_PREDNISOLONE_RESISTANCE_B_ALL_DN	15	Down	0.697001708746542	0.925805602152502
ALTEMEIER_RESPONSE_TO_LPS_WITH_MECHANICAL_VENTILATION	135	Up	0.69709173622099	0.925805602152502
KEGG_OXIDATIVE_PHOSPHORYLATION	108	Up	0.697260373785213	0.925805602152502
SABATES_COLORECTAL_ADENOMA_UP	121	Up	0.697431686778011	0.925805602152502
WATANABE_COLON_CANCER_MSI_VS_MSS_UP	42	Up	0.697489868344783	0.925805602152502
LINDGREN_BLADDER_CANCER_CLUSTER_2B	497	Up	0.697921227760014	0.926117943802895
ZHOU_PANCREATIC_BETA_CELL	2	Up	0.698159364950764	0.926173782653021
SHEN_SMARCA2_TARGETS_DN	289	Up	0.699246673190736	0.926176048743095
SEKI_INFLAMMATORY_RESPONSE_LPS_DN	24	Down	0.699465029346013	0.926176048743095
KEGG_MTOR_SIGNALING_PATHWAY	51	Down	0.699579210163605	0.926176048743095
REACTOME_PURINE_RIBONUCLEOSIDE_MONOPHOSPHATE_BIOSYNTHESIS	15	Down	0.699766114755634	0.926176048743095
REACTOME_HS_GAG_BIOSYNTHESIS	24	Down	0.699924102721436	0.926176048743095
CHUANG_OXIDATIVE_STRESS_RESPONSE_UP	40	Up	0.699995791857771	0.926176048743095
LIU_CDX2_TARGETS_UP	34	Up	0.700222018365496	0.926176048743095
RAY_TUMORIGENESIS_BY_ERBB2_CDC25A_UP	128	Down	0.700256706816718	0.926176048743095
SUZUKI_CTCFL_TARGETS_UP	12	Down	0.700311929710761	0.926176048743095
REACTOME_REGULATION_OF_MRNA_STABILITY_BY_PROTEINS_THAT_BIND_AU_RICH_ELEMENTS	100	Down	0.700606932370489	0.926176048743095
PROVENZANI_METASTASIS_UP	269	Down	0.700783187965378	0.926176048743095
SUBTIL_PROGESTIN_TARGETS	70	Up	0.700981469384569	0.926176048743095
WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_DN	197	Down	0.701064134263038	0.926176048743095
BYSTRYKH_HEMATOPOIESIS_STEM_CELL_SCP2_QTL_TRANS	42	Up	0.70121192514196	0.926176048743095
WANG_BARRETTS_ESOPHAGUS_UP	71	Down	0.701231653111888	0.926176048743095
REACTOME_G_ALPHA_I_SIGNALLING_EVENTS	79	Down	0.701375918001278	0.926176048743095
GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_UP	1573	Down	0.701494052159779	0.926176048743095
REACTOME_INHIBITION_OF_INSULIN_SECRETION_BY_ADRENALINE_NORADRENALINE	26	Down	0.70202523333046	0.926502513522829
WEI_MYCN_TARGETS_WITH_E_BOX	1007	Down	0.702455671886487	0.926502513522829
PID_ATF2_PATHWAY	86	Up	0.702501323312662	0.926502513522829
REACTOME_DNA_REPAIR	113	Down	0.702525826299486	0.926502513522829
PHONG_TNF_RESPONSE_NOT_VIA_P38	511	Up	0.702743735949598	0.926531233219621
NIKOLSKY_BREAST_CANCER_19Q13.1_AMPLICON	70	Down	0.703721948681826	0.927562077447808
LY_AGING_MIDDLE_UP	15	Down	0.704115566741739	0.927822018769309
DER_IFN_ALPHA_RESPONSE_UP	134	Down	0.704451653437129	0.928006026446458
KUMAR_AUTOPHAGY_NETWORK	99	Down	0.704860334543808	0.92828553676748
BROWNE_HCMV_INFECTION_48HR_DN	693	Down	0.705263801774124	0.928558026639064
REACTOME_FORMATION_OF_THE_HIV1_EARLY_ELONGATION_COMPLEX	33	Up	0.705839248316187	0.92860374645184
FUJII_YBX1_TARGETS_UP	71	Down	0.705915733763419	0.92860374645184
CASTELLANO_HRAS_AND_NRAS_TARGETS_UP	6	Down	0.705938841581778	0.92860374645184
MIKKELSEN_PLURIPOTENT_STATE_DN	15	Down	0.706084813136116	0.92860374645184
VANTVEER_BREAST_CANCER_BRCA1_DN	57	Down	0.706407856366987	0.928700881389773
REACTOME_FANCONI_ANEMIA_PATHWAY	23	Down	0.706810450358653	0.928700881389773
SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP	493	Up	0.707196122139696	0.928700881389773
CADWELL_ATG16L1_TARGETS_DN	117	Up	0.707264104491261	0.928700881389773
DASU_IL6_SIGNALING_SCAR_DN	38	Down	0.707430213881317	0.928700881389773
DAVICIONI_PAX_FOXO1_SIGNATURE_IN_ARMS_UP	87	Up	0.707620984856321	0.928700881389773
REACTOME_AUTODEGRADATION_OF_THE_E3_UBIQUITIN_LIGASE_COP1	52	Up	0.707713832581982	0.928700881389773
REACTOME_MAPK_TARGETS_NUCLEAR_EVENTS_MEDIATED_BY_MAP_KINASES	53	Down	0.708024320815029	0.928700881389773
ACEVEDO_METHYLATED_IN_LIVER_CANCER_DN	794	Up	0.708109102821511	0.928700881389773
MCCABE_BOUND_BY_HOXC6	504	Down	0.708283531589958	0.928700881389773
VANLOO_SP3_TARGETS_DN	102	Down	0.708440980538564	0.928700881389773
CHANG_CORE_SERUM_RESPONSE_DN	292	Down	0.708565769212459	0.928700881389773
TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_TOP20_UP	17	Up	0.708714368630426	0.928700881389773
MARTORIATI_MDM4_TARGETS_FETAL_LIVER_DN	745	Down	0.709097347467927	0.9289450553074
DOUGLAS_BMI1_TARGETS_UP	796	Down	0.710066952311446	0.929957383620535
VANTVEER_BREAST_CANCER_ESR1_UP	228	Up	0.710317760764755	0.9300280215778
REACTOME_NFKB_AND_MAP_KINASES_ACTIVATION_MEDIATED_BY_TLR4_SIGNALING_REPERTOIRE	110	Down	0.710795666578365	0.930395879444775
CLIMENT_BREAST_CANCER_COPY_NUMBER_UP	30	Down	0.711742524345425	0.931377198063099
GOBERT_CORE_OLIGODENDROCYTE_DIFFERENTIATION	51	Up	0.712453259383808	0.931491812364907
DING_LUNG_CANCER_MUTATED_RECURRENTLY	10	Down	0.71264538313351	0.931491812364907
REACTOME_CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION	271	Up	0.712743869352491	0.931491812364907
CHEBOTAEV_GR_TARGETS_UP	111	Up	0.712953283092273	0.931491812364907
RUAN_RESPONSE_TO_TROGLITAZONE_UP	40	Down	0.712970586206976	0.931491812364907
LEIN_CHOROID_PLEXUS_MARKERS	136	Up	0.713078460213481	0.931491812364907
REACTOME_CASPASE_MEDIATED_CLEAVAGE_OF_CYTOSKELETAL_PROTEINS	17	Down	0.713210390627407	0.931491812364907
IVANOVA_HEMATOPOIESIS_INTERMEDIATE_PROGENITOR	175	Down	0.713949286301851	0.932103435367118
LU_TUMOR_VASCULATURE_DN	14	Down	0.714073313419475	0.932103435367118
DAUER_STAT3_TARGETS_DN	74	Up	0.715425474757933	0.932930313648117
BIOCARTA_PML_PATHWAY	21	Up	0.715445680122828	0.932930313648117
PID_ERB_GENOMIC_PATHWAY	35	Up	0.715489245183101	0.932930313648117
CHIARETTI_ACUTE_LYMPHOBLASTIC_LEUKEMIA_ZAP70	68	Up	0.715496724459595	0.932930313648117
REACTOME_ERKS_ARE_INACTIVATED	32	Down	0.715845082317292	0.933126978164152
NIKOLSKY_BREAST_CANCER_16P13_AMPLICON	128	Up	0.716622751686679	0.933883001094586
MCBRYAN_PUBERTAL_BREAST_6_7WK_UP	300	Down	0.717000659135513	0.934094775820951
WANG_THOC1_TARGETS_DN	18	Up	0.717180726482343	0.934094775820951
AMIT_EGF_RESPONSE_40_HELA	62	Down	0.717571671624595	0.934155840452867
LANDIS_ERBB2_BREAST_TUMORS_65_UP	43	Down	0.717623104361443	0.934155840452867
WANG_RESPONSE_TO_FORSKOLIN_DN	14	Down	0.718357621537431	0.934854381306563
CAFFAREL_RESPONSE_TO_THC_24HR_3_DN	22	Down	0.718925767608921	0.935336085426753
CHIANG_LIVER_CANCER_SUBCLASS_UNANNOTATED_UP	158	Up	0.719314299895632	0.935583907683636
KEGG_GLYCOSAMINOGLYCAN_BIOSYNTHESIS_CHONDROITIN_SULFATE	20	Down	0.719915674185596	0.936047470498444
SHAFFER_IRF4_MULTIPLE_MYELOMA_PROGRAM	66	Down	0.720066999955831	0.936047470498444
LEE_CALORIE_RESTRICTION_NEOCORTEX_DN	159	Up	0.721073916032406	0.936974051805491
ZHU_CMV_8_HR_DN	72	Down	0.721657503081922	0.936974051805491
REACTOME_SIGNALING_BY_WNT	72	Up	0.721960825512005	0.936974051805491
PID_AP1_PATHWAY	124	Up	0.721972749258796	0.936974051805491
ELVIDGE_HYPOXIA_UP	227	Up	0.722329608036782	0.936974051805491
KUROZUMI_RESPONSE_TO_ONCOCYTIC_VIRUS	20	Down	0.722442152975147	0.936974051805491
REACTOME_SEMA4D_INDUCED_CELL_MIGRATION_AND_GROWTH_CONE_COLLAPSE	36	Down	0.722729296618619	0.936974051805491
BHATI_G2M_ARREST_BY_2METHOXYESTRADIOL_DN	184	Down	0.722762272944546	0.936974051805491
PID_AVB3_INTEGRIN_PATHWAY	103	Up	0.722793288641119	0.936974051805491
RIZKI_TUMOR_INVASIVENESS_3D_UP	304	Up	0.723174131801393	0.936974051805491
DORSAM_HOXA9_TARGETS_DN	39	Up	0.72383242025626	0.936974051805491
SIG_REGULATION_OF_THE_ACTIN_CYTOSKELETON_BY_RHO_GTPASES	44	Down	0.723833517384505	0.936974051805491
PURBEY_TARGETS_OF_CTBP1_NOT_SATB1_UP	496	Up	0.724118407112517	0.936974051805491
HOLLMANN_APOPTOSIS_VIA_CD40_DN	411	Down	0.724303152069972	0.936974051805491
KUROKAWA_LIVER_CANCER_CHEMOTHERAPY_DN	53	Down	0.724621848066593	0.936974051805491
BERENJENO_TRANSFORMED_BY_RHOA_REVERSIBLY_UP	10	Down	0.724685180235093	0.936974051805491
WANG_CISPLATIN_RESPONSE_AND_XPC_UP	246	Down	0.724889040327729	0.936974051805491
PECE_MAMMARY_STEM_CELL_UP	211	Down	0.725041936892237	0.936974051805491
CROONQUIST_NRAS_VS_STROMAL_STIMULATION_UP	58	Down	0.725063071562014	0.936974051805491
LANDIS_ERBB2_BREAST_PRENEOPLASTIC_UP	21	Down	0.725190428961918	0.936974051805491
HOSHIDA_LIVER_CANCER_SUBCLASS_S3	346	Up	0.725351511141956	0.936974051805491
GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_UP	96	Down	0.725422695981057	0.936974051805491
MAGRANGEAS_MULTIPLE_MYELOMA_IGG_VS_IGA_DN	30	Up	0.725508301380098	0.936974051805491
KRIGE_RESPONSE_TO_TOSEDOSTAT_6HR_DN	1119	Down	0.725540025720679	0.936974051805491
BILANGES_SERUM_SENSITIVE_VIA_TSC1	38	Down	0.726017545665894	0.937334486396743
RIZKI_TUMOR_INVASIVENESS_2D_DN	71	Down	0.726341618244986	0.937476864378273
CHYLA_CBFA2T3_TARGETS_DN	313	Down	0.726524724912967	0.937476864378273
REACTOME_CELL_DEATH_SIGNALLING_VIA_NRAGE_NRIF_AND_NADE	71	Down	0.727428739623545	0.937544496810768
REACTOME_METABOLISM_OF_VITAMINS_AND_COFACTORS	53	Down	0.72799552710103	0.937544496810768
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_7	105	Down	0.728027262157289	0.937544496810768
TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_UP	101	Down	0.728439746103827	0.937544496810768
KEGG_ALPHA_LINOLENIC_ACID_METABOLISM	16	Up	0.728582369689364	0.937544496810768
AZARE_NEOPLASTIC_TRANSFORMATION_BY_STAT3_DN	22	Up	0.728616014931531	0.937544496810768
LAU_APOPTOSIS_CDKN2A_DN	7	Down	0.728792679626747	0.937544496810768
BIOCARTA_D4GDI_PATHWAY	14	Down	0.729042806526237	0.937544496810768
SERVITJA_LIVER_HNF1A_TARGETS_UP	161	Down	0.729053173557609	0.937544496810768
HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN	368	Down	0.729143009885099	0.937544496810768
HESS_TARGETS_OF_HOXA9_AND_MEIS1_DN	115	Down	0.729161055038137	0.937544496810768
TIEN_INTESTINE_PROBIOTICS_6HR_DN	225	Up	0.729194830820247	0.937544496810768
BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN	863	Down	0.729413335697436	0.937544496810768
VERHAAK_AML_WITH_NPM1_MUTATED_UP	218	Down	0.729525245932104	0.937544496810768
REACTOME_CDK_MEDIATED_PHOSPHORYLATION_AND_REMOVAL_OF_CDC6	53	Up	0.729554100397202	0.937544496810768
RADMACHER_AML_PROGNOSIS	130	Up	0.730675493873162	0.938730223839222
CLAUS_PGR_POSITIVE_MENINGIOMA_UP	12	Down	0.73117626936754	0.939110961751921
REACTOME_CIRCADIAN_CLOCK	63	Down	0.731411194074161	0.939110961751921
REACTOME_DCC_MEDIATED_ATTRACTIVE_SIGNALING	18	Down	0.73156823438761	0.939110961751921
KEGG_PYRIMIDINE_METABOLISM	96	Up	0.73251466406977	0.939839704941984
WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_8D	1195	Down	0.73253382590948	0.939839704941984
LEIN_CEREBELLUM_MARKERS	105	Up	0.733003452595934	0.939849353913346
MOLENAAR_TARGETS_OF_CCND1_AND_CDK4_UP	95	Down	0.733056801368182	0.939849353913346
ODONNELL_TFRC_TARGETS_UP	562	Up	0.733138202618688	0.939849353913346
KEGG_HOMOLOGOUS_RECOMBINATION	27	Up	0.733553500151906	0.940126623634728
REACTOME_BINDING_AND_ENTRY_OF_HIV_VIRION	4	Down	0.733941053511109	0.940236058608147
REACTOME_HEPARAN_SULFATE_HEPARIN_HS_GAG_METABOLISM	52	Down	0.734308776876952	0.940236058608147
PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_DN	65	Up	0.734423686221445	0.940236058608147
PID_RHODOPSIN_PATHWAY	15	Up	0.73443502461136	0.940236058608147
BYSTRYKH_HEMATOPOIESIS_STEM_CELL_QTL_TRANS	1095	Down	0.734641709236264	0.940245850564105
DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_UP	135	Up	0.735106731479831	0.940448798784893
ZHANG_GATA6_TARGETS_DN	143	Down	0.735490534446794	0.940448798784893
WESTON_VEGFA_TARGETS_3HR	83	Down	0.735529897535321	0.940448798784893
BURTON_ADIPOGENESIS_2	126	Up	0.735596594307828	0.940448798784893
IIZUKA_LIVER_CANCER_PROGRESSION_L1_G1_DN	13	Up	0.736083716567677	0.940816958080549
REACTOME_CYTOSOLIC_SULFONATION_OF_SMALL_MOLECULES	4	Down	0.736749171327068	0.940962048201442
SANSOM_APC_MYC_TARGETS	272	Down	0.736795678340934	0.940962048201442
IKEDA_MIR30_TARGETS_DN	38	Down	0.736971883192113	0.940962048201442
CHANG_IMMORTALIZED_BY_HPV31_UP	97	Up	0.736993983561671	0.940962048201442
REACTOME_TRANSCRIPTION	199	Down	0.738048214934348	0.941559869734265
SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1	510	Up	0.738079227631871	0.941559869734265
YANG_BREAST_CANCER_ESR1_LASER_DN	63	Down	0.738266298839041	0.941559869734265
JI_RESPONSE_TO_FSH_UP	144	Down	0.738363202515888	0.941559869734265
BROWNE_HCMV_INFECTION_2HR_DN	98	Down	0.738458788604033	0.941559869734265
MARTINEZ_RB1_TARGETS_UP	892	Down	0.739794318900474	0.942914899535614
DACOSTA_UV_RESPONSE_VIA_ERCC3_UP	470	Down	0.740302083904783	0.942914899535614
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_UP	218	Up	0.741047846517048	0.942914899535614
REACTOME_ION_CHANNEL_TRANSPORT	30	Down	0.74106911092167	0.942914899535614
MARIADASON_RESPONSE_TO_CURCUMIN_SULINDAC_5	41	Down	0.741242723833413	0.942914899535614
DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP	445	Down	0.741358033838458	0.942914899535614
MAHAJAN_RESPONSE_TO_IL1A_DN	159	Up	0.741362451484311	0.942914899535614
KEGG_ALZHEIMERS_DISEASE	163	Down	0.741710519013906	0.942914899535614
PASQUALUCCI_LYMPHOMA_BY_GC_STAGE_DN	226	Down	0.741828925877095	0.942914899535614
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_LIGHTYELLOW_DN	10	Down	0.742423403998367	0.942914899535614
DARWICHE_PAPILLOMA_RISK_HIGH_UP	158	Down	0.742534557985133	0.942914899535614
CAFFAREL_RESPONSE_TO_THC_UP	47	Up	0.742801896140546	0.942914899535614
BUDHU_LIVER_CANCER_METASTASIS_UP	4	Down	0.742816248728278	0.942914899535614
REACTOME_SEMA4D_IN_SEMAPHORIN_SIGNALING	41	Down	0.742962155677108	0.942914899535614
REACTOME_ACETYLCHOLINE_BINDING_AND_DOWNSTREAM_EVENTS	1	Down	0.743192706243797	0.942914899535614
REACTOME_HIGHLY_CALCIUM_PERMEABLE_POSTSYNAPTIC_NICOTINIC_ACETYLCHOLINE_RECEPTORS	1	Down	0.743192706243797	0.942914899535614
REACTOME_PRESYNAPTIC_NICOTINIC_ACETYLCHOLINE_RECEPTORS	1	Down	0.743192706243797	0.942914899535614
PURBEY_TARGETS_OF_CTBP1_AND_SATB1_UP	154	Up	0.74328742656319	0.942914899535614
KONDO_EZH2_TARGETS	300	Up	0.743589576774254	0.942914899535614
POOLA_INVASIVE_BREAST_CANCER_UP	272	Up	0.743964267116474	0.942914899535614
TERAO_AOX4_TARGETS_SKIN_UP	57	Up	0.744168761759013	0.942914899535614
LANG_MYB_FAMILY_TARGETS	47	Down	0.744190267390784	0.942914899535614
WONG_MITOCHONDRIA_GENE_MODULE	316	Down	0.744197652485066	0.942914899535614
REACTOME_MITOCHONDRIAL_PROTEIN_IMPORT	58	Down	0.744596386352151	0.942914899535614
REACTOME_LIGAND_GATED_ION_CHANNEL_TRANSPORT	6	Up	0.744691346384302	0.942914899535614
SHIRAISHI_PLZF_TARGETS_UP	11	Up	0.74471115371875	0.942914899535614
GENTILE_UV_LOW_DOSE_UP	40	Up	0.745280058920985	0.943148130960554
HESSON_TUMOR_SUPPRESSOR_CLUSTER_3P21_3	7	Up	0.745315433320454	0.943148130960554
WU_HBX_TARGETS_2_UP	37	Up	0.745716487258791	0.943148130960554
KEGG_MISMATCH_REPAIR	23	Down	0.745745185293438	0.943148130960554
REACTOME_MAP_KINASE_ACTIVATION_IN_TLR_CASCADE	74	Down	0.746186006157375	0.943148130960554
LEE_DIFFERENTIATING_T_LYMPHOCYTE	271	Down	0.746249344449775	0.943148130960554
MAHADEVAN_GIST_MORPHOLOGICAL_SWITCH	23	Down	0.746292911416289	0.943148130960554
KEGG_SPLICEOSOME	172	Down	0.747207887389797	0.943760858750628
KEGG_GLYCOSAMINOGLYCAN_BIOSYNTHESIS_KERATAN_SULFATE	14	Down	0.747252168410249	0.943760858750628
IM_SREBF1A_TARGETS	7	Down	0.747377089878514	0.943760858750628
BIOCARTA_TOB1_PATHWAY	13	Down	0.747886263376237	0.944151445267061
KOHOUTEK_CCNT1_TARGETS	71	Down	0.748116976005269	0.944190380616856
CHANG_IMMORTALIZED_BY_HPV31_DN	72	Up	0.7484921189848	0.944411530471206
SU_PLACENTA	26	Up	0.748845892085637	0.944461067097825
RODRIGUES_DCC_TARGETS_DN	204	Down	0.748931235679181	0.944461067097825
PID_P38_ALPHA_BETA_DOWNSTREAM_PATHWAY	50	Up	0.749422814203779	0.944828762823232
HILLION_HMGA1_TARGETS	113	Down	0.749693455680667	0.944917792058557
NABA_PROTEOGLYCANS	19	Down	0.749915980831585	0.94494614389128
LOPEZ_MBD_TARGETS_IMPRINTED_AND_X_LINKED	24	Up	0.751337064846102	0.945956471852373
WU_SILENCED_BY_METHYLATION_IN_BLADDER_CANCER	70	Up	0.751338841885208	0.945956471852373
REACTOME_GPVI_MEDIATED_ACTIVATION_CASCADE	61	Down	0.751504920193319	0.945956471852373
TIAN_TNF_SIGNALING_VIA_NFKB	26	Down	0.751554566686394	0.945956471852373
BENPORATH_OCT4_TARGETS	421	Down	0.751961305258259	0.945956471852373
RIGGINS_TAMOXIFEN_RESISTANCE_DN	305	Up	0.752324227086278	0.945956471852373
KIM_GLIS2_TARGETS_UP	132	Down	0.752329066719704	0.945956471852373
RHODES_CANCER_META_SIGNATURE	137	Down	0.752564633011533	0.945956471852373
MCCLUNG_COCAINE_REWARD_5D	116	Up	0.752684284055711	0.945956471852373
MARKEY_RB1_ACUTE_LOF_UP	276	Down	0.752720232365172	0.945956471852373
CAFFAREL_RESPONSE_TO_THC_8HR_3_DN	25	Up	0.753136724214758	0.946023637608543
SUZUKI_AMPLIFIED_IN_ORAL_CANCER	15	Down	0.753174195818317	0.946023637608543
VERHAAK_AML_WITH_NPM1_MUTATED_DN	281	Up	0.753490160325396	0.946168930722267
PID_FANCONI_PATHWAY	48	Down	0.753699533041853	0.946180333268592
KANG_FLUOROURACIL_RESISTANCE_UP	34	Up	0.754072129729987	0.946396583646244
WIEMANN_TELOMERE_SHORTENING_AND_CHRONIC_LIVER_DAMAGE_UP	19	Down	0.754525685323219	0.946714299459997
SA_G1_AND_S_PHASES	19	Down	0.754938494718656	0.946903523796281
VANHARANTA_UTERINE_FIBROID_UP	81	Up	0.755087070927625	0.946903523796281
LIN_MELANOMA_COPY_NUMBER_DN	57	Up	0.755277831851055	0.946903523796281
MOREIRA_RESPONSE_TO_TSA_UP	48	Up	0.755665310274385	0.946935549683394
LEE_METASTASIS_AND_RNA_PROCESSING_UP	30	Down	0.755788023081984	0.946935549683394
PID_ARF6_DOWNSTREAM_PATHWAY	28	Down	0.756260114330602	0.946935549683394
BIOCARTA_AGR_PATHWAY	47	Up	0.756271175617918	0.946935549683394
VANASSE_BCL2_TARGETS_DN	106	Down	0.756416417586983	0.946935549683394
YAMASHITA_LIVER_CANCER_STEM_CELL_DN	67	Down	0.756506089014634	0.946935549683394
KEGG_OTHER_GLYCAN_DEGRADATION	17	Down	0.756884757006005	0.947087531620266
YAGI_AML_WITH_T_8_21_TRANSLOCATION	554	Down	0.757028475740501	0.947087531620266
MOREIRA_RESPONSE_TO_TSA_DN	23	Up	0.757393722154593	0.947120604118373
REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS	97	Up	0.757455893810164	0.947120604118373
KORKOLA_TERATOMA_UP	20	Up	0.757910131592208	0.947437804086158
CUI_TCF21_TARGETS_DN	69	Up	0.758392279030706	0.947505180825313
REACTOME_PROCESSING_OF_CAPPED_INTRONLESS_PRE_MRNA	30	Down	0.758505957450879	0.947505180825313
BIOCARTA_CYTOKINE_PATHWAY	5	Up	0.758565748069715	0.947505180825313
PID_ARF6_TRAFFICKING_PATHWAY	61	Up	0.7590816243798	0.947874171450986
MCBRYAN_PUBERTAL_TGFB1_TARGETS_UP	300	Down	0.759468446771698	0.947874171450986
KASLER_HDAC7_TARGETS_1_UP	234	Down	0.759915247297335	0.947874171450986
XU_HGF_TARGETS_INDUCED_BY_AKT1_48HR_DN	51	Up	0.759922598485578	0.947874171450986
WOO_LIVER_CANCER_RECURRENCE_DN	92	Down	0.760942151551767	0.947874171450986
REACTOME_SIGNALING_BY_NOTCH4	15	Up	0.76122799428562	0.947874171450986
REACTOME_SIGNALING_BY_NOTCH2	15	Up	0.76122799428562	0.947874171450986
REACTOME_SIGNALING_BY_NOTCH3	15	Up	0.76122799428562	0.947874171450986
BYSTRYKH_HEMATOPOIESIS_STEM_CELL_QTL_CIS	176	Down	0.761294957255502	0.947874171450986
MCCABE_HOXC6_TARGETS_DN	27	Down	0.761308225947269	0.947874171450986
RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP	1017	Down	0.761425066714306	0.947874171450986
CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN	672	Down	0.761757350409365	0.947874171450986
STEGER_ADIPOGENESIS_UP	19	Down	0.761833648192767	0.947874171450986
SCHMIDT_POR_TARGETS_IN_LIMB_BUD_DN	17	Up	0.761933210069283	0.947874171450986
LU_TUMOR_ANGIOGENESIS_UP	35	Up	0.761997057604536	0.947874171450986
MOOTHA_MITOCHONDRIA	563	Down	0.762071571374015	0.947874171450986
WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_36HR	260	Up	0.762277256810021	0.947880432000668
LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_QTL	23	Up	0.762691227338502	0.948098169949369
PID_CDC42_REG_PATHWAY	39	Up	0.762853756134113	0.948098169949369
VANTVEER_BREAST_CANCER_METASTASIS_UP	83	Up	0.76450250028647	0.949575483820615
SMID_BREAST_CANCER_BASAL_UP	807	Down	0.765053220323787	0.949575483820615
PARENT_MTOR_SIGNALING_UP	764	Down	0.765058389375821	0.949575483820615
PARENT_MTOR_SIGNALING_DN	44	Down	0.765087805677931	0.949575483820615
AKL_HTLV1_INFECTION_UP	45	Down	0.765835816947087	0.949575483820615
PENG_GLUCOSE_DEPRIVATION_UP	70	Down	0.765856760993015	0.949575483820615
PID_IL12_STAT4_PATHWAY	19	Up	0.765881396504645	0.949575483820615
WANG_SMARCE1_TARGETS_DN	493	Down	0.766326631327703	0.949575483820615
ZIRN_TRETINOIN_RESPONSE_WT1_UP	29	Down	0.766374490962739	0.949575483820615
MULLIGHAN_NPM1_SIGNATURE_3_DN	227	Up	0.766519944704252	0.949575483820615
DIRMEIER_LMP1_RESPONSE_EARLY	86	Down	0.766810970223022	0.949575483820615
LEE_AGING_NEOCORTEX_DN	105	Down	0.76690226503073	0.949575483820615
FARMER_BREAST_CANCER_CLUSTER_3	17	Down	0.767173441192394	0.949575483820615
BARRIER_CANCER_RELAPSE_NORMAL_SAMPLE_DN	50	Up	0.767177933665748	0.949575483820615
REACTOME_MRNA_3_END_PROCESSING	47	Down	0.767278031366425	0.949575483820615
ZHAN_MULTIPLE_MYELOMA_MF_UP	71	Up	0.767472491640619	0.949575483820615
SMIRNOV_RESPONSE_TO_IR_2HR_DN	68	Down	0.767977302463863	0.949575483820615
SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN	720	Down	0.768439374670026	0.949575483820615
JUBAN_TARGETS_OF_SPI1_AND_FLI1_DN	148	Down	0.768472706418865	0.949575483820615
REACTOME_N_GLYCAN_ANTENNAE_ELONGATION	10	Up	0.768696718028177	0.949575483820615
CLIMENT_BREAST_CANCER_COPY_NUMBER_DN	8	Down	0.768738899831061	0.949575483820615
REACTOME_ACTIVATED_POINT_MUTANTS_OF_FGFR2	10	Up	0.768773988738512	0.949575483820615
KOHOUTEK_CCNT2_TARGETS	67	Down	0.768908214968108	0.949575483820615
IYENGAR_RESPONSE_TO_ADIPOCYTE_FACTORS	11	Down	0.769198036886596	0.949575483820615
FONTAINE_THYROID_TUMOR_UNCERTAIN_MALIGNANCY_UP	42	Down	0.769449544452215	0.949575483820615
KEGG_GLYCEROLIPID_METABOLISM	50	Down	0.769539147186674	0.949575483820615
CAFFAREL_RESPONSE_TO_THC_24HR_5_DN	83	Down	0.770015459351532	0.949575483820615
WANG_RESPONSE_TO_BEXAROTENE_DN	34	Down	0.770104092439988	0.949575483820615
PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_DN	191	Up	0.770291988830578	0.949575483820615
NADERI_BREAST_CANCER_PROGNOSIS_UP	80	Up	0.770292465681439	0.949575483820615
REACTOME_SCF_BETA_TRCP_MEDIATED_DEGRADATION_OF_EMI1	56	Up	0.770467761715575	0.949575483820615
REACTOME_P75_NTR_RECEPTOR_MEDIATED_SIGNALLING	99	Down	0.770474773387895	0.949575483820615
BOHN_PRIMARY_IMMUNODEFICIENCY_SYNDROM_DN	85	Up	0.771685730963155	0.950552549637899
HANN_RESISTANCE_TO_BCL2_INHIBITOR_UP	81	Down	0.771726824533632	0.950552549637899
LANDIS_ERBB2_BREAST_TUMORS_65_DN	47	Down	0.772299443005314	0.950552549637899
SILIGAN_TARGETS_OF_EWS_FLI1_FUSION_UP	17	Up	0.772466541279072	0.950552549637899
BIOCARTA_MAPK_PATHWAY	101	Up	0.77258639308616	0.950552549637899
SESTO_RESPONSE_TO_UV_C4	31	Up	0.772745439522495	0.950552549637899
GAUSSMANN_MLL_AF4_FUSION_TARGETS_C_UP	247	Up	0.772847773343199	0.950552549637899
LINDSTEDT_DENDRITIC_CELL_MATURATION_B	72	Down	0.772877295334286	0.950552549637899
REACTOME_PRE_NOTCH_PROCESSING_IN_GOLGI	22	Up	0.773622336511571	0.951221217511885
RUAN_RESPONSE_TO_TNF_TROGLITAZONE_UP	32	Up	0.774063913707298	0.951516504905874
MENSSEN_MYC_TARGETS	89	Down	0.774475216928344	0.951565382196151
REACTOME_SIGNALING_BY_NOTCH	107	Up	0.774680839132137	0.951565382196151
STAMBOLSKY_TARGETS_OF_MUTATED_TP53_DN	88	Up	0.774713347292958	0.951565382196151
LEE_RECENT_THYMIC_EMIGRANT	299	Up	0.775000450274002	0.951565382196151
SABATES_COLORECTAL_ADENOMA_SIZE_DN	10	Up	0.77511083630203	0.951565382196151
CHEN_METABOLIC_SYNDROM_NETWORK	1406	Down	0.775762535448272	0.951706040215637
REACTOME_G_ALPHA_Q_SIGNALLING_EVENTS	88	Down	0.775806210086451	0.951706040215637
SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_2FC_DN	22	Up	0.775829796966642	0.951706040215637
INGRAM_SHH_TARGETS	8	Down	0.776222151215329	0.951940145986816
LINDGREN_BLADDER_CANCER_CLUSTER_2A_UP	8	Down	0.776626697984891	0.951987864761843
HOLLEMAN_VINCRISTINE_RESISTANCE_ALL_DN	28	Down	0.776664104740081	0.951987864761843
BEIER_GLIOMA_STEM_CELL_DN	109	Up	0.776883139768008	0.95200932613854
RASHI_RESPONSE_TO_IONIZING_RADIATION_5	242	Down	0.777242409277074	0.952202578170357
STAMBOLSKY_RESPONSE_TO_VITAMIN_D3_UP	116	Up	0.777989123775805	0.952870267232798
HAMAI_APOPTOSIS_VIA_TRAIL_DN	237	Down	0.778581302492872	0.95323272292486
LEE_SP4_THYMOCYTE	27	Up	0.778688627808433	0.95323272292486
VANTVEER_BREAST_CANCER_BRCA1_UP	42	Down	0.779201287737837	0.953529315006039
CHANG_CORE_SERUM_RESPONSE_UP	297	Down	0.779334607374749	0.953529315006039
VALK_AML_CLUSTER_6	44	Down	0.77997337086889	0.953853617931848
LEE_LIVER_CANCER_DENA_UP	88	Down	0.78023487992124	0.953853617931848
PID_ANTHRAX_PATHWAY	16	Up	0.780276525874547	0.953853617931848
RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_DN	313	Down	0.780681956083369	0.953853617931848
BIOCARTA_P53HYPOXIA_PATHWAY	38	Up	0.780716414226921	0.953853617931848
SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX1_UP	29	Down	0.781163021143631	0.953853617931848
ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP	29	Down	0.781545906785676	0.953853617931848
REACTOME_PHASE1_FUNCTIONALIZATION_OF_COMPOUNDS	33	Down	0.781671574603714	0.953853617931848
ZHONG_SECRETOME_OF_LUNG_CANCER_AND_ENDOTHELIUM	123	Down	0.782632746839737	0.953853617931848
KYNG_ENVIRONMENTAL_STRESS_RESPONSE_UP	96	Up	0.782754236322794	0.953853617931848
SCHRAMM_INHBA_TARGETS_UP	19	Down	0.782775129901301	0.953853617931848
PID_INTEGRIN1_PATHWAY	78	Up	0.7829091452948	0.953853617931848
BIOCARTA_WNT_PATHWAY	45	Down	0.783222705465695	0.953853617931848
MEISSNER_BRAIN_HCP_WITH_H3K4ME2	18	Down	0.783311108385275	0.953853617931848
FRASOR_TAMOXIFEN_RESPONSE_DN	19	Up	0.783760007963486	0.953853617931848
LU_AGING_BRAIN_UP	363	Down	0.783923861562001	0.953853617931848
KEGG_JAK_STAT_SIGNALING_PATHWAY	95	Up	0.784182431755118	0.953853617931848
WU_HBX_TARGETS_3_UP	27	Down	0.784240884046791	0.953853617931848
REACTOME_ACTIVATED_TLR4_SIGNALLING	133	Down	0.784423824112993	0.953853617931848
MARSHALL_VIRAL_INFECTION_RESPONSE_DN	38	Down	0.78454810217059	0.953853617931848
CHANDRAN_METASTASIS_UP	305	Up	0.784726803677257	0.953853617931848
DARWICHE_SQUAMOUS_CELL_CARCINOMA_UP	166	Down	0.784756634472484	0.953853617931848
REACTOME_ER_PHAGOSOME_PATHWAY	74	Up	0.784944590334802	0.953853617931848
HORIUCHI_WTAP_TARGETS_UP	455	Up	0.785083652810453	0.953853617931848
MARSON_FOXP3_TARGETS_STIMULATED_DN	15	Up	0.785238234654584	0.953853617931848
YAGI_AML_WITH_INV_16_TRANSLOCATION	598	Down	0.785423722397322	0.953853617931848
HE_PTEN_TARGETS_DN	8	Up	0.785663186737429	0.953853617931848
ACOSTA_PROLIFERATION_INDEPENDENT_MYC_TARGETS_DN	134	Down	0.785743828549161	0.953853617931848
WILSON_PROTEASES_AT_TUMOR_BONE_INTERFACE_DN	4	Up	0.786060121111741	0.953853617931848
BARIS_THYROID_CANCER_DN	101	Down	0.786147691414723	0.953853617931848
HEDENFALK_BREAST_CANCER_BRACX_DN	32	Down	0.786161626852093	0.953853617931848
ZEMBUTSU_SENSITIVITY_TO_DOXORUBICIN	23	Down	0.786246188028274	0.953853617931848
DUAN_PRDM5_TARGETS	86	Down	0.786262910293526	0.953853617931848
KEGG_MAPK_SIGNALING_PATHWAY	242	Down	0.787014412235406	0.954520175455727
KEGG_PENTOSE_AND_GLUCURONATE_INTERCONVERSIONS	24	Down	0.78760857255619	0.954995610050165
SESTO_RESPONSE_TO_UV_C0	147	Down	0.787997359177655	0.955127429080263
PID_ALK2_PATHWAY	11	Down	0.788391364399244	0.955127429080263
LIU_TARGETS_OF_VMYB_VS_CMYB_UP	18	Down	0.788507012749762	0.955127429080263
SIG_CD40PATHWAYMAP	45	Down	0.788526031628498	0.955127429080263
BOYAULT_LIVER_CANCER_SUBCLASS_G23_UP	64	Down	0.789009092681745	0.955467560581533
FARMER_BREAST_CANCER_BASAL_VS_LULMINAL	476	Up	0.790090657779233	0.956461976057363
ONDER_CDH1_TARGETS_1_DN	217	Up	0.790441841485395	0.956461976057363
HELLER_SILENCED_BY_METHYLATION_UP	287	Down	0.790574293767967	0.956461976057363
SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX1_DN	10	Down	0.791110047982139	0.956461976057363
YOSHIMURA_MAPK8_TARGETS_UP	1187	Down	0.791151405512072	0.956461976057363
BROWNE_HCMV_INFECTION_20HR_DN	177	Down	0.791390447839016	0.956461976057363
DANG_MYC_TARGETS_DN	37	Down	0.791915884157221	0.956461976057363
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN	216	Down	0.79193905595713	0.956461976057363
MARIADASON_RESPONSE_TO_BUTYRATE_CURCUMIN_SULINDAC_TSA_8	16	Down	0.792372262128612	0.956461976057363
NIKOLSKY_BREAST_CANCER_8P12_P11_AMPLICON	58	Up	0.792528946216738	0.956461976057363
REACTOME_SIGNALING_BY_FGFR1_MUTANTS	37	Down	0.792589073264001	0.956461976057363
VARELA_ZMPSTE24_TARGETS_DN	51	Up	0.792731738761456	0.956461976057363
SHANK_TAL1_TARGETS_DN	6	Up	0.793009813448505	0.956461976057363
NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP	59	Down	0.793261046986068	0.956461976057363
REACTOME_ELONGATION_ARREST_AND_RECOVERY	33	Up	0.793325532120115	0.956461976057363
KEGG_FATTY_ACID_METABOLISM	49	Down	0.793592236717466	0.956461976057363
SHI_SPARC_TARGETS_DN	14	Down	0.793758079243812	0.956461976057363
LIM_MAMMARY_LUMINAL_PROGENITOR_UP	56	Up	0.794134389454368	0.956461976057363
REACTOME_GPCR_LIGAND_BINDING	153	Up	0.794158754581941	0.956461976057363
ZEMBUTSU_SENSITIVITY_TO_VINCRISTINE	20	Down	0.794278564831379	0.956461976057363
GHO_ATF5_TARGETS_UP	36	Down	0.794473678020149	0.956461976057363
BOGNI_TREATMENT_RELATED_MYELOID_LEUKEMIA_UP	40	Down	0.794488666390785	0.956461976057363
MATZUK_STEROIDOGENESIS	4	Up	0.79468621798517	0.956461976057363
SCIAN_INVERSED_TARGETS_OF_TP53_AND_TP73_UP	16	Down	0.794689512283054	0.956461976057363
INAMURA_LUNG_CANCER_SCC_SUBTYPES_UP	21	Up	0.795024387345782	0.956621295420651
COLLIS_PRKDC_REGULATORS	22	Up	0.795605345037372	0.957076559703729
LIN_NPAS4_TARGETS_UP	213	Up	0.796077875301225	0.957218858910087
ISHIKAWA_STING_SIGNALING	7	Down	0.796243981885244	0.957218858910087
CHOW_RASSF1_TARGETS_UP	36	Down	0.796379682196652	0.957218858910087
BANDRES_RESPONSE_TO_CARMUSTIN_WITHOUT_MGMT_24HR_UP	24	Up	0.796534152069337	0.957218858910087
PID_MYC_ACTIV_PATHWAY	119	Down	0.797027158898618	0.957345717775291
KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN	480	Up	0.797045027097845	0.957345717775291
SHARMA_PILOCYTIC_ASTROCYTOMA_LOCATION_UP	24	Down	0.797443238401524	0.95736094685646
GAUSSMANN_MLL_AF4_FUSION_TARGETS_D_DN	28	Up	0.797491609618384	0.95736094685646
PID_CIRCADIAN_PATHWAY	16	Down	0.79766944689031	0.95736094685646
RAY_TARGETS_OF_P210_BCR_ABL_FUSION_UP	39	Up	0.79790501759384	0.95736094685646
MATZUK_CUMULUS_EXPANSION	7	Up	0.798231119562372	0.95736094685646
BOYAULT_LIVER_CANCER_SUBCLASS_G2	41	Up	0.798273659963505	0.95736094685646
WANG_METASTASIS_OF_BREAST_CANCER_ESR1_UP	30	Up	0.798495027497667	0.957383378146949
VANASSE_BCL2_TARGETS_UP	42	Down	0.798720001288844	0.957384570255015
REACTOME_MITOCHONDRIAL_FATTY_ACID_BETA_OXIDATION	59	Down	0.798901349692056	0.957384570255015
SMITH_LIVER_CANCER	84	Up	0.799170536383463	0.957464269306487
REACTOME_LYSOSOME_VESICLE_BIOGENESIS	45	Up	0.799856286229161	0.958042874276511
KUMAR_PATHOGEN_LOAD_BY_MACROPHAGES	381	Up	0.800364127519736	0.958312733560106
FUNG_IL2_TARGETS_WITH_STAT5_BINDING_SITES_T1	3	Down	0.800487308769724	0.958312733560106
ZHANG_GATA6_TARGETS_UP	21	Up	0.800834438957037	0.958485404011412
WNT_SIGNALING	107	Up	0.801402415930493	0.958922242364652
WATTEL_AUTONOMOUS_THYROID_ADENOMA_DN	59	Up	0.802129755715335	0.959084560548797
SUNG_METASTASIS_STROMA_UP	180	Down	0.80291291691836	0.959084560548797
MULLIGHAN_NPM1_MUTATED_SIGNATURE_2_UP	192	Up	0.803079170299242	0.959084560548797
VERRECCHIA_RESPONSE_TO_TGFB1_C3	27	Up	0.803633805708102	0.959084560548797
GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN	1488	Up	0.803682660946201	0.959084560548797
NADLER_OBESITY_DN	55	Up	0.803763918990121	0.959084560548797
REACTOME_MHC_CLASS_II_ANTIGEN_PRESENTATION	101	Down	0.804078667164701	0.959084560548797
DAVIES_MULTIPLE_MYELOMA_VS_MGUS_DN	47	Up	0.804319279774576	0.959084560548797
IVANOVA_HEMATOPOIESIS_STEM_CELL_LONG_TERM	400	Up	0.804559623158033	0.959084560548797
CONRAD_GERMLINE_STEM_CELL	12	Down	0.804672037697759	0.959084560548797
PEPPER_CHRONIC_LYMPHOCYTIC_LEUKEMIA_UP	47	Up	0.804686779685592	0.959084560548797
AMIT_SERUM_RESPONSE_40_MCF10A	47	Down	0.804822881288484	0.959084560548797
ROVERSI_GLIOMA_COPY_NUMBER_UP	103	Down	0.805361871310029	0.959084560548797
JU_AGING_TERC_TARGETS_UP	9	Down	0.805458642392263	0.959084560548797
PLASARI_TGFB1_TARGETS_10HR_DN	365	Up	0.805626325039663	0.959084560548797
BYSTRYKH_HEMATOPOIESIS_STEM_CELL_FLI1	7	Up	0.805689949638749	0.959084560548797
SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A5	170	Up	0.806242782392061	0.959084560548797
WUNDER_INFLAMMATORY_RESPONSE_AND_CHOLESTEROL_DN	20	Down	0.806496358839188	0.959084560548797
SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM1	298	Down	0.807676235471896	0.959084560548797
PID_ERA_GENOMIC_PATHWAY	79	Up	0.807807828385994	0.959084560548797
DER_IFN_ALPHA_RESPONSE_DN	5	Down	0.807879278859349	0.959084560548797
ST_P38_MAPK_PATHWAY	64	Up	0.807929274996757	0.959084560548797
REACTOME_ACTIVATION_OF_IRF3_IRF7_MEDIATED_BY_TBK1_IKK_EPSILON	29	Down	0.808069899310678	0.959084560548797
BILBAN_B_CLL_LPL_UP	100	Up	0.80811503925899	0.959084560548797
PID_WNT_NONCANONICAL_PATHWAY	48	Down	0.808470513847442	0.959084560548797
ZHANG_ADIPOGENESIS_BY_BMP7	28	Down	0.808742299029237	0.959084560548797
REACTOME_TRAF6_MEDIATED_INDUCTION_OF_NFKB_AND_MAP_KINASES_UPON_TLR7_8_OR_9_ACTIVATION	119	Down	0.808860233109298	0.959084560548797
REACTOME_APOPTOTIC_CLEAVAGE_OF_CELLULAR_PROTEINS	43	Up	0.808945867147996	0.959084560548797
MATZUK_EMBRYONIC_GERM_CELL	20	Up	0.808964406320237	0.959084560548797
DARWICHE_SKIN_TUMOR_PROMOTER_DN	252	Up	0.809343797505716	0.959084560548797
SANDERSON_PPARA_TARGETS	52	Down	0.809637222488642	0.959084560548797
GUTIERREZ_WALDENSTROEMS_MACROGLOBULINEMIA_1_DN	21	Down	0.80978541650183	0.959084560548797
ZHOU_INFLAMMATORY_RESPONSE_LPS_UP	408	Up	0.809800061543867	0.959084560548797
JECHLINGER_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP	97	Down	0.809914479443502	0.959084560548797
YAMASHITA_SILENCED_BY_METHYLATION	12	Down	0.81005697458038	0.959084560548797
GROSS_HYPOXIA_VIA_ELK3_DN	233	Up	0.81027439719903	0.959084560548797
SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A4	298	Up	0.810344962023011	0.959084560548797
HEIDENBLAD_AMPLICON_8Q24_DN	64	Down	0.810425132010368	0.959084560548797
SCIBETTA_KDM5B_TARGETS_UP	26	Down	0.81044898750534	0.959084560548797
REACTOME_NETRIN1_SIGNALING	40	Up	0.810841840265903	0.959084560548797
LINDVALL_IMMORTALIZED_BY_TERT_UP	105	Up	0.811026709880319	0.959084560548797
BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_DN	247	Down	0.811482022019228	0.959084560548797
MULLIGHAN_NPM1_MUTATED_SIGNATURE_1_UP	362	Up	0.812080807160044	0.959084560548797
KEGG_ADIPOCYTOKINE_SIGNALING_PATHWAY	63	Up	0.812131414045123	0.959084560548797
REACTOME_GLYCOSPHINGOLIPID_METABOLISM	34	Up	0.81215205148105	0.959084560548797
YANAGISAWA_LUNG_CANCER_RECURRENCE	13	Down	0.812157561182228	0.959084560548797
GROSS_HIF1A_TARGETS_UP	22	Down	0.812505810208642	0.959084560548797
FRASOR_TAMOXIFEN_RESPONSE_UP	65	Down	0.812557584163497	0.959084560548797
LABBE_TGFB1_TARGETS_DN	119	Down	0.81287959078456	0.959084560548797
GAZDA_DIAMOND_BLACKFAN_ANEMIA_PROGENITOR_DN	126	Up	0.813046692026373	0.959084560548797
LEE_AGING_CEREBELLUM_DN	117	Down	0.813061043815096	0.959084560548797
KEGG_CIRCADIAN_RHYTHM_MAMMAL	13	Up	0.813062109617208	0.959084560548797
REACTOME_E2F_ENABLED_INHIBITION_OF_PRE_REPLICATION_COMPLEX_FORMATION	13	Down	0.813209390717335	0.959084560548797
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN	127	Down	0.813249379602701	0.959084560548797
LOPEZ_MESOTHELIOMA_SURVIVAL_OVERALL_UP	9	Up	0.81325899874419	0.959084560548797
PID_ERBB_NETWORK_PATHWAY	15	Up	0.813526678328327	0.959084560548797
REACTOME_N_GLYCAN_ANTENNAE_ELONGATION_IN_THE_MEDIAL_TRANS_GOLGI	15	Down	0.813603697572776	0.959084560548797
LI_WILMS_TUMOR_ANAPLASTIC_DN	12	Up	0.813839153584169	0.959084560548797
ST_TUMOR_NECROSIS_FACTOR_PATHWAY	31	Down	0.813918622435032	0.959084560548797
GROSS_HYPOXIA_VIA_ELK3_ONLY_DN	57	Down	0.813918938358761	0.959084560548797
MASSARWEH_TAMOXIFEN_RESISTANCE_DN	312	Up	0.813922523971238	0.959084560548797
DASU_IL6_SIGNALING_SCAR_UP	46	Down	0.814178030336811	0.959146387858128
FIGUEROA_AML_METHYLATION_CLUSTER_3_UP	230	Up	0.814468506474163	0.959249370377448
CARDOSO_RESPONSE_TO_GAMMA_RADIATION_AND_3AB	23	Up	0.814810065988357	0.959412450580509
ST_INTERFERON_GAMMA_PATHWAY	8	Up	0.81503228973276	0.959434970520199
BIOCARTA_TOLL_PATHWAY	55	Down	0.815307578218214	0.95951993012029
ACEVEDO_LIVER_CANCER_WITH_H3K9ME3_UP	129	Up	0.815816330225371	0.959879537729676
KEGG_TYPE_II_DIABETES_MELLITUS	45	Up	0.816882549532147	0.96089471214887
HAHTOLA_CTCL_PATHOGENESIS	8	Up	0.817652029292873	0.961560414831847
SCHAEFFER_SOX9_TARGETS_IN_PROSTATE_DEVELOPMENT_DN	68	Down	0.818059773034852	0.961699447048303
MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_2	9	Down	0.818269894377565	0.961699447048303
BENPORATH_SOX2_TARGETS	1064	Down	0.818380985845508	0.961699447048303
SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP	453	Up	0.818839236054413	0.961816787502293
JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_DN	56	Up	0.818888043889548	0.961816787502293
KIM_GLIS2_TARGETS_DN	7	Down	0.819223423880816	0.961971527321147
REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES	153	Up	0.81987797553383	0.962500883802638
FALVELLA_SMOKERS_WITH_LUNG_CANCER	118	Down	0.820369231725417	0.962838323148043
KEGG_TAURINE_AND_HYPOTAURINE_METABOLISM	4	Down	0.821021821471987	0.962847258526739
DURAND_STROMA_S_UP	504	Up	0.821331812789937	0.962847258526739
MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_13	8	Up	0.821359679620582	0.962847258526739
BLALOCK_ALZHEIMERS_DISEASE_DN	1629	Down	0.821360697682975	0.962847258526739
ELVIDGE_HIF2A_TARGETS_UP	7	Down	0.821395946626325	0.962847258526739
BIOCARTA_EGFR_SMRTE_PATHWAY	14	Down	0.821965590469424	0.963073838631269
REACTOME_NEGATIVE_REGULATION_OF_FGFR_SIGNALING	32	Up	0.822029251154818	0.963073838631269
WHITFIELD_CELL_CYCLE_S	205	Down	0.822534294032308	0.963073838631269
FIGUEROA_AML_METHYLATION_CLUSTER_7_UP	185	Up	0.822684486797702	0.963073838631269
ONO_FOXP3_TARGETS_UP	21	Down	0.82297542548823	0.963073838631269
ASGHARZADEH_NEUROBLASTOMA_POOR_SURVIVAL_DN	99	Down	0.823312175766857	0.963073838631269
GERY_CEBP_TARGETS	194	Up	0.823673176554174	0.963073838631269
YANG_MUC2_TARGETS_COLON_3MO_DN	4	Down	0.824080148372784	0.963073838631269
HOLLEMAN_VINCRISTINE_RESISTANCE_ALL_UP	63	Up	0.824164413892695	0.963073838631269
LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_SMALL_VS_HUGE_DN	44	Up	0.824251189072747	0.963073838631269
TAVOR_CEBPA_TARGETS_UP	51	Up	0.82438250856265	0.963073838631269
COLLER_MYC_TARGETS_DN	28	Up	0.824443120291318	0.963073838631269
GRASEMANN_RETINOBLASTOMA_WITH_6P_AMPLIFICATION	20	Down	0.824507013079234	0.963073838631269
HECKER_IFNB1_TARGETS	77	Up	0.824519679123938	0.963073838631269
KEGG_ETHER_LIPID_METABOLISM	24	Down	0.824647264450357	0.963073838631269
GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN	701	Down	0.824911676373272	0.963144527727963
REACTOME_LIPID_DIGESTION_MOBILIZATION_AND_TRANSPORT	40	Down	0.825262991320947	0.96331662243641
BRUECKNER_TARGETS_OF_MIRLET7A3_DN	122	Up	0.825587544370834	0.963457401088888
JAATINEN_HEMATOPOIETIC_STEM_CELL_UP	438	Up	0.825841573240374	0.963515829090523
BREDEMEYER_RAG_SIGNALING_NOT_VIA_ATM_DN	93	Up	0.826788614782345	0.964382571909086
ROME_INSULIN_TARGETS_IN_MUSCLE_UP	589	Down	0.82711663940683	0.964515040347967
BIOCARTA_EXTRINSIC_PATHWAY	4	Up	0.827374177899727	0.964515040347967
PYEON_CANCER_HEAD_AND_NECK_VS_CERVICAL_DN	28	Up	0.827514703329871	0.964515040347967
HOFFMAN_CLOCK_TARGETS_UP	8	Up	0.827897346525129	0.964723005669638
LEE_METASTASIS_AND_ALTERNATIVE_SPLICING_UP	115	Down	0.828356480659264	0.965019978948055
GAVIN_FOXP3_TARGETS_CLUSTER_T4	105	Down	0.828614819676142	0.965082940865408
MOTAMED_RESPONSE_TO_ANDROGEN_UP	22	Down	0.829339627029494	0.965315986783941
SCIAN_INVERSED_TARGETS_OF_TP53_AND_TP73_DN	52	Down	0.82956402492757	0.965315986783941
REACTOME_PPARA_ACTIVATES_GENE_EXPRESSION	126	Down	0.829599585619808	0.965315986783941
WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_UP	169	Down	0.829870854431247	0.965315986783941
WANG_LMO4_TARGETS_DN	524	Up	0.82988676251054	0.965315986783941
AMIT_EGF_RESPONSE_120_HELA	110	Down	0.830071456557797	0.965315986783941
RHEIN_ALL_GLUCOCORTICOID_THERAPY_UP	118	Up	0.830515697771463	0.965315986783941
REACTOME_VIF_MEDIATED_DEGRADATION_OF_APOBEC3G	56	Up	0.830781574556696	0.965315986783941
HUMMERICH_BENIGN_SKIN_TUMOR_UP	17	Down	0.831043048107562	0.965315986783941
MADAN_DPPA4_TARGETS	37	Up	0.831071421919081	0.965315986783941
CALVET_IRINOTECAN_SENSITIVE_VS_RESISTANT_UP	5	Down	0.831223820625661	0.965315986783941
YIH_RESPONSE_TO_ARSENITE_C3	45	Up	0.831267026722497	0.965315986783941
DARWICHE_SQUAMOUS_CELL_CARCINOMA_DN	243	Down	0.831701195210364	0.965582808103652
WANG_RESPONSE_TO_FORSKOLIN_UP	35	Up	0.831973433790102	0.965661548212394
LANDIS_BREAST_CANCER_PROGRESSION_DN	120	Up	0.832584222273139	0.965964419808701
ST_G_ALPHA_I_PATHWAY	47	Down	0.832813524031924	0.965964419808701
GRAESSMANN_APOPTOSIS_BY_SERUM_DEPRIVATION_DN	302	Down	0.832847815808815	0.965964419808701
GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_UP	199	Down	0.833071051267715	0.965986167449359
LEE_AGING_NEOCORTEX_UP	150	Down	0.833792552539083	0.96651729396966
DELACROIX_RAR_BOUND_ES	561	Down	0.834053545787559	0.96651729396966
REACTOME_INNATE_IMMUNE_SYSTEM	227	Up	0.834142888974239	0.96651729396966
KRIEG_HYPOXIA_VIA_KDM3A	88	Up	0.834870532154242	0.9668990079233
BRUECKNER_TARGETS_OF_MIRLET7A3_UP	154	Up	0.83503029107267	0.9668990079233
REACTOME_P75NTR_SIGNALS_VIA_NFKB	19	Down	0.835093639258964	0.9668990079233
REACTOME_SEMA3A_PLEXIN_REPULSION_SIGNALING_BY_INHIBITING_INTEGRIN_ADHESION	31	Up	0.835573057410159	0.9668990079233
TOOKER_GEMCITABINE_RESISTANCE_UP	103	Up	0.835811329699358	0.9668990079233
IGARASHI_ATF4_TARGETS_UP	4	Down	0.836020118872496	0.9668990079233
POMEROY_MEDULLOBLASTOMA_PROGNOSIS_UP	68	Down	0.836086206529906	0.9668990079233
SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_2FC_UP	24	Down	0.836120374104845	0.9668990079233
GUO_HEX_TARGETS_DN	76	Up	0.836314425566174	0.9668990079233
REACTOME_PECAM1_INTERACTIONS	12	Down	0.836649339034448	0.96693282180415
TSAI_DNAJB4_TARGETS_DN	8	Down	0.836803124239827	0.96693282180415
BIOCARTA_ASBCELL_PATHWAY	3	Up	0.83708531966969	0.96693282180415
BENPORATH_NOS_TARGETS	286	Up	0.837190500446908	0.96693282180415
REACTOME_BASIGIN_INTERACTIONS	25	Up	0.837367098645381	0.96693282180415
KANG_IMMORTALIZED_BY_TERT_DN	121	Up	0.837573888719667	0.96693525178683
YAGI_AML_WITH_T_9_11_TRANSLOCATION	174	Up	0.83814836546074	0.967362051902403
AMBROSINI_FLAVOPIRIDOL_TREATMENT_TP53	184	Down	0.838466733035032	0.967493123316436
VALK_AML_CLUSTER_1	32	Up	0.839029701909946	0.967695022439053
COLDREN_GEFITINIB_RESISTANCE_UP	114	Down	0.839151078994172	0.967695022439053
PID_INTEGRIN_CS_PATHWAY	18	Down	0.839257597274763	0.967695022439053
HAN_SATB1_TARGETS_UP	492	Up	0.839461092708561	0.967695022439053
REACTOME_GENERIC_TRANSCRIPTION_PATHWAY	380	Up	0.839777502108618	0.967771769500946
MUNSHI_MULTIPLE_MYELOMA_DN	12	Down	0.840028417447517	0.967771769500946
WONG_IFNA2_RESISTANCE_DN	64	Down	0.840358828134888	0.967771769500946
REACTOME_P53_INDEPENDENT_G1_S_DNA_DAMAGE_CHECKPOINT	54	Up	0.840665832737205	0.967771769500946
DAZARD_UV_RESPONSE_CLUSTER_G1	110	Up	0.840704887637037	0.967771769500946
LEE_AGING_MUSCLE_UP	67	Up	0.840803633037957	0.967771769500946
BIOCARTA_BARRESTIN_PATHWAY	19	Up	0.840961709102748	0.967771769500946
LI_INDUCED_T_TO_NATURAL_KILLER_DN	156	Up	0.841827285107701	0.96853192763
REACTOME_SIGNALING_BY_NODAL	15	Down	0.842164801102226	0.968684324423402
IIZUKA_LIVER_CANCER_PROGRESSION_L0_L1_UP	36	Up	0.842583134702564	0.968690547780175
GENTILE_UV_RESPONSE_CLUSTER_D2	62	Down	0.84283078567203	0.968690547780175
GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP	85	Down	0.842969804903723	0.968690547780175
CAIRO_LIVER_DEVELOPMENT_UP	245	Up	0.842990440712172	0.968690547780175
BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_D	360	Down	0.843987664573267	0.969408338869966
DAZARD_UV_RESPONSE_CLUSTER_G2	44	Up	0.844025507572433	0.969408338869966
BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_48HR_DN	198	Up	0.844501009814297	0.969718709373538
DER_IFN_BETA_RESPONSE_DN	18	Down	0.845474910844976	0.970128247858035
CHEOK_RESPONSE_TO_MERCAPTOPURINE_AND_HD_MTX_UP	9	Up	0.845535110267485	0.970128247858035
KYNG_WERNER_SYNDROM_UP	23	Up	0.845994318236511	0.970128247858035
MURAKAMI_UV_RESPONSE_6HR_DN	25	Down	0.846145228638676	0.970128247858035
REACTOME_CREATION_OF_C4_AND_C2_ACTIVATORS	4	Down	0.846248120635751	0.970128247858035
NUYTTEN_EZH2_TARGETS_UP	1302	Down	0.846275776708708	0.970128247858035
BOYAULT_LIVER_CANCER_SUBCLASS_G56_DN	24	Up	0.846499910653731	0.970128247858035
MARTINEZ_TP53_TARGETS_DN	748	Up	0.846500558355381	0.970128247858035
BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP	1174	Up	0.847171684043256	0.970425262199945
BILD_E2F3_ONCOGENIC_SIGNATURE	361	Up	0.847212549931739	0.970425262199945
ENK_UV_RESPONSE_EPIDERMIS_DN	735	Up	0.847572032070832	0.970425262199945
REACTOME_CHONDROITIN_SULFATE_BIOSYNTHESIS	14	Down	0.847581420795295	0.970425262199945
BANDRES_RESPONSE_TO_CARMUSTIN_WITHOUT_MGMT_48HR_DN	52	Up	0.847992116164589	0.970660226983649
LE_SKI_TARGETS_UP	32	Down	0.849067684104621	0.971655944697246
FONTAINE_PAPILLARY_THYROID_CARCINOMA_DN	95	Down	0.849460532774449	0.971834097074238
CHYLA_CBFA2T3_TARGETS_UP	461	Up	0.850103510973448	0.971834097074238
REACTOME_NRIF_SIGNALS_CELL_DEATH_FROM_THE_NUCLEUS	18	Down	0.850764734485536	0.971834097074238
MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_21	9	Up	0.850918682390591	0.971834097074238
ACEVEDO_LIVER_CANCER_DN	654	Down	0.851065453971601	0.971834097074238
IVANOVA_HEMATOPOIESIS_STEM_CELL_AND_PROGENITOR	844	Up	0.851203670758048	0.971834097074238
BIOCARTA_RANMS_PATHWAY	13	Up	0.851252929022721	0.971834097074238
BROCKE_APOPTOSIS_REVERSED_BY_IL6	243	Up	0.851271468353899	0.971834097074238
TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_UP	132	Down	0.85150679927217	0.971834097074238
LEE_LIVER_CANCER_MYC_TGFA_UP	90	Up	0.851658779121195	0.971834097074238
LEE_TARGETS_OF_PTCH1_AND_SUFU_UP	68	Up	0.851689476786124	0.971834097074238
WOTTON_RUNX_TARGETS_UP	28	Down	0.851692032575644	0.971834097074238
DORMOY_ELAVL1_TARGETS	21	Down	0.852352727943834	0.972039123256949
POMEROY_MEDULLOBLASTOMA_DESMOPLASIC_VS_CLASSIC_UP	105	Up	0.852477423974751	0.972039123256949
RASHI_RESPONSE_TO_IONIZING_RADIATION_3	71	Down	0.852572453208239	0.972039123256949
IVANOVSKA_MIR106B_TARGETS	138	Down	0.853619951999135	0.972039123256949
REACTOME_RETROGRADE_NEUROTROPHIN_SIGNALLING	16	Up	0.853809956136996	0.972039123256949
REN_MIF_TARGETS_DN	7	Up	0.853887759856568	0.972039123256949
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_DN	49	Down	0.854881587180872	0.972039123256949
DAVICIONI_RHABDOMYOSARCOMA_PAX_FOXO1_FUSION_UP	84	Up	0.855029565173312	0.972039123256949
LEE_LIVER_CANCER_DENA_DN	89	Up	0.855455185944823	0.972039123256949
MARIADASON_REGULATED_BY_HISTONE_ACETYLATION_UP	113	Down	0.855795091860355	0.972039123256949
HAHTOLA_SEZARY_SYNDROM_DN	50	Down	0.855908333970899	0.972039123256949
NUYTTEN_NIPP1_TARGETS_UP	953	Up	0.856195919923525	0.972039123256949
AMIT_EGF_RESPONSE_480_MCF10A	50	Up	0.856262167165762	0.972039123256949
BILANGES_SERUM_SENSITIVE_VIA_TSC2	149	Up	0.856310133953387	0.972039123256949
REACTOME_DEADENYLATION_DEPENDENT_MRNA_DECAY	49	Down	0.856927970975821	0.972039123256949
REACTOME_ENDOSOMAL_SORTING_COMPLEX_REQUIRED_FOR_TRANSPORT_ESCRT	27	Up	0.85705561177571	0.972039123256949
BROWNE_HCMV_INFECTION_48HR_UP	300	Up	0.857123803119814	0.972039123256949
KEGG_SPHINGOLIPID_METABOLISM	41	Up	0.857549750779015	0.972039123256949
LANDIS_ERBB2_BREAST_TUMORS_324_UP	195	Down	0.858173115353008	0.972039123256949
BURTON_ADIPOGENESIS_PEAK_AT_2HR	83	Down	0.858286561692784	0.972039123256949
REACTOME_CROSS_PRESENTATION_OF_SOLUBLE_EXOGENOUS_ANTIGENS_ENDOSOMES	50	Up	0.858444120361354	0.972039123256949
REACTOME_TRAF6_MEDIATED_NFKB_ACTIVATION	20	Up	0.858803344081233	0.972039123256949
PALOMERO_GSI_SENSITIVITY_DN	8	Up	0.859117310410367	0.972039123256949
GOERING_BLOOD_HDL_CHOLESTEROL_QTL_TRANS	22	Down	0.859502545828158	0.972039123256949
REACTOME_RNA_POL_I_TRANSCRIPTION_TERMINATION	20	Up	0.859546189955984	0.972039123256949
SINGH_NFE2L2_TARGETS	32	Down	0.859585900537152	0.972039123256949
ROY_WOUND_BLOOD_VESSEL_UP	88	Down	0.859806644662985	0.972039123256949
KEGG_GALACTOSE_METABOLISM	35	Down	0.859927738453626	0.972039123256949
DARWICHE_PAPILLOMA_RISK_HIGH_DN	251	Down	0.859927990744137	0.972039123256949
MIKKELSEN_MEF_LCP_WITH_H3K4ME3	203	Down	0.860037724437258	0.972039123256949
LEE_TARGETS_OF_PTCH1_AND_SUFU_DN	101	Up	0.860154393930051	0.972039123256949
ZAMORA_NOS2_TARGETS_DN	147	Down	0.860341734362141	0.972039123256949
ZHAN_MULTIPLE_MYELOMA_LB_DN	56	Down	0.86040173405188	0.972039123256949
WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP	171	Down	0.860462315152163	0.972039123256949
LOPEZ_MESOTELIOMA_SURVIVAL_TIME_UP	23	Up	0.860520084586345	0.972039123256949
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_UP	345	Down	0.861033333388143	0.972039123256949
TUOMISTO_TUMOR_SUPPRESSION_BY_COL13A1_UP	17	Up	0.861194939467316	0.972039123256949
CASTELLANO_NRAS_TARGETS_DN	21	Down	0.861250334062981	0.972039123256949
BONOME_OVARIAN_CANCER_SURVIVAL_OPTIMAL_DEBULKING	348	Up	0.861623113004324	0.972039123256949
MIZUKAMI_HYPOXIA_DN	8	Up	0.861626550471923	0.972039123256949
KEGG_ONE_CARBON_POOL_BY_FOLATE	17	Up	0.861715163958626	0.972039123256949
REACTOME_DOWNREGULATION_OF_ERBB2_ERBB3_SIGNALING	14	Down	0.862047353328046	0.972039123256949
NICK_RESPONSE_TO_PROC_TREATMENT_UP	7	Up	0.862115240313054	0.972039123256949
SCHRAETS_MLL_TARGETS_DN	48	Down	0.862121688070392	0.972039123256949
REACTOME_RIG_I_MDA5_MEDIATED_INDUCTION_OF_IFN_ALPHA_BETA_PATHWAYS	64	Down	0.862222901378908	0.972039123256949
CUI_TCF21_TARGETS_2_DN	1183	Up	0.86251441315248	0.972039123256949
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINED_IN_GRANULOCYTE_UP	22	Up	0.862541066997289	0.972039123256949
PID_LYMPH_ANGIOGENESIS_PATHWAY	64	Up	0.862766882865054	0.972039123256949
BIOCARTA_IL5_PATHWAY	4	Down	0.86291565807376	0.972039123256949
VISALA_AGING_LYMPHOCYTE_DN	24	Up	0.862974961962222	0.972039123256949
SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_DN	212	Up	0.863215252551865	0.972039123256949
MA_MYELOID_DIFFERENTIATION_DN	52	Up	0.8633296633199	0.972039123256949
REACTOME_ASSEMBLY_OF_THE_PRE_REPLICATIVE_COMPLEX	69	Down	0.863350154255697	0.972039123256949
HUANG_FOXA2_TARGETS_DN	52	Up	0.863354269854028	0.972039123256949
YAMANAKA_GLIOBLASTOMA_SURVIVAL_DN	22	Down	0.863410875936078	0.972039123256949
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLUE_UP	169	Down	0.863500240742407	0.972039123256949
ROME_INSULIN_TARGETS_IN_MUSCLE_DN	239	Up	0.863600381098521	0.972039123256949
LEIN_PONS_MARKERS	111	Up	0.86407340557387	0.972239086331777
GENTILE_UV_HIGH_DOSE_UP	36	Up	0.864189653578986	0.972239086331777
KEGG_RIBOFLAVIN_METABOLISM	15	Down	0.864652421843779	0.972329672204141
JAIN_NFKB_SIGNALING	180	Up	0.864936125439021	0.972329672204141
BAE_BRCA1_TARGETS_UP	106	Down	0.865130442754701	0.972329672204141
WORSCHECH_TUMOR_EVASION_AND_TOLEROGENICITY_DN	20	Up	0.86542242072369	0.972329672204141
CERVERA_SDHB_TARGETS_1_DN	39	Up	0.865723591906337	0.972329672204141
REACTOME_HDL_MEDIATED_LIPID_TRANSPORT	16	Down	0.866097635395782	0.972329672204141
ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_DN	304	Up	0.866332054031838	0.972329672204141
LINDSTEDT_DENDRITIC_CELL_MATURATION_C	94	Down	0.86726952104377	0.972329672204141
GROSS_HYPOXIA_VIA_ELK3_AND_HIF1A_DN	193	Up	0.867469930914352	0.972329672204141
GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_DN	315	Up	0.867572657346326	0.972329672204141
KOMMAGANI_TP63_GAMMA_TARGETS	27	Down	0.867727710930622	0.972329672204141
ALFANO_MYC_TARGETS	389	Up	0.867739312785651	0.972329672204141
SHIPP_DLBCL_VS_FOLLICULAR_LYMPHOMA_DN	73	Up	0.867913293557754	0.972329672204141
LIAO_HAVE_SOX4_BINDING_SITES	60	Down	0.867914810984211	0.972329672204141
REACTOME_ERK_MAPK_TARGETS	42	Down	0.868091388396157	0.972329672204141
CHEN_LVAD_SUPPORT_OF_FAILING_HEART_DN	40	Up	0.868832773203133	0.972329672204141
KAYO_CALORIE_RESTRICTION_MUSCLE_UP	159	Down	0.868931336167821	0.972329672204141
REACTOME_INTEGRATION_OF_ENERGY_METABOLISM	118	Up	0.869166705399326	0.972329672204141
ALCALAY_AML_BY_NPM1_LOCALIZATION_UP	213	Up	0.869212603299977	0.972329672204141
STEIN_ESRRA_TARGETS	826	Down	0.869717439887281	0.972329672204141
REACTOME_APOPTOSIS	165	Down	0.869984551835576	0.972329672204141
IIZUKA_LIVER_CANCER_PROGRESSION_G1_G2_DN	75	Down	0.870077317553481	0.972329672204141
GILMORE_CORE_NFKB_PATHWAY	14	Up	0.870275966651314	0.972329672204141
CERIBELLI_GENES_INACTIVE_AND_BOUND_BY_NFY	30	Up	0.870393473946614	0.972329672204141
ICHIBA_GRAFT_VERSUS_HOST_DISEASE_D7_UP	128	Down	0.870442672758829	0.972329672204141
CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_UP	286	Up	0.870757411547125	0.972329672204141
BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_24HR_UP	13	Up	0.870816063114261	0.972329672204141
RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN	1082	Up	0.871295683601674	0.972329672204141
REACTOME_MYD88_MAL_CASCADE_INITIATED_ON_PLASMA_MEMBRANE	124	Down	0.871310910402854	0.972329672204141
BIOCARTA_41BB_PATHWAY	22	Up	0.871366939745557	0.972329672204141
REACTOME_SIGNALING_BY_HIPPO	25	Up	0.871380224838303	0.972329672204141
VERNELL_RETINOBLASTOMA_PATHWAY_DN	33	Down	0.871554757698638	0.972329672204141
REACTOME_ADENYLATE_CYCLASE_INHIBITORY_PATHWAY	12	Up	0.871991594761297	0.972329672204141
REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS	22	Down	0.87203339871719	0.972329672204141
TERAMOTO_OPN_TARGETS_CLUSTER_3	4	Down	0.872129541595352	0.972329672204141
BIOCARTA_KREB_PATHWAY	12	Up	0.872364595199586	0.972329672204141
WAKABAYASHI_ADIPOGENESIS_PPARG_BOUND_8D	944	Down	0.872532949281552	0.972329672204141
MCDOWELL_ACUTE_LUNG_INJURY_UP	75	Down	0.872542131943705	0.972329672204141
MEISSNER_NPC_HCP_WITH_H3K4ME2	593	Up	0.872808920387832	0.972329672204141
KIM_WT1_TARGETS_12HR_DN	293	Up	0.872840871647801	0.972329672204141
MOOTHA_ROS	7	Up	0.872901080947589	0.972329672204141
MELLMAN_TUT1_TARGETS_DN	84	Down	0.872914932222219	0.972329672204141
REACTOME_PEPTIDE_LIGAND_BINDING_RECEPTORS	57	Down	0.874127822714209	0.973165246230855
ST_INTEGRIN_SIGNALING_PATHWAY	103	Up	0.874190014272692	0.973165246230855
DIRMEIER_LMP1_RESPONSE_LATE_UP	78	Up	0.874885920745259	0.973165246230855
FIGUEROA_AML_METHYLATION_CLUSTER_2_DN	9	Up	0.874950507436921	0.973165246230855
KEGG_PURINE_METABOLISM	139	Up	0.874965497332495	0.973165246230855
REACTOME_METABOLISM_OF_PROTEINS	486	Up	0.875286647943412	0.973165246230855
SWEET_KRAS_TARGETS_DN	97	Down	0.87597283145782	0.973165246230855
BENPORATH_ES_CORE_NINE_CORRELATED	123	Down	0.875975565376444	0.973165246230855
KEGG_MELANOGENESIS	90	Down	0.876529966054472	0.973165246230855
JISON_SICKLE_CELL_DISEASE_DN	258	Up	0.876542397810287	0.973165246230855
MATTHEWS_SKIN_CARCINOGENESIS_VIA_JUN	14	Down	0.876547049392464	0.973165246230855
AUNG_GASTRIC_CANCER	53	Up	0.876766987988955	0.973165246230855
BIOCARTA_EIF4_PATHWAY	36	Up	0.876864042576103	0.973165246230855
BLUM_RESPONSE_TO_SALIRASIB_UP	323	Up	0.876937919173445	0.973165246230855
AIYAR_COBRA1_TARGETS_DN	47	Down	0.877291219522073	0.973165246230855
KEGG_ALDOSTERONE_REGULATED_SODIUM_REABSORPTION	37	Down	0.877738220347738	0.973165246230855
CUI_TCF21_TARGETS_2_UP	568	Down	0.877866831320346	0.973165246230855
MAGRANGEAS_MULTIPLE_MYELOMA_IGLL_VS_IGLK_UP	67	Down	0.877999591299585	0.973165246230855
SCHAEFFER_PROSTATE_DEVELOPMENT_12HR_DN	68	Down	0.878354856939587	0.973165246230855
FOSTER_TOLERANT_MACROPHAGE_UP	210	Up	0.878419608433881	0.973165246230855
REACTOME_ACTIVATION_OF_RAC	17	Up	0.878701781481202	0.973165246230855
PLASARI_TGFB1_SIGNALING_VIA_NFIC_1HR_DN	164	Down	0.87892722864909	0.973165246230855
SHEPARD_CRUSH_AND_BURN_MUTANT_UP	246	Up	0.879091097667409	0.973165246230855
BIOCARTA_CFTR_PATHWAY	22	Down	0.879156684107115	0.973165246230855
ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_DN	151	Up	0.879252727535623	0.973165246230855
HUMMERICH_SKIN_CANCER_PROGRESSION_UP	135	Down	0.879263867746518	0.973165246230855
BIOCARTA_HIF_PATHWAY	22	Up	0.879334975707868	0.973165246230855
KEGG_BASAL_TRANSCRIPTION_FACTORS	33	Down	0.87943319986442	0.973165246230855
MOOTHA_GLUCONEOGENESIS	41	Down	0.880586660737468	0.97320797531233
HOFMANN_MYELODYSPLASTIC_SYNDROM_RISK_UP	44	Up	0.880694560873662	0.97320797531233
REACTOME_RNA_POL_II_PRE_TRANSCRIPTION_EVENTS	62	Down	0.880753438139823	0.97320797531233
GARY_CD5_TARGETS_DN	592	Down	0.880971692321109	0.97320797531233
WIEDERSCHAIN_TARGETS_OF_BMI1_AND_PCGF2	89	Down	0.880987511453367	0.97320797531233
MULLIGHAN_NPM1_SIGNATURE_3_UP	434	Up	0.881121860034574	0.97320797531233
FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_DN	108	Up	0.881260876626912	0.97320797531233
PETRETTO_HEART_MASS_QTL_CIS_UP	38	Down	0.881743036030779	0.97320797531233
KANG_AR_TARGETS_DN	42	Up	0.881787562142726	0.97320797531233
REACTOME_LATE_PHASE_OF_HIV_LIFE_CYCLE	110	Down	0.881958086186598	0.97320797531233
WU_HBX_TARGETS_2_DN	16	Up	0.882110900695134	0.97320797531233
BERGER_MBD2_TARGETS	4	Up	0.882334520403798	0.97320797531233
MEISSNER_NPC_ICP_WITH_H3K4ME3	40	Down	0.882557411541018	0.97320797531233
REACTOME_OXYGEN_DEPENDENT_PROLINE_HYDROXYLATION_OF_HYPOXIA_INDUCIBLE_FACTOR_ALPHA	18	Up	0.882599269804255	0.97320797531233
REACTOME_NFKB_ACTIVATION_THROUGH_FADD_RIP1_PATHWAY_MEDIATED_BY_CASPASE_8_AND10	11	Up	0.88295135510011	0.97320797531233
DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN	386	Up	0.883252998616072	0.97320797531233
REACTOME_TRANS_GOLGI_NETWORK_VESICLE_BUDDING	93	Down	0.883272981893603	0.97320797531233
PENG_LEUCINE_DEPRIVATION_UP	270	Down	0.883731831479931	0.97320797531233
PID_MTOR_4PATHWAY	94	Down	0.883847208679347	0.97320797531233
NAKAJIMA_MAST_CELL	65	Up	0.883883518631182	0.97320797531233
TERAMOTO_OPN_TARGETS_CLUSTER_5	8	Up	0.884111418403767	0.97320797531233
REACTOME_DEVELOPMENTAL_BIOLOGY	394	Down	0.884126393736594	0.97320797531233
MCCLUNG_CREB1_TARGETS_DN	88	Up	0.884240738545667	0.97320797531233
SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM3	115	Up	0.88441613844535	0.97320797531233
BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_DN	264	Down	0.885211488383988	0.973705882234703
ZHAN_MULTIPLE_MYELOMA_MF_DN	49	Down	0.885280856096116	0.973705882234703
SENESE_HDAC2_TARGETS_DN	161	Up	0.88557352762996	0.973801057850077
REACTOME_CTNNB1_PHOSPHORYLATION_CASCADE	18	Down	0.886987688369751	0.97491950058608
RAMJAUN_APOPTOSIS_BY_TGFB1_VIA_SMAD4_UP	6	Up	0.887035036548709	0.97491950058608
NABA_ECM_REGULATORS	143	Up	0.887385882705578	0.97491950058608
MUNSHI_MULTIPLE_MYELOMA_UP	164	Down	0.88785436854581	0.97491950058608
REACTOME_IKK_COMPLEX_RECRUITMENT_MEDIATED_BY_RIP1	24	Down	0.888133257764145	0.97491950058608
ST_INTERLEUKIN_13_PATHWAY	5	Up	0.888240760383835	0.97491950058608
ST_IL_13_PATHWAY	5	Up	0.888240760383835	0.97491950058608
BREDEMEYER_RAG_SIGNALING_VIA_ATM_NOT_VIA_NFKB_DN	74	Down	0.888465843093805	0.97491950058608
REACTOME_DIGESTION_OF_DIETARY_CARBOHYDRATE	5	Up	0.888592340648873	0.97491950058608
CROONQUIST_NRAS_SIGNALING_UP	48	Down	0.88865439659688	0.97491950058608
EBAUER_TARGETS_OF_PAX3_FOXO1_FUSION_UP	266	Down	0.889062876073744	0.97514117171404
KUMAMOTO_RESPONSE_TO_NUTLIN_3A_UP	34	Up	0.88948501455509	0.975377717910456
FIRESTEIN_CTNNB1_PATHWAY_AND_PROLIFERATION	15	Down	0.890006965489798	0.975692716251126
MIYAGAWA_TARGETS_OF_EWSR1_ETS_FUSIONS_UP	401	Down	0.890345793030003	0.975692716251126
YIH_RESPONSE_TO_ARSENITE_C2	24	Up	0.890391892412914	0.975692716251126
SENESE_HDAC1_TARGETS_UP	624	Down	0.891030455878978	0.976166018917507
BRIDEAU_IMPRINTED_GENES	53	Up	0.891246447579155	0.976176262082989
MENSE_HYPOXIA_UP	122	Down	0.891930234894954	0.976698755133001
SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX3	10	Up	0.892343018237808	0.976795998836161
REACTOME_SYNTHESIS_AND_INTERCONVERSION_OF_NUCLEOTIDE_DI_AND_TRIPHOSPHATES	24	Up	0.892629960720789	0.976795998836161
BOQUEST_STEM_CELL_DN	265	Up	0.892639357954214	0.976795998836161
DARWICHE_PAPILLOMA_RISK_LOW_DN	222	Up	0.892870867126198	0.976823060746679
BIOCARTA_CTCF_PATHWAY	28	Up	0.893171300385128	0.976925497341825
REACTOME_FATTY_ACYL_COA_BIOSYNTHESIS	20	Down	0.89351829072859	0.977041335045487
REACTOME_RESOLUTION_OF_AP_SITES_VIA_THE_SINGLE_NUCLEOTIDE_REPLACEMENT_PATHWAY	12	Down	0.893780135083825	0.977041335045487
CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_4	390	Down	0.89403942416185	0.977041335045487
REACTOME_P130CAS_LINKAGE_TO_MAPK_SIGNALING_FOR_INTEGRINS	15	Up	0.894328802389249	0.977041335045487
LOPEZ_TRANSLATION_VIA_FN1_SIGNALING	47	Down	0.894403424633452	0.977041335045487
GRABARCZYK_BCL11B_TARGETS_UP	117	Up	0.89455228584201	0.977041335045487
WINTER_HYPOXIA_UP	147	Up	0.894899987182287	0.977041335045487
REACTOME_APOPTOTIC_EXECUTION_PHASE	60	Down	0.895029728132324	0.977041335045487
ACEVEDO_LIVER_CANCER_UP	1257	Down	0.895393486880471	0.977041335045487
SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM5	110	Down	0.895522516380329	0.977041335045487
LI_AMPLIFIED_IN_LUNG_CANCER	276	Up	0.895552282122557	0.977041335045487
REACTOME_P75NTR_RECRUITS_SIGNALLING_COMPLEXES	15	Up	0.895818657455254	0.977106289036855
DAVICIONI_PAX_FOXO1_SIGNATURE_IN_ARMS_DN	35	Down	0.896051337091497	0.977134468241051
KEGG_RIG_I_LIKE_RECEPTOR_SIGNALING_PATHWAY	54	Down	0.896771428112512	0.97769402871071
LIU_COMMON_CANCER_GENES	145	Down	0.897406760556357	0.978160945285701
REACTOME_GLYCOSAMINOGLYCAN_METABOLISM	108	Down	0.898269316402379	0.97887525967355
REACTOME_ACTIVATION_OF_NF_KAPPAB_IN_B_CELLS	68	Up	0.898841430724776	0.978940512564416
WEBER_METHYLATED_IN_COLON_CANCER	16	Up	0.899127939838386	0.978940512564416
JONES_TCOF1_TARGETS	5	Up	0.899152835233423	0.978940512564416
KEGG_COMPLEMENT_AND_COAGULATION_CASCADES	31	Up	0.899158104152625	0.978940512564416
REACTOME_M_G1_TRANSITION	84	Down	0.899660291750464	0.979261571020551
PID_IL23_PATHWAY	30	Down	0.900194994326235	0.979617865283837
REACTOME_NFKB_IS_ACTIVATED_AND_SIGNALS_SURVIVAL	15	Down	0.900433817671784	0.979652085371144
SESTO_RESPONSE_TO_UV_C5	82	Down	0.900770443546287	0.97979267218804
LANDIS_ERBB2_BREAST_PRENEOPLASTIC_DN	105	Down	0.901143387592052	0.979972689453235
RICKMAN_TUMOR_DIFFERENTIATED_MODERATELY_VS_POORLY_UP	201	Down	0.901511410927651	0.98011472585583
IWANAGA_CARCINOGENESIS_BY_KRAS_PTEN_UP	208	Up	0.902265346499432	0.98011472585583
AMIT_SERUM_RESPONSE_480_MCF10A	44	Up	0.902669428795957	0.98011472585583
IGLESIAS_E2F_TARGETS_UP	233	Down	0.90274107060143	0.98011472585583
BOYAULT_LIVER_CANCER_SUBCLASS_G1_DN	66	Up	0.902901928901111	0.98011472585583
ABDELMOHSEN_ELAVL4_TARGETS	27	Up	0.903420433162032	0.98011472585583
MCCLUNG_DELTA_FOSB_TARGETS_8WK	80	Up	0.903954046872498	0.98011472585583
REACTOME_ABACAVIR_TRANSPORT_AND_METABOLISM	10	Up	0.90460516584806	0.98011472585583
REACTOME_ETHANOL_OXIDATION	8	Down	0.904948273502312	0.98011472585583
BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_B	708	Up	0.905154163789499	0.98011472585583
AMIT_EGF_RESPONSE_20_MCF10A	28	Up	0.905339601491994	0.98011472585583
FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN	773	Down	0.905378648837963	0.98011472585583
VARELA_ZMPSTE24_TARGETS_UP	52	Up	0.905640862365213	0.98011472585583
REACTOME_AUTODEGRADATION_OF_CDH1_BY_CDH1_APC_C	65	Down	0.905686658884949	0.98011472585583
CAIRO_HEPATOBLASTOMA_POOR_SURVIVAL	25	Down	0.905731293218746	0.98011472585583
PID_RB_1PATHWAY	79	Down	0.905780122704552	0.98011472585583
REACTOME_CHONDROITIN_SULFATE_DERMATAN_SULFATE_METABOLISM	45	Down	0.905867955691751	0.98011472585583
FIGUEROA_AML_METHYLATION_CLUSTER_6_UP	178	Up	0.905912148149039	0.98011472585583
FONTAINE_PAPILLARY_THYROID_CARCINOMA_UP	89	Up	0.906232051315963	0.98011472585583
SANSOM_APC_TARGETS_UP	173	Down	0.906301188859413	0.98011472585583
BIOCARTA_TH1TH2_PATHWAY	6	Up	0.906350911438038	0.98011472585583
BIOCARTA_LECTIN_PATHWAY	6	Up	0.906682744240123	0.98011472585583
SCHOEN_NFKB_SIGNALING	47	Up	0.907040505799708	0.98011472585583
PASINI_SUZ12_TARGETS_UP	138	Down	0.907206984726406	0.98011472585583
RAMPON_ENRICHED_LEARNING_ENVIRONMENT_EARLY_UP	28	Up	0.907442380898791	0.98011472585583
GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_UP	24	Up	0.907449941651865	0.98011472585583
TAYLOR_METHYLATED_IN_ACUTE_LYMPHOBLASTIC_LEUKEMIA	105	Up	0.907708909128254	0.98011472585583
TOMLINS_PROSTATE_CANCER_DN	58	Down	0.907808108963097	0.98011472585583
BIOCARTA_BLYMPHOCYTE_PATHWAY	7	Down	0.907970616676284	0.98011472585583
NIKOLSKY_BREAST_CANCER_12Q13_Q21_AMPLICON	75	Up	0.908008122837382	0.98011472585583
BIOCARTA_GABA_PATHWAY	9	Down	0.908548083151874	0.98011472585583
RAO_BOUND_BY_SALL4_ISOFORM_A	193	Down	0.90864901732767	0.98011472585583
PECE_MAMMARY_STEM_CELL_DN	188	Down	0.908867328274603	0.98011472585583
KYNG_DNA_DAMAGE_BY_4NQO_OR_UV	96	Down	0.909217117533894	0.98011472585583
KEGG_DRUG_METABOLISM_OTHER_ENZYMES	36	Down	0.909453708133948	0.98011472585583
SARTIPY_NORMAL_AT_INSULIN_RESISTANCE_UP	59	Down	0.909640197320195	0.98011472585583
DELYS_THYROID_CANCER_UP	570	Up	0.91019596606004	0.98011472585583
WORSCHECH_TUMOR_EVASION_AND_TOLEROGENICITY_UP	22	Up	0.910255705800544	0.98011472585583
SHIN_B_CELL_LYMPHOMA_CLUSTER_1	10	Up	0.910379180771711	0.98011472585583
REACTOME_MEMBRANE_BINDING_AND_TARGETTING_OF_GAG_PROTEINS	12	Up	0.910459992022419	0.98011472585583
NOJIMA_SFRP2_TARGETS_UP	34	Down	0.910520502739815	0.98011472585583
LEE_BMP2_TARGETS_DN	1102	Down	0.910715147176227	0.98011472585583
FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP	109	Up	0.910818523907164	0.98011472585583
LIANG_SILENCED_BY_METHYLATION_2	53	Down	0.910925851717793	0.98011472585583
PID_RHOA_PATHWAY	56	Up	0.911376643055818	0.98011472585583
WILLERT_WNT_SIGNALING	33	Down	0.911570561446988	0.98011472585583
ZWANG_CLASS_1_TRANSIENTLY_INDUCED_BY_EGF	704	Down	0.91164588557042	0.98011472585583
LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_SMALL_VS_HUGE_UP	53	Up	0.911834683864507	0.98011472585583
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_TURQUOISE_UP	131	Down	0.912223392579561	0.98011472585583
BIOCARTA_MAL_PATHWAY	34	Down	0.913046088497305	0.98011472585583
POOLA_INVASIVE_BREAST_CANCER_DN	181	Up	0.913091353305506	0.98011472585583
REACTOME_GOLGI_ASSOCIATED_VESICLE_BIOGENESIS	76	Up	0.913152916743224	0.98011472585583
POS_RESPONSE_TO_HISTAMINE_DN	14	Down	0.913618226336844	0.98011472585583
ZWANG_DOWN_BY_2ND_EGF_PULSE	333	Down	0.913776296265743	0.98011472585583
REACTOME_PROLACTIN_RECEPTOR_SIGNALING	16	Up	0.913950294350516	0.98011472585583
CAMPS_COLON_CANCER_COPY_NUMBER_UP	103	Up	0.9140371680277	0.98011472585583
KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_UV_IN_WS	14	Up	0.914107235080742	0.98011472585583
IVANOVA_HEMATOPOIESIS_STEM_CELL	345	Down	0.914239064280254	0.98011472585583
BECKER_TAMOXIFEN_RESISTANCE_UP	87	Up	0.914303506280222	0.98011472585583
MIKKELSEN_IPS_LCP_WITH_H3K4ME3_AND_H3K27ME3	9	Up	0.914402886591042	0.98011472585583
AMIT_SERUM_RESPONSE_60_MCF10A	86	Up	0.91459668135805	0.98011472585583
WANG_NFKB_TARGETS	37	Down	0.914755811040104	0.98011472585583
ONO_AML1_TARGETS_DN	32	Down	0.914773742453595	0.98011472585583
KEGG_VASOPRESSIN_REGULATED_WATER_REABSORPTION	51	Up	0.914780137312728	0.98011472585583
LINDGREN_BLADDER_CANCER_CLUSTER_3_DN	344	Down	0.915106413992951	0.98011472585583
REACTOME_PTM_GAMMA_CARBOXYLATION_HYPUSINE_FORMATION_AND_ARYLSULFATASE_ACTIVATION	24	Up	0.915142815746414	0.98011472585583
MARTINEZ_TP53_TARGETS_UP	790	Down	0.915174863621945	0.98011472585583
ACEVEDO_NORMAL_TISSUE_ADJACENT_TO_LIVER_TUMOR_DN	456	Down	0.91565081209702	0.980232630834543
RIZKI_TUMOR_INVASIVENESS_3D_DN	383	Down	0.915699957636079	0.980232630834543
BIOCARTA_TNFR2_PATHWAY	32	Down	0.915972067948117	0.980301778202743
REACTOME_RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2_	89	Down	0.916767442246322	0.980930780786325
CHEN_HOXA5_TARGETS_9HR_DN	53	Down	0.917711110084192	0.981718134972311
SCHLOSSER_MYC_AND_SERUM_RESPONSE_SYNERGY	58	Down	0.918160962188504	0.981976994652138
MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_12	13	Up	0.919165050836699	0.98270608495787
FARMER_BREAST_CANCER_APOCRINE_VS_BASAL	496	Down	0.919258719184765	0.98270608495787
BUCKANOVICH_T_LYMPHOCYTE_HOMING_ON_TUMOR_UP	30	Up	0.91972587790784	0.982811290942882
REACTOME_ACTIVATED_TAK1_MEDIATES_P38_MAPK_ACTIVATION	19	Up	0.919773225499256	0.982811290942882
PID_TCR_JNK_PATHWAY	14	Down	0.919993059023088	0.982823883045018
SHEPARD_BMYB_MORPHOLINO_UP	288	Down	0.920765787589899	0.983426990860204
WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_UP	508	Down	0.921153460866776	0.983618659388483
FIRESTEIN_PROLIFERATION	210	Down	0.921857900722515	0.98379507353271
BENPORATH_ES_1	499	Down	0.92202806528016	0.98379507353271
WU_HBX_TARGETS_3_DN	17	Down	0.922198705373267	0.98379507353271
KARAKAS_TGFB1_SIGNALING	20	Up	0.922325314831235	0.98379507353271
MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_14	6	Down	0.922359945105075	0.98379507353271
BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_C	140	Down	0.922820478628306	0.983884700404663
BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_AND_PAX3	10	Up	0.922860522331301	0.983884700404663
REACTOME_TRAF3_DEPENDENT_IRF_ACTIVATION_PATHWAY	13	Down	0.923647220596296	0.984123555340286
KATSANOU_ELAVL1_TARGETS_DN	212	Up	0.923775995910088	0.984123555340286
MCLACHLAN_DENTAL_CARIES_DN	216	Down	0.923878890057862	0.984123555340286
LIAO_METASTASIS	773	Down	0.924064160913473	0.984123555340286
REACTOME_FORMATION_OF_RNA_POL_II_ELONGATION_COMPLEX_	44	Up	0.924372461340266	0.984123555340286
REACTOME_TRAF6_MEDIATED_INDUCTION_OF_TAK1_COMPLEX	29	Up	0.924493385368638	0.984123555340286
TSAI_RESPONSE_TO_RADIATION_THERAPY	47	Up	0.924542832049151	0.984123555340286
LI_PROSTATE_CANCER_EPIGENETIC	38	Up	0.925797031329389	0.984946836753456
GUTIERREZ_CHRONIC_LYMPHOCYTIC_LEUKEMIA_DN	77	Up	0.92589859344479	0.984946836753456
REACTOME_BASE_FREE_SUGAR_PHOSPHATE_REMOVAL_VIA_THE_SINGLE_NUCLEOTIDE_REPLACEMENT_PATHWAY	10	Down	0.926060537814726	0.984946836753456
PHESSE_TARGETS_OF_APC_AND_MBD2_UP	14	Up	0.926150264364701	0.984946836753456
DAZARD_UV_RESPONSE_CLUSTER_G28	23	Up	0.926403462090124	0.984994363023575
KEGG_NOTCH_SIGNALING_PATHWAY	44	Down	0.9270019879307	0.985408953866928
REACTOME_PREFOLDIN_MEDIATED_TRANSFER_OF_SUBSTRATE_TO_CCT_TRIC	32	Down	0.9277315711799	0.985901891174906
CHIARADONNA_NEOPLASTIC_TRANSFORMATION_CDC25_DN	243	Up	0.927883109264105	0.985901891174906
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLACK_DN	18	Up	0.929338976712615	0.987062953040492
ZHOU_INFLAMMATORY_RESPONSE_FIMA_DN	377	Up	0.929394542885862	0.987062953040492
SANA_TNF_SIGNALING_UP	116	Down	0.929602683758923	0.987062953040492
REACTOME_TRAFFICKING_OF_AMPA_RECEPTORS	25	Up	0.930260542574321	0.98721895393103
BIOCARTA_RARRXR_PATHWAY	17	Up	0.930276687232838	0.98721895393103
REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX	18	Up	0.930479591536338	0.98721895393103
OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP	337	Up	0.930908689973069	0.98721895393103
MATSUDA_NATURAL_KILLER_DIFFERENTIATION	613	Down	0.931001894254716	0.98721895393103
COATES_MACROPHAGE_M1_VS_M2_UP	106	Down	0.931016072062789	0.98721895393103
KAAB_HEART_ATRIUM_VS_VENTRICLE_UP	392	Up	0.931289539778136	0.98721895393103
WAMUNYOKOLI_OVARIAN_CANCER_LMP_UP	352	Up	0.931819792583803	0.98721895393103
STEIN_ESRRA_TARGETS_DN	168	Down	0.931838126929667	0.98721895393103
CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP	352	Up	0.93183939787859	0.98721895393103
MOOTHA_TCA	20	Down	0.932279098466342	0.987463332097534
UROSEVIC_RESPONSE_TO_IMIQUIMOD	21	Down	0.932811959851746	0.9878062538309
BIOCARTA_CD40_PATHWAY	28	Down	0.933084946243161	0.987873887506206
LEE_LIVER_CANCER	38	Up	0.933701316550275	0.98830495616928
MANALO_HYPOXIA_UP	350	Up	0.93463815222616	0.989073557269802
SEKI_INFLAMMATORY_RESPONSE_LPS_UP	93	Up	0.935175712858167	0.989073557269802
DACOSTA_UV_RESPONSE_VIA_ERCC3_XPCS_DN	143	Up	0.935194667178977	0.989073557269802
REACTOME_SLBP_DEPENDENT_PROCESSING_OF_REPLICATION_DEPENDENT_HISTONE_PRE_MRNAS	14	Up	0.935264940796826	0.989073557269802
SUZUKI_RESPONSE_TO_TSA_AND_DECITABINE_1B	26	Up	0.935672929832947	0.989167730965056
MCLACHLAN_DENTAL_CARIES_UP	197	Up	0.935851752352147	0.989167730965056
BIOCARTA_BARR_MAPK_PATHWAY	22	Up	0.936505116750493	0.989167730965056
REACTOME_ENDOGENOUS_STEROLS	5	Up	0.936588603471298	0.989167730965056
NAKAMURA_ADIPOGENESIS_LATE_UP	162	Up	0.93663270553873	0.989167730965056
REACTOME_YAP1_AND_WWTR1_TAZ_STIMULATED_GENE_EXPRESSION	26	Down	0.936692028009775	0.989167730965056
ABBUD_LIF_SIGNALING_1_DN	36	Up	0.936839536520609	0.989167730965056
WILSON_PROTEASES_AT_TUMOR_BONE_INTERFACE_UP	22	Down	0.937080246294482	0.989167730965056
PID_IL4_2PATHWAY	88	Down	0.937317002955622	0.989167730965056
REACTOME_OLFACTORY_SIGNALING_PATHWAY	8	Up	0.93744791099292	0.989167730965056
RIZKI_TUMOR_INVASIVENESS_2D_UP	102	Down	0.937942803137727	0.989459764547383
ROSS_LEUKEMIA_WITH_MLL_FUSIONS	109	Up	0.938328548343854	0.989459764547383
KEGG_LYSOSOME	117	Down	0.938738554431256	0.989459764547383
LEIN_MEDULLA_MARKERS	96	Up	0.938742631629937	0.989459764547383
ST_JNK_MAPK_PATHWAY	65	Down	0.93881660519826	0.989459764547383
PID_EPHA2_FWD_PATHWAY	38	Down	0.939055531457283	0.989459764547383
WELCH_GATA1_TARGETS	25	Down	0.93936681063308	0.989459764547383
PID_BMP_PATHWAY	47	Up	0.939400305672103	0.989459764547383
KEGG_RENIN_ANGIOTENSIN_SYSTEM	7	Down	0.940019856338087	0.989891618667214
KYNG_DNA_DAMAGE_UP	306	Up	0.940795823766072	0.990473780254633
KIM_WT1_TARGETS_UP	307	Up	0.941012908615103	0.990473780254633
QI_PLASMACYTOMA_UP	282	Down	0.941201693387606	0.990473780254633
RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_DN	693	Up	0.941513709218624	0.990581461547612
FU_INTERACT_WITH_ALKBH8	15	Down	0.942110348492369	0.99098848503183
CHENG_IMPRINTED_BY_ESTRADIOL	189	Up	0.942366190745316	0.991036929002865
SCHLINGEMANN_SKIN_CARCINOGENESIS_TPA_UP	43	Up	0.942758808982221	0.991095164767011
CASTELLANO_HRAS_AND_NRAS_TARGETS_DN	12	Down	0.943090414836306	0.991095164767011
RIGGI_EWING_SARCOMA_PROGENITOR_DN	231	Down	0.943118029521756	0.991095164767011
REACTOME_REGULATION_OF_INSULIN_SECRETION_BY_ACETYLCHOLINE	9	Down	0.943740712677145	0.991095164767011
HOSHIDA_LIVER_CANCER_LATE_RECURRENCE_DN	68	Down	0.94382234832091	0.991095164767011
SARTIPY_BLUNTED_BY_INSULIN_RESISTANCE_DN	26	Up	0.944103263981297	0.991095164767011
KEGG_FOLATE_BIOSYNTHESIS	10	Up	0.944120994039134	0.991095164767011
REACTOME_MTORC1_MEDIATED_SIGNALLING	12	Up	0.944240885127712	0.991095164767011
SHIPP_DLBCL_CURED_VS_FATAL_UP	91	Up	0.944471361491869	0.991095164767011
CASTELLANO_NRAS_TARGETS_UP	99	Down	0.944983094213784	0.991095164767011
ZHONG_RESPONSE_TO_AZACITIDINE_AND_TSA_UP	292	Up	0.945122791440681	0.991095164767011
KASLER_HDAC7_TARGETS_2_UP	4	Down	0.945133819127697	0.991095164767011
BIOCARTA_SET_PATHWAY	15	Down	0.945350991885254	0.991095164767011
LIAN_LIPA_TARGETS_3M	51	Down	0.945610699772501	0.991095164767011
PID_EPO_PATHWAY	44	Down	0.945848361226648	0.991095164767011
PID_SYNDECAN_2_PATHWAY	55	Up	0.945977979490132	0.991095164767011
ZHU_SKIL_TARGETS_UP	31	Up	0.945988166370545	0.991095164767011
REACTOME_METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES	196	Down	0.946395777821834	0.991302362401406
ACEVEDO_NORMAL_TISSUE_ADJACENT_TO_LIVER_TUMOR_UP	284	Down	0.946854811979617	0.991563318951831
PETROVA_ENDOTHELIUM_LYMPHATIC_VS_BLOOD_DN	269	Up	0.947450572122548	0.991689544522075
BOYAULT_LIVER_CANCER_SUBCLASS_G6_UP	137	Down	0.947527481873214	0.991689544522075
BROWNE_HCMV_INFECTION_1HR_DN	320	Up	0.948430160029365	0.991689544522075
FERRANDO_TAL1_NEIGHBORS	22	Down	0.948484644880349	0.991689544522075
PYEON_HPV_POSITIVE_TUMORS_DN	8	Up	0.948529466575175	0.991689544522075
LIN_NPAS4_TARGETS_DN	82	Up	0.94864902312944	0.991689544522075
REACTOME_RNA_POL_II_TRANSCRIPTION_PRE_INITIATION_AND_PROMOTER_OPENING	42	Down	0.948688282163187	0.991689544522075
BENPORATH_NANOG_TARGETS	1334	Down	0.948968048196828	0.991689544522075
BURTON_ADIPOGENESIS_12	49	Up	0.949146726699664	0.991689544522075
NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN	845	Up	0.949440592796596	0.991689544522075
RATTENBACHER_BOUND_BY_CELF1	585	Up	0.949661702746744	0.991689544522075
BRUINS_UVC_RESPONSE_EARLY_LATE	444	Down	0.949681411141982	0.991689544522075
BIOCARTA_RELA_PATHWAY	18	Down	0.950011543829169	0.991689544522075
KYNG_RESPONSE_TO_H2O2_VIA_ERCC6	26	Up	0.950090554850113	0.991689544522075
AMIT_EGF_RESPONSE_60_HELA	59	Up	0.950817090515783	0.991689544522075
XU_GH1_AUTOCRINE_TARGETS_DN	220	Down	0.95096227542962	0.991689544522075
PID_CMYB_PATHWAY	131	Down	0.951040976406804	0.991689544522075
NAKAMURA_METASTASIS_MODEL_UP	72	Up	0.951289491856608	0.991689544522075
SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A12	325	Up	0.951310466515385	0.991689544522075
JIANG_TIP30_TARGETS_DN	31	Down	0.951484658914899	0.991689544522075
REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS	45	Down	0.951532839264312	0.991689544522075
WANG_HCP_PROSTATE_CANCER	179	Down	0.951869245794545	0.991689544522075
WU_ALZHEIMER_DISEASE_UP	24	Up	0.95237140259556	0.991689544522075
KOYAMA_SEMA3B_TARGETS_UP	359	Up	0.952445715828269	0.991689544522075
SIG_PIP3_SIGNALING_IN_CARDIAC_MYOCTES	86	Down	0.952697651986548	0.991689544522075
FERRANDO_LYL1_NEIGHBORS	15	Up	0.952718276492919	0.991689544522075
COULOUARN_TEMPORAL_TGFB1_SIGNATURE_DN	212	Down	0.952751259668622	0.991689544522075
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_DN	55	Up	0.952978391846443	0.991689544522075
KEGG_NITROGEN_METABOLISM	17	Down	0.953240286898443	0.991689544522075
MULLIGHAN_MLL_SIGNATURE_2_DN	400	Up	0.953396478163788	0.991689544522075
OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN	363	Up	0.953525885827433	0.991689544522075
ZWANG_TRANSIENTLY_UP_BY_1ST_EGF_PULSE_ONLY	1998	Down	0.95369297221926	0.991689544522075
PID_P53_DOWNSTREAM_PATHWAY	185	Up	0.954940557607913	0.992768308569494
NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_UP	392	Up	0.955514255650081	0.992985019440101
MIKHAYLOVA_OXIDATIVE_STRESS_RESPONSE_VIA_VHL_DN	13	Down	0.955621090264507	0.992985019440101
KENNY_CTNNB1_TARGETS_DN	84	Up	0.955949000924625	0.992985019440101
OUILLETTE_CLL_13Q14_DELETION_UP	120	Up	0.955989811264517	0.992985019440101
REACTOME_SPRY_REGULATION_OF_FGF_SIGNALING	20	Up	0.956481423673016	0.993277257733859
REACTOME_AXON_GUIDANCE	268	Up	0.957484189791756	0.994100068698078
ALONSO_METASTASIS_NEURAL_UP	23	Down	0.957746798584125	0.994154224678402
PID_HES_HEY_PATHWAY	61	Down	0.95808074654462	0.994228308060785
MACLACHLAN_BRCA1_TARGETS_DN	35	Up	0.958418802881554	0.994228308060785
ROSS_ACUTE_MYELOID_LEUKEMIA_CBF	119	Down	0.958778609003501	0.994228308060785
BIOCARTA_P35ALZHEIMERS_PATHWAY	16	Up	0.958975680561575	0.994228308060785
KEGG_ENDOCYTOSIS	190	Down	0.959002206668322	0.994228308060785
REACTOME_P53_DEPENDENT_G1_DNA_DAMAGE_RESPONSE	59	Down	0.959240351798359	0.994228308060785
MACLACHLAN_BRCA1_TARGETS_UP	38	Up	0.959291411545524	0.994228308060785
WATANABE_ULCERATIVE_COLITIS_WITH_CANCER_DN	35	Up	0.959611510686325	0.994341911928537
CHAUHAN_RESPONSE_TO_METHOXYESTRADIOL_UP	94	Down	0.960019310788876	0.994353988044343
TERAMOTO_OPN_TARGETS_CLUSTER_7	24	Down	0.960123851157388	0.994353988044343
STEIN_ESRRA_TARGETS_UP	619	Up	0.960450282033095	0.994353988044343
YAMASHITA_LIVER_CANCER_WITH_EPCAM_UP	76	Down	0.960465124353585	0.994353988044343
SAFFORD_T_LYMPHOCYTE_ANERGY	128	Down	0.961360853138029	0.994658022278321
DODD_NASOPHARYNGEAL_CARCINOMA_UP	1738	Up	0.961413790376203	0.994658022278321
REACTOME_INSULIN_RECEPTOR_SIGNALLING_CASCADE	84	Up	0.961472647748168	0.994658022278321
MAHAJAN_RESPONSE_TO_IL1A_UP	109	Up	0.961758612558255	0.994658022278321
LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP	312	Down	0.961811567689959	0.994658022278321
NAKAMURA_ADIPOGENESIS_EARLY_UP	81	Up	0.962074783747683	0.994700965273503
IKEDA_MIR30_TARGETS_UP	244	Down	0.962416768412329	0.994700965273503
COLIN_PILOCYTIC_ASTROCYTOMA_VS_GLIOBLASTOMA_DN	48	Down	0.962654809331133	0.994700965273503
KEGG_ADHERENS_JUNCTION	94	Down	0.962698135044313	0.994700965273503
SHIN_B_CELL_LYMPHOMA_CLUSTER_8	40	Up	0.962905909016877	0.994700965273503
RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_DN	157	Up	0.963322996564925	0.994785746893915
FIGUEROA_AML_METHYLATION_CLUSTER_1_UP	149	Up	0.963464559347045	0.994785746893915
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_16	132	Down	0.963782928997507	0.994785746893915
TURJANSKI_MAPK1_AND_MAPK2_TARGETS	15	Down	0.963830305574396	0.994785746893915
PARK_HSC_VS_MULTIPOTENT_PROGENITORS_DN	28	Up	0.964350872619313	0.994941611275014
FIGUEROA_AML_METHYLATION_CLUSTER_4_UP	151	Down	0.964532382180259	0.994941611275014
SCIBETTA_KDM5B_TARGETS_DN	105	Down	0.964683663507374	0.994941611275014
KORKOLA_SEMINOMA_UP	63	Up	0.964857827140114	0.994941611275014
IWANAGA_CARCINOGENESIS_BY_KRAS_PTEN_DN	461	Down	0.965419451961117	0.994941611275014
HEDENFALK_BREAST_CANCER_BRCA1_VS_BRCA2	236	Down	0.965431787310549	0.994941611275014
SMIRNOV_RESPONSE_TO_IR_6HR_UP	260	Up	0.965455619408269	0.994941611275014
JIANG_HYPOXIA_NORMAL	426	Down	0.965865711850522	0.995147136920799
CHIBA_RESPONSE_TO_TSA	83	Down	0.966202955317326	0.995277531818371
PARK_TRETINOIN_RESPONSE_AND_PML_RARA_FUSION	36	Up	0.966639570756257	0.995408394495489
MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP	510	Up	0.967373173690264	0.995408394495489
DOANE_RESPONSE_TO_ANDROGEN_DN	406	Down	0.967385311237402	0.995408394495489
YAO_HOXA10_TARGETS_VIA_PROGESTERONE_UP	97	Up	0.967420828556797	0.995408394495489
BOYAULT_LIVER_CANCER_SUBCLASS_G3_DN	56	Down	0.967546589236918	0.995408394495489
PID_S1P_S1P2_PATHWAY	31	Down	0.967754712943629	0.995408394495489
CORRADETTI_MTOR_PATHWAY_REGULATORS_DN	6	Down	0.968329070318685	0.995408394495489
CHEOK_RESPONSE_TO_MERCAPTOPURINE_AND_LD_MTX_DN	17	Up	0.96839464085315	0.995408394495489
SMID_BREAST_CANCER_ERBB2_DN	6	Down	0.968968408757396	0.995408394495489
FOURNIER_ACINAR_DEVELOPMENT_LATE_UP	11	Down	0.969128020795781	0.995408394495489
MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_15	19	Up	0.96974053920477	0.995408394495489
HOEBEKE_LYMPHOID_STEM_CELL_DN	114	Up	0.970760372714213	0.995408394495489
REACTOME_HYALURONAN_UPTAKE_AND_DEGRADATION	12	Up	0.970808722155679	0.995408394495489
BRUNEAU_SEPTATION_VENTRICULAR	14	Down	0.970938441932292	0.995408394495489
TENEDINI_MEGAKARYOCYTE_MARKERS	77	Up	0.970967403534183	0.995408394495489
LIU_CMYB_TARGETS_DN	8	Up	0.971332119003306	0.995408394495489
KANG_GIST_WITH_PDGFRA_UP	55	Down	0.97133624765194	0.995408394495489
YU_MYC_TARGETS_DN	73	Down	0.971631015581013	0.995408394495489
REACTOME_ANTIGEN_PROCESSING_CROSS_PRESENTATION	87	Down	0.971648905201055	0.995408394495489
IGLESIAS_E2F_TARGETS_DN	15	Up	0.971718035256522	0.995408394495489
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLUE_DN	71	Down	0.971793319629984	0.995408394495489
CERVERA_SDHB_TARGETS_1_UP	143	Down	0.97196790373405	0.995408394495489
IVANOVA_HEMATOPOIESIS_MATURE_CELL	371	Down	0.97204239966079	0.995408394495489
CHESLER_BRAIN_HIGHEST_EXPRESSION	64	Up	0.972216343589659	0.995408394495489
ELLWOOD_MYC_TARGETS_UP	17	Up	0.972237458526384	0.995408394495489
DUNNE_TARGETS_OF_AML1_MTG8_FUSION_DN	44	Down	0.972349112499308	0.995408394495489
KEGG_PANTOTHENATE_AND_COA_BIOSYNTHESIS	16	Down	0.972753346964002	0.995408394495489
KYNG_DNA_DAMAGE_BY_4NQO	50	Down	0.973120657457717	0.995408394495489
MIKKELSEN_MCV6_LCP_WITH_H3K4ME3	198	Up	0.973342160664147	0.995408394495489
PID_ALPHA_SYNUCLEIN_PATHWAY	38	Down	0.973385439406005	0.995408394495489
BIDUS_METASTASIS_DN	223	Down	0.97349025410162	0.995408394495489
LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_DN	1057	Down	0.973871671384189	0.995408394495489
REACTOME_FORMATION_OF_TRANSCRIPTION_COUPLED_NER_TC_NER_REPAIR_COMPLEX	31	Down	0.974234023147393	0.995408394495489
NAKAJIMA_EOSINOPHIL	17	Down	0.9742902653763	0.995408394495489
SU_PANCREAS	44	Down	0.974370973309195	0.995408394495489
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_4	14	Down	0.974416533559153	0.995408394495489
ZEMBUTSU_SENSITIVITY_TO_MITOMYCIN	25	Down	0.974554794063449	0.995408394495489
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_DN	22	Up	0.974658123990711	0.995408394495489
WANG_CLIM2_TARGETS_DN	308	Down	0.974742823727285	0.995408394495489
MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_1	4	Down	0.974940783235093	0.995408394495489
GESERICK_TERT_TARGETS_DN	36	Down	0.974969229748228	0.995408394495489
SCHLOSSER_MYC_TARGETS_AND_SERUM_RESPONSE_UP	79	Down	0.975741900430652	0.995596728905807
HELLER_HDAC_TARGETS_DN	397	Up	0.975829934430132	0.995596728905807
REACTOME_ABCA_TRANSPORTERS_IN_LIPID_HOMEOSTASIS	16	Up	0.975974160857771	0.995596728905807
REACTOME_RNA_POL_I_RNA_POL_III_AND_MITOCHONDRIAL_TRANSCRIPTION	95	Down	0.976250718027658	0.995596728905807
REACTOME_CLASS_B_2_SECRETIN_FAMILY_RECEPTORS	51	Down	0.976406733786502	0.995596728905807
REACTOME_DSCAM_INTERACTIONS	14	Up	0.97652123199559	0.995596728905807
TARTE_PLASMA_CELL_VS_PLASMABLAST_UP	494	Up	0.976967869407693	0.995596728905807
ENK_UV_RESPONSE_EPIDERMIS_UP	397	Down	0.977023908481888	0.995596728905807
MUELLER_METHYLATED_IN_GLIOBLASTOMA	46	Down	0.97705047315989	0.995596728905807
ZHENG_FOXP3_TARGETS_IN_T_LYMPHOCYTE_UP	13	Up	0.977353514677835	0.995690749048543
URS_ADIPOCYTE_DIFFERENTIATION_DN	76	Down	0.977771173225227	0.995901470960753
SIMBULAN_UV_RESPONSE_NORMAL_UP	9	Down	0.978351104096712	0.996111743048617
KEGG_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION	93	Up	0.978399341182385	0.996111743048617
HOEBEKE_LYMPHOID_STEM_CELL_UP	146	Up	0.978646954813192	0.996149152022736
APRELIKOVA_BRCA1_TARGETS	70	Up	0.979309097198619	0.996608396201266
JECHLINGER_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_DN	106	Down	0.979808296407834	0.996901656737154
REACTOME_ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION	216	Up	0.980043625278805	0.996926375068277
PID_EPHB_FWD_PATHWAY	65	Down	0.980483574770596	0.996967135016389
KIM_GASTRIC_CANCER_CHEMOSENSITIVITY	127	Down	0.980505780966584	0.996967135016389
WU_HBX_TARGETS_1_DN	37	Down	0.981065804217979	0.997193411393338
HOWLIN_CITED1_TARGETS_1_UP	36	Up	0.981248192421626	0.997193411393338
VANTVEER_BREAST_CANCER_POOR_PROGNOSIS	78	Down	0.981361593896619	0.997193411393338
LEE_METASTASIS_AND_ALTERNATIVE_SPLICING_DN	70	Up	0.981629938508364	0.997197228339095
CREIGHTON_AKT1_SIGNALING_VIA_MTOR_DN	39	Up	0.981834440729193	0.997197228339095
SA_CASPASE_CASCADE	16	Down	0.982028191005157	0.997197228339095
PID_RXR_VDR_PATHWAY	30	Up	0.982209717074896	0.997197228339095
GAZDA_DIAMOND_BLACKFAN_ANEMIA_MYELOID_DN	82	Up	0.982607509822991	0.997386737516934
LEE_LIVER_CANCER_HEPATOBLAST	19	Down	0.983199689668887	0.997773433726278
VANDESLUIS_NORMAL_EMBRYOS_DN	24	Down	0.983863581628685	0.998232723284774
PID_SYNDECAN_4_PATHWAY	46	Down	0.984116370161278	0.998262208464356
BOYAULT_LIVER_CANCER_SUBCLASS_G1_UP	189	Up	0.984341506919578	0.998262208464356
KEGG_BUTANOATE_METABOLISM	52	Down	0.984550774580051	0.998262208464356
SASSON_RESPONSE_TO_FORSKOLIN_DN	150	Up	0.9847957289031	0.998262208464356
ZHAN_EARLY_DIFFERENTIATION_GENES_UP	4	Down	0.984949228122854	0.998262208464356
SABATES_COLORECTAL_ADENOMA_SIZE_UP	19	Down	0.985250920374666	0.998307173348846
HOFMANN_MYELODYSPLASTIC_SYNDROM_RISK_DN	33	Up	0.985556906719762	0.998307173348846
MARCHINI_TRABECTEDIN_RESISTANCE_UP	28	Down	0.985897775362789	0.998307173348846
MIKKELSEN_MEF_LCP_WITH_H3K27ME3	37	Down	0.986001734306474	0.998307173348846
LINDGREN_BLADDER_CANCER_WITH_LOH_IN_CHR9Q	191	Up	0.986260222620764	0.998307173348846
SCHURINGA_STAT5A_TARGETS_DN	11	Up	0.986261553348659	0.998307173348846
SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM2	251	Up	0.986891360021307	0.998310275027893
KEGG_GLYOXYLATE_AND_DICARBOXYLATE_METABOLISM	16	Down	0.98702771849034	0.998310275027893
XU_CREBBP_TARGETS_UP	32	Down	0.987043660720669	0.998310275027893
CLAUS_PGR_POSITIVE_MENINGIOMA_DN	14	Down	0.987183296946269	0.998310275027893
SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN	368	Up	0.987485750199593	0.998310275027893
CHEMELLO_SOLEUS_VS_EDL_MYOFIBERS_UP	46	Up	0.987660884733741	0.998310275027893
REACTOME_PROCESSING_OF_INTRONLESS_PRE_MRNAS	18	Down	0.987931320661872	0.998310275027893
REACTOME_SIGNALING_BY_RHO_GTPASES	107	Up	0.988263576120711	0.998310275027893
GRUETZMANN_PANCREATIC_CANCER_DN	295	Down	0.98963161030142	0.998310275027893
TERAO_AOX4_TARGETS_HG_DN	8	Down	0.989648377264342	0.998310275027893
JOHANSSON_BRAIN_CANCER_EARLY_VS_LATE_UP	16	Up	0.989661432483299	0.998310275027893
CHICAS_RB1_TARGETS_CONFLUENT	743	Up	0.989730152304755	0.998310275027893
APPIERTO_RESPONSE_TO_FENRETINIDE_UP	53	Up	0.989748335230393	0.998310275027893
ZUCCHI_METASTASIS_UP	63	Up	0.989913967590695	0.998310275027893
REACTOME_ACTIVATION_OF_ATR_IN_RESPONSE_TO_REPLICATION_STRESS	36	Up	0.990153452533498	0.998310275027893
MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_27	20	Down	0.990293107536746	0.998310275027893
BOSCO_ALLERGEN_INDUCED_TH2_ASSOCIATED_MODULE	185	Down	0.990515548483839	0.998310275027893
MASRI_RESISTANCE_TO_TAMOXIFEN_AND_AROMATASE_INHIBITORS_UP	29	Down	0.990587464743139	0.998310275027893
SHAFFER_IRF4_TARGETS_IN_MYELOMA_VS_MATURE_B_LYMPHOCYTE	142	Up	0.99085948987469	0.998310275027893
BROWNE_HCMV_INFECTION_16HR_DN	177	Up	0.990941254488991	0.998310275027893
KYNG_RESPONSE_TO_H2O2_VIA_ERCC6_DN	77	Up	0.991113771025761	0.998310275027893
GENTILE_UV_RESPONSE_CLUSTER_D6	55	Down	0.99139170151282	0.998310275027893
RAMALHO_STEMNESS_DN	102	Down	0.991520217675147	0.998310275027893
BROWNE_HCMV_INFECTION_30MIN_DN	220	Down	0.991696987439298	0.998310275027893
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN	158	Down	0.99169815512849	0.998310275027893
FERNANDEZ_BOUND_BY_MYC	262	Down	0.991994685179307	0.998310275027893
BROWNE_HCMV_INFECTION_24HR_DN	255	Down	0.992488269796317	0.998310275027893
BASSO_B_LYMPHOCYTE_NETWORK	194	Up	0.992810964122152	0.998310275027893
WANG_THOC1_TARGETS_UP	4	Down	0.993193196950304	0.998310275027893
BERENJENO_ROCK_SIGNALING_NOT_VIA_RHOA_UP	35	Down	0.993214392177775	0.998310275027893
ZWANG_EGF_INTERVAL_UP	86	Down	0.993370635325858	0.998310275027893
WIKMAN_ASBESTOS_LUNG_CANCER_UP	21	Up	0.993391886099493	0.998310275027893
PID_AR_TF_PATHWAY	72	Up	0.99349510629972	0.998310275027893
REN_ALVEOLAR_RHABDOMYOSARCOMA_UP	113	Down	0.993959215558606	0.998310275027893
MANTOVANI_VIRAL_GPCR_SIGNALING_DN	70	Up	0.9939813154261	0.998310275027893
VERHAAK_GLIOBLASTOMA_NEURAL	148	Up	0.994067249759367	0.998310275027893
WENG_POR_TARGETS_GLOBAL_DN	53	Down	0.994083728562915	0.998310275027893
WINTER_HYPOXIA_DN	62	Up	0.994462338439389	0.998478233111089
ZHOU_INFLAMMATORY_RESPONSE_LIVE_DN	522	Up	0.995318392123144	0.998645809926043
CHOI_ATL_CHRONIC_VS_ACUTE_DN	39	Down	0.995457287666396	0.998645809926043
NIKOLSKY_BREAST_CANCER_11Q12_Q14_AMPLICON	201	Down	0.995589071056575	0.998645809926043
TOMIDA_METASTASIS_DN	29	Down	0.995729101088975	0.998645809926043
AMIT_SERUM_RESPONSE_20_MCF10A	43	Up	0.996017983723869	0.998645809926043
ZWANG_EGF_PERSISTENTLY_DN	88	Up	0.996083644500776	0.998645809926043
ZHENG_GLIOBLASTOMA_PLASTICITY_UP	361	Down	0.996242109020919	0.998645809926043
REACTOME_AKT_PHOSPHORYLATES_TARGETS_IN_THE_CYTOSOL	14	Down	0.996413741112506	0.998645809926043
RAY_TARGETS_OF_P210_BCR_ABL_FUSION_DN	24	Down	0.996552110011095	0.998645809926043
BHATI_G2M_ARREST_BY_2METHOXYESTRADIOL_UP	155	Down	0.996792295301129	0.998645809926043
NAKAMURA_CANCER_MICROENVIRONMENT_DN	68	Up	0.996954623118379	0.998645809926043
FIRESTEIN_CTNNB1_PATHWAY	62	Down	0.997221101041096	0.99870097123556
TAGHAVI_NEOPLASTIC_TRANSFORMATION	20	Up	0.997512268360743	0.998780829956793
CASORELLI_APL_SECONDARY_VS_DE_NOVO_DN	11	Up	0.998670194518362	0.999728332041691
SHIRAISHI_PLZF_TARGETS_DN	8	Up	0.998972420965564	0.999819007762993
SUZUKI_RESPONSE_TO_TSA	23	Up	0.999578155686281	0.999865916258792
BROWNE_HCMV_INFECTION_14HR_UP	243	Down	0.999638619502332	0.999865916258792
LINDGREN_BLADDER_CANCER_CLUSTER_1_UP	160	Down	0.999810013053207	0.999865916258792
BROWNE_HCMV_INFECTION_30MIN_UP	85	Down	0.999865916258792	0.999865916258792
